Sentence,class,file
Immunity 2009; 31:527-8; PMID:19833080; http://dx.doi.org/10.1016/j.immu- ni.2009.09.007.213.,OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Proc Natl Acad Sci U S A 2000; 97:12198- 203; PMID:11027314; http://dx.doi.org/10.1073/ pnas.220413497.,OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Cancer Immunol Immunother 2000; 49:517-29; PMID:11129322; http://dx.doi.org/10.1007/ s002620000145.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Int J Cancer 2000; 88:232- 8; PMID:11004674; http://dx.doi.org/10.1002/1097- 0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8.,OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Cell Immunol 1997; 182:137- 51; PMID:9514698; http://dx.doi.org/10.1006/ cimm.1997.1224.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Clin Cancer Res  2004; 10:929-37; PMID:14871969; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
J Immunother 1999;  22:155-65; PMID:10093040; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Cancer Metastasis Rev 2011; 30:61-9;  PMID:21249425; http://dx.doi.org/10.1007/s10555- 011-9273-4.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Cancer Immunol Immunother 2009; 58:1801-7;  PMID:19294381; http://dx.doi.org/10.1007/s00262- 009-0691-x.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Cancer  Sci 2011; 102:324-9; PMID:21143701; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Jpn J Clin Oncol 2006; 36:231- 6; PMID:16611662; http://dx.doi.org/10.1093/jjco/hyl005.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
Clin  Cancer Res 2006; 12:7397-405; PMID:17189412;  http://dx.doi.org/10.1158/1078-0432.CCR-06-1546.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
J Clin Oncol  2009; 27:5270-7; PMID:19752336; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/2c/onci-1-1557.PMC3525611.pdf
"1,5 CARs have  been generated against a large number of cell surface molecules,4  including CD19, HER2, GD2, prostate-specific membrane anti - gen (PSMA) and mesothelin, and many of them are presently  *Correspondence to: Michel Sadelain; Email: m-sadelain@ski.mskcc.org Submitted: 08/30/12; Revised: 10/10/12; Accepted: 10/11/12http://dx.doi.org/10.4161/onci.22524Second-generation chimeric antigen receptors (CARs) are  powerful tools to redirect antigen-specific T cells independently of HLA-restriction.",Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Cancer Cell 2003; 3:431-7; PMID:12781360;  http://dx.doi.org/10.1016/S1535-6108(03)00113-2.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Curr Opin Immunol 2010; 22:251-7;  PMID:20171074; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Curr  Opin Immunol 2009; 21:215-23; PMID:19327974; http://dx.doi.org/10.1016/j.coi.2009.02.009.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Nat Biotechnol 2002; 20:70-5; PMID:11753365;  http://dx.doi.org/10.1038/nbt0102-70.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2010; 116:4099-102;  PMID:20668228; http://dx.doi.org/10.1182/blood- 2010-04-281931.7.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Sci T ransl  Med 2011; 3:95ra73; PMID:21832238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2011; 118:4817-28;  PMID:21849486; http://dx.doi.org/10.1182/blood- 2011-04-348540.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2009; 114:2888-99;  PMID:19589923; http://dx.doi.org/10.1182/blood- 2009-01-199216.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood  2012; 119:4133-41; PMID:22354001; http://dx.doi.org/10.1182/blood-2011-12-400044.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2010; 116:3875-86;  PMID:20631379; http://dx.doi.org/10.1182/blood- 2010-01-265041.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Immunol 2010; 184:1885-96; PMID:20089697;  http://dx.doi.org/10.4049/jimmunol.0901440.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Clin Oncol 2008; 26:5233-9; PMID:18809613; http://dx.doi.org/10.1200/JCO.2008.16.5449.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Clin Oncol 2006; 24:1575- 81; PMID:16520464; http://dx.doi.org/10.1200/ JCO.2005.04.3836.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Br J Haematol 2011; 153:351-7; PMID:21371003;  http://dx.doi.org/10.1111/j.1365-2141.2011.08597.x.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Br J Haematol 2012; In Press;  PMID:22224845; http://dx.doi.org/10.1111/j.1365- 2141.2011.09000.x.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Immunol Cell  Biol 1991; 69:411-22; PMID:1725979; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Neoplasia 1999; 1:123-7; PMID:10933046;  http://dx.doi.org/10.1038/sj.neo.7900018.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Mol Ther 2010; 18:413-20; PMID:19773745; http://dx.doi.org/10.1038/mt.2009.210.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Proc Natl Acad Sci U S A 2009; 106:3360- 5; PMID:19211796; http://dx.doi.org/10.1073/ pnas.0813101106.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2012; 119:696-706; PMID:22117050;  http://dx.doi.org/10.1182/blood-2011-03-344275.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Hum Gene  Ther 2010; 21:75-86; PMID:19719389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Mol Ther 2005; 12:933-41; PMID:15979412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Nat Med  2007; 13:1440-9; PMID:18026115; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Hum Gene Ther 2007; 18:712-25; PMID:17685852;  http://dx.doi.org/10.1089/hum.2007.028.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Immunol 2009; 183:5563-74; PMID:19843940; http://dx.doi.org/10.4049/jimmu- nol.0900447.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Leukemia  2004; 18:676-84; PMID:14961035; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood 2012; 119:3940-50;  PMID:22308288; http://dx.doi.org/10.1182/blood- 2011-10-387969.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Sci T ransl Med 2012; 4:132ra53; PMID:22553251; http://dx.doi.org/10.1126/scitrans- lmed.3003761.10.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Immunity 1996; 5:527-35;  PMID:8986713; http://dx.doi.org/10.1016/S1074- 7613(00)80268-X.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Exp Med  1993; 178:951-60; PMID:8350062; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Nat Med 2003; 9:279-86; PMID:12579196; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Clin Cancer Res 2007; 13:5426-35; PMID:17855649;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0674.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Mol Ther 2009; 17:1453-64; PMID:19384291;  http://dx.doi.org/10.1038/mt.2009.83.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Cancer  Res 2006; 66:10995-1004; PMID:17108138; http://dx.doi.org/10.1158/0008-5472.CAN-06-0160.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Blood  2003; 101:1637-44; PMID:12393484; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Mol  Ther 2011; 19:432-8; PMID:21358705; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
Biol Blood Marrow T ransplant 2010; 16:1245-56;  PMID:20304086; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Clin Invest 2011; 121:1822-6; PMID:21540550; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
J Exp Med 1995; 181:1653- 9; PMID:7722445; http://dx.doi.org/10.1084/ jem.181.5.1653.,Non-OADS,/arxiv_data1/oa_pdf/4e/b8/onci-1-1577.PMC3525612.pdf
"The topical or intratumoral administration of DC-activating agents—including interferon α (IFN α), bacillus Calmette-Guérin (BCG), or puri - fied Toll-like receptor (TLR) ligands such as imiquimod—are  *Correspondence to: Edith M. Janssen; Email: edith.janssen@cchmc.org Submitted: 09/12/12; Revised: 10/24/12; Accepted: 10/24/12http://dx.doi.org/10.4161/onci.22660The infiltration of melanoma lesions by dendritic cells (DCs) has  been suggested to play a tumorigenic role due to the capacity of DCs to induce tumor tolerance and promote angiogenesis as  well as metastasis.",Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunotherapy  2011; 3:653-71; PMID:21554094; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Am Acad Dermatol 2011; 64:413- 22; PMID:20334952; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunotherapy 2011; 3:673-90; PMID:21554095;  http://dx.doi.org/10.2217/imt.11.45.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Clin Cancer Res 2008; 14:4532-42;  PMID:18628468; http://dx.doi.org/10.1158/1078-0432.CCR-07-4711.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
"CA Cancer J Clin 2000; 50:215-36, quiz 237-40; PMID:10986965; http://dx.doi.org/10.3322/ canjclin.50.4.215.",OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J  Exp Med 1999; 189:1981-6; PMID:10377194; http://dx.doi.org/10.1084/jem.189.12.1981.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Blood 2002; 100:3175-82;  PMID:12384415; http://dx.doi.org/10.1182/blood- 2001-12-0207.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Clin Cancer Res  2009; 15:3277-86; PMID:19447870; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nature 2010; 466:133-7; PMID:20596026;  http://dx.doi.org/10.1038/nature09161.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Oncoimmunology  2012; 1:539-40; PMID:22754779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Int J Dermatol  1975; 14:3-11; PMID:1092622; http://dx.doi.org/10.1111/j.1365-4362.1975.tb00071.x.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Pigment Cell Melanoma Res  2010; 23:853-9; PMID:20973935; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Chin J Cancer 2011; 30:153-62; PMID:21352692;  http://dx.doi.org/10.5732/cjc.011.10007.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:45-54;  PMID:20193011; http://dx.doi.org/10.1111/j.0105- 2896.2009.00879.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:5-17;  PMID:20193008; http://dx.doi.org/10.1111/j.0105- 2896.2009.00888.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:55-75;  PMID:20193012; http://dx.doi.org/10.1111/j.0105- 2896.2009.00885.x.23.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2011; 241:206-27; PMID:21488899; http://dx.doi.org/10.1111/ j.1600-065X.2011.01015.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:317-34; PMID:20193028; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Immunol  Immunother 2007; 56:1459-69; PMID:17279413;  http://dx.doi.org/10.1007/s00262-007-0286-3.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res 2004; 64:2192-8; PMID:15026362;  http://dx.doi.org/10.1158/0008-5472.CAN-03-2969.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res 2011; 71:5601-5; PMID:21846822; http://dx.doi.org/10.1158/0008-5472.CAN-11-1316.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res 2012; 72:1070-80;  PMID:22266112; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3218.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer 2012; 118:2476- 85; PMID:21953023; http://dx.doi.org/10.1002/ cncr.26511.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Exp Med  2010; 207:1261-71; PMID:20479117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Contact Dermatitis 2009; 60:2-20; PMID:19125717;  http://dx.doi.org/10.1111/j.1600-0536.2008.01443.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Annu Rev Immunol 2012; 30:491-529;  PMID:22224766; http://dx.doi.org/10.1146/annurev-immunol-031210-101352.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J  Pathol 2003; 200:255-68; PMID:12754747; http://dx.doi.org/10.1002/path.1344.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
PLoS  One 2011; 6:e17515; PMID:21390236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Clin Cancer Res 2009; 15:4382-90; PMID:19549770; http://dx.doi.org/10.1158/1078- 0432.CCR-09-0399.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2009; 182:2726-37;  PMID:19234167; http://dx.doi.org/10.4049/jimmu- nol.0803479.47.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2010; 185:1999-2003;  PMID:20644171; http://dx.doi.org/10.4049/jimmu- nol.1001398.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2010; 185:3337-47; PMID:20720209;  http://dx.doi.org/10.4049/jimmunol.1001619.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2009; 182:4200-7; PMID:19299718; http://dx.doi.org/10.4049/jim- munol.0802286.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:259-67; PMID:20193024; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Exp Med  2009; 206:3115-30; PMID:20008528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:120-41;  PMID:20193016; http://dx.doi.org/10.1111/j.0105- 2896.2009.00886.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
T rends Immunol 2010; 31:446- 51; PMID:21035396; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Exp Med 2010; 207:189-206; PMID:20038600;  http://dx.doi.org/10.1084/jem.20091964.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Immunol 2009; 10:488-95; PMID:19349986; http://dx.doi.org/10.1038/ni.1724.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Eur J Immunol  2001; 31:3388-93; PMID:11745357; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunity  2007; 27:481-92; PMID:17869134; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Exp Med 2010; 207:1283-92; PMID:20479118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Cell Biol 2005; 83:451-61;  PMID:16174093; http://dx.doi.org/10.1111/j.1440- 1711.2005.01371.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Res 2010; 46:165-76;  PMID:19756409; http://dx.doi.org/10.1007/s12026- 009-8118-5.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Oncol 2010;  2010:201026; PMID:20490273; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Br J Cancer 2005; 92:1182- 7; PMID:15785750; http://dx.doi.org/10.1038/sj.bjc.6602476.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Scand J Immunol 2007; 65:329-35; PMID:17386023;  http://dx.doi.org/10.1111/j.1365-3083.2007.01903.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev  2010; 234:177-98; PMID:20193019; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Mol Immunol 2010; 47:1765-73; PMID:20347150; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Exp Med 2012; 209:1053-6; PMID:22665701; http://dx.doi.org/10.1084/ jem.20121038.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Eur J Immunol 2003; 33:827- 33; PMID:12672047; http://dx.doi.org/10.1002/ eji.200323797.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunity  2008; 29:352-61; PMID:18799143; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Immunol Rev 2010; 234:18-31; PMID:20193009;  http://dx.doi.org/10.1111/j.0105-2896.2009.00870.x.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Rev Drug Discov 2012; 11:503-5; PMID:22743965;  http://dx.doi.org/10.1038/nrd3775.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Mater 2009; 8:151-8;  PMID:19136947; http://dx.doi.org/10.1038/ nmat2357.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Sci T ransl Med 2009; 1:8ra19;  PMID:20368186; http://dx.doi.org/10.1126/scitrans- lmed.3000359.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Eur J Immunol 2003; 33:1052-62; PMID:12672071;  http://dx.doi.org/10.1002/eji.200323676.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Invest Dermatol 2010; 130:1646-56; PMID:20220766; http://dx.doi.org/10.1038/ jid.2010.24.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
OncoImmunology 2012;  1:829-39; http://dx.doi.org/10.4161/onci.20492.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res  2010; 70:5549-57; PMID:20516123; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Oncogene 1998; 17:1885- 8; PMID:9778055; http://dx.doi.org/10.1038/ sj.onc.1202077.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Metastasis  Rev 2006; 25:333-56; PMID:17029028; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Biochem J 2008; 409:635- 49; PMID:18177271; http://dx.doi.org/10.1042/ BJ20071493.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Semin Cancer Biol  2012; 22:319-26; PMID:22349515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Med 2010; 16:880- 6; PMID:20622859; http://dx.doi.org/10.1038/nm.2172.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Med 2010; 16:98- 105; PMID:20037595; http://dx.doi.org/10.1038/ nm.2074.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res 2009; 69:3086-94;  PMID:19293186; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2826.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer  Res 2010; 70:89-98; PMID:19996282; http://dx.doi.org/10.1158/0008-5472.CAN-09-2970.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Clin Cancer Res 2006; 12:2826-33; PMID:16675577;  http://dx.doi.org/10.1158/1078-0432.CCR-05-2431.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res 2004; 64:8456-60;  PMID:15548718; http://dx.doi.org/10.1158/0008-5472.CAN-03-3251.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Clin Oncol 2008; 26:3445-55; PMID:18612161; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Immunol  Immunother 2004; 53:17-25; PMID:12955480;  http://dx.doi.org/10.1007/s00262-003-0417-4.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Med  2007; 13:552-9; PMID:17479101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Immunol Immunother 2008; 57:1665-73;  PMID:18311487; http://dx.doi.org/10.1007/s00262- 008-0487-4.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2011; 186:5058-67;  PMID:21430223; http://dx.doi.org/10.4049/jimmu- nol.1004125.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Semin Cancer Biol 2004; 14:161-9;  PMID:15246051; http://dx.doi.org/10.1016/j.sem-cancer.2003.10.002.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol 2010; 184:1261-7; PMID:20026742; http://dx.doi.org/10.4049/jimmu- nol.0903050.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
FASEB J 2010; 24:1411- 8; PMID:20008545; http://dx.doi.org/10.1096/fj.09- 147025.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Med 2004; 10:950-8;  PMID:15334073; http://dx.doi.org/10.1038/nm1097.,OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Cancer Res  2008; 68:7684-91; PMID:18768667; http://dx.doi.org/10.1158/0008-5472.CAN-08-1167.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Melanoma Res 2007; 17:169-76; PMID:17505262;  http://dx.doi.org/10.1097/CMR.0b013e3281844531.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol Methods 2006; 310:12- 9; PMID:16510151; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
J Immunol  2011; 186:6905-13; PMID:21551365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Am J Pathol 2004; 165:1853-63;  PMID:15579430; http://dx.doi.org/10.1016/S0002-9440(10)63238-5.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
Nat Immunol  2012; 13:832-42; PMID:22842346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/0d/onci-1-1584.PMC3525613.pdf
"OncoImmunology 1:9, 1594–1597; December 2012; © 2012 Landes Bioscience Aut OphA gIc punctum 1594 OncoImmunology Volume 1 Issue 9Keywords:  NFκB, immune response,  senescence, Fas, SASP Submitted: 09/21/12Revised: 10/09/12Accepted: 10/11/12http://dx.doi.org/10.4161/onci.22525 Correspondence to: Raffaele De Palma   and Antonio Leonardi;   Email: raffaele.depalma@unina2.it  and leonardi@unina.itThe induction of senescence in tumor  cells impairs transformation and  promotes an anticancer immune response resulting from the production by senes - cent cells of cytokines and chemokines, an aspect known as “senescence-associ - ated secretory phenotype” (SASP).",Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/nature02118.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
EMBO J 2012; 31:2839-51; PMID:22569128; http://dx.doi.org/10.1038/ emboj.2012.132.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Annu Rev Pathol  2010; 5:99-118; PMID:20078217; http://dx.doi.org/10.1146/annurev-pathol-121808-102144.5.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Curr Opin Cell Biol  2008; 20:150-5; PMID:18353625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Cell 2002; 109:335-46;  PMID:12015983; http://dx.doi.org/10.1016/S0092- 8674(02)00734-1.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Cell 2008; 133:1019-31; PMID:18555778; http://dx.doi.org/10.1016/j.cell.2008.03.039.9.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Cell  2008; 133:1006-18; PMID:18555777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Cell 2008; 134:657- 67; PMID:18724938; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Nature  2007; 445:661-5; PMID:17251932; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Nature 2007; 445:656- 60; PMID:17251933; http://dx.doi.org/10.1038/ nature05529.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Blood 2009; 113:3503-11; PMID:19098271; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Oncogene 2011; 30:2707-17; PMID:21278794;  http://dx.doi.org/10.1038/onc.2011.1.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
J Exp Med 1999; 189:999- 1004; PMID:10075983; http://dx.doi.org/10.1084/ jem.189.6.999.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
J Cell Sci 2007; 120:4126- 33; PMID:18003704; http://dx.doi.org/10.1242/ jcs.009761.19.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
J Biol Chem 2000; 275:6421- 7; PMID:10692445; http://dx.doi.org/10.1074/ jbc.275.9.6421.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
EMBO J  2011; 30:1536-48; PMID:21399611; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Mol Biol Cell 2005; 16:943-53; PMID:15574883;  http://dx.doi.org/10.1091/mbc.E04-05-0392.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Genes Dev  2007; 21:3244-57; PMID:18055696; http://dx.doi.org/10.1101/gad.1588507.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
J Cell Physiol 2009; 218:215-27; PMID:18803232; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Oncogene 2011; 30:2356-66; PMID:21242976; http://dx.doi.org/10.1038/ onc.2010.611.25.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
EMBO Rep 2009; 10:1272-8; PMID:19779484; http://dx.doi.org/10.1038/ embor.2009.197.,Non-OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
Cell 2011; 145:92- 103; PMID:21458669; http://dx.doi.org/10.1016/j.cell.2011.02.023.,OADS,/arxiv_data1/oa_pdf/2e/9b/onci-1-1594.PMC3525614.pdf
"5  It is however not clear if vaccine-induced Killing from within John B. Mumm,1 Jan e mmerich2 and Martin Oft1,* 1targenics; s an Francisco, CA us A; 2triMod t herapeutics; Dublin, Ireland Keywords:  CD8 T cells, IL-10, cytotoxicity, intratumoral, tumor immune surveillance, cytokine therapy *Correspondence to: Martin Oft; Email: martinoft@gmail.com Submitted: 06/22/12; Accepted: 07/10/12http://dx.doi.org/10.4161/onci.21423tumor-specific T cells can infiltrate the  tumor tissue nor if they maintain an activ - ity once inside the tumor.6 The identifi - cation of therapies that activate tumor specific CD8 + CTLs within the tumor  mass in the absence of severe peripheral toxicity has been challenging.",Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Cancer Cell 2011; 20:781- 96; PMID:22172723; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Clin Cancer Res 2011; 17:861-70; PMID:21163871;  http://dx.doi.org/10.1158/1078-0432.CCR-10-1811.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
J Natl Cancer Inst 2012;  104:599-613; PMID:22395641; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Annu Rev Immunol 2001; 19:683-765;  PMID:11244051; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Nat Rev Cancer 2012; 12:298-306;  PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Curr Opin Immunol 1997; 9:684-93;  PMID:9368778; http://dx.doi.org/10.1016/S0952- 7915(97)80050-7.,Non-OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
T rends Immunol 2007; 28:207-12; PMID:17395538;  http://dx.doi.org/10.1016/j.it.2007.03.006.,OADS,/arxiv_data1/oa_pdf/24/e6/onci-1-1598.PMC3525615.pdf
"We found that these cells, but Surviving host innate immunity Cancer cells can turn a deadly assault into an advantage Pnina Brodt Departments of s urgery; Medicine and Oncology; McGill u niversity; Montreal, Canada Keywords:  TNF, IGF, IL-6, liver metastasis, inflammation, apoptosis, survival, STAT3 Correspondence to: Pnina Brodt; Email: pnina.brodt@mcgill.ca Submitted: 07/03/12; Accepted: 07/10/12http://dx.doi.org/10.4161/onci.21424not poorly metastatic counterparts, can  be rescued from apoptosis in the presence of high TNF α concentrations, due to a  marked increase in IL-6 production that ensues the TNF α-induced activation of  NFκB.",Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
World J Gastroenterol 2009; 15:61- 6; PMID:19115469; http://dx.doi.org/10.3748/ wjg.15.61.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
Cancer Res 2012;  72:865-75; PMID:22194466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
J Leukoc Biol 2006; 80:227-36; PMID:16707558;  http://dx.doi.org/10.1189/jlb.1105674.,OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
Am J Pathol 2007; 170:1781- 92; PMID:17456781; http://dx.doi.org/10.2353/ ajpath.2007.060886.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
Eur J Cancer 2010; 46:1223- 31; PMID:20335016; http://dx.doi.org/10.1016/j.ejca.2010.02.026.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
J Clin Oncol  2012; 30:1005-14; PMID:22355058; http://dx.doi.org/10.1200/JCO.2010.31.8907.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
Immunol Rev 2011; 244:29-43; PMID:22017429; http://dx.doi.org/10.1111/j.1600- 065X.2011.01060.x.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/onci-1-1601.PMC3525616.pdf
"Keywords:  CD27, regulatory T cells, leukemia stem cell, cancer, tumor-infiltrating lymphocytes *Correspondence to: Adrian F. Ochsenbein; Email: adrian.ochsenbein@insel.ch Submitted: 07/06/12; Accepted: 07/10/12http://dx.doi.org/10.4161/onci.21425of secondary lymphoid organ architecture.",Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
Nature 2001; 411:1058-64; PMID:11429607;  http://dx.doi.org/10.1038/35082583.,OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
J Clin Invest  2012; 122:624-38; PMID:22232214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
Blood 2007; 109:4810-5; PMID:17311995;  http://dx.doi.org/10.1182/blood-2006-11-057216.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
J  Immunother 2010; 33:769-79; PMID:20842060;  http://dx.doi.org/10.1097/CJI.0b013e3181ee238f.References 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
Curr Opin Immunol  2005; 17:275-81; PMID:15886117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
Immunol Rev 2009; 229:216-31; PMID:19426224;  http://dx.doi.org/10.1111/j.1600-065X.2009.00774.x.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
J Exp Med 2006;  203:2145-55; PMID:16923852; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
Blood 2007; 110:2537-44;  PMID:17615291; http://dx.doi.org/10.1182/blood-2007-03-082578.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/onci-1-1604.PMC3525617.pdf
"1,3 Remarkably, most immu - nosuppressive factors that are produced in the tumor microenvironment, such as transforming growth factor β (TGF β),  indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE 2), also proved Melanoma immunoediting by NK cells Mirna Balsamo,1 Gabriella Pietra,1 william Vermi,2 Lorenzo Moretta,3 Maria Cristina Mingari1,4,5 and Massimo Vitale5,* 1Dipartimento di Medicina s perimentale; u niversità di Genova; Genova, Italy; 2servizio di Anatomia Patologica; s pedali Civili di Brescia; Brescia, Italy; 3Istituto Giannina Gaslini;  Genova, Italy; 4Centro di e ccellenza per la r icerca Biomedica; Genova, Italy; 5IrCCs Azienda Ospedaliera u niversitaria s an Martino—I st, Istituto Nazionale per la r icerca sul  Cancro, Genova, Italy Keywords:  Cytokines, HLA-I, immunoediting, melanoma, NK cells *Correspondence to: Massimo Vitale; Email: massimo.vitale@istge.it Submitted: 07/10/12; Accepted: 07/11/12http://dx.doi.org/10.4161/onci.21456effective in inhibiting natural killer (NK)  cell function, through the downregulation of several activating NK receptors that contribute to tumor-cell recognition and killing.",Non-OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Nat Rev Immunol 2006; 6:715-27;  PMID:16977338; http://dx.doi.org/10.1038/nri1936.,Non-OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Cancer Res  2012; 72:1407-15; PMID:22258454; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Proc Natl Acad Sci U S A 2009;  106:20847-52; PMID:19934056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Blood  2011; 117:764-71; PMID:20889923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Blood  2008; 111:4862-70; PMID:18334671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324.,Non-OADS,/arxiv_data1/oa_pdf/57/85/onci-1-1607.PMC3525618.pdf
"Keywords:  radiotherapy, mouse, dendritic cells, human, CD8 T cells *Correspondence to: Maries van den Broek; Email: maries@van-den-broek.ch Submitted: 07/06/12; Accepted: 07/13/12http://dx.doi.org/10.4161/onci.21478of Coley’s toxin—a mixture of heat-killed  Streptococcus pyogenes  and Serratia marces - cens that was used by William Coley in the  19th century to treat cancer patients6— may also result from the activation of DCs, which obviously was not appreciated at that time.",Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
Nat  Immunol 2005; 6:280-6; http://dx.doi.org/10.1038/ ni1165; PMID:15685176.,Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
Science 2011; 331:1565-70; http://dx.doi.org/10.1126/science.1203486;  PMID:21436444.,OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
Proc Natl  Acad Sci U S A 2010; 107:199-203; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
J Immunol 2012; 189:558-66;  http://dx.doi.org/10.4049/jimmunol.1200563;  PMID:22685313.,Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
Semin  Immunol 2011; 23:42-9; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
Cancer Res  2011; 71:2488-96; http://dx.doi.org/10.1158/0008-5472.CAN-10-2820; PMID:21300764.9.,Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
J Exp Med  2011; 208:2005-16; http://dx.doi.org/10.1084/ jem.20101159; PMID:21930765.,OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
PLoS One 2011; 6:e28217; http://dx.doi.org/10.1371/ journal.pone.0028217; PMID:22140550.,Non-OADS,/arxiv_data1/oa_pdf/d1/4a/onci-1-1610.PMC3525619.pdf
"Analyzing cell signaling pathways  recurrently altered by gene mutations and/or homozygous deletions in tumors, we identified several signaling pathways Next-generation sequencing identified   new oncogenes and tumor suppressor genes   in human hepatic tumors Giuliana Amaddeo,1,2 Cécile Guichard,1,2 sandrine Imbeaud1,2 and Jessica Zucman- rossi1,2,3,* 1INserM u Mr-674; Génomique Fonctionnelle des t umeurs s olides; I uh; Paris, France; 2université Paris Descartes; Labex Immuno-Oncology; Faculté de Médecine;   sorbonne Paris Cité; Paris, France; 3Assistance Publique- hôpitaux de Paris; h opital e uropeen Georges Pompidou; Paris, France Keywords:  hepatocellular carcinoma, exome sequencing, oncogene, tumor suppressor gene, IRF2 *Correspondence to: Jessica Zucman-Rossi; Email: Jessica.zucman-rossi@inserm.fr Submitted: 07/10/12; Accepted: 07/13/12http://dx.doi.org/10.4161/onci.21480(Fig.",Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Semin Liver Dis 2011;  31:173-87; PMID:21538283; http://dx.doi.org/10.1055/s-0031-1276646.,Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Nature 2009; 457:200-4; PMID:19020503;  http://dx.doi.org/10.1038/nature07475.,Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
J Biol Chem 2007; 282:14437- 46; PMID:17379603; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Annu Rev Immunol 2008; 26:535-84;  PMID:18303999; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Biochem J 2009; 418:575-85; PMID:19032150;  http://dx.doi.org/10.1042/BJ20082087.,Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Hepatology 2007; 45:42- 52; PMID:17187432; http://dx.doi.org/10.1002/hep.21467.,Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
Nat Genet 2012; 44:760-4; PMID:22634756;  http://dx.doi.org/10.1038/ng.2291.,OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
"Carcinogenesis 2001; 22:367-74; PMID:11238174;  http://dx.doi.org/10.1093/carcin/22.3.367.series of 125 HCCs, we identified a sig - nificant association between mutations  in ARID1A , RPSK6KA3  or NFE2L2  and  mutations in CTNNB1  or AXIN1 , sug - gesting that the Wnt/ β-catenin signal - ing might cooperate with either oxidative stress responses, chromatin remodeling and the RAS/MAPK pathway to promote liver carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/ee/da/onci-1-1612.PMC3525620.pdf
"Thus, the devel - opment of immunotherapeutic strategies Immunotherapy of acute myeloid leukemia   based on γδ T cells Julie Gertner-Dardenne,1,2,3,* Cyril Fauriat,2 Norbert Vey4 and Daniel Olive1,2,3 1Aix-Marseille u niversité; Marseille, France; 2Institut National de la s anté et de la r echerche Médicale; Centre de r echerche en Cancérologie de Marseille; Marseille, France;  3Institut Paoli Calmettes; IBi sA Cancer Immunomonitoring Platform; Marseille, France; 4Institut Paoli-Calmettes; s ervice d’ hématologie; Marseille, France Keywords:  acute myeloid leukemia, antitumor immunity, γδ  T cells, immunosurveillance *Correspondence to: Julie Gertner-Dardenne; Email: j.gertner-dardenne@hotmail.fr Submitted: 07/16/12; Accepted: 07/17/12http://dx.doi.org/10.4161/onci.21512that would be applicable to all patients  appears highly desirable.",Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
J Immunol 2012; 188:4701- 8; PMID:22467661; http://dx.doi.org/10.4049/jim- munol.1103710.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
Blood  2009; 114:3909-16; PMID:19710498; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
Eur J Immunol  2009; 39:1361-8; PMID:19404979; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
Blood 2009; 113:4875-84;  PMID:19278954; http://dx.doi.org/10.1182/blood- 2008-08-172296.8.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
J Immunol  2010; 184:3260-8; PMID:20154204; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
PLoS One  2011; 6:e16700; PMID:21304898; http://dx.doi.org/10.1371/journal.pone.0016700.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
Bone Marrow T ransplant  2001; 27:601-6; PMID:11319589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/12/onci-1-1614.PMC3525621.pdf
"Yann Godet,1,2,3 Magalie Dosset,1,2,3 Christophe Borg1,2,3,4 and Olivier Adotevi1,2,3,4,* 1INserM; u nité Mixte de r echerche; Besançon, France; 2etablissement Français du s ang de Bourgogne Franche-Comté; Besançon, France; 3université de Franche-Comté;  Besançon, France; 4Chru  de Besançon, s ervice d’Oncologie; Besançon, France Keywords:  telomerase, immunomonitoring, models of immunochemotherapy and immunoradiotherapy, new targets *Correspondence to: Olivier Adotevi; Email: olivier.adotevi@univ-fcomte.fr Submitted: 07/14/12; Accepted: 07/17/12http://dx.doi.org/10.4161/onci.21513types of cancer.5 The naturally occurring  UCP-specific CD4+ T-cell response was  studied in non-small cell lung carcinoma  (NSCLC) patients using an interferon γ (IFNγ)-specific ELISPOT assay.",Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Immunol Rev  2008; 222:129-44; PMID:18363998; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Nat Rev Cancer 2012; 12:298-306;  PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688;  http://dx.doi.org/10.1038/nrclinonc.2010.223.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Clin  Cancer Res 2012; 18:2943-53; PMID:22407833;  http://dx.doi.org/10.1158/1078-0432.CCR-11-3185.with the blockade of the PD1 pathway.10  The use of antibodies that alleviate the  inhibition of antitumor T-cell responses clearly require the presence of spontaneous antitumor immunity prior to treatment.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690.9.,OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Clin Cancer Res 2012; 18:2326-35;  PMID:22355009; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2515.6.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Nat  Rev Immunol 2008; 8:59-73; PMID:18097448;  http://dx.doi.org/10.1038/nri2216.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
J Clin Oncol 2012; 30:1835-41; PMID:22529253;  http://dx.doi.org/10.1200/JCO.2011.40.2271.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
Blood 2008; 111:5342-9;  PMID:18326818; http://dx.doi.org/10.1182/blood- 2007-12-128397.,Non-OADS,/arxiv_data1/oa_pdf/85/08/onci-1-1617.PMC3525622.pdf
"This strategy would add up to local Antigen shedding into the circulation contributes  to tumor immune escape Bastian h öchst and Linda Diehl* Institutes of Molecular Medicine and e xperimental Immunology; u niversity of Bonn; Bonn, Germany Keywords:  B7H1, CD8+ T cells, CEA, circulating antigen, liver sinusoidal endothelial cells, tumor immune escape Abbreviations:  CEA, carcinoembryonic antigen; LSECs, liver sinusoidal endothelial cells *Correspondence to: Linda Diehl; Email: linda.diehl@ukb.uni-bonn.de Submitted: 07/14/12; Accepted: 07/17/12http://dx.doi.org/10.4161/onci.21514immunosuppressive mechanisms engaged  by tumor cells following the interaction with immune cells in their close proximity.",Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Immunol Rev  2006; 213:131-45; PMID:16972901; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Cancer Invest 2005; 23:338-51; PMID:16100946; http://dx.doi.org/10.1081/CNV- 58878.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Hepatology  2012; •••: http://dx.doi.org/10.1002/hep.25844;  PMID:22610745.5.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Hepatology  2008; 47:296-305; PMID:17975811; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Gastroenterology 2008; 134:1927-37;  PMID:18549878; http://dx.doi.org/10.1053/j.gas- tro.2008.02.033.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
Hepatology 2009; 50:1904- 13; PMID:19787806; http://dx.doi.org/10.1002/ hep.23191.7.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690.,OADS,/arxiv_data1/oa_pdf/9b/42/onci-1-1620.PMC3525623.pdf
"Nelson1,2,3, 1trev and Joyce Deeley r esearch Centre; BC Cancer Agency; Victoria, BC Canada; 2Department of Medical Genetics; u niversity of British Columbia; Vancouver, BC Canada;  3Department of Biochemistry and Microbiology; u niversity of Victorial; Victoria, BC Canada Keywords:  antigen-presenting cells, B cells, ovarian cancer, T cells, tumor-infiltrating lymphocytes *Correspondence to: Julie S. Nielsen; Email: jnielsen@bccancer.bc.ca Submitted: 07/19/12; Accepted: 07/26/12http://dx.doi.org/10.4161/onci.21650have been reported in breast and germ cell  tumors.2 Thus, CD20+ TILs have hall - marks of antigen-experienced, clonally expanded B cells.",Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
Oncogene 2010; 29:1093- 102; PMID:19946335; http://dx.doi.org/10.1038/ onc.2009.416.,Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
J Immunol 2010; 185:4977-82;  PMID:20962266; http://dx.doi.org/10.4049/jimmu- nol.1001323.,Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
"Int J Cancer 2003; 104:73-84; PMID:12532422;  http://dx.doi.org/10.1002/ijc.10900.cell depletion with rituximab disrupts  T-cell infiltrates in affected tissues.9  Third, B cells can produce cytokines that polarize T cells toward Th1, Th2 and maybe other functional phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
Immunol Rev  2008; 223:284-99; PMID:18613843; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
Annu Rev Immunol  2006; 24:467-96; PMID:16551256; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/43/onci-1-1623.PMC3525624.pdf
"The sys - temic administration of cytokines such as interleukin (IL)-12, IL-15, granulocyte Chemoimmunotherapy for advanced  gastrointestinal carcinomas A successful combination of gene therapy   and cyclophosphamide Mariana Malvicini,1 Flavia Piccioni,1 Juan Bayo,1 esteban Fiore,1 Catalina Atorrasagasti,1 Laura Alaniz,1 Mariana García,1   Jorge B. Aquino,1 Manuel Gidekel,4 Pablo Matar2,3 and Guillermo Mazzolini1,3,* 1Gene t herapy Laboratory; Liver u nit; s chool of Medicine; Austral u niversity; Buenos Aires, Argentina; 2Institute of e xperimental Genetics; s chool of Medical s ciences;  National u niversity of rosario; rosario, Argentina; 3CONIC et (Consejo Nacional de Investigaciones Científicas y t écnicas); Buenos Aires, Argentina;   4universidad de la Frontera; t emuco, Chile Keywords:  advanced gastrointestinal carcinomas, cyclophosphamide, gene therapy, immunomodulation, interleukin-12 *Correspondence to: Guillermo Mazzolini; Email: gmazzoli@cas.austral.edu.ar Submitted: 07/21/12; Accepted: 07/26/12http://dx.doi.org/10.4161/onci.21651macrophage colony-stimulating factor  (GM-CSF) and tumor necrosis factor α  (TNF α) has been shown to be efficient  in generating immunity against many tumors, although it is frequently associ - ated with toxicity.",Non-OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Expert Opin Biol Ther  2008; 8:385-95; PMID:18352844; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Cancer Immunol Immunother 2011; 60:1161-71;  PMID:21626032; http://dx.doi.org/10.1007/s00262- 011-1012-8.,Non-OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Nat Rev Cancer 2004; 4:11-22;  PMID:14708024; http://dx.doi.org/10.1038/nrc1252.5.,Non-OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Nat Immunol  2008; 9:239-44; PMID:18285775; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
Mol Ther 2011; 19:1737- 46; PMID:21673660; http://dx.doi.org/10.1038/ mt.2011.113.,Non-OADS,/arxiv_data1/oa_pdf/34/ac/onci-1-1626.PMC3525625.pdf
"Johnstone2,4 and Nicole M. h aynes2,4,* 1Division of Cell Biology II; t he Netherlands Cancer Institute; Amsterdam, t he Netherlands; 2Cancer t herapeutics Program; s ir Donald and Lady t rescowthick Laboratories;  Peter MacCallum Cancer Centre; e ast Melbourne, VIC Australia; 3Cancer Immunology Program; s ir Donald and Lady t rescowthick Laboratories; Peter MacCallum Cancer Centre;  east Melbourne, VIC Australia; 4sir Peter MacCallum Department of Oncology; u niversity of Melbourne; Parkville, VIC Australia Keywords:  breast cancer, CD137, CD40, immunotherapy, PD-1, radiotherapy, T cells Abbreviations:  APC, antigen-presenting cell; DC, dendritic cell; IL, interleukin; mAb, monoclonal antibody; MHC, Major  histocompatibility complex; PD-(L)1, programmed death (ligand) 1 *Correspondence to: Inge Verbrugge and Nicole M. Haynes; Email: i.verbrugge@nki.nl and nicole.haynes@petermac.org Submitted: 07/24/12; Accepted: 07/26/12http://dx.doi.org/10.4161/onci.21652combinatorial immunotherapy may  constitute a promising approach.",Non-OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
J  Mammary Gland Biol Neoplasia 2010; 15:411-21;  PMID:21161342; http://dx.doi.org/10.1007/s10911- 010-9194-9.,Non-OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
Cancer J 2011; 17:351-8; PMID:21952286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
N Engl J Med  2012; 366:925-31; PMID:22397654; http://dx.doi.org/10.1056/NEJMoa1112824.4.,OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
J Immunol 2011; 187:1634-42;  PMID:21742975; http://dx.doi.org/10.4049/jimmu- nol.1100077.,Non-OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
Nat Med 2006; 12:693-8; PMID:16680149; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b0/onci-1-1629.PMC3525626.pdf
"Thus, the formation of complexes with DAMPs enables nucleic acids to gain access to the endosomal compartment, in Regulatory mechanisms of nucleic   acid-mediated innate immune responses in the  tumor microenvironment Masahisa Jinushi research Center for Infection-Associated Cancer; Institute for Genetic Medicine; h okkaido u niversity; s apporo, Japan Keywords:  dendritic cells, HMGB1, innate immunity, nucleic acids, TIM-3 Abbreviations:  DAMPs, danger-associated molecular patterns; DC, dendritic cells; HMGB1, high mobility group box 1; TIM-3, T  cell-immunoglobulin mucin protein 3; TLRs, Toll-like receptors Correspondence to: Masahisa Jinushi; Email: jinushi@igm.hokudai.ac.jp Submitted: 07/26/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21681which receptors from the innate immune  system recognize nucleic acids and orches - trate proinflammatory responses.3 In addi - tion, recent studies reveal that exogenous nucleic acids mediate immunogenic activi - ties by interacting with pattern recogni - tion systems.",OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Cell 2010; 140:805-20;  PMID:20303872; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Immunity 2010; 32:305-15; PMID:20346772; http://dx.doi.org/10.1016/j.immuni.2010.03.012.,OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Nat Rev Immunol 2012; 12:479-91; PMID:22728526; http://dx.doi.org/10.1038/nri3247.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Nat Med 2011; 17:996-1002; PMID:21765404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Annu  Rev Immunol 2011; 29:139-62; PMID:21219181;  http://dx.doi.org/10.1146/annurev-immu- nol-030409-101323.9.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Nature 2009; 462:99-103;  PMID:19890330; http://dx.doi.org/10.1038/ nature08512.6.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
Nat Immunol 2012;  PMID:22842346; http://dx.doi.org/10.1038/ni.2376.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/onci-1-1632.PMC3525627.pdf
"Conversely, DCs that, upon antigen uptake, undergo maturation, upregulate MHC Class I In vivo evidence for dendritic cell lysis by NK cells Hints on improving cancer vaccines by targeting NK cell  activation Guido Ferlazzo Laboratory of Immunology and Biotherapy; Department of h uman Pathology; u niversity of Messina; Messina, Italy Keywords:  Cancer vaccines, cytotoxic T lymphocytes, dendritic cells, natural killer cells, lymph nodes, perforin Correspondence to: Guido Ferlazzo; Email: guido.ferlazzo@unime.it Submitted: 07/27/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21682expression and become resistant to NK  cells.1 During the process of maturation,  DCs not only upregulate MHC mole - cules but also chemokine receptors, such as CCR7, and co-stimulatory molecules.",Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
J Exp Med  2002; 195:343-51; PMID:11828009; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
J Clin Immunol  2009; 29:265-73; PMID:19280325; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Nat Immunol 2004; 5:1260-5;  PMID:15531883; http://dx.doi.org/10.1038/ni1138.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Immunol  Lett 2005; 101:12-7; PMID:15941591; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Nat Rev Immunol  2002; 2:957-64; PMID:12461568; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Nat  Immunol 2000; 1:311-6; PMID:11017102; http://dx.doi.org/10.1038/79758.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Eur J Immunol 2004; 34:2579- 88; PMID:15307190; http://dx.doi.org/10.1002/ eji.200425092.,Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
Immunity  2003; 19:561-9; PMID:14563320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
"PLoS  One 2012; 7:e39170; PMID:22723958; http://dx.doi.org/10.1371/journal.pone.0039170.NK cell activation, such as the use of  NK-sensitive cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/75/95/onci-1-1635.PMC3525628.pdf
"In addition, tumors actively Autochthonous T cells to the rescue IL-10 directly activates tumor-resident CD8+ T cells Jan e mmerich,1 John B. Mumm2 and Martin Oft2,* 1triMod t herapeutics; Dublin, Ireland; 2targenics; s an Francisco, CA us A Keywords:  IL-10, CD8+ T cell, immunotherapy, tumor resident T cell, autochthon, TIL, tumor infiltrating T cells, cytotoxicity *Correspondence to: Martin Oft; Email: martinoft@gmail.com Submitted: 07/28/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21683suppress immune response via inhibitory  molecules such as PD-L1 or transforming growth factor β  (TGF β).",Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
Nat Rev Cancer 2012; 12:298-306;  http://dx.doi.org/10.1038/nrc3245; PMID:22419253.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
J Natl Cancer Inst 2012;  104:599-613; http://dx.doi.org/10.1093/jnci/djs033;  PMID:22395641.4.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
Annu Rev Immunol 2001; 19:683-765; PMID:11244051; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
Blood 2001; 98:2143-51;  PMID:11568001; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
Cancer Cell 2011; 20:781-96; PMID:22172723; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
Gut 2002; 50:191-5; PMID:11788558;  http://dx.doi.org/10.1136/gut.50.2.191.,Non-OADS,/arxiv_data1/oa_pdf/9c/64/onci-1-1637.PMC3525629.pdf
"2 Multiple  studies have previously explored this hypothesis, testing the cytotoxic potential Anticancer activity of cardiac glycosides At the frontier between cell-autonomous   and immunological effects Oliver Kepp,1,2,3 Laurie Menger,1,2,3 erika Vacchelli,1,2,3 sandy Adjemian,1,2,3 Isabelle Martins,1,2,3 Yuting Ma,1,2,3   Abdul Qader s ukkurwala,1,2,3 Mickaël Michaud,1,2,3 Lorenzo Galluzzi,4,5 Laurence Zitvogel2,3,6,7 and Guido Kroemer1,4,5,8,9,* 1INserM, u 848; Villejuif, France; 2Institut Gustave r oussy; Villejuif, France; 3université Paris s ud/Paris XI; Le Kremlin Bicêtre, France;   4université Paris Descartes/Paris V; s orbonne Paris Cité, Paris, France; 5Centre de r echerche des Cordeliers; Paris, France; 6INserM, u 1015; Villejuif, France;   7Center of Clinical Investigations CB t507; Institut Gustave r oussy; Villejuif, France; 8Metabolomics Platform; Institut Gustave r oussy; Villejuif, France;   9Pôle de Biologie; h ôpital e uropéen Georges Pompidou AP- hP; Paris, France Keywords:  calreticulin, digitoxin, digoxin, HMGB1, immunogenic cell death, Na+/K+ ATPase *Correspondence to: Guido Kroemer; Email: kroemer@orange.fr Submitted: 07/31/12; Accepted: 07/31/12http://dx.doi.org/10.4161/onci.21684of CGs on human carcinoma or leuke - mia cells.2,3 Of note, the human Na+/K+  ATPase has a much higher affinity for  digoxin than its mouse equivalent.",Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Crit Pathw Cardiol 2011; 10:93- 8; PMID:21988950; http://dx.doi.org/10.1097/HPC.0b013e318221e7dd.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Mol  Interv 2008; 8:36-49; PMID:18332483; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Oncogene  2012; 31:3536-46; PMID:22105358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
PLoS One 2009; 4:e8292;  PMID:20016840; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Nat Chem  Biol 2011; 7:25-33; PMID:21076398; http://dx.doi.org/10.1038/nchembio.476.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Sci T ransl Med 2012; 4:143ra99; PMID:22814852; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Cell 2010; 140:798-804; PMID:20303871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026.10.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
J Clin Oncol 2011; 29:2165-70; PMID:21422417; http://dx.doi.org/10.1200/JCO.2010.32.8146.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Cancer Discov  2011; 1:68-77; PMID:22140654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
Nature 2011; 472:486-90; PMID:21441909;  http://dx.doi.org/10.1038/nature09978.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/onci-1-1640.PMC3525630.pdf
"3 Thus, to obtain high-avidity T cells  one must seek within a non-negatively selected T-cell repertoire, for example using foreign MHC-molecules to present High-quality and high-avidity T cell clones  specific for tumor-associated antigens   and how to find them susanne w ilde1 and Dolores J. s chendel1,2,* 1Institute of Molecular Immunology; h elmholtz Zentrum München; German r esearch Center for e nvironmental h ealth; Munich, Germany;   2Clinical Cooperation Group “Immune Monitoring”; h elmholtz Zentrum München; German r esearch Center for e nvironmental h ealth; Munich, Germany Keywords:  adoptive T cell therapy, human cytotoxic CD8+ T lymphocytes, melanoma, T-cell receptor, TCR gene therapy,   Th1/Th2 polycytokines Abbreviations:  CTL, cytotoxic T lymphocytes; TCR, T-cell receptor; Th1, Type 1 helper; tgTCR, transgenic TCR;   pMHC, peptide-MHC *Correspondence to: Dolores J. Schendel; Email: schendel@helmholtz-muenchen.de Submitted: 08/01/12; Accepted: 08/03/12http://dx.doi.org/10.4161/onci.21717self-peptides.",Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
J Gene Med  2012; 14:386-99; PMID:22610778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
J Clin Invest 2007; 117:1466-76; PMID:17549249;  http://dx.doi.org/10.1172/JCI32446.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
Nat Rev  Immunol 2002; 2:512-9; PMID:12094225; http://dx.doi.org/10.1038/nri841.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
Curr Opin Immunol 2009; 21:190- 9; PMID:19297140; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
Blood 2009; 113:6351-60;  PMID:19389882; http://dx.doi.org/10.1182/blood- 2009-02-206557.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
J Immunol 2012; 189:598-605; PMID:22689880; http://dx.doi.org/10.4049/jimmunol.1102165.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/onci-1-1643.PMC3525631.pdf
"2 Since then, multiple IL-2-based ther - apies have been investigated to increase Radiation and immunotherapy Renewed allies in the war on cancer steven K. s eung,1,2,3,* Brendan Curti,1,3 Marka Crittenden1,2,3 and w alter u rba1,3 1earle A. Chiles r esearch Institute; Portland, O r us A; 2the Oregon Clinic; Portland, O r us A; 3Providence Cancer Center; Portland, O r usA Keywords:  IL-2, radiation, SBRT, melanoma, renal cell cancer *Correspondence to: Steven K. Seung; Email: steven.seung@providence.org Submitted: 07/31/12; Accepted: 08/07/12http://dx.doi.org/10.4161/onci.21746the response rates, without much success.",Non-OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
J Immunother (1991)  1992; 12:265-71; PMID:1477077; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
Curr Opin Immunol  2006; 18:226-31; PMID:16459066; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
"Curr  Opin Immunol 2011; 23:146-52; PMID:20970973;  http://dx.doi.org/10.1016/j.coi.2010.09.008.the anti-CTLA4 monoclonal antibody ipi - limumab, based on the results of a Phase  III clinical study showing a four-month increase in median survival.",Non-OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.6.,OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
Sci T ransl Med 2012; 4:137ra74;  PMID:22674552; http://dx.doi.org/10.1126/scitrans- lmed.3003649.,OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
J Exp Med 2006; 203:1259- 71; PMID:16636135; http://dx.doi.org/10.1084/jem.20052494.,Non-OADS,/arxiv_data1/oa_pdf/36/aa/onci-1-1645.PMC3525632.pdf
"In epen - dymoma, a common childhood brain Emerging evidence of anti-tumor immune control  in the central nervous system Andrew M. Donson* and Nicholas K. Foreman Department of Pediatrics; u niversity of Colorado Anschutz Medical Campus and Children’s h ospital; Colorado Center for Cancer and Blood Disorders; Aurora, CO us A Keywords:  brain, microarray, immunosurveillance, infiltration, prognosis *Correspondence to: Andrew M. Donson; Email: Andrew.donson@ucdenver.edu Submitted: 08/03/12; Accepted: 08/07/12http://dx.doi.org/10.4161/onci.21747tumor, approximately 50% of patients  suffer from tumor recurrence.",Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Nat Rev Cancer 2012; 12:298-306;  PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Ann Neurol 1978;  4:219-24; PMID:718133; http://dx.doi.org/10.1002/ ana.410040305.,OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Acta Neuropathol 1989; 78:189-93; PMID:2750489;  http://dx.doi.org/10.1007/BF00688208.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
J Immunol  2009; 183:7428-40; PMID:19917695; http://dx.doi.org/10.4049/jimmunol.0902811.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
J Immunol 2012; 189:1920-7;  PMID:22802421; http://dx.doi.org/10.4049/jimmu- nol.1103373.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Cancer Res 2011; 71:2664-74;  PMID:21324923; http://dx.doi.org/10.1158/0008- 5472.CAN-10-3055.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Neuro Oncol 2011; 13:591-9;  PMID:21636707; http://dx.doi.org/10.1093/neuonc/nor042.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
Clin Cancer Res 2008; 14:5166-72; PMID:18698034; http://dx.doi.org/10.1158/1078-0432.CCR-08-0320.,Non-OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
J Neuroimmunol 2010; 225:195-9; PMID:20537408;  http://dx.doi.org/10.1016/j.jneuroim.2010.05.020.,OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
"Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.specifically as they regulate cell migration,  none of them had been implicated in anti - tumor immunity.",OADS,/arxiv_data1/oa_pdf/f9/cc/onci-1-1648.PMC3525633.pdf
"A significant proportion of the ICTI are myeloid-derived suppressor cells that maintain an immune suppressive environment 1–3 and support tumor expan - sion in the surrounding tissue as well as Targeting MDSCs enhance therapeutic  vaccination responses against lung cancer Minu K. s rivastava,1,3 steven Dubinett1,2,3 and s herven s harma1,2,3,* 1Department of Medicine; u CLA Lung Cancer r esearch Program; David Geffen s chool of Medicine; u niversity of California at Los Angeles; Los Angeles, CA us A;   2Jonsson Comprehensive Cancer Center; David Geffen s chool of Medicine; u niversity of California at Los Angeles; Los Angeles, CA us A;   3Molecular Gene Medicine Laboratory; Veterans Affairs Greater Los Angeles h ealthcare s ystem; Los Angeles, CA us A Keywords:  immune suppression, immunotherapy, lung cancer, myeloid-derived suppressor cells *Correspondence to: Sherven Sharma; Email: ssharma@mednet.ucla.edu Submitted: 08/16/12; Accepted: 08/25/12http://dx.doi.org/10.4161/onci.21970at distant sites, by facilitating angiogen - esis and metastases.4 In humans, MDSCs  are identified by the surface expression of  CD33, and by the lack of expression of markers that characterize mature myeloid and lymphoid cells.",Non-OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
Adv Exp  Med Biol 1998; 451:189-94; PMID:10026871; http://dx.doi.org/10.1007/978-1-4615-5357-1_30.4.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
T rends Immunol 2011; 32:19- 25; PMID:21067974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
Cancer Res 2010; 70:4335-45; PMID:20484028;  http://dx.doi.org/10.1158/0008-5472.CAN-09-3767.7.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
Cancer Immunol Immunother  2008; 57:1493-504; PMID:18322683; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
PLoS  One 2012; 7:e40677; PMID:22815789; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/onci-1-1650.PMC3525634.pdf
"Keywords:  γδ T cells, antibody opsonisation, antigen presentation, APC, CD16, licensing Abbreviations:  APC, antigen-presenting cell; IPP, isoprenyl pyrophosphate; NK, natural killer; TCR, T-cell receptor *Correspondence to: John Anderson; Email: j.anderson@ucl.ac.uk Submitted: 08/22/12; Accepted: 08/25/12http://dx.doi.org/10.4161/onci.21971naïve αβ T cells.2,3 When compared with  mature human dendritic cells, γδ  T lym - phocytes express equivalent levels of co- stimulatory molecules and CCR7, and are equally potent at promoting proliferative responses in αβ  T cells.",Non-OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Cell Immunol 1992; 143:97-107;  PMID:1377991; http://dx.doi.org/10.1016/0008- 8749(92)90008-D. 2.,Non-OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Science 2005; 309:264-8; PMID:15933162;  http://dx.doi.org/10.1126/science.1110267.,OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Proc Natl Acad Sci U S A 2009; 106:2307- 12; PMID:19171897; http://dx.doi.org/10.1073/ pnas.0810059106.,OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
J Immunol 2009; 183:5622-9; PMID:19843947; http://dx.doi.org/10.4049/jimmunol.0901772.,Non-OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Proc Natl Acad Sci U S A 2010; 107:8730-5; PMID:20413723; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
J Immunol  2012; 188:1708-16; PMID:22250090; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Nature  1998; 393:478-80; PMID:9624004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Nature  1998; 393:480-3; PMID:9624005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
Nature 1998; 393:474-8;  PMID:9624003; http://dx.doi.org/10.1038/30989.,Non-OADS,/arxiv_data1/oa_pdf/8b/4b/onci-1-1652.PMC3525635.pdf
"Critical Care Medicine and s urgery; u niversity of Florence; Florence, Italy Keywords:  cancer immunity, cancer immunotherapy, dendritic cells, electrochemotherapy, melanoma Abbreviations:  CpG-ODN, CpG oligodeoxynucleotide; CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; DC, dendritic  cell; dDC, dermal DC; ECT, electrochemotherapy; GM-CSF, granulocyte-macrophage colony-stimulating factor; LC, Langerhans  cell; pDC, plasmacytoid dendritic cell; TAA, tumor associated antigen; TLR, Toll-like receptor *Correspondence to: Gianni Gerlini; Email: gianni.gerlini@asf.toscana.it Submitted: 08/25/12; Accepted: 08/27/12http://dx.doi.org/10.4161/onci.21991the administration of antineoplastic drugs  followed by the electroporation of tumor cells, which strongly increases thera - peutic efficacy.",Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
Nature 2007; 449:419-26; PMID:17898760;  http://dx.doi.org/10.1038/nature06175.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
Nat Rev Cancer 2012; 12:265-77; PMID:22437871; http://dx.doi.org/10.1038/nrc3258.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
Cancer Immunol Immunother 2008; 57:1291-300;  PMID:18259749; http://dx.doi.org/10.1007/s00262- 008-0462-0.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
Clin Exp Metastasis 2012; In Press; PMID:22735940;  http://dx.doi.org/10.1007/s10585-012-9505-1.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
J Clin Invest 2012; 122:575-85; PMID:22251703; http://dx.doi.org/10.1172/JCI61034.8.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
J Immunol 2010; 184:4625-9; PMID:20357255;  http://dx.doi.org/10.4049/jimmunol.0903873.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
N Engl J Med  2012; 366:925-31; PMID:22397654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/ba/onci-1-1655.PMC3525636.pdf
"Joy h o, John Gibson and Douglas Joshua Institute of h aematology; r oyal Prince Alfred h ospital; s ydney, Australia Keywords:  dendritic cell, immunosurveillance, immunotherapy, multiple myeloma, T cell, T cell clones, Th17, Treg, trogocytosis Abbreviations:  CDR3, complementarity determining region 3; DC, dendritic cell; MM, multiple myeloma; NK, natural killer;  nTregs, natural regulatory T cells; rIL-12, recombinant interleukin-12; TCR, T-cell receptor; TGF β, transforming growth factor β ;  Th, T helper; WM, Waldenstrom’s macroglobuminaemia *Correspondence to: Ross Brown; Email: ross.brown@sswahs.nsw.gov.au Submitted: 07/25/12; Accepted: 08/31/12http://dx.doi.org/10.4161/onci.22032(nTregs).",Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Blood 2012; 120:2055-63;  PMID:22705596; http://dx.doi.org/10.1182/blood- 2012-03-416792.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
J Clin Invest 2007; 117:1167-74; PMID:17476346;  http://dx.doi.org/10.1172/JCI31202.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Blood  2010; 115:3580-8; PMID:20190191; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Clin Lymphoma Myeloma  2008; 8:283-6; PMID:18854282; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Blood 2007; 109:2040-8;  PMID:17077329; http://dx.doi.org/10.1182/blood- 2006-05-024547.7.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Br J Haematol 2004; 125:743-8; PMID:15180863;  http://dx.doi.org/10.1111/j.1365-2141.2004.04984.x.4.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Br J Haematol 2000; 110:203-9; PMID:10930999;  http://dx.doi.org/10.1046/j.1365-2141.2000.02131.x.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Leuk Lymphoma  2009; 50:1860-4; PMID:19883313; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
Blood 2001; 98:2817- 27; PMID:11675356; http://dx.doi.org/10.1182/ blood.V98.9.2817.,Non-OADS,/arxiv_data1/oa_pdf/8c/58/onci-1-1658.PMC3525637.pdf
"2 Commonly, CD8+ T cells and  NK cells need to acquire special features to kill tumor cells, such as the expression of granzyme B and perforin as well as How imiquimod licenses plasmacytoid   dendritic cells to kill tumors Martin h olcmann, Barbara Drobits and Maria s ibilia* Institute of Cancer r esearch; Department of Medicine I; Comprehensive Cancer Center; Medical u niversity of Vienna; Vienna, Austria Keywords:  imiquimod, pDC, CCL2, Type I IFN, cancer *Correspondence to: Maria Sibilia; Email: maria.sibilia@meduniwien.ac.at Submitted: 08/29/12; Accepted: 08/31/12http://dx.doi.org/10.4161/onci.22033that of tumor necrosis factor (TNF) fam - ily members like TNF-related apoptosis- inducing ligand (TRAIL).",Non-OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
Oncogene 2008; 27:190-9;  PMID:18176600; http://dx.doi.org/10.1038/ sj.onc.1210913.2.,OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
Oncogene  2002; 21:1251-62; PMID:11850845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
J Immunol  2012; 188:1583-91; PMID:22231699; http://dx.doi.org/10.4049/jimmunol.1102437.7.,Non-OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.4.,OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
Blood 2012; 119:4345-6;  PMID:22577157; http://dx.doi.org/10.1182/blood- 2012-03-415026.,Non-OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
J Exp Med  2007; 204:1441-51; PMID:17535975; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
J Clin Invest 2012; 122:575-85; PMID:22251703;  http://dx.doi.org/10.1172/JCI61034.,Non-OADS,/arxiv_data1/oa_pdf/98/77/onci-1-1661.PMC3525638.pdf
"Vol3, No4,Dec2012Bone Turnover Markers and Bone Mass in Female Rates 227 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 1:The experimental groups, including the training and sedenta ry periods, and age of the rats Groups n Standard training programTraining at dif ferent frequencies and intensities 8S 10 S - 8STP 10 5d/w,40J/d - 32S 10 S S 8STP24E (5d/w,40J/d)(200J/w) 10 5d/w,40J/d 5d/w,40J/d (200J/w) 8STP24E (5d/w,20J/d)(100J/w) 10 5d/w,40J/d 5d/w,20J/d (100J/w) 8STP24E (5d/w,10J/d)(50J/w) 10 5d/w,40J/d 5d/w,10J/d (50J/w) 8STP24E (3d/w,40J/d)(120J/w) 10 5d/w,40J/d 3d/w,40J/d (120J/w) 8STP24E (3d/w,20J/d)(60J/w) 10 5d/w,40J/d 3d/w,20J/d (60J/w) 8STP24E (3d/w,10J/d)(30J/w) 10 5d/w,40J/d 3d/w,10J/d (30J/w) 8STP24E(1d/w,40J/d)(40J/w) 10 5d/w,40J/d 1d/w,40J/d (40J/w) 8STP24E (1d/w,20J/d)(20J/w) 10 5d/w,40J/d 1d/w,20J/d (20J/w) 8STP24E (1d/w,10J/d)(10J/w) 10 5d/w,40J/d 1d/w,10J/d (10J/w) Training/Sedentary period (weeks) 0 8 32 Age of the rats (weeks)                                                       12 20 44 S= Sedentary //8S= 8 weeks sedentary control //8STP= 8 weeks of exercise with standard tra ining program for 5d/w at 40J/d 32S = 32 weeks sedentary control //E = Exercise //J/w = Number of jumps per week //d/w = Number of days per week J/d = Number of jumps per day 8STP24E(5d/w,40J/d)(200J/w) = 8 weeks of exercise with standard training program then followed by 200 jumps.week-1for 24 weeks o f 5d/w at 40J/d 8STP24E(5d/w,20J/d)(100J /w) = 8 weeks of exercise with standard training program then followed by 100 jumps.week-1for 24 weeks of 5d/w at 20J/d 8STP24E(5d/w,10J/d)(50J/w) = 8 weeks of exercise with standard training program then followed by 50 jumps.week-1for 24 weeks of 5d/ w at 10J/d 8STP24E(3d/w,40J/d)(120J/w) = 8 weeks of exercise with standard training program then followed by 120 jumps.week-1for 24 weeks of 3d/w at 40J/d 8STP24E(3d/w,20J/d)(60J/w) = 8 weeks of exercise with standard training program then followed by 60 jumps.week-1for 24 weeks of 3d/w at 20J/d 8STP24E(3d/w,10J/d)(30J/w) = 8 weeks of exercise with standard training programthen followed by 30 jumps.week-1for 24 weeks of 3d/w at 10J/d 8STP24E(1d/w,40J/d)(40J/w) = 8 weeks of exercise with standar d training program then followed by 40 jumps.week-1for 24 weeks of 1d/w at 40J/d 8STP24E(1d/w,20J/d)(20J/w) = 8 weeks of exercise with standard training program then followed by 20 jumps.week-1for 24 weeks of 1d /w at 20J/d [8STP24E(1d/w,10J/d)(10J/w) = 8 weeks of exercise with standard training program then followed by 10 jumps.week-1for 24 weeks of 1d/w at 10J/d (Heto Ultra Freezer 3410, Denmark) until analysis at a later date.",Non-OADS,/arxiv_data1/oa_pdf/c1/b0/ASJSM-3-225.PMC3525818.pdf
"Vol3, No4,Dec2012Bone Turnover Markers and Bone Mass in Female Rates 229 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 2:Mean tibial mass, serum osteocalcin, Alk-Phand 1CTP concentrations in th e exercise and sedentary groups Groups Tibial mass(mg)Serum Concentration Osteocalcin (ng.mL-1)Alk-Ph(U.L-1)1CTP (µg.L-1) 8S 393.25(42.49) 124.45(57.13) 177.25(31.29) 1.01(0.53) 8STP 424.47(27.57)*151.14(48.03) 189.00(36.46) 1.20(0.52) 32S 430.04(30.00) 66.01(30.58) 119.70(29.12) 1.08(0.48) 8STP24E (1d/w,10J/d)(10J/w) 444.67(28.25) 62.68(18.65) 113.89(18.71) 0.96(0.32) 8STP24E(1d/w,20J/d) (20J/w) 435.04(33.94) 76.79(40.95) 118.14(15.20) 0.60(0.28)# 8STP24E(3d/w,10J/d)(30J/w) 493.53(25.46)‡83.89(43.60) 110.00(37.70) 0.97(0.08) 8STP24E(1d/w,40J/d)(40J/w) 455.66(24.56) 88.27(56.31) 147.40(34.59)#0.33(0.10)‡ 8STP24E(5d/w, 10J/d)(50J/w) 476.24(28.90)†4.68(29.34) 146.50(26.56)#0.31(0.14)‡ 8STP24E(3d/w,20J/d)(60J/w) 484.92(20.71)†70.74(38.01) 110.00(23.80) 0.18(0.14)‡ 8STP24E(5d/w,20J/d)(100J/w) 482.62(37.61)†61.16(20.06) 130.60(33.64) 0.18(0.15)‡ 8STP24E(3d/w,40J/d)(120J/w) 479.06(31.93)†72.21(26.92) 125.50(24.94) 0.13(0.07)‡ 8STP24E (5d/w,40J/d)(200J/w) 497.51 (50.09)‡86.48(14.57) 152.40(32.77)+0.17(0.10)‡ *P<0.05 compared to age -matched sedentary controls (8S).",Non-OADS,/arxiv_data1/oa_pdf/c1/b0/ASJSM-3-225.PMC3525818.pdf
"Vol3, No4,Dec2012Bone Turnover Markers and Bone Mass in Female Rates 231 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )on a logarithmic curve fit against workload (J/w).",OADS,/arxiv_data1/oa_pdf/c1/b0/ASJSM-3-225.PMC3525818.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 239 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Effect of Short -Term Maximal Exercise on Biochemical Markers of Muscle Damage, Total Antioxidant Status, and Homocysteine Levels in Football Players Omar Hammouda*1, PhD;Hamdi Chtourou1, PhD;Anis Chaouachi1, PhD;Henda Chahed2,MD; Salyma Ferchichi2, MD;Choumous Kallel3, MD;Karim Chamari1,4, PhD;Nizar Souissi1,4, PhD Authors’ Affiliation : 1.Research Laboratory ‘’Sport Performance Optimisation’’, National Center of Medicine and Science in Sport 2.Laboratory of Bioch emistry, CHU Farhat Hached, Sousse, Tunisia 3.Laboratory of hematology, CHU Habib Bourguiba, Sfax, Tunisia 4.High Institute of Sport and Physical Education, Ksar -Saïd, Manouba University, Tunisia *Corresponding Author; Address: National Center of Medicin e and Science in Sports (CNMSS ), Bp263, Ave Med Ali Akid, 1004 El Menzah, Tunis, Tunisia E-mail:omar_hammouda86@yahoo.fr Received: Mar21, 2012 Accepted: May08, 2012 Key Words: Muscles;Injury; Exercise;Homocysteine ; Antioxidant s;WingateTestAbstract Purpose: Prolonged physical exercise results in transient elevations of biochemical markers of muscular damage.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Hammouda O, et al Vol3No4,Dec2012240 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )acidosis both in blood and muscle[7]and also with a major increase in plasma catecholamine levels[8].",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Vol3, No4,Dec2012Effect of Short -term Exercise on Biochemical Mar kers of Muscle Damag 241 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )(Plow) divided by the highest power: Fatigue Index = (Ppeak−Plow)/Ppeak[21] Dietary Records : To assess the adequacy of nutrient intake, a 7 -day consecutive dietary record was completed.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Hammouda O, et al Vol3No4,Dec2012242 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )enzymatic system.",OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Vol3, No4,Dec2012Effect of Short -term Exercise on Biochemical Mar kers of Muscle Damag 243 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 3:Values(mean±standard deviation ) of biochemical parameters before and after the Wingate test Lac (mmol/L)CRE (µmol/L)GLC (mmol/L)MG (mmol/L)PO43- (mmol/L)TBIL (µmol/ L)UA (µmol/ L)TAS (μmol·L−1) Before 1.14 (0.39) 81.39 (21.34) 4.71 (0.69) 0.92 (0.13) 1.31 (0.26) 16.52 (3.52) 253 (60.04) 1.25 (0.19) After 9.68 (0.77) 90.4 (14.31) 5.12 (0.49) 0.98 (0.07) 1.46 (0.27) 17.89 (4.06) 269.53(61.05) 1.30 (0.18) P.Value 0.001 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 Lac: Lactate, CRE: Creatinine, GLC: Blood Glucose, MG: Magnesium, PO43-: inorganic phosphate, TBIL: Total Bilirubin, UA: Uric Acid , TAS: Total antioxidant status damage, Hcy levels, and TAS in trained subjects.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Hammouda O, et al Vol3No4,Dec2012244 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )lactic acid production[7].",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Vol3, No4,Dec2012Effect of Short -term Exercise on Biochemical Mar kers of Muscle Damag 245 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )CONCLUSION In conclusion, the present study shows for the first time that a single bout of 30 -s maximal ex ercise is sufficient to increase muscle damage enzymes and TAS, and that WBC were selectively mobilized, and such changes were even observed as early as 3 -mins post -exercise.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"Hammouda O, et al Vol3No4,Dec2012246 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )16.Chtourou H, Chaouachi A, Hammouda O, et al.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ASJSM-3-239.PMC3525820.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 247 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )DoesMuscleMassAffectRunningTimes inMaleLong-distance MasterRunners?",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec2012248 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )marathoners, however, the age of peak running performance across life is shorter and between 30 to 49 years[9,11,12].",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Vol3, No4,Dec2012MuscleMass and Running Performance 249 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )male master’s level half -marathoners and 91 male master’s level marathoners were measured pre -race.",OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec2012250 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )measurements were taken following the ISAK standard once for all seven skin -folds and then the procedure was repeated twice more by the same investigator; the mean of the three measures was then used for the analyses.",OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Vol3, No4,Dec2012MuscleMass and Running Performance 251 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )to skeletal muscle mass for master half-marathoners (r=-0.31,P=0.002) and master marathoners ( r=-0.38, P=0.0002).",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec2012252 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )for master half -marathoners ( r=0.22) (Panel D), master marathoners ( r=0.24) (Panel E) and 100 -km master ultra -marathoners (r=0.23) (Panel F) showed the same coeff icient of correlation strongly significant and positively related to race times in master half -marathoners ( r=0.45,P<0.0001), master marathoners ( r=0.48,P<0.0001) and master ultra - marathoners ( r=0.48,P<0.0001) where the coefficients of correlation als o increased wi th increasing running distance.",OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec20126 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Weekly running kilometres -4.8 3.9 0.2 Speed in running training -1.5 0.3 < 0.0001 ß= regression coefficient; SE= standard error of the regression coefficient.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec2012254 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )subjects.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Vol3, No4,Dec2012MuscleMass and Running Performance 255 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )distances in training is a limitation since we have no way of establishing the reliability and precision of reporting.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"Knechtle B, et al Vol3,No4;Dec2012256 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )17.Trappe S. Marathon runners: how dotheyage?Sports Med 2007;37:302 -5.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/ASJSM-3-247.PMC3525821.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 257 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )BodyComposition and DietaryIntake ofEliteCross-countrySkiers Members of the Greek National Team Sousana K .Papadopoulou1;Anna Gouvianaki1;Maria G.Grammatikopoulou1;Zoi Maraki1;Ioannis G .Pagkalos2; Nikolaos Malliaropoulos3,MD,PhD;Maria N.Hassapidou1;Nicola Maffulli *4,MD, PhD, FRCS(Orth) Authors’ Affiliation : 1.Department of Nutrition & Dietetics, Alexander Technological Educational Institute, Thessaloniki, Greece 2.Department of Mathematical, PhysicalandComputational Sciences, Faculty of Engineering, Aristotle University of Thessaloniki, Greece 3.National Track & Field Centre, Sports Injury Clinic, Sports Medicine Clinic of S.E.G.A.S., Thessaloniki, Greece 4.Centre of Sports and Exercise Medicine, Barts a nd The London School of Medicine and Dentistry, Mile End Hospital , London, UK *Corresponding Author; Address: Centre for Sports and Exercise Medicine, Mile End Hospital, 275 Bancroft Road, London E1 4DG, UK E-mail:n.maffulli@qmul.ac.uk Received: Apr29, 2012 Accepted: Jul20, 2012 Key Words: Athletes;Body Fat; Cross-countrySkiing;Nutrients; DietAbstract Purpose: To assess the anthropometric characteristics and dietary intake of the Greek national cross -country skiing team.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Papadopoulou SK, et al Vol3No4,Dec2012258 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )lean as distance runners[6].However, within the sport itself variations in physiology have been noted[6]being attributed mainly to the body mass of the athletes, with the heavy skiers being faster in all types of terrain, except for the steep uphills[7], and the light skiers having an advantage on steep uphill courses.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Vol3, No4,Dec2012Body Composition and Dietary Intake of Cr oss-country Skiers 259 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Columbia, USA) .",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Papadopoulou SK, et al Vol3No4,Dec2012260 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 1:Means and standard deviations of anthropometric characteristics of female and male cross country skiers ParameterWomen (n=10)Men (n=23)Pvalue Weight(kg) 54.2(6.2)†† 69.0(9.0) <0.001 Height(cm) 164.7(6.2)† 175.3(6.3) <0.05 BodyMassIndex(Kg/m2) 20.0(1.4)† 22.4(2.2) <0.05 Waist-to-hip ratio 0.71(0.03)††0.78(0.03) <0.001 % body fat (calliper) 14.6(3.0)†† 7.5(2.8) <0.001 % body fat (BIA) 14.2(1.9)†† 11.0(1.5) <0.001 Fat body mass (Kg)(BIA) 7.8(1.8) 7.7(1.6) NS Lean body mass (Kg)(BIA) 46.4(4.6)†† 61.3(7.9)<0.001 % Body water (BIA) 62.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Vol3, No4,Dec2012Body Composition and Dietary Intake of Cr oss-country Skiers 261 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 2:Energy expenditure, energy intake and macronutrient intake of female and male cross country skiers, during training and competit ion days ParameterWomen(n=10) Men(n=23) Training Competition Training Competition Energy expenditure (Kcal/day) 2580(307)†2466(327)†3095(582)2911(508) Energy intake (Kcal/day) 1988(319)2011(330)2255(790)2125(639) Protein (g) 72.6(18.5)62.7(16.5)92.5(39.9)79.7(28.5) Protein (g/kg B odyWeight) 1.4(0.4) 1.2(0.3) 1.3(0.5) 1.2(0.4) Protein (% EnergyIntake) 14.3(2.5)*12.4(2.7)16.1(3.7) 15.3(4.7) Carbohydrate (g) 266.7(43.8)293.8(59.3)254.5(108.7)290.1(104.2) Carbohydrate(g/kgBodyWeight)4.9(1.1)†5.5(1.3)† 3.7(1.5) 4.2(1.4) Carbohydrate (%EnergyIntake)52.8(5.6)†57.7(7.7)44.5(7.1)** 53.7(9.0) Fat (g) 74.6(15.8)†68.1(17.4)98.7(32.9)**72.6(29.6) Fat (g/kg BodyWeight) 1.4(0.4) 1.3(0.3) 1.4(0.5) 1.1(0.5) Fat (%EnergyIntake) 33.0(3.7)†29.9(5.7)39.2(5.3)** 30.3(8.1) Saturated fat (g) 25.3(9.9)23.9(9.0)33.6(12.3)24.2(12.3) Alcohol (% EnergyIntake) 0.0(0.0) 0.0(0.0) 0.2(0.6) 0.7(3.0) Fibre (g) 17.7(3.9)13.2(4.4)16.6(7.5) 13.6(6.9) Cholesterol (mg) 159.9(73.7)129.7(63.8)239.9(123.6)183.8(86.3) †Significant difference compared to the men ( P<0.05) * Significant difference compared to competition days ( P<0.05) ** Significant difference compared to competition day s (P<0.001) in Table 3.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Papadopoulou SK, et al Vol3No4,Dec2012262 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 4:% DRI intake of vitamins and mine rals during training and competition days in female and male cross country skiers Women(n=10) Men(n=23) training Competition training competition Vit A 122.1(43.3) 84.3(37.9) 101.9(50.4)** 62.7(30.3) Vit B1 155.8(34.4) 177.7(40.0) 147.4(59.8)* 176(79.5) Vit B2 209.7(49.6)* 171.8(25.5) 198.1(96.7)* 165.7(65.7) Vit B3 139.6(30.1) 143.5(37.5) 145.2(76) 160.6(51.5) Vit B6 146.8(50.9) 122.2(41.8)† 146.6(84.1) 163.2(76.7) Vit B12 138.4(54.3)* 89.7(45.4) 204.2(148.6)* 136.5(72.8) Biotin 78.5(19.4) 78.1(29.2) 83.2(44.0)* 66.7(49.4) Vit C 413.1(300.5)†528.8(486.6) 252.5(153.1) 292.2(349.1) Vit D 78.8(45.9) 44.5(38.8) 106.6(86.6)* 61.2(50.1) Vit E 77.7(15.6)* 48.6(14.6) 91.6(45.1)* 54.6(30.8) Vit K 36.5(28.6)* 16.10(11.3) 31.6(29.0)* 16.0(12.5) Folate 82(22.9)* 111.1(28.8) 90.6(37.9) 91.5(42.8) Pantothenic Acid 113.3(35.5) 98.1(40.4) 130.6(76.4) 109.4(60.8) Calcium (Ca) 85.5(27.4)* 68.1(22.6) 103.4(57.3)** 65.6(34.2) Iron (Fe) 73.1 (15.5)†† 67.3(19.6)†† 138.0(71.3) 140.0(60.0) Magnesium ( Mg) 75.4(12.9) 68.1(16.5) 75.0(54.2) 61.3(19.7) Phosphor ( P) 121.5(32.7) 105.4(37.2) 147.4(93.6) 123.9(56.6) Potassium ( K) 75.4(19.9) 62.5(32.1) 71.8(33.5) 66.0(37.0) Sodium ( Na) 132.8(56.8) 127.9(61.7) 162.2(72.2) 135.8(71.8) Iodine (I) 61.1(36.8) 35.5(34.6) 78.9(66.9) 41.1(37.7) Manganese (Mn) 102.1(22.2) 107.0(39.7) 88.8(49.1) 86.9(39.7) Selenium ( Se) 121.8(34.3)* 154.0(51.7) 166.9(77.6) 177.6(82.2) †Significant differe nce compared to the men ( P<0.05) ††Significant difference compared to the men ( P<0.001) * Significant difference compared to competition days ( P<0.05) ** Significant difference compared to competition days ( P<0.001) DISCUSSION Anthropometry: In terms of physique and body composition, our female cross country skiers demonstrated lower values in all anthropometric indices measured, except for the triceps and thigh skinfolds and their total body fat contentcompared to the men.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Vol3, No4,Dec2012Body Composition and Dietary Intake of Cr oss-country Skiers 263 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )female Ironman triathletes[32].",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Papadopoulou SK, et al Vol3No4,Dec2012264 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Consumption of food groups : Female cross country skiers have adopted a diet low in grains and vegetables during competition days, and a diet low in meat, grains and vegetables during training days.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Vol3, No4,Dec2012Body Composition and Dietary Intake of Cr oss-country Skiers 265 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )ACKNOWLEDGMENTS The present study was co -funded by “Archimedes 1” ,a research project funded by the EU and the Greek Ministry of Education.Conflict of interests: None REFERENCES 1.Rees D.Cross-country skiing: touring and competition (3rded).",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Available at:http://www.fis -ski.com.Access date: 9.Burke LM, Cox GR, Culmmings NK, Desbrow B.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Papadopoulou SK, et al Vol3No4,Dec2012266 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )27.U.S.Department of Agriculture.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"Available at: http://www.nal.usda.gov/fnic/Fpyr/pmap.htm .Access date: April 17, 2012.",Non-OADS,/arxiv_data1/oa_pdf/5f/be/ASJSM-3-257.PMC3525822.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 267 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Reliability of 1 -Repetition Maximum Estimation for Upper and Lower Body Muscular Strength Measurement in Untrained Middle Aged Type 2 Diabetic Patients Unaise Abdul -Hameed*1, MPThPrateek Rangra2,MSc;Mohd.Yakub Shareef3,MSc;Mohd.Ejaz Hussain1, PhD Authors’ Affiliation : 1.Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia (A Central University), New Delhi , India 2.Queen Margaret University, UK 3.Ansari Health Centre, Jamia Millia Islamia (A Central University), New Delh i-25 *Corresponding Author; Address: Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia: Jamia Nagar, New Delhi-25, India E-mail:unaisephysio@gmail.com Received: Feb21, 2012 Accepted: Jun19, 2012 Key Words: Reliability ;Prediction; Type 2 Diabetes ;1-Repetition Maximum ;ExerciseAbstract Purpose: The 1-repetition maximum (1 -RM) test is the gold standard test for evaluating maximal dynamic strength of groups of muscles.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Abdul-Hameed Y, et al Vol3No4,Dec2012268 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )subjects, estimation of the1-RM method is preferred to actual 1 -RM testing.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Vol3, No4,Dec2012Reliability of 1 -RM Estimation for Muscular Strength 269 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 1:Details of exercises used for I -Repetition Maximum estimation Exercise Muscles Worked Equipment Technique Execution Instructions* Supine bench pressPectorals, Anterior deltoids, TricepsBench press machineWith your back flat on the bench without arching your back, lift the selected weight by e xtending the handles straight up in a slow, controlled motion until thearms are fully extended.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Abdul-Hameed Y, et al Vol3No4,Dec2012270 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 2: Characteristics ofuntrained type 2 diabetic patients before study CharacteristicFrequency orMean(SD)Range(Min -Max) No.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Vol3, No4,Dec2012Reliability of 1 -RM Estimation for Muscular Strength 271 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )occasions (t= -0.225, P=0.8).",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Abdul-Hameed Y, et al Vol3No4,Dec2012272 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir ) Fig 2:Limits of Agreement Plots for two lower body ex ercises.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"Vol3, No4,Dec2012Reliability of 1 -RM Estimation for Muscular Strength 273 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )established, but minimal research has been done on the reliability of prediction 1 -RM on people with health disorders such as type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir ),Non-OADS,/arxiv_data1/oa_pdf/26/38/ASJSM-3-267.PMC3525823.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 274 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Effects of Prefabricated Ankle Orthoses on Postural Stability in Basketball Players with Chronic Ankle Instability ElaheFaraji*1,BSc, MSc;HassanDaneshmandi2,PhD;AhmadEbrahimiAtri1,PhD; VahidOnvani3, MSc;FarideRezaee Namjoo1,BSc,MA Authors’ Affiliation : 1.Department of sport Medicine and Corrective Exercise ,Ferdowsi University of Mashhad , Mashhad, Iran 2.Department of Sport medicine and corrective exercise , University of Guilan, Rasht, Iran 3.Azad University ,Mashhad Branch, Mashhad, Iran *Corresponding Author; Address: Department of sport Medicine and Corrective Exercise , Ferdowsi University of Mashhad , Mashhad, Iran E-mail:faraji_1383@yahoo.com Received: Mar25, 2012 Accepted :Jul20, 2012 Key Words: PosturalBalance;Ankle; JointInstability ;Basketball ;OrthosesAbstract Purpose: Ankle sprain is one of the most common injuries among athletes and instability and injury to this joint is responsible for long time los sofphysical and recreational activity.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/ASJSM-3-274.PMC3525824.pdf
"Vol3, No4,Dec2012Effects of Prefabricated Ankle Orthoses on Postural Stability 275 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )dynamic situations[6].",Non-OADS,/arxiv_data1/oa_pdf/a5/70/ASJSM-3-274.PMC3525824.pdf
"Faraji E, et al Vol3,No4,Dec2012276 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )RESULTS For semi-dynamic, the between groups tes t indicated that the variable group was not significant (F=0.56; P=0.5).Subjects in the CAI group ( 1.35±0.6)didn’t have asignificant postural stability score difference from those in the healthy group ( 1.06±0.5).The within subject test indicated that t here was a significant orthoses effect, in other words, the groups changed and improved postural stability with the orthoses (F=6.2; P<0.001).Thereweresignificant differences observed between the types of orthosis subjectshad alower score inpostural stability in the soft orthosis condition (0.97±0.42) and semi -rigid orthosis condition (0.97±0.38) compared to without orthoses condition (1.21±0.59) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/a5/70/ASJSM-3-274.PMC3525824.pdf
"Vol3, No4,Dec2012Effects of Prefabricated Ankle Orthoses on Postural Stability 277 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )from a jump.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/ASJSM-3-274.PMC3525824.pdf
"Faraji E, et al Vol3,No4,Dec2012278 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )3.Garrick JG.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/ASJSM-3-274.PMC3525824.pdf
"© 20 13bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 279 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Resistance TrainingandVibrationImproveMuscleStrength and Functional Capacity in FemalePatients with MultipleSclerosis Elham Eftekhari*1,PhD;Mina Mostahfezian2,PhD;Masoud Etemadifar3, MD;Ardeshir Zafari4,PhD Authors’Affiliation : 1.Department of Physical Education and Sport Sciences ,Najafabad Branch, Islamic Azad University , Isfahan,Iran 2.Department of Physical Education and Sport Sciences, Najafabad Branch, Islamic Azad University , Isfahan,Iran 3.Isfahan Eye Res earchCenter, Isfahan,Iran 4.Department of Physical Education and Sport Sciences ,Zanjan Branch,Islamic Aza d University, Zanjan,Iran *Corresponding Author; Address: Najafabad Branch, Islamic Azad University.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"Eftekhari E , et al Vol3,No4,Dec2012280 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )conduction block arethepathophysiologic hallmarks of MS.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"Vol3,No4,Dec2012Effect of Resistance Training and Vibration on Muscle Strength 281 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )between exercise sessions.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"Eftekhari E , et al Vol3,No4,Dec2012282 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 2:Before and after values of MVC and functional indexes in the studied subjects (values expressed as mean ±SD) VariablesExercise group (n=12) Control group (n=12) Before After Before After Knee extensor s (Kg) 17.05(4.25) 22.56(4.28) 18.86(3.92) 16.61(3.33) Abduction of the scapula girdle (Kg) 12.87(2.66) 16.06(2.03)12.56(2.48) 12.04(1.82) Downward rotation of the scapular girdle (Kg) 19.23(5.36) 26.76(4.39) 19.71(4.20) 17.49(3.89) RLB (Sec) 10.02(4.46) 13.38(5.13) 13.28(2.89) 9.69(3.43) LLB (Sec) 7.76(2.12) 8.50(3.27) 8.95(4.23) 5.13(2.99) 10MWT (m/min) 60.73(11.46) 66.41(10.83) 51.47(11.19)47.41(10.30) MVC: Maximal Voluntary Contraction; SD: Standard Deviation; RLB: Right Leg Balance; LLB: Left Leg Balance ; 10MWT: 10-Meter Walk Test (11.2%) muscle groups, also exercise group showed significant increase in RLB (33.5%), LLB (9.5%), and significant decrease in 10MWT (9.3%), whereas the control group showed adecrease in RLB (27.0%), LLB (42.6%), and increase in 10MWT (7.8%), (P <0.05).",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"Vol3,No4,Dec2012Effect of Resistance Training and Vibration on Muscle Strength 283 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )balance and physical activity[42].",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"Eftekhari E , et al Vol3,No4,Dec2012284 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )16.Ouellette MM, LeBrasseur NK, Bean JF, et al.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/ASJSM-3-279.PMC3525825.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.ORIGINAL ARTICLE 285 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Fatalities Among Iranian High-altitudeOutdoorEnthusiasts :Causes and Mechanisms Ramin Kordi1,MD, MSc, PhD ;Mohsen Rostami *1,MD;Pedram Heidari2,MD; Sanaz Ameli3,MD;Lotfali Foroughifard1,MD;Mahboobeh Kordi*1, MSc Authors’ Affiliation : 1.Sports Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran 2.Center for T ranslational Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA 3.Noorafshar Rehabilitation & Sports Medicine Hospital, Tehran, Iran *Corresponding Author; Address: Sport Med icine Research Center, No 7, Al -e-Ahmad Highway, Tehran, P.O Box: 14395 -578,IR Iran E-mail:mahboobeh.kordi@gmail.com Received: Apr16, 2012 Accepted: Sep16, 2012 Key Words: Mortality;Altitude; Mountaineering ;RiskFactorsAbstract Purpose: This study was performed to determine the possible causes and mechanisms of fatalities among Iranian mountaineers during climbing.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"Kordi R, et al Vol 3,No4, Dec2012286 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Accidents during mountain climbing impose a high burden on both individuals and society.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"Vol3, No4,Dec2012Risksof Fatality among Mountaineers 287 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 2:Description of the reported fatalities sustained during high -altitude outdoor activities in Iran from 2006 to 2010 CASE No.Age (years)Time of deathAltitude above sea level (m )Mechanism of accidentCause of  deathType of activityPerformance level 1232009/Win <2000 Falling Internal bleeding Rock climbing Level2 2482006/Spr 2000-4000 MI Mountaineering Level2 3492008/Sum <2000 Falling Internal bleeding Rock Climbing Level 1 4562009/Spr 2000-4000 Lightning Multiple Trauma Climbing Level2 5252008/Spr ?",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"Kordi R, et al Vol 3,No4, Dec2012288 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )accidents.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"Vol3, No4,Dec2012Risksof Fatality among Mountaineers 289 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Burtscher et al have reported that SCD is 11 times more prevalent among mountain hikers with a previous history of myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"Kordi R, et al Vol 3,No4, Dec2012290 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )CONCLUSION In conclusion, results of this small d escriptive study showed that falling was the most common and avalanche was the second most common mechanism of accident among Iranian mountaineers.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/ASJSM-3-285.PMC3525826.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.STUDENT CORNER ORIGINAL ARTICLE 291 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Pelvic Incidence and Lumbar Spine Instability Correlations in Patients with Chronic Low Back Pain Mohammad -Reza Golbakhsh1,MD;Majid Attar Hamidi1, MD;Bahar Hassanmirzaei *2, MD Authors’Affiliation : 1.Sina Hospital Tehran University of Medical Sciences, Tehran, Iran 2.Sports Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran *Corresponding Author; Address: Sports Medicine Research Center,No 6, Al-e-AhmadHighway, Tehran, Iran,P.O.BOX: 14395-578 E-mail:bahariane@yahoo.com Received: Mar15, 2012 Accepted: Jul08, 2012 Key Words: LumbarVertebrae; Postural Balance ;LowBackPain; Spine; Pelvic RegionAbstract Purpose: Many factors su ch as lumbar instability and spinopelvic alignment are associated with low back pain.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"Golbakhsh M, et al Vol3,No4,Dec2012292 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )pain,[20,21]and disk diseases[22,23].",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"Vol3, No4,Dec2012Pelvic Incidence in Patients with Chronic Low Back Pain 293 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir ) Fig.2:C angle shows pelvic incidence.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"Golbakhsh M, et al Vol3,No4,Dec2012294 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 1: descriptive characteristics of the subjects Group Age (y)Female Male Height (m )Weight (kg) BMI (kg/m2) Group A 38.50 13 17 1.65 75.1 22.74 Group B 38.10 9 13 1.68 79.3 23.46 P value 0.2 0.4 0.7 0.3 0.08 0.9 BMI: Body Mass Index 1.89, 44.12 ± 1.94 and 44.79 ±1.87 respectively and without any significant difference between two groups.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"Vol3, No4,Dec2012Pelvic Incidence in Patients with Chronic Low Back Pain 295 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Yoshimito denotes that in patients with hi p osteoarthritis, pelvic incidence is significantly higher and concludes patients with higher pelvic incidences are at a higher risk for developing hip osteoarthritis in late life[30].In 2007, some notable studies assessing pelvic incidence, low back pai n and degenerative disk diseases were published.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"Golbakhsh M, et al Vol3,No4,Dec2012296 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )5.Berthonnaud E,Dimnet J, Roussouly P, Labelle H. Analysis of the sagittal balance of the spine and pelvis using shape and orientation parameters.",OADS,/arxiv_data1/oa_pdf/e8/06/ASJSM-3-291.PMC3525827.pdf
"© 20 12bySports Medicine Research Center ,Tehran University of Medical Sciences, All rights reserved.Short Communication 297 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Behavior and Knowledge of Iranian Professional Athletes towards Smoking Zahra Hessami*,MD,MPH;Mahshid Aryanpur, MD,MPH;Habib Emami ,PhD; Mohammadreza Masjedi,MD Authors’ Affiliation : Tobacco Prevention and Control Research Center ,National Research Institute Tuberculosis and Lung Diseases, Shahid Beheshti University ofMedical Science, Tehran, Iran *Corresponding Author; Address: Massih Daneshvari Hospital, Darabad, Bahonar Ave, Tehr an, Iran E-mail:zahra_hessami@yahoo.com Received: Feb14, 2012 Accepted: Aug20, 2012 Key Words: TobaccoSmoking; Athletes;Knowledge ; Attitude; PracticeAbstract Purpose: This study aimed to assess the rate of tobacco consumption among professional athletes in Iran and assessing their knowledge and attitude in this regard.",Non-OADS,/arxiv_data1/oa_pdf/32/83/ASJSM-3-297.PMC3525828.pdf
"Hessami Z, et al Vol3,No4,Dec2012298 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )In this study, we aimed at evaluating tobacco consumption among professional athletes in our country.",Non-OADS,/arxiv_data1/oa_pdf/32/83/ASJSM-3-297.PMC3525828.pdf
"Vol3, No4,Dec2012Behavior of Iranian Professional Athletes towards Smoking 299 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )Table 1: demographic and descriptive statistics of all study participants Parameter Mean (SD) Age (years) 28.4 (2.7) EducationUnder high school diploma High school diploma Bachelor's degree Higher than BS degree117(15.9%) 283(44.7%) 202(31.9%) 31(4.2%) Smoking statusSmoker Non smoker64(9%) 674(91%) Number of cigarettes per day<10 10-15 15-20 >2021(44.7%) 12(25.5%) 4(8.5%) 10(21.3%) SD: Standard Deviation DISCUSSION According to our study results, 9% of professional athletes in our country are current smokers.",Non-OADS,/arxiv_data1/oa_pdf/32/83/ASJSM-3-297.PMC3525828.pdf
"Hessami Z, et al Vol3,No4,Dec2012300 Published by: Tehran University of Medical Sciences ( http://asjsm.tums.ac.ir )athletes were significantly more likely to have smoked [12].",Non-OADS,/arxiv_data1/oa_pdf/32/83/ASJSM-3-297.PMC3525828.pdf
"Anhänge Verfügbarunter http://www.egms.de/en/journals/zma/20 12-29/zma00083 7.shtml 1.Tabelle1.pdf(42KB) AuszugausdemCurriculum ""Klasse Allgemeinmedizin"" Vorklinik Literatur 1.Bundesminist eriumfürGesundheit (BMG).Approbationsordnung fürÄrzte(ÄAppO).BGBl.2002;I:2405.",Non-OADS,/arxiv_data1/oa_pdf/ec/05/ZMA-29-67.PMC3525912.pdf
Attachments Availablefrom http://www.egms.de/en/journals/zma/20 12-29/zma00083 7.shtml 1.Table1.pdf(73KB) ExcerptfromtheCurriculum fortheGeneralPractice Class(Preclinic) References 1.Bundesminist eriumfürGesundheit (BMG).Approbationsordnung fürÄrzte(ÄAppO).BGBl.2002;I:2405.,OADS,/arxiv_data1/oa_pdf/ec/05/ZMA-29-67.PMC3525912.pdf
"WiebereitsPabstundStrateinihrerUntersuchungim Jahre2000feststellten,sowirdauchinderaktuellen Beschreibung desTerminus„außerplanmäßiger Profes- sor“beiWikipediabeschrieben, dassgeradeinderMedi- zin-nebenderPromotionundHabilitation- überdurch- schnittlich häufigdieBezeichnung desAPL-Professors verliehenwird(http://de.wikipedia.org/wiki/Pr ofessur), [1].TrotzdieserHäufigkeit,unterscheidensichdieAnfor- derungen,welchevonderHochschule andiePrivatdozen- tengestelltwerden,zumTeildocherheblich[2].ImJahre2000wurden,nacheinererstenBestandsaufnahme der damalsgültigenAPL-OrdnungendeutscherMedizinischer Fakultäten,mögliche PunktezurVereinheitlichung und/oderVereinfachungdesVerfahrenszurErnennung zumAPL-Professorbereitsdiskutiert.Umeinesolide Vergleichbar keitherzustellen,habenwirerstmalsinder aktuellen UntersuchungeineBestandsaufnahme der aktuellen APL-Ordnungen Medizinischer Fakultäten deutscher Hochschulen aufBasiseinesqualitativen Scoring-Syst emsdurchgeführt,derenParameterundEr- gebnissehierdargestelltunddiskutiertwerdensollen.",Non-OADS,/arxiv_data1/oa_pdf/84/7b/ZMA-29-69.PMC3525914.pdf
"Keywords:associateprofessor,GermanMedicalFaculties, standardization,equalityofopportunities,scoringsystem Introduction Thepromotionasanassociateprofessor(AP)represents thefinalacademicstepfollowedonlybyafullprofessor- shipatGermanUniversities.Theacademicdegreeofan associateprofessorisinvestedbyfacultiestopersons, whichhavereceivedadoctoratesdegree,havequalified asaprofessorbywritingahabilitation thesisandobtained postdoctorallecturequalification.Theacademicdegree asanAPcannotbedistinguished byoutsiderstoafull universityprofessorasthespecialprefix“apl”hasnotto beaddressed byAP´s.However,atmostoftheGerman MedicalFacultiesthenomination foranassociatepro- fessordoesnotonlyinvolvethecompletionofacertain timeframe,butisalsoconnectedtoacontinuous and outstanding researchperformanceaswellasacademic teaching.AsPabstandStratehavealreadynoticedin 2000andasanactualWikipediadescription ofGerman associateprofessors(„Außerplanmäßiger Professor“) furtherdelineates,thatthetitleofanassociateprofessor isinvestedaboveaverageespeciallyinmedicine,nextto medicaldoctorates(„Dr.med.“)andassistantprofessors („Privatdozent“) (http://de.wikipedia.org/wiki/Pr ofessur), [1].Therequirements forassistantprofessorstobecomeanassociateprofessor,however,differsubstantially betweenthe35GermanMedicalFaculties[2].Intheyear 2000severalpointsforastandardizationandsimplifica- tionofthepreconditions tobecomeanassociateprofess- orhavealreadybeendiscussed.",Non-OADS,/arxiv_data1/oa_pdf/84/7b/ZMA-29-69.PMC3525914.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/89/srep01004.PMC3525935.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Bharti, B., Findenegg, G.H.",Non-OADS,/arxiv_data1/oa_pdf/b7/89/srep01004.PMC3525935.pdf
http://wwwcms.pref.fukushima.jp/pcp_portal/PortalServlet?DISPLAY_ID 5 DIRECT&NEXT_DISPLAY_ID 5U000004&CONTENTS_ID 525756 (accessed 2012.8.4).,OADS,/arxiv_data1/oa_pdf/4f/6f/srep01005.PMC3525936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4f/6f/srep01005.PMC3525936.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Koarashi, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/6f/srep01005.PMC3525936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/96/srep01002.PMC3525937.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Shiba-Fukushima, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/57/96/srep01002.PMC3525937.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gao, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/19/cf/srep00998.PMC3525938.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/50/srep00999.PMC3525939.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Yang, N., Zhang, H., Wang, M., Hao, Q.",Non-OADS,/arxiv_data1/oa_pdf/97/50/srep00999.PMC3525939.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/srep01003.PMC3525940.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/c7/srep01006.PMC3525979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Carrera, J.",Non-OADS,/arxiv_data1/oa_pdf/90/c7/srep01006.PMC3525979.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/94/5d/299.PMC3526018.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/28/64/205.PMC3526019.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/02/96/149.PMC3526020.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/63/3d/85.PMC3526021.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/da/44/102.PMC3526022.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/87/3c/4.PMC3526023.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/aa/f4/234.PMC3526024.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5e/ca/158.PMC3526025.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ad/e4/194.PMC3526026.pdf
http://www.cdc.gov/diabetes/statis-tics/prev/national/menuage.htm 2010 2.,Non-OADS,/arxiv_data1/oa_pdf/ad/e4/194.PMC3526026.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/34.PMC3526027.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/75/f4/27.PMC3526028.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/18/ba/56.PMC3526029.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0f/10/39.PMC3526030.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/75/a5/223.PMC3526031.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/10/70/e3.PMC3526032.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bb/2b/44.PMC3526033.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/170.PMC3526034.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4d/31/273.PMC3526035.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cc/65/183.PMC3526036.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/65.PMC3526037.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/79/35/115.PMC3526038.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/52/d9/74.PMC3526039.pdf
"See  http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.DIGESTS 312 DIABETES, VOL.",Non-OADS,/arxiv_data1/oa_pdf/f0/89/311.PMC3526040.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/36/6b/18.PMC3526041.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/63/7f/9.PMC3526042.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/08/31.PMC3526043.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/31/30/261.PMC3526044.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5c/82/22.PMC3526045.pdf
Available from http://investors.xoma.com/releasedetail.cfm?ReleaseID=559470 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/82/22.PMC3526045.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3c/2e/1.PMC3526046.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0d/80/36.PMC3526047.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f3/fd/29.PMC3526048.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/01/b3/e2.PMC3526049.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c8/00/124.PMC3526050.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c2/d6/41.PMC3526051.pdf
"In order to facilitate this con- version, a table and calculator are available on the NGSP website (http://www.ngsp.org/convert1.asp).TABLE 1 Selected attributes of HbA 1c Positive Negative Biology Reﬂects chronic glycemia Variable glycation Value independent of acute factors (e.g.,stress, exercise)Age Very low intraindividual variabilityRace Erythrocyte life span Analysis Subject need not be fastingHemoglobin variants may interfere Blood may be collected any time of the dayChemical modi ﬁcation of hemoglobin may interfere Sample is stableAssay is standardizedAccuracy is monitored Clinical Monitor long-term glucose controlMay be altered by factors other than glucose (e.g.,hemolysis, CKD, iron deﬁciency anemia) Used to guide therapyConcentration predicts the risk of microvascular complications of diabetes Used to diagnose diabetesCOMMENTARY 42 DIABETES, VOL.",Non-OADS,/arxiv_data1/oa_pdf/c2/d6/41.PMC3526051.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/2e/137.PMC3526052.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/de/7f/214.PMC3526053.pdf
"Images were generated using a combination of Chimera (University of California San Francisco), Gimp (Gnu Image Manipulation Program, http://www.gimp.org/), and Powerpoint (Microsoft).",OADS,/arxiv_data1/oa_pdf/de/7f/214.PMC3526053.pdf
Additional homology modeling was performed using HHPRED software (ftp://toolkit.lmb.uni-muenchen.de/HH- suite/) to predict the effect of alanine substitution for W799 and for C909 usinglower sequence identity PTP homologs as templates.Statistical analysis.,OADS,/arxiv_data1/oa_pdf/de/7f/214.PMC3526053.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2a/70/e1.PMC3526054.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a4/d8/283.PMC3526055.pdf
"Microarray analysis andexpression quanti ﬁcation was performed by guanine cytosine robust multi- array analysis from Bioconductor (http://www.bioconductor.org) as describedpreviously (14,15).",OADS,/arxiv_data1/oa_pdf/a4/d8/283.PMC3526055.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d6/7c/49.PMC3526056.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/71/98/96.PMC3526057.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/23/7b/243.PMC3526059.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/24/b8/25.PMC3526060.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/35/18/291.PMC3526061.pdf
The samples that passed all QC criteria were thenused to impute for the ungenotyped or missing SNPs from the phase 2 HapMap CHB+JPT (release number 22) reference panel using IMPUTE (version 2.1.2; http://mathgen.stats.ox.ac.uk/impute/impute.html) software (14).,OADS,/arxiv_data1/oa_pdf/35/18/291.PMC3526061.pdf
"For stage 1 GWAS, the genotyped SNPs (495,686) and imputed SNPs (1,738,508) were tested for their associations with T2D using PLINK (version 1.07; http://pngu.mgh.harvard.edu/~purcell/plink/) (15), andSNPTEST (version 2.2.0; https://mathgen.stats.ox.ac.uk/genetics_software/ snptest/snptest.html) (14), respectively.",OADS,/arxiv_data1/oa_pdf/35/18/291.PMC3526061.pdf
"Associations between each SNP and mRNA expression level of nearby genes were obtainedby using Spearman rank correlation for ,10,000 permutations as the default settings of Genevar (version 3.1.1; http://www.sanger.ac.uk/resources/software/genevar/).",OADS,/arxiv_data1/oa_pdf/35/18/291.PMC3526061.pdf
"Thecis-eQTL ( cis-expression quantitative loci) analysis using the Genevar eQTL database (19) (http://www.sanger.ac.uk/resources/software/genevar/) showed suggestive ev- idence of association between an intronic SNP (rs4752300, r 2= 0.79 with rs10886471) in GRK5 andGRK5 mRNA expression levels at P=631024(r= 0.361 between the risk allele and GRK5 expression levels) in adipose tissue.",OADS,/arxiv_data1/oa_pdf/35/18/291.PMC3526061.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/38/96/254.PMC3526062.pdf
"ADA EVENTS Intensive Diabetes Management for Primary Care 9 February 2013Hyatt RegencyDenver, ColoradoWeb site: professional.diabetes.org/colorado E-mail: sglass@diabetes.org 60th Annual Advanced Postgraduate Course 22–24 February 2013 Hilton New YorkNew York, New YorkWeb site: http://professional.diabetes.org/pg13 2013 Diabetes Professional Educators Conference 15–16 March 2013 Radisson Paper Valley HotelAppleton, WisconsinWeb site: professional.diabetes.org/wisconsin E-mail: pkasprzak@diabetes.org28th Clinical Conference on Diabetes 23–26 May 2013 Hyatt Regency Grand CypressOrlando, FloridaWeb site: professional.diabetes.org/cc E-mail: plowe@diabetes.org 73rd Scienti ﬁc Sessions 21–25 June 2013 McCormick Place Convention CenterChicago, IllinoisWeb site: http://scienti ﬁcsessions.diabetes.org 74th Scienti ﬁc Sessions 13–17 June 2014 Moscone Center San Francisco, CaliforniaWeb site: http://scienti ﬁcsessions.diabetes.org Contact for information on ADA events: American Diabetes Association, 1701 N. Beauregard St., Alexandria, VA 22311.Tel: 800-232-3472, select option 1.",Non-OADS,/arxiv_data1/oa_pdf/5d/af/310.PMC3526063.pdf
Web site: http://professional.diabetes.org/ce.,Non-OADS,/arxiv_data1/oa_pdf/5d/af/310.PMC3526063.pdf
Authors should use the NGSP ’sH b A 1cconverter at http://www.ngsp.org/convert1.asp to calculate HbA 1cvalues as both % and mmol/mol.,Non-OADS,/arxiv_data1/oa_pdf/5d/af/310.PMC3526063.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society Biochemical Journal    www.biochemj.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"For co-localization studies with exogenously and endogenouslyexpressed proteins, cells (1 ×10 5) were plated on to 13 mm glass coverslips and transfected with 1 μg each of the indicated c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"Similarly, no co-localization was observed between c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
Three-dimensional reconstruction of the acquired image stacks conﬁrmed that allCD63-positive structures were co-labelled by LAMP1–YCaM (Figure 3B and Supplementary Movie S1 at http://www.biochemj.,Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"Consistent with these observations, treatment of LAMP1–YCaM-transfected c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
also assessed the utility of this probe to measure Ca2+release at the single-organelle level (Figure 6 and Supplementary Movie S2 at http://www.biochemj.org/bj/449/bj4490449add.htm).,OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"Interestingly, c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"With these facts in mind we started the present study by constructing a lysosomally targeting c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"1, 11–21 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
"Cell Calcium 34, 109–119 Received 1 June 2012/24 October 2012; accepted 25 October 2012 Published as BJ Immediate Publication 25 October 2012, doi:10.1042/BJ20120898 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/26/bj4490449.PMC3526116.pdf
Available  from: http://www.bd.com/ds/   technicalCenter/inserts/Pseudomonas_Agars.pdf  [Last accessed   on 2011 Dec 31].,OADS,/arxiv_data1/oa_pdf/2b/cc/JRMS-17-332.PMC3526125.pdf
"Ministry of Health and Medical Education, Deputy of Research  [Online] 2011 [Citd 2011 Sept 22]; Available from: URL:  http://www.hbi.ir   11.",Non-OADS,/arxiv_data1/oa_pdf/09/eb/JRMS-17-393.PMC3526136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the origin-al work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/cd/dds427.PMC3526159.pdf
"Spike detection and analysis wereeither carried out in pClamp 10 or with routines written inIgor (TaroTools, Dr Taro Ishikawa, https://sites.google.com/site/tarotoolsregister) and further analysis was performedusing Excel or Igor software.",OADS,/arxiv_data1/oa_pdf/51/cd/dds427.PMC3526159.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.Human Molecular Genetics, 2013, Vol.",Non-OADS,/arxiv_data1/oa_pdf/bf/13/dds435.PMC3526165.pdf
Twelve of 40 basepositions containing heteroplasmic variants are reported tobe polymorphic ( .1% of reported sequences with variants) at the population level (http://www.mtdb.igp.uu.se/).,Non-OADS,/arxiv_data1/oa_pdf/bf/13/dds435.PMC3526165.pdf
"In our data, 21 of 31 controlregion ( MT-HV2 ) heteroplasmic variants were detected, and 2 of 9 coding region ( MT-CO3 ) variants have previous been reported as somatic variants (http://www.mitomap.org/MITOMAP) (Supplementary Material, Table S4).",OADS,/arxiv_data1/oa_pdf/bf/13/dds435.PMC3526165.pdf
Available at (http://hdl.handle.net/10101/ npre.2011.6466.1).,Non-OADS,/arxiv_data1/oa_pdf/ac/4a/ismej201290a.PMC3526173.pdf
"To view a copy of this license, visit h ttp://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on The I SME Journal website (http://www.nature.com/ismej)Genome sequence of the predatory Bacteriovorax marinus LC Crossman et al 160 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/ac/4a/ismej201290a.PMC3526173.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on The I SME Journal website (http://www.nature.com/ismej)Microbial mats of Guerrero Negro J Kirk Harris et al 60 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/5c/d0/ismej201279a.PMC3526174.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on The ISME Journal website (http: //www.nature.com/ismej)Biomolecular isolation for eco-systems biology H Roume et al 121 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/34/52/ismej201272a.PMC3526178.pdf
"Materials and methods Recovery of single-cell genomic DNA Genomic DNA was recovered from an individual cell representing the acI lineage at the Bigelow Laboratory Single Cell Genomics Center (http://www.bigelow.org/scgc), as previously described (Martinez-Garcia et al.",OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
All general aspects of and detailed protocols for library con- struction and sequencing can be found on the JGIwebsite (http://www.jgi.doe.gov/).,OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
"Genome size estimate An estimate of complete genome size was obtainedfor SCGC AAA027-L06 using core gene analysis.To identify the core genes, 138 Actinobacteria classfinished genomes, currently available at the DOE Joint Genome Institute Integrated Microbial Gen- omes site (IMG, http://img.jgi.doe.gov/, (Markowitzet al.",OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
", 2008) with 1000 bootstrap runs on the CIPRES web portal (http://www.phylo.org) using near-full-length reference 16S rRNA gene sequences from a manually curated alignment (Newton et al.",OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
http://infernal.janelia.org).Additional gene-prediction analysis and manualfunctional annotation was performed within the IMG platform.,OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
"To view acopy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on The IS ME Journal website (http://www.nature.com/ismej)Single-cell genomics of freshwater Actinobacteria SL Garcia et al 147 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/24/1f/ismej201286a.PMC3526179.pdf
Metagenomic sequences are deposited in Short Read Archive (http://www.ncbi.nlm.nih.gov/sra) with accession number SRA053109.,OADS,/arxiv_data1/oa_pdf/b5/87/ismej201282a.PMC3526184.pdf
org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on The I SME Journal website (http://www.nature.com/ismej)Microbial response to polyaromatics M-E Guazzaroni et al 136 The ISME Journal,OADS,/arxiv_data1/oa_pdf/b5/87/ismej201282a.PMC3526184.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a2/32/77.PMC3526198.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cc/54/98.PMC3526200.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d3/af/84.PMC3526201.pdf
Available from http://www.cdc.gov/nchs/about/major/ nhanes/datalink.htm.,OADS,/arxiv_data1/oa_pdf/d3/af/84.PMC3526201.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/97/0a/130.PMC3526202.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/89/4e/34.PMC3526204.pdf
"Corresponding author: Catherine Pihoker, catherine.pihoker@seattlechildrens.org.Received 16 April 2012 and accepted 3 July 2012.DOI: 10.2337/dc12-0720This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0720/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/17/d6/27.PMC3526205.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/17/d6/27.PMC3526205.pdf
DOI: 10.2337/dc12-0741 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0741/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f5/54/56.PMC3526206.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f5/54/56.PMC3526206.pdf
Avail-able from http://www.cdc.gov/pednss/ pdfs/PNSS_2009.pdf.,OADS,/arxiv_data1/oa_pdf/f5/54/56.PMC3526206.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/20.PMC3526207.pdf
"Corresponding author: L.A. Raynor, rayno007@umn.edu.Received 29 March 2012 and accepted 1 July 2012.DOI: 10.2337/dc12-0609This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0609/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/57/04/70.PMC3526210.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/57/04/70.PMC3526210.pdf
"Corresponding author: Thomas J. Hoerger, tjh@rti.org.Received 20 April 2012 and accepted 23 June 2012.DOI: 10.2337/dc12-0759This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0759/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/92/c5/63.PMC3526214.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/63.PMC3526214.pdf
Available at http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/PDFs/2010HepSurveillanceRpt.pdf.,OADS,/arxiv_data1/oa_pdf/92/c5/63.PMC3526214.pdf
Available at http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/63.PMC3526214.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c0/86/6.PMC3526217.pdf
"NCT01034319, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0884/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/a2/18/13.PMC3526219.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a2/18/13.PMC3526219.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f0/4a/104.PMC3526221.pdf
"Corresponding author: Carlos Lorenzo, lorenzo@uthscsa.edu.Received 16 January 2012 and accepted 6 July 2012.DOI: 10.2337/dc12-0101This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0101/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/18/d8/101.PMC3526225.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/18/d8/101.PMC3526225.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cb/b1/90.PMC3526228.pdf
Available from http://care.diabetesjournals.org/site/misc/stats.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/80/1.PMC3526229.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/64/f4/150.PMC3526231.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8d/5f/124.PMC3526233.pdf
Available from: http://www.connectingforhealth.nhs.uk/systemsandservices/data/uktc/ readcodes.,OADS,/arxiv_data1/oa_pdf/8d/5f/124.PMC3526233.pdf
Available from http://www.itmat.upenn.,Non-OADS,/arxiv_data1/oa_pdf/8d/5f/124.PMC3526233.pdf
"NCT01394055, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1128/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/37/7d/41.PMC3526234.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/37/7d/41.PMC3526234.pdf
DOI: 10.2337/dc12-0493 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0493/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/43/7a/137.PMC3526236.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/43/7a/137.PMC3526236.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/145.PMC3526237.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ea/23/157.PMC3526238.pdf
"Issues and Events ADA Events Intensive Diabetes Management for Primary Care 9 February 2013Hyatt RegencyDenver, ColoradoWeb site: professional.diabetes.org/colorado E-mail: sglass@diabetes.org 60th Annual Advanced Postgraduate Course 22–24 February 2013 Hilton New YorkNew York, New YorkWeb site: http://professional.diabetes.org/pg13 2013 Diabetes Professional Educators Conference 15–16 March 2013 Radisson Paper Valley Hotel Appleton, Wisconsin Web site: professional.diabetes.org/wisconsin E-mail: pkasprzak@diabetes.org28th Clinical Conference on Diabetes 23–26 May 2013 Hyatt Regency Grand CypressOrlando, FloridaWeb site: professional.diabetes.org/cc E-mail: plowe@diabetes.org 73rd Scienti ﬁc Sessions 21–25 June 2013 McCormick Place Convention CenterChicago, IllinoisWeb site: http://scienti ﬁcsessions.diabetes.org 74th Scienti ﬁc Sessions 13–17 June 2014 Moscone CenterSan Francisco, CaliforniaWeb site: http://scienti ﬁcsessions.diabetes.org Contact for information on ADA events: American Diabetes Association, 1701 N. Beauregard St., Alexandria, VA22311.Tel: 800-232-3472, select option 1.",Non-OADS,/arxiv_data1/oa_pdf/4d/9d/184.PMC3526240.pdf
Web site: http://professional.diabetes.org/ce.,Non-OADS,/arxiv_data1/oa_pdf/4d/9d/184.PMC3526240.pdf
Authors should use the NGSP ’sH b A 1cconverter at http://www.ngsp.org/ convert1.asp to calculate HbA 1cvalues as both % and mmol/mol.,Non-OADS,/arxiv_data1/oa_pdf/4d/9d/184.PMC3526240.pdf
DOI: 10.2337/dc12-0421This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0421/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/111.PMC3526241.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/111.PMC3526241.pdf
"Corresponding author: Johan Ärnlöv, johan.arnlov@pubcare.uu.se.Received 14 March 2012 and accepted 1 July 2012.DOI: 10.2337/dc12-0494This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0494/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/8a/a1/163.PMC3526243.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8a/a1/163.PMC3526243.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4b/4e/118.PMC3526247.pdf
DOI: 10.2337/dc11-1864This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-1864/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
Available at http://www.cdc.gov/nchs/ data/series/sr_02/sr02_130.pdf.,OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
Available at http://www.cdc.gov/nchs/data/datalinkage/match- ing_methodology_nhis_ ﬁnal.pdf.,OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
Available at http://www.census.gov/hhes/ www/poverty/publications/p60-210.pdf.Accessed 6 August 2012 32.,Non-OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
Available at http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
Available at http://www.ahrq.gov/news/press/pr2011/lowhlitpr.htm.,Non-OADS,/arxiv_data1/oa_pdf/f1/fc/49.PMC3526248.pdf
"Corresponding author: Lie-Gang Liu, lgliu@mails.tjmu.edu.cn.Received 12 April 2012 and accepted 26 July 2012.DOI: 10.2337/dc12-0702This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0702/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/80/de/166.PMC3526249.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/80/de/166.PMC3526249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/20/ec/gks757.PMC3526259.pdf
"MATERIALS AND METHODS System and software requirements PanOCT was written in PERL (http://www.perl.org (1 August 2012, date last accessed)) and tested using PERL version 5.10 on Linux CentOS and Mac OS X 10.6 operating systems.",OADS,/arxiv_data1/oa_pdf/20/ec/gks757.PMC3526259.pdf
"To perform BLAST searches, either National Center for Biotechnology Information (NCBI) BLASTALL (23) version 2.2.10 or later (ftp://ftp.ncbi.nih.gov/blast/executables/release/ (1 August 2012, date last accessed)) or WUBLAST 2.0 (now called AB-BLAST available at http://blast.advbiocomp.com (1 August 2012, date last accessed)) are required.",Non-OADS,/arxiv_data1/oa_pdf/20/ec/gks757.PMC3526259.pdf
"AVAILABILITY ThePanOCT source code as well as the input and output ﬁles used in this study can be freely obtained at http:// panoct.sourceforge.net/ (2 August 2012, date lastaccessed) under version 3 of the GNU General Public License (http://www.gnu.org/licenses/ (2 August 2012, date last accessed)).",OADS,/arxiv_data1/oa_pdf/20/ec/gks757.PMC3526259.pdf
"the NIH Roadmap Epigenomics Mapping Consortium (www.roadmapepigenomics.org), the Human Epigenome Project (www.epigenome.org) and theBlueprint project (http://www.blueprint-epigenome.eu)are addressed to map DNA methylation, histone modiﬁ- cations and other chromatin features in different cell and tissue types.",Non-OADS,/arxiv_data1/oa_pdf/03/4e/gks928.PMC3526261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/4e/gks928.PMC3526261.pdf
"Reads weredownloaded from http://neomorph.salk.edu/human_ methylome/data.html (H1 and IMR90) and http://neo morph.salk.edu/ips_methylomes/data.html (rest of celllines), processed to be SAM-like, transformed to the BAM format and indexed using the C + + program SAMTOOLS (32).",OADS,/arxiv_data1/oa_pdf/03/4e/gks928.PMC3526261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/a3/gks1131.PMC3526263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/2a/16/gks765.PMC3526265.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/gks926.PMC3526267.pdf
Chicken DT40-CRE cells (34) were grown as des- cribed on the DT40 website (http://pheasant.gsf.de/ DEPARTMENT/dt40.html).,Non-OADS,/arxiv_data1/oa_pdf/87/0e/gks926.PMC3526267.pdf
DT40 website (http://pheasant.gsf.de/DEPARTMENT/ dt40.html).,Non-OADS,/arxiv_data1/oa_pdf/87/0e/gks926.PMC3526267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/c4/gks957.PMC3526268.pdf
Enrichment for TF motifs was done using the Analysis of Motif Enrichment (AME) (17) and MEME Suite (18); sequences 100 bp (±50 bp) around signiﬁcant CpGswere retrieved and analysed with core motifs from the TRANSFAC Professional (http://www.gene-regulation.,OADS,/arxiv_data1/oa_pdf/03/c4/gks957.PMC3526268.pdf
"DNA sequences, positional information of the NCBI reference genes, the ENCODE chromatin immunoprecipitation sequencing (ChIP-Seq) data, and CpG island (CGI) annotations were retrieved from the UCSC database (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/03/c4/gks957.PMC3526268.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/bd/gks956.PMC3526270.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/87/gks953.PMC3526272.pdf
Secondary structures of 50non-coding region (nucleotides 3–263) of HCV RNA (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).,OADS,/arxiv_data1/oa_pdf/31/87/gks953.PMC3526272.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/7c/gks1317.PMC3526274.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/d7/gks929.PMC3526276.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/08/gks898.PMC3526277.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/07/gks925.PMC3526278.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/1e/gks921.PMC3526279.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/35/gks944.PMC3526282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/82/gks920.PMC3526284.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/af/gks895.PMC3526287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/fd/gks933.PMC3526288.pdf
"Structural quality was assessed using PROCHECK-NMR (29).Molecular images were generated using molecular visual-ization system Pymol, Delano Scientiﬁc (http://www.pymol.org/).",OADS,/arxiv_data1/oa_pdf/a1/fd/gks933.PMC3526288.pdf
Structure similarity searches were performedusing the DALI server (http://www.ebi.ac.uk/dali/index.html) (30).,OADS,/arxiv_data1/oa_pdf/a1/fd/gks933.PMC3526288.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/f0/gks913.PMC3526291.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/85/gks927.PMC3526292.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/86/e7/gks754.PMC3526293.pdf
"A number of lossy compression algorithms for quality scores have been proposed, including various binningschemes implemented in QScores-Archiver (8) andSCALCE (http://scalce.sourceforge.net), scaling to a reduced alphabet with randomized rounding inSlimGene (5), and discarding quality scores for baseswhich match a reference sequence in Cramtools (6).",Non-OADS,/arxiv_data1/oa_pdf/86/e7/gks754.PMC3526293.pdf
"To perform ameaningful benchmark, we compared our dlCBF imple- mentation with the sparsehash library (http://code.google .com/p/sparsehash/), an open-source hash table imple-mentation with the expressed goal of maximizing space efﬁciency.",OADS,/arxiv_data1/oa_pdf/86/e7/gks754.PMC3526293.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/a3/gks903.PMC3526294.pdf
"Bioinformatic predictions, based on theNetNGlyc 1.0 and NetOGlyc 3.1 server interfaces(http://www.cbs.dtu.dk/services/NetOGlyc/), unveiled,among others, the presence of a total of 12 putativeglycosylation sites, i.e.",OADS,/arxiv_data1/oa_pdf/a2/a3/gks903.PMC3526294.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/55/gks954.PMC3526295.pdf
Chk1blots were performed as previously described (30) using 90Gy of IR and harvested 30 minutes post treatment and were quantiﬁed using ImageJ software (http://rsb.info .nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/1c/55/gks954.PMC3526295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/0c/gks948.PMC3526297.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c6/96/gks778.PMC3526298.pdf
It is available at https://github.com/dgrtwo/ OASIS.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/gks778.PMC3526298.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/a2/gks934.PMC3526299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/gks931.PMC3526300.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/26/gks973.PMC3526302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/83/gks943.PMC3526303.pdf
"RESULTS Identiﬁcation of the novel lncRNA CRG To study the function of lncRNAs in the nervous system ofDrosophila , we screened 16 302 D. melanogaster ESTs downloaded from Unigene (Build #37, ftp://ftp.ncbi.nih.gov/repository/UniGene/) for lncRNAs that were expressed in the central nervous system (CNS).",OADS,/arxiv_data1/oa_pdf/0e/83/gks943.PMC3526303.pdf
We then analysed 5 kb of genomic sequence ﬂanking both sides of each EST locus using GenScan (39) and Genie (41) and compared the ESTs and their ﬂanking regions against the Swiss-Prot protein sequence database (ftp://us.expasy.org/databases/swiss-prot) using BLAST to identify any remaining sequences with protein-coding capacity.,OADS,/arxiv_data1/oa_pdf/0e/83/gks943.PMC3526303.pdf
After checking the expression information for these candidates in the EST database (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/0e/83/gks943.PMC3526303.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/c4/gks914.PMC3526304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/be/gks952.PMC3526306.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/1d/f3/gks784.PMC3526307.pdf
"Maximum intensity projections or single Z-slices were assembled into galleries and videos and annotated using ImageJ (http://rsb.info.nih.gov/ij/ 6 August 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/1d/f3/gks784.PMC3526307.pdf
"Structural data were displayed and annotated using PyMOL software (http://pymol.sourceforge.net/ 6 August 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/1d/f3/gks784.PMC3526307.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/d7/gks923.PMC3526308.pdf
Ms6482 is a hypothetical protein-coding gene and Ms6484 encodes a glycosyl transferase (http://www.ncbi .nlm.nih.gov/protein/).,Non-OADS,/arxiv_data1/oa_pdf/25/d7/gks923.PMC3526308.pdf
This use of distributed computing allows the analysis of an average-sized prokaryotic genome in less than 5 h. GNARE is available at http://compbio.mcs.anl.,Non-OADS,/arxiv_data1/oa_pdf/18/c4/gkm366.PMC3526309.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/c4/gkm366.PMC3526309.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/db/gks947.PMC3526311.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/41/7f/gks751.PMC3526312.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/d6/gks930.PMC3526313.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f4/fc/gks771.PMC3526315.pdf
"We implementedmodiﬁcations of the motif modeling approach one by oneto illustrate the effect of each modiﬁcation on accuracy.The PMM that incorporates all improvements consideredhere (both new features and new algorithmic steps),SVMR-PMM-FS, was found to be the most accurate.The source code for the software used to generate ourresults is freely available at http://dinner-group.uchicago.edu/downloads.html.e175 Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/f4/fc/gks771.PMC3526315.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/d7/gks932.PMC3526316.pdf
"The aligned reads were used as input to identify peaksas well as visualization in the UCSC Genome Browser.To compare the genomic locations of our FoxO1 ChIP- seq peaks with those of FoxA2 ChIP-seq peaks, the FoxO1 ChIP-seq bed ﬁles aligned to the mm9 mouse ref-erence genome were re-mapped onto the mm8 mouse ref-erence genome using UCSC liftOver (http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/c8/d7/gks932.PMC3526316.pdf
The FoxA2 ChIP-seq data were obtainedfrom http://www.bcgsc.ca/data/chipseq/chip-seq-data (20).,OADS,/arxiv_data1/oa_pdf/c8/d7/gks932.PMC3526316.pdf
We alsopresent experimental validation for LoFreq on twodifferent platforms (Fluidigm and Sequenom) andits application to call rare somatic variants fromexome sequencing datasets for gastric cancer.Source code and executables for LoFreq are freely available at http://sourceforge.net/projects/lofreq/.,OADS,/arxiv_data1/oa_pdf/b0/b4/gks918.PMC3526318.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/b4/gks918.PMC3526318.pdf
Availability of datasets All simulated and sequencing datasets generated in this study can be downloaded from http://collaborations.gis.a- star.edu.sg/ /C24wilma/lofreq_paper_data/ and sequencing data will be available soon from the Sequence Read Archive.,OADS,/arxiv_data1/oa_pdf/b0/b4/gks918.PMC3526318.pdf
"Currently, there are more than 1500 known miRNAs in the human genome (http://www.mirbase.org).",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/gks912.PMC3526334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/gks912.PMC3526334.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1006/exnr.1994.114 9 Barrett, P.J., Y.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1126/science   .121998 8 Bełtowski, J.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1111/j.1755-   5922.2008.00062. x Blauw, G.J., J. Shepherd, and M.B.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)80213- 5 Cordy, J.M., N.M. Hooper, and A.J.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/   10.1016/j.febslet.2009.12.04 3 Cramer, P.E., J.R. Cirrito, D.W. Wesson, C.Y.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1126/science.121769 7 Davidson, C.D., N.F .",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1371/journal.pone.000695 1 Di Paolo, G., and T.W.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1038/nrn301 2 Dickson, T.C., C.E.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1006/exnr.1998.701 0 Ehehalt, R., P. Keller, C. Haass, C. Thiele, and K. Simons.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1083/   jcb.20020711 3 Fontaine, C., E. Rigamonti, B. Pourcet, H. Duez, C. Duhem, J.C. Fruchart,  G. Chinetti-Gbaguidi, and B. Staels.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1210/   me.2007-043 9 Guirland, C., S. Suzuki, M. Kojima, B. Lu, and J.Q.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00157- 6 Hartmann, T., J. Kuchenbecker, and M.O.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
http://addiandcassi.com/wordpress/wp-content/ uploads/Hempel-Cyclodextrin-Intrathecal-FDA-Filing-2010-Aug.pdf  Accessed.,Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1074/ jbc.M50878120 0 Jessup, W ., I.C.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.1317-11.201 1 Bahr, B.A., B. Abai, C.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1038/nature0661 6 Mondal, M., B. Mesmin, S. Mukherjee, and F.R.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1091/mbc.E08-07-078 5 Morgan, D. 2011.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
http://dx.doi.org/10.1111/j.1365-2796.2010.02315.,Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)63163- X Nixon, R.A., A.M. Cataldo, and P .M.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1023/   A:100767550841 3 Peake, K.B., and J.E.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/ 10.1038/   nn0403-34 5 Ramirez, C.M., B. Liu, A.M. Taylor, J.J. Repa, D.K.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1203/PDR   .0b013e3181ee4dd 2 Ramirez, C.M., B. Liu, A. Aqul, A.M. Taylor, J.J. Repa, S.D.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1194/jlr   .M01378 9 Rigamonti, E., L. Helin, S. Lestavel, A.L.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/j.abb.2010.06.00 4 Schmitz, G., and W. Drobnik.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1159/00029566 0 T erwel, D., K.R.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.6546-10.201 1 Vetrivel, K.S., and G. Thinakaran.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/j.bbalip.2010.03.00 7 Wahrle, S., P. Das, A.C. Nyborg, C. McLendon, M. Shoji, T.  Kawarabayashi, L.H.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1006/nbdi.2001.047 0 Wahrle, S.E., H. Jiang, M. Parsadanian, R.E.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1097/01.mol.0000226116   .35555.e b Jick, H., G.L.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1016/S0140-6736(00)03155- X Kågedal, K., W.S.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/   j.bbalip.2010.05.00 5 Kim, W.S., A.S. Rahmanto, A. Kamili, K.A.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1074/jbc.M60783120 0 Kivipelto, M., E.L. Helkala, M.P .",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1136/   bmj.322.7300.144 7 Kodam, A., M. Maulik, K. Peake, A. Amritraj, K.S.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/   10.1002/glia.2100 1 Koldamova, R., M. Staufenbiel, and I. Lefterov.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi   .org/10.1074/jbc.M50451320 0 Koldamova, R.P., I.M.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"280:4079– 4088. http://dx.doi.org/10.1074/jbc.M41142020 0 Lee, S.J., U. Liyanage, P.E.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1038/   nm0698-73 0 Liu, B., H. Li, J.J. Repa, S.D.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1194/jlr.M700525-JLR20 0 Liu, B., S.D.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1073/   pnas.081089510 6 Liu, B., C.M.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1194/ jlr.M00025 7 Maulik, M., B. Ghoshal, J. Kim, Y. Wang, J. Yang, D. Westaway, and  S. Kar.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1093/hmg/dds32 2 Maxwell, K.N., R.E.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"44:2109– 2119. http://dx.doi.org/10.1194/jlr.M300203-JLR20 0 McGuinness, B., D. Craig, R. Bullock, and P. Passmore.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/j.bbalip.2009   .03.00 2 Meyer-Luehmann, M., T.L.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1074/ jbc.M50878020 0 Wahrle, S.E., H. Jiang, M. Parsadanian, J. Kim, A. Li, A. Knoten, S. Jain,  V. Hirsch-Reinshagen, C.L.",Non-OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1016/j.nbd.2007.10.00 5 Yang, D.S., P. Stavrides, P.S.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1093/brain/awq34 1 Yao, J., Y. Sasaki, Z. Wen, G.J.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1038/nn177 3 Yao, J., T. Hennessey, A. Flynt, E. Lai, M.F.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
"http://dx.doi.org/10.1371/journal.pone.001554 6 Zhang, L., R. Sheng, and Z. Qin.",OADS,/arxiv_data1/oa_pdf/ee/85/JEM_20121239.PMC3526350.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/nature0753 7 Cupedo, T., N.K.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/ni.166 8 Eberl, G., and D.R.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
http://dx.doi.org/10.1034/j.1600- 065X.2003.00074.,Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1016/j.cell.2007.08.01 7 Ghoreschi, K., A. Laurence, X.P.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/nature0944 7 Gordon, S.M., J. Chaix, L.J.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"36:55– 67. http://dx.doi.org/10.1016/j.immuni.2011.11.01 6 Hooper, L.V., and A.J.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/nri271 0 Jenne, C.N., A. Enders, R. Rivera, S.R.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1084/jem   .2009052 5 Kennedy, M.K., M. Glaccum, S.N.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/   10.1038/ni.218 7 Luci, C., A. Reynders, I.I.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/ni.168 1 Luther, S.A., K.M.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/   10.1084/jem.2002129 4 Molloy, M.J., N. Bouladoux, and Y .",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1016/j.smim.2011.11.00 8 Pearson, C., H.H.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1016/j.it.2012.04.00 4 Qiu, J., J.J. Heller, X. Guo, Z.M.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1007/978-1-60761-362-6_3 2 Sanos, S.L., V .L.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/   ni.168 4 Satoh-Takayama, N., C.A.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1016/j.immuni   .2008.11.00 1 Satoh-Takayama, N., L. Dumoutier, S. Lesjean-Pottier, V .S.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.4049/   jimmunol.090193 5 Satoh-Takayama, N., S. Lesjean-Pottier, P .",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi   .org/10.1084/jem.2009202 9 Sawa, S., M. Cherrier, M. Lochner, N. Satoh-Takayama, H.J.",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/   10.1182/blood-2010-07-29710 1 Sonnenberg, G.F ., L.A. Fouser, and D. Artis.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/   ni.202 5 Spits, H., and J.P .",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
http://dx.doi.org/10.1038/ni.196 2,Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1126/science.288.5475.236 9 Takahashi, H., T. Kanno, S. Nakayamada, K. Hirahara, G. Sciumè, S.A. Muljo,  S. Kuchen, R. Casellas, L. Wei, Y .",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1038/ni.228 6 Takatori, H., Y .",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi   .org/10.1084/jem.2007271 3 Townsend, M.J., A.S. Weinmann, J.L.",Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
"http://dx.doi.org/10.1016/S1074-7613   (04)00076- 7 Y okota, Y ., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P .",OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
397:702– 706. http://dx.doi.org/10.1038/1781 2,Non-OADS,/arxiv_data1/oa_pdf/62/63/JEM_20122097.PMC3526352.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi   .org/10.1161/CIRCRESAHA.109.20110 3 Cechin, S.R., P.R.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi   .org/10.1007/s11064-005-2747- 4 Chen, Y., S.S. Yan, J. Colgan, H.P.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1146/annurev   .pharmtox.010909.10575 3 Chun, J., T. Hla, K.R.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1124/pr.110.00311 1 Copeland, J.W., and R. Treisman.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi   .org/10.1091/mbc.02-06-009 2 Dattilo, B.M., G. Fritz, E. Leclerc, C.W.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1021/bi700373 5 Eng, C.H., T.M.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1091/mbc.E05-10-091 4 Georas, S.N.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80801- 6 Hudson, B.I., A.Z.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"283:34457– 34468. http://dx.doi.org/10.1074/jbc.M80146520 0 Kim, J., J.R. Keys, and A.D. Eckhart.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/j.cellsig.2006.01.00 9 Kitzing, T.M., A.S. Sahadevan, D.T.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1101/gad.42480 7 Koch, M., S. Chitayat, B.M.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/   j.str.2010.05.01 7 Leclerc, E., G. Fritz, M. Weibel, C.W.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1158/1535-7163.MCT-08-110 6 Lin, M.E., D.R.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/j.prostaglandins   .2009.02.00 2 Liu, S., M. Umezu-Goto, M. Murph, Y. Lu, W. Liu, F. Zhang, S. Yu,  L.C.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/   10.1016/j.ccr.2009.03.02 7 McIntyre, T.M., A.V.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1002/bies.2008 1 Pamuklar, Z., L. Federico, S. Liu, M. Umezu-Goto, A. Dong, M. Panchatcharam,  Z. Fulkerson, E. Berdyshev, V. Natarajan, X. Fang, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1074/jbc   .M80782020 0 Panchatcharam, M., S. Miriyala, F. Yang, M. Rojas, C. End, C. Vallant,  A. Dong, K. Lynch, J. Chun, A.J.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.108.18077 8 Park, L., K.G.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1038/201 2 Roby, K.F., C.C.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1093/carcin/21.4.58 5 Sakaguchi, T., S.F.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/   10.1016/j.bbalip.2008.05.00 8 Taguchi, A., D.C.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"405:354– 360. http://dx.doi.org/10.1038/3501262 6 Touré, F., G. Fritz, Q. Li, V. Rai, G. Daffu, Y.S.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi   .org/10.1161/CIRCRESAHA.111.26251 9 Valentine, W.J., Y. Fujiwara, R. Tsukahara, and G. Tigyi.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/j.bbagen.2007.08.00 8 Xu, Y., F. Toure, W. Qu, L. Lin, F. Song, X. Shen, R. Rosario, J. Garcia,  A.M. Schmidt, and S.F.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi   .org/10.1074/jbc.M110.11745 7 Xue, J., V. Rai, D. Singer, S. Chabierski, J. Xie, S. Reverdatto, D.S.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1016/j.str.2011.02.01 3 Yan, S.F ., R. Ramasamy, and A.M. Schmidt.",OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA   .109.21221 7 Zhou, Z., K. Wang, M.S.",Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
107:2238– 2243. http://dx.doi.org/10.1161/01.CIR.0000063577.32819.2 3,Non-OADS,/arxiv_data1/oa_pdf/d5/b6/JEM_20120873.PMC3526353.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1038/7320 0 Biesiekierski, J.R., E.D.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1038/ajg.2010.48 7 Brandl, K., T. Glück, P .",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/j.crvi.2010.12.01 3 Chowers, Y., M.N.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1038/nri163 0 Maiuri, L., C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, S. Auricchio, J.  Picard, M. Osman, S. Quaratino, and M. Londei.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/S0140-   6736(03)13803- 2 McGettrick, A.F., E.K.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1038/   nature0624 6 Molberg, O., S.N.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"4:713– 717. http://dx.doi.org/10.1038/nm0698-71 3 Nikulina, M., C. Habich, S.B.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1007/s10875-008-9228- x Ryan, C.A.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"28:425– 449. http://dx.doi.org/10.1146/annurev.py.28.090190.00223 3 Sands, D.C., C.E.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi   .org/10.1016/j.plantsci.2009.07.01 1 Schuppan, D., Y. Junker, and D. Barisani.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi   .org/10.1053/j.gastro.2009.09.00 8 Shan, L., O. Molberg, I. Parrot, F. Hausch, F. Filiz, G.M.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1126/science.107412 9 Sheedy, F.J., E. Palsson-McDermott, E.J.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"11:141– 147. http://dx.doi.org/10.1038/ni.182 8 Shewry, P.R., N.G.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/   S0065-2660(03)01003- 4 Szebeni, B., G. Veres, A. Dezsofi, K. Rusai, A. Vannay, G. Bokodi, B.  Vásárhelyi, I.R.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/   10.1007/s10875-006-9061- z Cordain, L. 1999.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1159/00005967 7 Di Sabatino, A., and G.R.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/S0140-6736(09)60254- 3 Dieterich, W., T. Ehnis, M. Bauer, P. Donner, U. Volta, E.O.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/   10.1038/nm0797-79 7 Erridge, C. 2010.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1189/jlb   .120977 5 Fasano, A., I. Berti, T. Gerarduzzi, T. Not, R.B.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi   .org/10.1001/archinte.163.3.28 6 Fitzgerald, K.A., D.C. Rowe, B.J.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1084/   jem.2003102 3 Fortier, A.H., D.L.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/S0140-6736   (59)92051- 3 Green, P.H., and C. Cellier.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"357:1731– 1743. http://dx.doi.org/10.1056/NEJMra07160 0 Hüe, S., J.J.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi   .org/10.1016/j.immuni.2004.06.01 8 Iwasaki, A., and R. Medzhitov.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10   .1038/ni111 2 Kawai, T., and S. Akira.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1186/ar146 9 Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80086- 2 Kim, K.D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y.X.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi/org/10.1038/nm163 3 Kontakou, M., R.T. Przemioslo, R.P.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1136/gut.37.1.5 2 Kornek, M., Y. Popov, T.A.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1002/hep.2399 9 Krishnamurthy, D., Y. Levin, L.W.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1002/pmic.20100049 6 Lammers, K.M., R. Lu, J. Brownley, B. Lu, C. Gerard, K. Thomas, P.  Rallabhandi, T. Shea-Donohue, A. Tamiz, S. Alkan, et al.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
http://dx.doi.org/10.1053/j.gastro.2008.03.02 3,Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/   10.1038/nature0754 8 van de W al, Y ., Y .",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1038/ajg.2009.18 8Vissers, M.C., S.A. Jester, and J.C. Fantone.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1016/j.fm.2006.07.00 4 Wieser, H., and P. Koehler.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
"http://dx.doi.org/10.1094/CCHEM-85-   1-000 1 Wieser, H., S. Antes, and W. Seilmeier.",OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
http://dx.doi   .org/10.1094/CCHEM.1998.75.5.64 4,Non-OADS,/arxiv_data1/oa_pdf/95/63/JEM_20102660.PMC3526354.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1084/   jem.2010012 4 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1038/nature0444 4 Barber, D.L., K.D.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/0166-0934(91)90018- U Berman, D., S.M.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1053/j.seminoncol.2010.09.00 7 Dong, H., G. Zhu, K. Tamada, D.B.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1016/S1074-7613(04)00050- 0 Driessens, G., J. Kline, and T.F.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
http://dx.doi.org/10.1111/j.1600-065X.2009.00771.,Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1093/infdis/155.3.46 5 Flatz, L., T. Rieger, D. Merkler, A. Bergthaler, T. Regen, M. Schedensack,  L. Bestmann, A. Verschoor, M. Kreutzfeldt, W .",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1371/journal.ppat.100083 6 Francisco, L.M., P.T.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1126/scitranslmed.300201 1 Grabie, N., I. Gotsman, R. DaCosta, H. Pang, G. Stavrakis, M.J. Butte,  M.E.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1084/jem   .191.7.124 7 Ha, S.J., S.N.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1084/jem.2007194 9 Hamel, K.M., Y .",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1002/eji.20104069 0 Hensley, L.E., M.A.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"8:205. http://dx.doi.org/10.1186/   1743-422X-8-20 5 Iwai, Y., S. Terawaki, M. Ikegawa, T. Okazaki, and T. Honjo.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1084/jem.2002223 5 Kägi, D., B. Ledermann, K. Bürki, P .",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1038/369031a 0 Keir, M.E., and A.H. Sharpe.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
http://dx.doi.org/10.1111/ j.0105-2896.2005.00242.,Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1038/nature0759 1 Kline, J., and T.F.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1083/jcb.20010410 3Blackburn, S.D., H. Shin, G.J.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1073/   pnas.080149710 5 Blackburn, S.D., H. Shin, W.N.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1128/JVI   .01579-0 9 Bolinger, B., D. Engeler, P .",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1002/   eji.20093970 6 Brahmer, J.R., C.G.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1200/JCO.2009.26.760 9 Brahmer, J.R., S.S. Tykodi, L.Q.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1056/   NEJMoa120069 4 Brown, K.E., G.J.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/j.coi.2010.03.00 7 Bucks, C.M., J.A.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.4049/   jimmunol.080099 7 Campbell, I.L.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/S0165-   5728(96)00129- 4 Campbell, I.L., A. Samimi, and C.S.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1371/journal.ppat.100134 7 Chiodi, F. 2010.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1172/JCI4487 2 Cines, D.B., E.S.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
http://dx.doi   .org/10.1038/nature0511 5,Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1128/JVI.79.10.5979-5987.200 5 Lafon, M., F. Mégret, S.G. Meuth, O. Simon, M.L.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1002/(SICI)1096- 9071(199912)59:4<552::AID-JMV21>3.0.CO;2- A Matthay, M.A., and R.L.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1146/annurev-pathol-011110-13015 8 Mkrtichyan, M., Y.G.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1002/eji.20114163 9 Mueller, S.N., and R. Ahmed.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1371/journal.ppat.100031 3 Nishimura, H., and T. Honjo.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1093/intimm/10.10.156 3 Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80089- 8Nishimura, H., T. Okazaki, Y .",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1126/science.291   .5502.31 9 Pascolo, S., N. Bervas, J.M.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1084/jem.185.12.204 3 Phares, T.W., S.A. Stohlman, D.R.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.4049/jimmunol.100198 4 Pircher, H., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and  R.M.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/   10.1038/346629a 0 Rodig, N., T. Ryan, J.A.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1002/eji.20032427 0 Shresta, S., K.L.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi   .org/10.1128/JVI.00062-0 6 Srikiatkhachorn, A.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1093/infdis/jiq02 0 Topalian, S.L., F.S.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/   10.1056/NEJMoa120069 0 Tracey, K.J., Y. Fong, D.G.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1038/330662a 0 Urbani, S., B. Amadei, D. Tola, G. Pedrazzi, L. Sacchelli, M.C.",Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/j.jhep.2007.12.01 4 Velu, V., K. Titanji, B. Zhu, S. Husain, A. Pladevega, L. Lai, T.H.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1038/nature0766 2 Virgin, H.W., E.J.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06   .036 Wilson, E.B., and D.G.",OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
http://dx.doi.org/10.1007/s12026-010-8162- 1,Non-OADS,/arxiv_data1/oa_pdf/94/63/JEM_20121015.PMC3526355.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20121387/DC1.,Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi   .org/10.1182/blood-2003-12-429 1 Basso, K., P. Sumazin, P. Morozov, C. Schneider, R.L.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.03.01 7 Basso, K., M. Saito, P. Sumazin, A.A. Margolin, K. Wang, W.K.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1182/   blood-2009-06-22701 7 Betel, D., A. Koppal, P. Agius, C. Sander, and C. Leslie.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1084/jem.2005145 0 Lefebvre, C., P. Rajbhandari, M.J. Alvarez, P. Bandaru, W.K.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"6:377. http://dx.doi   .org/10.1038/msb.2010.3 1 Lewis, B.P., C.B.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1016/   j.cell.2004.12.03 5 Niu, H., B.H.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi   .org/10.1101/gad.12.13.195 3 Pasqualucci, L., A. Migliazza, K. Basso, J. Houldsworth, R.S.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1182/blood-2002-11-   3387 Pasqualucci, L., G. Bhagat, M. Jankovic, M. Compagno, P. Smith, M.  Muramatsu, T. Honjo, H.C. Morse III, M.C.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1038/   ng.2007.3 5 Pasqualucci, L., D. Dominguez-Sola, A. Chiarenza, G. Fabbri, A. Grunn,  V. Trifonov, L.H.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1038/nature0973 0 Pedersen, I.M., D. Otero, E. Kao, A.V.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1002/emmm   .20090002 8 Rai, D., S.W.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1126/science.113925 3 Saito, M., J. Gao, K. Basso, Y. Kitagawa, P.M. Smith, G. Bhagat, A. Pernis,  L. Pasqualucci, and R. Dalla-Favera.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.08.01 1 Subramanian, A., P. Tamayo, V.K.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"274:157– 167. http://dx.doi.org/10.1016/S0378-1119(01)00612- 6 Tam, W., D. Ben-Yehuda, and W.S.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10   .1186/gb-2010-11-8-r9 0 Bornkamm, G.W., C. Berens, C. Kuklik-Roos, J.M.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/   10.1016/j.ccr.2005.03.03 7 Cattoretti, G., M. Büttner, R. Shaknovich, E. Kremmer, B. Alobeid, and   G. Niedobitek.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10   .1182/blood-2005-10-417 0 Chang, C.C., B.H.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/   10.1073/pnas.93.14.694 7 Chen, W., S. Iida, D.C. Louie, R. Dalla-Favera, and R.S.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1182/blood-2008-12-19303 7 Clurman, B.E., and W.S.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1182/blood-2011-   08-37053 6 Dorsett, Y., K.M.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"28:630– 638. http://dx.doi.org/10.1016/j.immuni.2008.04.00 2 Duan, S., L. Cermak, J.K. Pagan, M. Rossi, C. Martinengo, P.F.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1038/nature1068 8 Eis, P.S., W. Tam, L. Sun, A. Chadburn, Z. Li, M.F.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi   .org/10.1371/journal.pbio.002036 3 Klein, U., Y. Tu, G.A.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1126/science.114122 9 Thomas, M.D., C.S.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1016/   j.immuni.2005.08.00 5 van den Berg, A., B.J.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1002/gcc.1018 6 van den Hurk, J.A., M. Schwartz, H. van Bokhoven, T.J. van de Pol, L.  Bogerd, A.J.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1002/ (SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2- D Victora, G.D., and M.C.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/10.1146/annurev-immunol-   020711-07503 2 Victora, G.D., T.A.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.10.03 2 Victora, G.D., D. Dominguez-Sola, A.B.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/   10.1182/blood-2012-03-41538 0 Vigorito, E., K.L.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/   10.1016/j.immuni.2007.10.00 9 Volinia, S., G.A.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
"http://dx.doi.org/   10.1073/pnas.051056510 3 Ye, B.H., S. Chaganti, C.C.",OADS,/arxiv_data1/oa_pdf/16/e6/JEM_20121387.PMC3526356.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"183:1055– 1064. http://dx.doi.org/10.4049/jimmunol.090040 4 DeFord-Watts, L.M., D.S.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi   .org/10.4049/jimmunol.100272 1 Dustin, M.L., T. Starr, R. Varma, and V.K.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1083/jcb.20101202 8 Folmer, D.E., R.P.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1016/j.bbalip.2009.02.00 8 Fridriksson, E.K., P.A.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1021/bi982832 4 Grakoui, A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi   .org/10.1126/science.285.5425.22 1 Hashimoto-Tane, A., T. Yokosuka, C. Ishihara, M. Sakuma, W. Kobayashi,  and T. Saito.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1128/MCB.00160-1 0 Hirata, F., J. Axelrod, and F.T.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi   .org/10.1073/pnas.76.10.481 3 Huang, J., V.I.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1038/nature0874 6 Irvine, D.J., M.A.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1038/nature0107 6 Jordan, M.S., and G.A.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00250 1 Kay, J.G., M. Koivusalo, X. Ma, T. Wohland, and S. Grinstein.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1091/mbc.E11-11-093 6 Kuhns, M.S., M.M.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.01.00 6 Padilla-Parra, S., N. Audugé, H. Lalucque, J.C. Mevel, M. Coppey-Moisan,  and M. Tramier.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"97:2368– 2376. http://dx.doi.org/10.1016/j.bpj.2009.07.04 4 Reth, M. 1989.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1146/annurev.immunol.20.092601.11135 7 Schubert, D.A., S. Gordo, J.J. Sabatino Jr., S. Vardhana, E. Gagnon, D.K.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20120790/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1038/8093 0 Balagopalan, L., N.P.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1083/jcb.20020304 3 Call, M.J., X. Xing, G.D. Cuny, N.P.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.4049/jimmunol.080346 4 Campi, G., R. V arma, and M.L.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1084/jem.2005118 2 Choudhuri, K., D. Wiseman, M.H.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10   .1016/S0960-9822(01)00326- 8 Daleke, D.L.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1194/ jlr.R200019-JLR20 0 Day, C.L., N.P.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1101/   cshperspect.a00227 9 Wucherpfennig, K.W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J.L.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"179:279– 290. http://dx.doi.org/10.1084/jem.179.1.27 9 Xu, C., E. Gagnon, M.E.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.09.04 4 Yeung, T., M. Terebiznik, L. Yu, J. Silvius, W.M.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1126/science   .115206 6 Yeung, T., B. Heit, J.F.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1083/   jcb.20090302 0 Yokosuka, T., and T. Saito.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"340:81– 107. http://dx.doi.org/10.1007/978-3-642-03858-7_ 5 Zhang, T.T., H. Li, S.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
http://dx.doi.org/   10.1111/j.1600-065X.2009.00838.,Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1084/jem   .2011148 5 Schuiki, I., and G. Daum.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi   .org/10.1002/iub.15 9 Shi, J., C.W.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi   .org/10.1016/j.bbamem.2004.09.00 6 Sigalov, A.B., D.A.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1021/bi061108 f Stauffer, T.P., S. Ahn, and T. Meyer.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1016/S0960-   9822(98)70135- 6 Sun, Y., R.D.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1038/nprot.2011.36 4 Suzuki, J., M. Umeda, P.J.",OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
"http://dx.doi.org/10.1038/375148a 0 Vardhana, S., K. Choudhuri, R. Varma, and M.L.",Non-OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
http://dx.doi.org/10.1016/j.immuni.2006.04.01 0,OADS,/arxiv_data1/oa_pdf/d0/cb/JEM_20120790.PMC3526357.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi   .org/10.1101/gr.488760 6 Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/   sj.onc.120686 1 Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J.R. Nevins.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/387422a 0 Leone, G., F. Nuckolls, S. Ishida, M. Adams, R. Sears, L. Jakoi, A. Miron,  and J.R. Nevins.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1128/MCB .20.10   .3626-3632.200 0 Leung, J.Y., G.L.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/onc.2008.5 5 Li, Y., J.E.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10   .1128/MCB.14.3.186 1 Loo, D.T., J.I.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1126/science.349430 8 Ma, Y., J. Yuan, M. Huang, R. Jove, and W.D.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1074/jbc.M21270220 0 Mah, L.J., A. El-Osta, and T.C.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
http://dx.doi.org/10.1038/leu.2010.,Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1084/jem.2008133 5 Oberringer, M., H.P.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10   .1006/bbrc.1995.238 6 Ohtani, K., J. DeGregori, and J.R. Nevins.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/   10.1038/ncb102 4 Raulet, D.H. 2003.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/nri119 9 Raulet, D.H., and N. Guerra.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/nri260 4 Ruzankina, Y., C. Pinzon-Guzman, A. Asare, T. Ong, L. Pontano, G.  Cotsarelis, V.P.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1016/j.stem.2007.03.00 2 Schäfer, M., and S. Werner.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/   10.1016/j.phrs.2008.06.00 4 Singer, A.J., and R.A. Clark.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1056/NEJM19990902341100 6 Stiewe, T., and B.M.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10   .1038/8261 7 Textor, S., N. Fiegler, A. Arnold, A. Porgador, T.G.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-   10-321 1 Tokuyama, M., C. Lorin, F. Delebecque, H. Jung, D.H. Raulet, and L.  Coscoy.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/nrc269 6 Core, L.J., J.J. Waterfall, and J.T.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1126/science.116222 8 D’Souza, S.J., A. Vespa, S. Murkherjee, A. Maher, A. Pajak, and L. Dagnino.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1074/jbc.M11195620 0 Dagnino, L., C.J.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1016/S0925-4773(97)00083- X Daston, G., E. Faustman, G. Ginsberg, P. Fenner-Crisp, S. Olin, B. Sonawane,  J. Bruckner, W. Breslin, and T.J. McLaughlin.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"1:119– 126. http://dx.doi.org/10.1038/7779 3 Eagle, R.A., and J. Trowsdale.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/   nri214 4 Gariglio, P., M. Bellard, and P. Chambon.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/   10.1093/nar/9.11.258 9 Gasser, S., S. Orsulic, E.J.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/nature0388 4 Girardi, M., D.E.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1126/science.106391 6 Gray, E.E., K. Suzuki, and J.G.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.4049/jimmunol.110042 7 Guerra, N., Y.X.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/   10.1016/j.immuni.2008.02.01 6 Havran, W.L.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1385/IR:21:2-3:6 3 Iaquinta, P.J., A. Aslanian, and J.A.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1101/sqb.2005.70.05 0 Jameson, J., K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, and  W.L.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1126/science.106963 9 Jamieson, A.M., A. Diefenbach, C.W.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80452- 3 Kato, G.J., W.M.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi   .org/10.1101/gad.6.1.8 1 Lander, M.R., B. Moll, and W.P.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1371/ journal.ppat.100226 5 Unni, A.M., T. Bondar, and R. Medzhitov.",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/   10.4049/jimmunol.080243 9 Wu, L., C. Timmers, B. Maiti, H.I.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
"http://dx.doi.org/10.1038/3510659 3 Zou, Z., M. Nomura, Y. Takihara, T. Yasunaga, and K. Shimada.",OADS,/arxiv_data1/oa_pdf/c7/cb/JEM_20120565.PMC3526358.pdf
This article is distributed under the terms  of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for  the first six months after the publication date (see http://www.rupress.org/ terms).,Non-OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"After six months it is available under a Creative Commons License   (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10.1016/   j.febslet.2007.04.07 9 Bermudez, V.P., A. Farina, V. Raghavan, I. Tappin, and J. Hurwitz.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10.1172/   JCI4073 2 Dua, R., D.L.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"274:22283– 22288. http://dx.doi.org/10.1074/jbc.274.32.2228 3 Hubscher, U., G. Maga, and S. Spadari.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10.1146/annurev   .biochem.71.090501.15004 1 Imai, K., G. Slupphaug, W .I.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi   .org/10.1038/ni97 4 Kesti, T., K. Flick, S. Keränen, J.E.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi   .org/10.1016/S1097-2765(00)80361- 5 Le Goff, C., C. Mahaut, A. Abhyankar, W .",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10.1038/   ng.101 6 Li, Y ., H. Asahara, V .S.",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10   .1074/jbc.272.51.3233 7 Li, Y ., Z.F .",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
"http://dx.doi.org/10.1038/nrg234 5 Shikata, K., T. Sasa-Masuda, Y .",OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
7:21. http://dx.doi.org/10.1186/1471-2091-7-2 1Proliferation assays.,OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20121303/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ce/2e/JEM_20121303.PMC3526359.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"5:844– 852. http://dx.doi.org/10.1038/nri171 0 Geng, S., A. Mezentsev, S. Kalachikov, K. Raith, D.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1242/jcs.0328 2 Holman, G.D., I.J.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/ 10  .1093/nar/gkn92 3 Huang, W ., B.T.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1038/nprot.2008.21 1 Kalia, V ., S. Sarkar, S. Subramaniam, W .N.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.11.01 0 Kerdiles, Y .M., D.R.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1038/ni.168 9 Kurts, C., W .R.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1084/jem.184.3.92 3 Larance, M., K.J.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1016/j.immuni.2010.06.00 2 MacDonald, H.R., and C.J.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1084/jem.146.3.69 8 Macintyre, A.N., D. Finlay, G. Preston, L.V .",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1016/j.immuni.2011.01.01 2 Maciver, N.J., S.R.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1189/jlb.010802 4 Mora, A., A.M. Davies, L. Bertrand, I. Sharif, G.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1093/   emboj/cdg46 9 Navarro, M.N., J. Goebel, C. Feijoo-Carnero, N. Morrice, and D.A.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1038/ni.200 8 Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W.  Pearce, S.E.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1038/   nature0815 5 Brunn, G.J., J. Williams, C. Sabers, G. Wiederrecht, J.C. Lawrence Jr., and R.T.  Abraham.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1002/eji.20083828 9 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 Cruz-Guilloty, F ., M.E.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1084/jem.2008124 2 Delgoffe, G.M., K.N.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"12:295– 303. http://dx.doi.org/10.1038/ni.200 5 Fabre, S., F. Carrette, J. Chen, V. Lang, M. Semichon, C. Denoyelle, V.  Lazar, N. Cagnard, A. Dubart-Kupperschmitt, M. Mangeney, et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.11.01 2 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1038/342559a 0 Powell, J.D., and G.M.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.09.00 2 Rao, R.R., Q. Li, K. Odunsi, and P.A.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.10.01 0 Sarbassov, D.D., S.M.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"22:159– 168. http://dx.doi.org/10.1016/j.molcel.2006.03.02 9 Semenza, G.L.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1016/j.gde.2009.10.00 9Shi, L.Z., R. Wang, G. Huang, P .",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10.1084/jem   .2011027 8 Sinclair, L.V., D. Finlay, C. Feijoo, G.H.",Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
"http://dx.doi.org/10   .1016/j.immuni.2011.09.02 1 Waugh, C., L. Sinclair, D. Finlay, J.R. Bayascas, and D. Cantrell.",OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
http://dx.doi.org/10.1128/MCB.00585-0 9,Non-OADS,/arxiv_data1/oa_pdf/a3/f3/JEM_20112607.PMC3526360.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1074/   jbc.272.33.2077 4 Björck, L. 1988.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1084/jem.166.5.135 1 Carapetis, J.R., A.C.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"5:685– 694. http://dx.doi.org/10.1016/S1473 ­3099(05)70267 ­X Carlemalm, E., W. Villiger, J.A.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
http://dx.doi   .org/10.1111/j.1365 ­2818.1985.tb02660.,Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1084/jem.2003054 3 Cohen, J.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nature0132 6 Cole, J.N., T.C.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nrmicro264 8 Collin, M., and A. Olsén.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1046/j.1365­2958.2000   .01942. x Collin, M., and A. Olsén.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1093/emboj/20.12.304 6 Decleva, E., R. Menegazzi, S. Busetto, P .",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/   10.1189/jlb.060533 8 Engel, J., and H. Furthmayr.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1016/0076 ­6879(87)45003 ­9 Fischetti, V.A.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
http://dx.doi.org/10.1111/ j.1365 ­2958.1994.tb01003.,Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1016/0022 ­1759(91)90145 ­6conjugates, and then incubated for 1 h at room temperature.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20120325/DC1.,Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1007/978 ­1­60761 ­820­1_2 Herwald, H., H. Cramer, M. Mörgelin, W. Russell, U. Sollenberg, A.  Norrby­Teglund, H. Flodgaard, L. Lindbom, and L. Björck.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1016/S0092 ­8674(04)00057 ­1 Horstmann, R.D., H.J.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100014 9 Kantor, F.S.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1084/jem.121.5.84 9 Kaper, J.B., J.P. Nataro, and H.L.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nrmicro81 8 Kihlberg, B.M., J. Cooney, M.G.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1016/S0882­4010(96)80003­ 9 Kotb, M., A. Norrby ­Teglund, A. McGeer, H. El ­Sherbini, M.T.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1038/nm1202 ­800 Leo, J.C., and A. Goldman.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1016/j.molimm.2009.02.02 4 Lindahl, G., and G. Kronvall.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1016/S0065 ­2776(08)60868 ­8 Lu, P., C. Vogel, R. Wang, X. Yao, and E.M. Marcotte.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1038/nbt127 0 Macheboeuf, P., C. Buffalo, C. ­Y.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"319:1405– 1408. http://dx.doi.org/10.1126/science.115447 0 Mintz, K.P., and P.M. Fives­Taylor.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi   .org/10.1038/nri220 6 Nordenfelt, P., S. Bauer, P. Lönnbro, and H. Tapper.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1371/journal.pone.000736 3 Picotti, P ., O. Rinner, R. Stallmach, F .",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nmeth.140 8 Rai, A.J., C.A.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1002/pmic.20040124 5 Reis, K.J., E.M. Ayoub, and M.D.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nri240 2 Sandt, C.H., and C.W.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1128/IAI.69.12.7293­7203.200 1 Sansonetti, P.J.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1038/nri149 9 Staali, L., M. Mörgelin, L. Björck, and H. Tapper.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1093/   emboj/21.7.160 7 Wertheim, H.F.L., D.C. Melles, M.C.",Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
"http://dx.doi.org/10.1016/S1473­3099(05)70295­ 4 Zav’yalov, V .P ., V .M.",OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
http://dx.doi.org/10.1111/j.1574­ 695X.1996.tb00267.,Non-OADS,/arxiv_data1/oa_pdf/03/c8/JEM_20120325.PMC3526361.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1084/jem.2006192 9 Arendt, C.W ., B. Albrecht, T.J. Soos, and D.R.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/S0952-7915(02)00346- 1 Baier, G., and J. Wagner.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi   .org/10.1016/j.ceb.2008.12.00 8 Baum, L.G., and P.R.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2009   .00800. x Blixt, O., S. Head, T. Mondala, C. Scanlan, M.E.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/   10.1073/pnas.040790210 1 Braccia, A., M. Villani, L. Immerdal, L.L.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1074/jbc.M21122820 0 Geisler, C., and D.L.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1093/glycob/   cwr08 0 Gomez, T.S., K. Kumar, R.B.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.01.00 8 Green, R.S., E.L. Stone, M. Tenno, E. Lehtonen, M.G.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.06.00 8 Hokama, A., E. Mizoguchi, K. Sugimoto, Y. Shimomura, Y. Tanaka, M.  Yoshida, S.T.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/j.immuni.2004   .05.00 9 Hsu, D.K., H.Y.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
http://dx.doi.org/10.1111/ j.1600-065X.2009.00798.,Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1146/   annurev-immunol-030409-10122 5 Kingeter, L.M., and B.C.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00277- X Marth, J.D., and P.K.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/nri241 7After washing, they were fixed by IC Fixation Buffer (eBioscience) and  then incubated with goat anti-PKC  antibody (Santa Cruz Biotechnology,  Santa Cruz, CA) at room temperature for 20 min.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/B978-   0-12-394596-9.00009- 3 Mizoguchi, A., and E. Mizoguchi.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/   10.1016/j.coph.2010.05.00 7 Müller, S., T. Schaffer, B. Flogerzi, A. Fleetwood, R. Weimann, A.M.  Schoepfer, and F. Seibold.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1097/01.MIB.0000225341.37226.7 c Nagahama, K., A. Ogawa, K. Shirane, Y. Shimomura, K. Sugimoto, and  A. Mizoguchi.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1053/j.gastro.2011.12.03 6 Nolz, J.C., R.B.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1128/MCB.00136-0 7 Okazawa, A., T. Kanai, M. Watanabe, M. Yamazaki, N. Inoue, M. Ikeda, M.  Kurimoto, H. Ishii, and T. Hibi.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
http://dx.doi.org/10.1111/j.1572-0241.2002.07107.,Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1371/journal.pone.000262 9 Priatel, J.J., D. Chui, N. Hiraoka, C.J.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)80180- 6 Rabinovich, G.A., and M.A.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/nri253 6 Santucci, L., S. Fiorucci, N. Rubinstein, A. Mencarelli, B. Palazzetti, B.  Federici, G.A.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1053/j.gastro.2007   .11.05 9 Shimomura, Y., A. Ogawa, M. Kawada, K. Sugimoto, E. Mizoguchi, H.-N.  Shi, S. Pillai, A.K.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi   .org/10.1084/jem.2007157 2Srikrishna, G., O. Turovskaya, R. Shaikh, R. Newlin, D. Foell, S. Murch,  M. Kronenberg, and H.H.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1128/MCB.00204-0 9 Stowell, S.R., C.M.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/nm.210 3 Sun, Z., C.W.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"404:402– 407. http://dx.doi.org/10.1038/3500609 0 Surolia, I., S.P.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/nature0911 5 Toscano, M.A., G.A.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/ni148 2 Tsuboi, S., and M. Fukuda.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1093/emboj/   16.21.636 4 Tsuboi, S., and M. Fukuda.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1074/jbc.273.46.3068 0 van Kooyk, Y., and G.A.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/ni.f.20 3 Vokhmyanina, O.A., E.M. Rapoport, S. André, V.V.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1093/glycob/cws07 9 Xavier, R.J., and D.K.",Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1038/   nature0600 5 Xavier, R., T. Brennan, Q. Li, C. McCormack, and B.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80577- 4 Zanin-Zhorov, A., Y. Ding, S. Kumari, M. Attur, K.L.",OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
http://dx.doi.org/10.1126/science.118606 8,Non-OADS,/arxiv_data1/oa_pdf/81/e0/JEM_20112631.PMC3526363.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1084/jem   .2005073 2 Gattinoni, L., D.J.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/nri184 2 Geller, M.A., and J.S.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.2217/   imt.11.13 1 Geller, M.A., S. Cooley, P.L.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"13:98– 107. http://dx.doi.org/10.3109/14653249.2010.51558 2 He, X.S., M. Draghi, K. Mahmood, T.H.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1002/eji.20083865 9 Horowitz, A., K.C.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.4049/jimmunol.100010 6 Imai, K., S. Matsuyama, S. Miyake, K. Suga, and K. Nakachi.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1016/S0140-6736(00)03231- 1 Jamieson, A.M., P. Isnard, J.R. Dorfman, M.C.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/   319675a 0 Lee, S.H., M.F.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.4049/jimmunol.120152 8 Li, Z., F. Pradera, T. Kammertoens, B. Li, S. Liu, and Z. Qin.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"7:329– 339. http://dx.doi.org/10.1038/nri207 3 Martín-Fontecha, A., L.L.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/ni113 8 Miller, J.S., Y. Soignier, A. Panoskaltsis-Mortari, S.A. McNearney, G.H.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi   .org/10.1182/blood-2004-07-297 4 Moretta, L., F .",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1182/blood-2010-08-26408 5 Muranski, P., A. Boni, C. Wrzesinski, D.E.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
http://dx.doi.org/10.1038/ncponc066 6Author contributions: A. Cerwenka and J. Ni designed the study; J. Ni and   M. Miller performed experiments; J. Ni and M. Miller collected and analyzed   data; A. Stojanovic and N. Garbi provided mice; and A. Cerwenka and J. Ni wrote   the manuscript.,OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1007/s00262-010-   0896- z Bihl, F ., J. Pecheur, B. Bréart, G. Poupon, J. Cazareth, V .",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.4049/jimmunol.100148 6 Cerwenka, A.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1084/jem   .2009022 5 Cerwenka, A., and L.L.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/3509556 4 Coca, S., J. Perez-Piqueras, D. Martinez, A. Colmenarejo, M.A.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0142 (19970615)79:12<2320::AID-CNCR5>3.0.CO;2- P Cooper, M.A., J.M.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1016/j.immuni.2005.02.00 3 D’Urso, C.M., Z.G.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1172/JCI11498 4 Dudley, M.E., J.R. Wunderlich, P.F.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"298:850– 854. http://dx.doi.org/10.1126/science.107651 4 Dudley, M.E., J.C. Yang, R. Sherry, M.S.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1200/JCO.2008.16.544 9 Fehniger, T.A., M.A.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1182/blood-2002-09-287 6 Galani, I.E., M. Wendel, A. Stojanovic, M. Jesiak, M.M.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1002/ijc.2513 2 Ganss, R., E. Ryschich, E. Klar, B. Arnold, and G.J.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
http://dx.doi.org/10.1038/nature0388 4,Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi   .org/10.1056/NEJM19851205313232 7 Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W.D.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/   10.1126/science.106844 0 Salagianni, M., E. Lekka, A. Moustaki, E.G.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.4049/jimmunol.100065 2 Sun, J.C., J.N.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/   nature0766 5 Sun, J.C., A. Ma, and L.L.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.4049/jimmunol.090187 2 Sun, J.C., S. Lopez-Verges, C.C.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi   .org/10.1038/ni158 0 van den Broek, M.F., D. Kägi, R.M.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1002/   eji.183025124 6 Villegas, F.R., S. Coca, V.G.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1016/   S0169-5002(01)00292- 6 Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi   .org/10.1038/ni158 2 Vivier, E., D.H. Raulet, A. Moretta, M.A.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1158/   0008-5472.CAN-08-144 0 Wiesel, M., and A. Oxenius.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1002/eji.20114220 5 Xie, Y., A. Akpinarli, C. Maris, E.L. Hipkiss, M. Lane, E.K.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1084/jem.2009192 1 Zingoni, A., T. Sornasse, B.G.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/   ni133 2 Pandiyan, P., L. Zheng, S. Ishihara, J. Reed, and M.J. Lenardo.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"8:1353– 1362. http://dx.doi.org/10.1038/ni153 6 Parkhurst, M.R., J.P. Riley, M.E.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1158/1078- 0432  .CCR-11-134 7 Passweg, J.R., A. Tichelli, S. Meyer-Monard, D. Heim, M. Stern, T. Kühne,  G. Favre, and A. Gratwohl.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/sj.leu.240352 4 Paust, S., and U.H.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/ni.203 2 Pegram, H.J., N.M. Haynes, M.J. Smyth, M.H.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/icb.2010.7 8 Perez-Diez, A., N.T.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10   .1182/blood-2006-10-05131 8 Qin, Z., J. Schwartzkopff, F. Pradera, T. Kammertoens, B. Seliger, H.  Pircher, and T. Blankenstein.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi   .org/10.1084/jem.2008009 9 Quezada, S.A., T.R.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1084/jem.2009191 8 Raulet, D.H., and N. Guerra.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/10.1038/nri260 4 Romee, R., S.E.",OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
"http://dx.doi.org/   10.1182/blood-2012-04-41928 3 Rosenberg, S.A., M.T.",Non-OADS,/arxiv_data1/oa_pdf/41/af/JEM_20120944.PMC3526364.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20121846/DC1.,Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/   nrc265 7 Adolfsson, J., R. Månsson, N. Buza-Vidas, A. Hultquist, K. Liuba, C.T .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.cell.2005.02.01 3 Amin, R.H., and M.S.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ni.161 2 Avram, D., A.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1074/jbc.275.14.1031 5 Avram, D., A.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1042/BJ2002049 6 Bain, G., E.C.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90077- 9 Beerman, I., D. Bhattacharya, S. Zandi, M. Sigvardsson, I.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni.2010   .05.00 5 Carotta, S., S.H.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
http://dx.doi.org/10.1182/blood-2010-11-31895 6cells were stained for markers specific for B cells and myeloid cells and  analyzed on Fortessa (BD).,Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
Data are deposited in the online database   ArrayExpress Archive (http://www.ebi.ac.uk/arrayexpress/) with the acces - sion no.,OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1242/dev.07285 0 Jonkers, J., R. Meuwissen, H. van der Gulden, H. Peterse, M. van der Valk,  and A. Berns.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ng74 7 Kondo, M., I.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80453- 5 Kosan, C., I. Saba, M. Godmann, S. Herold, B. Herkert, M. Eilers, and T.  Möröy.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni   .2010.11.02 8 Kustikova, O., B. Fehse, U. Modlich, M. Yang, J. Düllmann, K. Kamino, N.  von Neuhoff, B. Schlegelberger, Z. Li, and C. Baum.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1126/science.110506 3 Kwon, K., C. Hutter, Q.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.04.01 4 Li, L., M. Leid, and E.V.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1126/science.118898 9 Li, P., S. Burke, J. Wang, X. Chen, M. Ortiz, S.C. Lee, D. Lu, L. Campos,  D. Goulding, B.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1101/gr.74920 3 Liu, P ., J.R. Keller, M. Ortiz, L. T essarollo, R.A. Rachel, T. Nakamura,  N.A.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1038/ni92 5 Liu, H., G.C.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"5:18. http://dx.doi.org/10.1186/1476-4598-5-1 8 Liu, Y., S.E.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1016/j.stem.2008.11.00 6 Liu, P., P. Li, and S. Burke.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
http://dx.doi.org/10.1111/j.1600-065X.2010.00953.,Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1126/science.114088 1 Maier, H., R. Ostraat, H. Gao, S. Fields, S.A. Shinton, K.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ni   .1667 Di Santo, J.P. 2006.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.24.021605.09070 0 Dias, S., R. Månsson, S. Gurbuxani, M. Sigvardsson, and B.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni   .2008.05.01 5 Doulatov, S., F .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ni.188 9 Fathman, J.W., D. Bhattacharya, M.A.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1182/blood-2011-04-34891 2 Ficara, F ., M.J. Murphy, M. Lin, and M.L.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/   j.stem.2008.03.00 4 Forsberg, E.C., K.M.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1182/blood-2009-08-23921 0 Hameyer, D., A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E.  Bindels, J. Jonkers, P .",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1152/physiolgenomics   .00019.200 7 Hardy, R.R., C.E.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1084/jem.173.5.121 3 Hu, H., B. Wang, M. Borde, J. Nardone, S. Maika, L. Allred, P .W .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10   .1038/ni135 8 Ikawa, T., S. Hirose, K. Masuda, K. Kakugawa, R. Satoh, A. Shibano-Satoh,  R. Kominami, Y .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1126/science.118899 5 Inlay, M.A., D. Bhattacharya, D. Sahoo, T. Serwold, J. Seita, H. Karsunky,  S.K.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1101/gad.183600 9 Iwasaki, H., S. Mizuno, R.A. Wells, A.B.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1371/journal.pone.003142 8 Jiang, X.X., Q. Nguyen, Y. Chou, T. Wang, V. Nandakumar, P. Yates,  L. Jones, L. Wang, H. Won, H.R.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
http://dx.doi.org/10.1016/j.immuni.2011.11.01 0,OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1182/blood.V98.12.341 3 Seet, C.S., R.L.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/   10.1084/jem.2003220 2 Seo, W ., T. Ikawa, H. Kawamoto, and I. Taniuchi.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1084/jem.2011274 5 Siatecka, M., and J.J. Bieker.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/   10.1182/blood-2011-03-33137 1 Spangrude, G.J., S. Heimfeld, and I.L.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1126/science.289881 0 Stehling-Sun, S., J. Dade, S.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1038/ni.169 4 TeKippe, M., D.E.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/S0301-472X(03)00072- 9 Treiber, T ., E.M. Mandel, S. Pott, I. Györy , S. Firner, E.T .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.04.01 3 Tydell, C.C., E.S.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"181:1519– 1526. http://dx.doi.org/10.1084/jem.181.4.151 9 Vucic, D., V .M.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/nrm314 3 Wade, M., Y.V.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1016/j.tcb.2010.01.00 9 Weber, B.N., A.W .",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/   nature1027 9 Xu, J., V.G.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1101/gad.189731 0 Yin, B., R. Delwel, P .J.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1182/blood-2008-03-14443 6 Yoshida, T., S.Y.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ni131 4 Zhou, D., K. Liu, C.W .",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ng.63 7 Zhuang, Y., P. Soriano, and H. Weintraub.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
http://dx.doi.org/10.1038/ni.236 5mb-1 transcription.,OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/   10.1038/ni111 9 Mandel, E.M., and R. Grosschedl.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/   10.1016/j.coi.2010.01.01 0 Månsson, R., A. Hultquist, S. Luc, L. Yang, K. Anderson, S. Kharazi, S.  Al-Hashmi, K. Liuba, L. Thorén, J. Adolfsson, et al.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1182/blood-2009-08-   23639 8 Maraskovsky, E., L.A. O’Reilly, M. Teepe, L.M.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80289- 5 Mendrysa, S.M., M.K.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1128/MCB.23.2.462-473.200 3 Morita, Y., H. Ema, and H. Nakauchi.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1084/jem.2009131 8 Nakamura, T., D.A.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1128/MCB.20.9.3178-3186.200 0 Ng, S.Y., T. Yoshida, J. Zhang, and K. Georgopoulos.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.01.01 4 Nutt, S.L., and B.L.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.05.01 0 Peschon, J.J., P.J.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1084/jem.180.5.195 5 Reynaud, D., I.A.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1038/ni   .1626 Rothenberg, E.V., J.E.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2010.00964.,Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi   .org/10.1126/science.116540 9 Sanyal, M., J.W.",OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
"http://dx.doi.org/10.1182/blood-2006-10-05421 3 Satterwhite, E., T. Sonoki, T.G.",Non-OADS,/arxiv_data1/oa_pdf/89/20/JEM_20121846.PMC3526365.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.329 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/kjfm-33-329.PMC3526714.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.330 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/9a/81/kjfm-33-330.PMC3526715.pdf
"Keywords:  Hypertension; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm Received: May 22, 2012,  Accepted: October 24, 2012 *Corresponding Author: Hee-Jeong Choi T el: 82-42-611-3231, Fax: 82-42-611-3776E-mail: ohinia@daum.net Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.decreases them by approximat ely one-third, a meaningful, but  clearly suboptimal result.2) Usual BP , the theoretical true underlying level of blood  pressure, is widely considered the main determinant of BP-related vascular risk and of benefit from antihypertensive treatment.",Non-OADS,/arxiv_data1/oa_pdf/9a/81/kjfm-33-330.PMC3526715.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.336 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/7a/95/kjfm-33-336.PMC3526716.pdf
"Keywords:  Usual Source of Care; Preventive Services; Chronic Disease Control; Systematic Review Received: August 26, 2011,  Accepted: October 11, 2012 *Corresponding Author: Soo Y oung Kim T el: 82-2-2224-2406, Fax: 82-2-2224-2409E-mail: hallymfm@gmail.com Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Strengthening primary care has been one of the main agenda  in family medicine as well as the entire medical profession for the past few decades.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/kjfm-33-336.PMC3526716.pdf
Available from: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/7a/95/kjfm-33-336.PMC3526716.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.346 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/ec/c3/kjfm-33-346.PMC3526717.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.356 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/d5/a2/kjfm-33-356.PMC3526718.pdf
"Keywords:  Coffee; Stroke; Epidemiologic Studies; Meta-analysis Received: August 31, 2011,  Accepted: October 11, 2012 *Corresponding Author: Byungsung Kim T el: 82-2-958-8696, Fax: 82-2-958-8699E-mail: byungskim@naver.com Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.are consumed per day worldwide; it is the world ’s second most  popular drink after water.",Non-OADS,/arxiv_data1/oa_pdf/d5/a2/kjfm-33-356.PMC3526718.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.366 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/9a/22/kjfm-33-366.PMC3526719.pdf
"Keywords:  BATHE Techniques; Interviews; Patient Satisfaction Received: August 31, 2011,  Accepted: October 24, 2012 *Corresponding Author: Eal Whan Park T el: 82-41-550-3997, Fax: 82-41-565-6167E-mail: ewpark@dku.edu Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION BATHE, the acronym for background, affect, trouble,  handling, and empathy, was created to help the interviewer remember with ease the essentials of interview in outpatient settings.",Non-OADS,/arxiv_data1/oa_pdf/9a/22/kjfm-33-366.PMC3526719.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.372 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/19/39/kjfm-33-372.PMC3526720.pdf
"Keywords:  Homeless Persons; Tuberculosis, Pulmonary; Treatment Received: August 25, 2011,  Accepted: October 11, 2012 *Corresponding Author: Hong Gi Min T el: 82-51-607-2179, Fax: 82-51-507-3001E-mail: fmhong70@naver.com Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION One-third of the world ’s population is currently infected  with tuberculosis (TB), and there are more than 8 million new TB cases worldwide each year.",Non-OADS,/arxiv_data1/oa_pdf/19/39/kjfm-33-372.PMC3526720.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.381 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/9c/50/kjfm-33-381.PMC3526721.pdf
"Keywords:  Vitamin D; Sunlight; Ambulatory Lux Meter; Questionnaires; Women Received: August 30, 2011,  Accepted: October 8, 2012 *Corresponding Author: Nam-Seok Joo T el: 82-31-219-5324, Fax: 82-31-219-5218E-mail: jchcmc@hanmail.net Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Vitamin D is a fat-soluble vi tamin with various and important  health benefits.1-3) Previous epidemiology studies have reported  a very high prevalence of vitamin D deficiency, ranging from 40% to 90%.",Non-OADS,/arxiv_data1/oa_pdf/9c/50/kjfm-33-381.PMC3526721.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.390 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/65/99/kjfm-33-390.PMC3526722.pdf
"Keywords:  Marital Status; Gender Identity; Smoking; Alcohol; Exercise; Breakfast; Mass Screening Received: August 22, 2012,  Accepted: October 20, 2012 *Corresponding Author: Hyun Ah Park T el: 82-2-2270-0952, Fax: 82-2-2267-2030E-mail: drparkhyunah@gmail.com Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.have better mental and physical health than their unmarried  counterparts,1,2) but also have lower morbidity and mortality.3)  Marital status also affects specific health behaviors.",Non-OADS,/arxiv_data1/oa_pdf/65/99/kjfm-33-390.PMC3526722.pdf
Available from: http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/65/99/kjfm-33-390.PMC3526722.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/65/99/kjfm-33-390.PMC3526722.pdf
Available from: http://www.moel.go.kr/view.jsp.,Non-OADS,/arxiv_data1/oa_pdf/65/99/kjfm-33-390.PMC3526722.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.398 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/9c/82/kjfm-33-398.PMC3526723.pdf
"Keywords:  Nailfold Capillary Blood Velocity; Smoking; Qxidative Stress Received: July 7, 2012,  Accepted: October 11, 2012 *Corresponding Author: Nam-Seok Joo T el: 82-31-219-5324, Fax: 82-31-219-5218E-mail: jchcmc@hanmail.net Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.cardiovascular diseases, lung diseases and some reproductive  diseases.1) According to 2007 data of the Korean Ministry of  Health and Welfare, the rate of cigarette smoking in Koreans over the age of 20 twenties was 22.8% and that of men was 42.5%.",Non-OADS,/arxiv_data1/oa_pdf/9c/82/kjfm-33-398.PMC3526723.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.406 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/3d/ba/kjfm-33-406.PMC3526724.pdf
"Keywords:  Missing Values; Socioeconomic State; Korea National Health and Nutrition Examination Survey Received: July 12, 2012,  Accepted: October 19, 2012 *Corresponding Author: Hyun Ah Park T el: 82-2-2270-0952, Fax: 82-2-2267-2030E-mail: drparkhyunah@gmail.com Korean Journal of Family Medicine Copyright © 2012 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.of the individuals surveyed.3) However, this issue rarely receives  specific focus as a shortcoming of studies, and has rarely been the focus of specific discussion within academic print.",Non-OADS,/arxiv_data1/oa_pdf/3d/ba/kjfm-33-406.PMC3526724.pdf
Detailed descriptions of the plan and operation of the survey have been described on the KNHANES website (http://knhanes.cdc.go.kr/).,OADS,/arxiv_data1/oa_pdf/3d/ba/kjfm-33-406.PMC3526724.pdf
 http://dx.doi.org/10.4082/kjfm.2012.33.6.410 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/c8/f1/kjfm-33-410.PMC3526725.pdf
"E-mail: rupert.lanzenberger@meduniwien.ac.at or http://www.meduniwien.ac.at/neuroimaging/Parts of this study were presented at the 24th ECNP congress, Paris, France.Molecular Psychiatry (2013) 18, 93 -- 100 &2013 Macmillan Publishers Limited All rights reserved 1359-4184/13 www.nature.com/mp",Non-OADS,/arxiv_data1/oa_pdf/1a/17/mp201293a.PMC3526726.pdf
Siemens Molecular Imaging 2007; (http://www.medical.siemens.com/siemens/it_IT/gg_nm_FBAs/ﬁles/whtpap/wp_07_btruep_psf_reconstruction.pdf).,OADS,/arxiv_data1/oa_pdf/1a/17/mp201293a.PMC3526726.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)ECT effects on serotonin-1A in MDD R Lanzenberger et al 100 Molecular Psychiatry (2013), 93 -- 100 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1a/17/mp201293a.PMC3526726.pdf
"Non-parametric Wilcoxon–Mann– Whitney test, FDR control, logistic regression andROC curves were carried out on the freely availablesoftware R (http://www.r-project.org) with corre- sponding packages.",OADS,/arxiv_data1/oa_pdf/0c/d2/mp2011131a.PMC3526727.pdf
"To view a copy of this license, visit http://creativecommon- s.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Mol ecular Psychiatry website (http://www.nature.com/mp)Potential metabolite markers of schizophrenia J Yang et al 78 Molecular Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/mp2011131a.PMC3526727.pdf
"To viewa copy of this license, visit http://creativecommon- s.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Mol ecular Psychiatry website (http://www.nature.com/mp)Alzheimer’s disease-related neuropathology D Schlesinger et al 85 Molecular Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/25/30/mp2011136a.PMC3526728.pdf
"fMRI data preprocessing was thenconducted by SPM8 (University College London, UK; http://www.fil.ion.ucl.ac.uk/spm) and DPARSF (Data Processing Assistant for resting-state fMRI).",OADS,/arxiv_data1/oa_pdf/84/37/mp2011127a.PMC3526729.pdf
"All T1-weighted structural data were pro-cessed with VBM5 toolbox (Structural Brain Mapping Group, Jena, Germany; http://dbm.neuro.unijena.",OADS,/arxiv_data1/oa_pdf/84/37/mp2011127a.PMC3526729.pdf
"Sci Am Mind News ; http://www.sciam.com/ article.cfm, 2007.",Non-OADS,/arxiv_data1/oa_pdf/84/37/mp2011127a.PMC3526729.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Mol ecular Psychiatry website (http://www.nature.com/mp)Depression uncouples brain hate circuit HT a o et al 111 Molecular Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/84/37/mp2011127a.PMC3526729.pdf
"[Available from: http://www.inseefr/fr/methodes/defaultasp?page = nomenclatures/pcs2003/pcs2003htm, 2010].",OADS,/arxiv_data1/oa_pdf/b9/ce/mp2011116a.PMC3526730.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/Socioeconomic position and depression trajectory M Melchior et al 121 Molecular Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/b9/ce/mp2011116a.PMC3526730.pdf
"369Korean J Physiol Pharmacol Vol 16: 369 －378, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.369 ABBREVIATIONS: AS, Angelman syndrome; ASD, autism spectrum  disorders; CaMKII, Ca2+/calmodulin-dependent protein kinase II;  DHPG, dihydroxyphenylglycine; E-LTP, early phase LTP; FMRP,  fragile X mental retardation protein; FXS, Fragile X syndrome; HFS,  high frequency stimulation; ID, intellectual disability; KO, knock-out; LFS-LTD, low frequecy stimulation LTD; L-LTP, late phase LTP;  LTD, long term depression; LTP, long term potentiation; mEPSC, miniature excitatory postsynaptic current; mGluR, metabotropic  glutamate receptor; mGluR-LTD, mGluR mediated LTD; NMDA,  N-methyl- D-aspartate; PP-LFS, paired-pulse low frequency stimula- tion; PSD, postsynaptic density; RTT, Rett syndrome; TSC, tuberous  sclerosis complex.",Non-OADS,/arxiv_data1/oa_pdf/ee/a7/kjpp-16-369.PMC3526740.pdf
"379Korean J Physiol Pharmacol Vol 16: 379 －386, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.379 ABBREVIATIONS: BER, berberine; CRF, corticotrophin-releasing  factor; TH, tyrosine hydroxylase; LC, locus coeruleus; BDNF, brain-  derived neurotrophic factor; SSRIs, serotonin reuptake inhibitors;  TCAs, tricyclic antidepressants; CNS, central nervous system; FST, forced swimming test; TST, tail-suspension test; EPM, elevated plus  maze; FLX, fluoxetine; PBS, phosphate-buffered saline; ABC, avidin-  biotin-peroxidase complex; DAB, diaminobenzidine; RT-PCR, reverse transcription-polymerase chain reaction; GAPDH, glyceraldehydes-  3-phosphate dehydrogenase; VTA, ventral tegmental area.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/kjpp-16-379.PMC3526741.pdf
"387Korean J Physiol Pharmacol Vol 16: 387 －392, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.387 ABBREVIATIONS: CCI, chronic constriction injury; CR, Cyperi  rhizoma ; CT, Corydalis tuber ; ir, immunoreactive; MA, mechanical  allodynia; pNR1, phosphorylation of NMDA receptor NR1 subunit;  POD, postoperative day; TH, thermal hyperalgesia.",Non-OADS,/arxiv_data1/oa_pdf/1c/71/kjpp-16-387.PMC3526742.pdf
"393Korean J Physiol Pharmacol Vol 16: 393 －398, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.393 ABBREVIATIONS: Dex, dexamethasone; GRE, glucocorticoid response element; ITAM, immunoreceptor tyrosine-based activation motif;  ITIM, immunoreceptor tyrosine-based inhibition motif; Fc εR, recep- tor for the Fc region of IgE; Fc γR, Fc receptor for the Fc region  of IgG.",Non-OADS,/arxiv_data1/oa_pdf/99/6f/kjpp-16-393.PMC3526743.pdf
"399Korean J Physiol Pharmacol Vol 16: 399 －404, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.399 ABBREVIATIONS: CAT, catalase; CMC, carboxy methyl cellulose;  ECQ, extracts containing QGC; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSH, glutathione sulfhydryl; HETAB, hexadecyl trimethyl ammonium bromide; IND, indomethacin; MDA, malondial- dehyde; MPO, myeloperoxidase; QGC, quercetin-3-O- β-D-glucuro- nopyranoside; ROS, reactive oxygen species; SOD, superoxide dismutase; TMB, tetra methylbenzidine; TBA, thiobarbituric acid;  TBARS, thiobarbituric acid reactive substances.",Non-OADS,/arxiv_data1/oa_pdf/f5/f7/kjpp-16-399.PMC3526744.pdf
"405Korean J Physiol Pharmacol Vol 16: 405 －411, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.405 ABBREVIATIONS: DMEM, Dulbecco’s Modified Eagle’s Medium;  GFAP, glial fibrillary acidic protein; hMSC, human mesenchymal  stem cell; MEP, motor evoked potential; MSC, mesenchymal stem cell; PWT, paw withdrawal threshold; SCI, spinal cord injury; SSEP,  somatosensory evoked potential.",Non-OADS,/arxiv_data1/oa_pdf/85/a9/kjpp-16-405.PMC3526745.pdf
"413Korean J Physiol Pharmacol Vol 16: 413 －422, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.413 ABBREVIATIONS: BSA, bovine serum albumin; DPH, 1,6-Diphenyl-  1,3,5-hexatriene; PBS, phosphate-buffered saline; Py-3-Py, 1,3-Di  (1-pyrenyl) propane; RET, radiationless energy transfer; SPMV,  synaptosomal plasma membrane vesicles isolated from bovine  cerebral cortex; SPMVTL, liposome of total lipids extracted from SPMV; SPMVPL, liposome of phospholipids extracted from SPMV;  TNBS, 2,4,6-Trinitrobenzenesulfonic acid.",Non-OADS,/arxiv_data1/oa_pdf/da/e2/kjpp-16-413.PMC3526746.pdf
"423Korean J Physiol Pharmacol Vol 16: 423 －429, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.423 ABBREVIATIONS: OGD, oxygen/glucose deprivation; PSD, postsynaptic density; PSD-95, postsynaptic density protein 95; NR1, NMDA receptor 1; NR2B, NMDA receptor 2B; CaMKII, calcium/calmodulin-  dependent protein kinase II.",Non-OADS,/arxiv_data1/oa_pdf/92/8c/kjpp-16-423.PMC3526747.pdf
"431Korean J Physiol Pharmacol Vol 16: 431 －436, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.431 ABBREVIATIONS: iNOS, inducible nitric oxide synthase; IFN- γ,  interferon- γ; LPS, lipopolysaccharide.",Non-OADS,/arxiv_data1/oa_pdf/4a/c8/kjpp-16-431.PMC3526748.pdf
"437Korean J Physiol Pharmacol Vol 16: 437 －446, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.437 ABBREVIATIONS: IBD, inflammatory bowel disease; TNBS, trinitro- benzensulfonic acid; DSS, dextran-sulphate sodium; mAchR, musca- rinic acetylcholine receptor; NSCC, non-selective cation channel; TRPC, canonical transient receptor potential; SCA, spontaneous  contractile activity; ICCs, interstitial cells of Cajal.",Non-OADS,/arxiv_data1/oa_pdf/1a/5a/kjpp-16-437.PMC3526749.pdf
"447Korean J Physiol Pharmacol Vol 16: 447 －453, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.447 ABBREVIATIONS: CCL2, chemokine (C-C motif) ligand 2; IL-1 β,  interleukin-1 beta; ERK, extracellular signal-regulated kinase;  MAPK, mitogen-activated protein kinase; OxPAPC, 1-palmitoyl-2- arachidonoyl-sn-glycerol-3-phosphatidylcholine; PI3K, phosphoinosi- tide 3-kinase; PKC, protein kinase C; TLR, toll-like receptor.",Non-OADS,/arxiv_data1/oa_pdf/33/64/kjpp-16-447.PMC3526750.pdf
"455Korean J Physiol Pharmacol Vol 16: 455 －462, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.455 ABBREVIATIONS: CMC, carboxy methyl cellulose; ECQ, extracts  containing QGC; GSH, glutathione sulfhydryl; HETAB, hexadecyl  trimethyl ammonium bromide; MDA, malondialdehyde; MPO,  myeloperoxidase; QGC, quercetin-3-O- β-D-glucuronopyranoside;  ROS, reactive oxygen species; TMB, tetra methylbenzidine; TBA,  thiobarbituric acid; TBARS, thiobarbituric acid reactive substance.",Non-OADS,/arxiv_data1/oa_pdf/41/74/kjpp-16-455.PMC3526751.pdf
"463Korean J Physiol Pharmacol Vol 16: 463 －468, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.463 ABBREVIATIONS: NO, nitric oxide; PRX, peroxiredoxin; T1D, type  1 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/a1/1e/kjpp-16-463.PMC3526752.pdf
"469Korean J Physiol Pharmacol Vol 16: 469 －476, December, 2012 http://dx.doi.org/10.4196/kjpp.2012.16.6.469 ABBREVIATIONS: 2,3,7,8-TCDD, 2,3,7,8-Tetrachlorodibenzo- p-dioxin; Realtime PCR, realtime polymerase chain reaction; HSP, heat shock protein; SOD, superoxide dismutase; GST, glutathione S-transferase;  GPX, glutathione peroxidase; GRP78, 78kD glucose-regulated protein.",Non-OADS,/arxiv_data1/oa_pdf/06/c1/kjpp-16-469.PMC3526753.pdf
"Lavage In the past, lavage of the knee joint itself was considered helpful Arthroscopic Treatment for Osteoarthritic Knee Chung Shik Shin, MD1 and Ju Hong Lee, MD, PhD2 1Department of Orthopedic Surgery, Presbyterian Medical Center, Jeonju; 2Department of Orthopedic Surgery, Research Institute of Clinical Medicine of Chonbuk  National University Hospital, Chonbuk National University Medical School, Jeonju, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/28/ksrr-24-187.PMC3526754.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgReview Article Knee Surg Relat Res 2012;24(4):187-192 http://dx.doi.org/10.5792/ksrr.2012.24.4.187 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Arthroscopic treatment for osteoarthritis of the knee has been widely performed as one of the surgical options, in spite of persisting concerns  regarding its efficacy.",Non-OADS,/arxiv_data1/oa_pdf/fb/28/ksrr-24-187.PMC3526754.pdf
Available from: http:// http://www.aaos.org/research/ guidelines/oakguideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/28/ksrr-24-187.PMC3526754.pdf
"The articular cartilage of the patella is similar to that of other Patellofemoral Osteoarthritis Y oung-Mo Kim, MD, PhD and Y ong-Bum Joo, MD, PhD Department of Orthopedic Surgery, Research Institue for Medical Sciences, Chungnam National University School of Medicine, Daejeon, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/38/ksrr-24-193.PMC3526755.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgReview Article Knee Surg Relat Res 2012;24(4):193-200 http://dx.doi.org/10.5792/ksrr.2012.24.4.193 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Patellofemoral arthritis is a fairly common disease, and it has been gaining interest with increasing number of studies due to its diverse treatment  methods.",Non-OADS,/arxiv_data1/oa_pdf/6f/38/ksrr-24-193.PMC3526755.pdf
"Pain after TKA is a  particularly serious problem, considering the substantially  increasing TKA use and the aging population.Guidelines for the Management of Postoperative Pain  after T otal Knee Arthroplasty Korean Knee Society Korean Knee Society This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/97/ksrr-24-201.PMC3526756.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgSpecial Article Knee Surg Relat Res 2012;24(4):201-207 http://dx.doi.org/10.5792/ksrr.2012.24.4.201 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research This clinical practice guideline was approved by Korean Knee Society on February 28, 2012.",Non-OADS,/arxiv_data1/oa_pdf/21/97/ksrr-24-201.PMC3526756.pdf
"However, mid- or long-term follow-up results of navigation-Results of T otal Knee Arthroplasty with NexGen LPS- flex Implant Using Navigation System (Brain Lab):  Results with a 5-year Follow-up Chul Hyung Kang, MD, PhD1, Kyung Jae Lee, MD, PhD1, Ki Cheor Bae, MD, PhD1, Chul Hyun Cho, MD,  PhD1, Si W ook Lee, MD1, Hong Kwan Shin, MD2, Y oung Kook Lee, MD2 and Ji Suk Bae, MD3 1Department of Orthopedic Surgery, Keimyung University School of Medicine, Daegu; 2Department of Orthopedic Surgery, Hanmi Hospital, Daegu; 3Department of  Preventive Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/d6/ksrr-24-208.PMC3526757.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):208-213 http://dx.doi.org/10.5792/ksrr.2012.24.4.208 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  T o evaluate the clinical and radiological results of patients that underwent total knee arthroplasty (TKA) with a NexGen LPS-Flex implant  using a Navigation system (Brain Lab).,Non-OADS,/arxiv_data1/oa_pdf/89/d6/ksrr-24-208.PMC3526757.pdf
"Nevertheless, it is unclear whether  these design modifications improve the range of motion and Outcomes of the Different Types of T otal Knee  Arthroplasty with the Identical Femoral Geometry Sang Min Lee, MD1, Sang Cheol Seong, MD, PhD2, Sahnghoon Lee, MD, PhD2, W on Chul Choi, MD3 and  Myung Chul Lee, MD, PhD2 1Department of Orthopedic Surgery, Eulji University College of Medicine, Daejeon; 2Department of Orthopedic Surgery, Seoul National University College of Medicine,  Seoul; 3Department of Orthopedic Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/24/ksrr-24-214.PMC3526758.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):214-220 http://dx.doi.org/10.5792/ksrr.2012.24.4.214 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  There are controversies around the role of the posterior cruciate ligament and the effect of design modifications for high flexion in total  knee arthroplasty (TKA).,Non-OADS,/arxiv_data1/oa_pdf/e0/24/ksrr-24-214.PMC3526758.pdf
"Han et al.7)  observed aseptic loosening in 38% of the patients at a mean of 32  months after high-flexion TKA, and 21% of which underwent  reoperation at a mean of 32 months postoperatively.Mid-term Results of T otal Knee Arthroplasty Using  PFC Sigma RP-F Jun-Y oung Kim, MD, Sang-Ho Cheon, MD and Hee-Soo Kyung, MD, PhD Department of Orthopaedic Surgery, Kyungpook National University School of Medicine, Daegu, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/b2/ksrr-24-221.PMC3526759.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):221-226 http://dx.doi.org/10.5792/ksrr.2012.24.4.221 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  We compared the mid-term results after total knee arthroplasty (TKA) using PFC Sigma RP-F mobile model with PFC Sigma PS fixed  model.,Non-OADS,/arxiv_data1/oa_pdf/c6/b2/ksrr-24-221.PMC3526759.pdf
"Among various Minimum Two-year Results of Revision T otal Knee  Arthroplasty Following Infectious or Non-infectious  Causes Kyoung-Jai Lee, MD, Jae-Y oung Moon, MD, Eun-Kyoo Song, MD, Hong-An Lim, MD and Jong-Keun Seon,  MD Center for Joint Disease, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/7a/ksrr-24-227.PMC3526760.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):227-234 http://dx.doi.org/10.5792/ksrr.2012.24.4.227 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  T o compare clinical outcome of revision total knee arthroplasty (TKA) between the infected and non-infected groups.,Non-OADS,/arxiv_data1/oa_pdf/8c/7a/ksrr-24-227.PMC3526760.pdf
"Of them, 67 patients underwent aspiration of Clinical Results of Direct Arthroscopic Excision of  Popliteal Cyst Using a Posteromedial Portal Jin Ho Cho, MD, PhD Department of Orthopedic Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/59/ksrr-24-235.PMC3526761.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):235-240 http://dx.doi.org/10.5792/ksrr.2012.24.4.235 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  T o evaluate the efficacy of the direct arthroscopic excision of a popliteal cyst without additional skin incision using a posteromedial portal  based on minimum 2 year follow-up clinical results.,Non-OADS,/arxiv_data1/oa_pdf/55/59/ksrr-24-235.PMC3526761.pdf
"Patients Of the patients who underwent ACL reconstruction between  March 2006 and March 2010 at our institution, 38 patients Morphologic Changes of the Posterior Cruciate  Ligament on Magnetic Resonance Imaging before and  after Reconstruction of Chronic Anterior Cruciate  Ligament Ruptures Jae Doo Y oo, MD and Hyung Mook Lim, MD Department of Orthopedic Surgery, Ewha W omans University Mokdong Hospital, Ewha W omans University School of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/0a/ksrr-24-241.PMC3526762.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(4):241-244 http://dx.doi.org/10.5792/ksrr.2012.24.4.241 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  The purpose of this study was to compare the morphologic change of the posterior cruciate ligament (PCL) on magnetic resonance imaging  (MRI) in chronic anterior cruciate ligament (ACL) tear before and after reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/35/0a/ksrr-24-241.PMC3526762.pdf
"He had been suffering from ITP for eleven  years and despite corticosteroids, dapsone and azathioprine Perioperative Care of a Patient with Refractory  Idiopathic Thrombocytopenic Purpura Undergoing  T otal Knee Arthroplasty Rohit Singhal, MS (Ortho), MRCSEd1, V eera Gudimetla, FRCA2, Andrew Stewart, FRCP Edin, FRCPath3,  Karen L Luscombe, FRCS (Tr & Orth)1 and Charalambos P Charalambous, MSc, MD, FRCS (Tr & Orth)4 1Department of Trauma and Orthopaedics, Leighton Hospital, Crewe; 2Department of Anaesthesiology, Leighton Hospital, Crewe; 3Department of Haematology,  University Hospital of North Staffordshire, Stoke-on-Trent; 4Department of Trauma and Orthopaedics, Blackpool Victoria Hospital, Blackpool, United Kingdom This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/8a/ksrr-24-245.PMC3526763.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2012;24(4):245-248 http://dx.doi.org/10.5792/ksrr.2012.24.4.245 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder leading to low platelet count and an increased risk of bleeding.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/ksrr-24-245.PMC3526763.pdf
"Baker’ s Cyst with Intramuscular Extension into V astus  Medialis Muscle Tae W an Kim, MD1, Jeung Tak Suh, MD1, Seung Min Son, MD1, Tae Y ong Moon, MD2, In Sook Lee, MD2,  Kyung Un Choi, MD3 and Jeung Il Kim, MD1 Departments of 1Orthopaedic Surgery, 2Radiology, 3Pathology, Pusan National University School of Medicine, Busan, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/b7/ksrr-24-249.PMC3526764.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report  Knee Surg Relat Res 2012;24(4):249-253 http://dx.doi.org/10.5792/ksrr.2012.24.4.249 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Baker’s cysts are one of the most common cystic lesions around the knee joint and mainly caused by fluid distension of the gastrocnemius- semimembranous bursa that is situated along the medial side of the popliteal fossa.,Non-OADS,/arxiv_data1/oa_pdf/bf/b7/ksrr-24-249.PMC3526764.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.DOI:10.1093/sysbio/sys057Advance Access publication on December 4, 2012 The Tree of Life DA VID R. M ADDISON Department of Zoology, Oregon State University, Corvallis, OR 97331 USA; E-mail: david.maddison@science.oregonstate.edu I think that I shall never see A thing so awesome as the TreeThat links us all in paths of genesDown into depths of time unseen; Whose many branches spreading wide House wondrous creatures of the tide,Ocean deep and mountain tall,Darkened cave and waterfall.",Non-OADS,/arxiv_data1/oa_pdf/37/00/sys057.PMC3526800.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.DOI:10.1093/sysbio/sys076Advance Access publication on September 4, 2012 TreeFix: Statistically Informed Gene Tree Error Correction Using Species Trees YI-CHIEH WU1,M ATTHEW D. R ASMUSSEN2,M UKUL S. B ANSAL1,AND MANOLIS KELLIS1,3,∗ 1Department of Electrical Engineering and Computer Science, Computer Science and Artiﬁcial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA;2Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, NY 14853, USA; and 3Broad Institute, Cambridge, MA 02142, USA ∗Correspondence to be sent to: 32 Vassar St. D530, Cambridge, MA 02139, USA; E-mail: manoli@mit.edu Received 21 November 2011; reviews returned 29 May 2012; accepted 25 August 2012 Associate Editor: Laura Kubatko Abstract .—Accurate gene tree reconstruction is a fundamental problem in phylogenetics, with many important applications.",Non-OADS,/arxiv_data1/oa_pdf/6a/f3/sys076.PMC3526801.pdf
"For further information onlikelihood tests, including a discussion of statisticalpower, how to correct for multiple comparisons,and an error rate analysis, see SupplementarySections S1 and S2 (available at http://datadryad.org,doi:10.5061/dryad.44cb5).",Non-OADS,/arxiv_data1/oa_pdf/6a/f3/sys076.PMC3526801.pdf
"S UPPLEMENTARY MATERIAL Supplementary material, including data ﬁles and/or online-only appendices, can be found athttp://datadryad.org and in the Dryad data repository(doi:10.5061/dryad.44cb5).",OADS,/arxiv_data1/oa_pdf/6a/f3/sys076.PMC3526801.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.DOI:10.1093/sysbio/sys078Advance Access publication on September 6, 2012 Pruning Rogue Taxa Improves Phylogenetic Accuracy: An Efﬁcient Algorithm and Webservice ANDRE J.",Non-OADS,/arxiv_data1/oa_pdf/c1/12/sys078.PMC3526802.pdf
S OFTW ARE AND WEBSERVICE The RogueNaRok algorithm is available as open-source code at https://github.com/aberer/RogueNaRok.,OADS,/arxiv_data1/oa_pdf/c1/12/sys078.PMC3526802.pdf
"The corresponding webservice for interactive deployment of RogueNaRok and related methods isavailable at http://exelixis-lab.org/roguenarok.html.After uploading a set of bootstrap trees, the user canexplore how various parameters (e.g., the maximumdropset size) inﬂuence rogue taxon identiﬁcation.If a best-known ML tree has also been uploaded,RogueNaRok can be used to detect rogue taxa thataffect support values on the best-known tree.",OADS,/arxiv_data1/oa_pdf/c1/12/sys078.PMC3526802.pdf
"S UPPLEMENTARY MATERIAL Supplementary material, including data ﬁles and online-only appendices, can be found in theDryad data repository at http://datadryad.org,doi:10.5061/dryad.sv515.",OADS,/arxiv_data1/oa_pdf/c1/12/sys078.PMC3526802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Savin, A.V.",Non-OADS,/arxiv_data1/oa_pdf/eb/5f/srep01012.PMC3526810.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Li, S.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/bb/srep01007.PMC3526812.pdf
"Nevertheless, there are emergingefforts to integrate various satellite observations for storm surgessuch as the European Space Agency’s eSurge consortium (http://www.storm-surge.info/esurge-consortium).",Non-OADS,/arxiv_data1/oa_pdf/3a/60/srep01010.PMC3526813.pdf
Wind data .We used the 3-hourly wind and pressure fields from the North American Regional Reanalysis (NARR) project which is an extension of the National Center for Environmental Prediction (NCEP) Global Reanalysis over the North AmericanRegion (http://www.esrl.noaa.gov/psd/).,OADS,/arxiv_data1/oa_pdf/3a/60/srep01010.PMC3526813.pdf
http://www.nhc.noaa.gov/pdf/TCR-AL112010_Igor.pdf (2010) 10.,Non-OADS,/arxiv_data1/oa_pdf/3a/60/srep01010.PMC3526813.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Han, G., Ma, Z., Chen, D., deYoung, B.",Non-OADS,/arxiv_data1/oa_pdf/3a/60/srep01010.PMC3526813.pdf
S48 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgtest probability had a value <1% [(0.99 + 5/439-1)/(0.99  + 0.95-1)].,OADS,/arxiv_data1/oa_pdf/2c/86/JPI-3-37j.PMC3526821.pdf
"S49 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgis more difficult than for an inpatient, the laboratory  met monthly targets for percentage results called back  (92% within 30 min) in five of 6 months (83%) following  implementation, compared with only three of 6 months  (50%) in the same months in 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/86/JPI-3-37j.PMC3526821.pdf
"S50 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONTENT Although computerized provider/physician order entry  (CPOE) modules in the electronic medical record (EMR)  and laboratory information system (LIS) have become  common in clinical pathology, their adoption in anatomic  pathology (AP) has been slower.",Non-OADS,/arxiv_data1/oa_pdf/2c/86/JPI-3-37j.PMC3526821.pdf
S51 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orginpatients.,Non-OADS,/arxiv_data1/oa_pdf/2c/86/JPI-3-37j.PMC3526821.pdf
S41 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgHow Can Laboratories Help  Their Hospital Decrease  Readmission Rates for Heart  Failure Patients?,Non-OADS,/arxiv_data1/oa_pdf/5c/d7/JPI-3-37h.PMC3526822.pdf
S42 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgTECHNOLOGY The technology to accomplish this project included A  Cognex industrial camera system with software that  enables the identification and reading of 2-D barcodes.,OADS,/arxiv_data1/oa_pdf/5c/d7/JPI-3-37h.PMC3526822.pdf
"S43 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgincreasing the number of comprehensive cancer panel  genes from 27 to 50 and introducing test panels for drug  metabolism and transport, renal, and cardiac diseases.",Non-OADS,/arxiv_data1/oa_pdf/5c/d7/JPI-3-37h.PMC3526822.pdf
"S19 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgUniversity of Pittsburgh, Pittsburgh, PA, 5International Academy of T elepathology,  Heidelberg, Germany, 6Department of Pathology, Emory University, Atlanta, GA,  7Department of Pathology, University of Michigan Medical School, Ann Arbor,  MI, 8Department of Pathology, Hospital General de Ciudad Real, Ciudad Real,  Spain, 9University of New South Wales, Centre for Health Systems and Safety  Research, Australian Institute of Health Innovation, New South Wales, Australia,  10University Freiburg, Institute of Pathology, Freiburg, Germany, 11Charite, Institute  of Pathology, Berlin, Germany, 12University of Wollongong, Centre for Health  Informatics and e-Health Research, New South Wales, Australia, 13Department  of Pathology, University of Calgary, Calgary, Ontario, Canada, 14Department of  Pathology, Iwate Medical University School of Medicine, Iwate Perfecture, Japan,  15Weiner Consulting Services, Florence, OR, 16Dennis Winsten & Associates, Inc.,  Tucson, AZ.",Non-OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
S20 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgDESIGN The 2nd ISC 2012 contained five domains to evaluate  different capabilities of participating systems.,OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
S21 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgworkflows and be compatible with AFMS IT-related  infrastructure.,OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
"S22 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgRecommendations for  Validating Whole Slide Imaging  for Diagnostic Purposes in  Pathology: College of American  Pathologists Pathology and  Laboratory Quality Center John H. Sinard1, Walter H. Henricks2, Alexis  B. Carter3, Lydia Contis4, Bruce A. Beckwith5,  Andrew J. Evans6, Christopher N. Otis7, Lisa  A. Fatheree8, Avtar Lal9, Anil V .",Non-OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
"S23 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgclient software installed on workstations for pathologists,  grossing, and autopsies.",OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
"S24 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgscan markers, RGBDemo and the Microsoft Kinect were  used to capture point cloud and color data from two  gross specimens: a mastectomy for breast cancer and a  hysterectomy for fibroids.",OADS,/arxiv_data1/oa_pdf/d9/97/JPI-3-37e.PMC3526823.pdf
"S12 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONCLUSION Automated analysis is a fast and useful tool in  assessment of Ki67 index, particularly at boundaries  of overlapping, but differentially managed diagnostic  entities.",OADS,/arxiv_data1/oa_pdf/d3/af/JPI-3-37b.PMC3526824.pdf
S13 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.org(UC).,Non-OADS,/arxiv_data1/oa_pdf/d3/af/JPI-3-37b.PMC3526824.pdf
S13 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.org(UC).,Non-OADS,/arxiv_data1/oa_pdf/a7/b3/JPI-3-37c.PMC3526825.pdf
S14 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgto support cost-effective high performance spatial queries  on commodity clusters.,OADS,/arxiv_data1/oa_pdf/a7/b3/JPI-3-37c.PMC3526825.pdf
S15 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgapplications related to digital pathology in the last two  decades.,Non-OADS,/arxiv_data1/oa_pdf/a7/b3/JPI-3-37c.PMC3526825.pdf
"S16 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONTENT In many cases, the size of an area of interest or image  analysis software may restrict simple quantitative  analysis.",Non-OADS,/arxiv_data1/oa_pdf/a7/b3/JPI-3-37c.PMC3526825.pdf
"TECHNOLOGY A Hamamatsu Nanozoomer 2.0 HT scanner with  associated scanning and viewing software, ImmunoRatio  image analysis software (http://imtmicroscope.uta.fi/ immunoratio/), and a basic desktop computer and  monitor were used in this study.",OADS,/arxiv_data1/oa_pdf/a7/b3/JPI-3-37c.PMC3526825.pdf
"S37 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orginviting module development by statisticians and human– machine interface researchers alike, is made available  with open source and in the public domain.",OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
"This result  is detailed in a July 2012 Pathology Informatics report,  and is also illustrated by a number of Y ouT ube webcasts,  including the two listed in http://imagejs.org.",OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
"S38 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgof Medicine, Atlanta, GA. E-mail: maggielou.hopkins3@gmail.com CONTENT Patient portals (PTPRs) are web portals typically offered  by a healthcare entity to allow patients to view their  entity-related medical information.",Non-OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
"TECHNOLOGY PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and  SurveyMonkey (http://www.surveymonkey.com) were used  to review the literature and collect data, respectively.",OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
S39 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgcetuximab and chemotherapy in first line therapy.,Non-OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
S40 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgunderstand relationships has been created.,Non-OADS,/arxiv_data1/oa_pdf/c9/19/JPI-3-37g.PMC3526826.pdf
"S16 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONTENT In many cases, the size of an area of interest or image  analysis software may restrict simple quantitative  analysis.",Non-OADS,/arxiv_data1/oa_pdf/fe/0b/JPI-3-37d.PMC3526827.pdf
"TECHNOLOGY A Hamamatsu Nanozoomer 2.0 HT scanner with  associated scanning and viewing software, ImmunoRatio  image analysis software (http://imtmicroscope.uta.fi/ immunoratio/), and a basic desktop computer and  monitor were used in this study.",OADS,/arxiv_data1/oa_pdf/fe/0b/JPI-3-37d.PMC3526827.pdf
"S17 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgexaminations lagged behind scores in other disciplines;  and evaluation of the small group sessions by students,  highly variable among instructors, ranged from high  praise to disappointment to virulent diatribes.",Non-OADS,/arxiv_data1/oa_pdf/fe/0b/JPI-3-37d.PMC3526827.pdf
"S18 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgthese, 76 required correction, with 73 corrected in the  first iteration.",Non-OADS,/arxiv_data1/oa_pdf/fe/0b/JPI-3-37d.PMC3526827.pdf
"S19 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgUniversity of Pittsburgh, Pittsburgh, PA, 5International Academy of T elepathology,  Heidelberg, Germany, 6Department of Pathology, Emory University, Atlanta, GA,  7Department of Pathology, University of Michigan Medical School, Ann Arbor,  MI, 8Department of Pathology, Hospital General de Ciudad Real, Ciudad Real,  Spain, 9University of New South Wales, Centre for Health Systems and Safety  Research, Australian Institute of Health Innovation, New South Wales, Australia,  10University Freiburg, Institute of Pathology, Freiburg, Germany, 11Charite, Institute  of Pathology, Berlin, Germany, 12University of Wollongong, Centre for Health  Informatics and e-Health Research, New South Wales, Australia, 13Department  of Pathology, University of Calgary, Calgary, Ontario, Canada, 14Department of  Pathology, Iwate Medical University School of Medicine, Iwate Perfecture, Japan,  15Weiner Consulting Services, Florence, OR, 16Dennis Winsten & Associates, Inc.,  Tucson, AZ.",Non-OADS,/arxiv_data1/oa_pdf/fe/0b/JPI-3-37d.PMC3526827.pdf
"S2 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgImmunohistochemical  Evaluation of Malignant  Mesothelioma Tissue Microarray:  National Mesothelioma Virtual  Bank Waqas Amin1, Malini Srinivasan2, Sang Y ong  Song2 Nancy B. Whelan1, Anil V .",Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
"S3 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.org(0.22 microns/pixel) and “×20” magnification (0.46  microns/pixel), respectively.",OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
S4 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgadversely affected by the presence of pen marks (dots)  on the glass slide surface.,Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
"S5 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgTECHNOLOGY Using an audience response system (T urning  Technologies, Y oungstown, Ohio, USA), we measured  answer accuracy and response time to questions  regarding information contained in the CAP Fallopian  tube Cancer Protocol; purposefully selected because it is  a complex report of a rare neoplasm and unfamiliar to  most clinicians.",Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
"S6 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgcases have had colposcopy and surgical biopsy follow-up,  of which 24 cases show correlation, with one case being  an under-interpreted as LSIL with a histological diagnosis  of squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
"S7 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgTeresa Bosler2, Richard Scheuermann2 1University of T exas Health Science Center San Antonio, San Antonio, 2University of  T exas Southwestern Dallas, Dallas, TX.",Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
S8 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.org38% per case for WSI “without dots” compared to 64% per  case for WSI “with dots” and 60% per case for static images.,OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
S9 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgunivariate logistical analysis looking for statistically and  clinically significant differences between the mean test  results and UP type.,Non-OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
"S10 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgRetrieving Molecular and  FISH Data from Pathology  Reports: A Comparison of  Synoptic and Natural Language  Search T ools in a Commercial  Anatomic Pathology Laboratory  Information System Geoffrey H. Smith, Shelley Caltharp, Deborah F .",OADS,/arxiv_data1/oa_pdf/fd/13/JPI-3-37a.PMC3526828.pdf
S26 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgin learning and using the software-3.3.,Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S27 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgof therapies, and to enable the discovery of morphological  hallmarks of specific, predictive genomic alterations.",Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
S28 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONTENT Quick response (QR) codes are barcodes with two- dimensional patterns that yield many possible  combinations.,OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"TECHNOLOGY Cerner CoPath v .3.2 with PICSPlus (Cerner Corporation, Kansas City, Missouri, USA) and online  QR code generator: http://qrcode.kaywa.com (Kaywa, San  Francisco, CA, USA).",OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S29 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgIndustrial Development Zone, Xiamen, Peoples Republic of China, 3Department  of Pathology, Division Cytopathology, H.-H.-University Düsseldorf, Germany.",Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
S30 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgDESIGN The core application development was completed in the  available release of the NYU VM (Beta 5).,OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S31 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.org0.671, and 0.656, respectively.",Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S32 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgCONTENT Digitizing glass slides using whole slide imaging (WSI)  scanners involves slide preparation and rapid, automated image acquisition aimed at generating an accurate digital representation of the original glass slide.",Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S33 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgRESULTS Prior to the PACS, all files were hosted on a shared server  based on a traditional file-folder hierarchy using accession  number as the root for cases.",OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"RESULTS The source code is made publicly available, with version control and documentation, at https://github.com/wilkinson/hpath.",OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"As detailed in the documentation, the  default hematopathology template, loaded by appending  “?https://raw.github.com/wilkinson/hpath/templates/ default.js”, can be replaced or extended by additional  user-defined modules.",OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S34 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgevaluation, is a tedious and time-consuming process  and it requires relatively complex, manual calculations.",Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
S35 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgwithin 48  h by electronically signing an attestation that  the patient was told of his/her diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/62/aa/JPI-3-37f.PMC3526829.pdf
"S44 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgMitigating the Risks of Custom  Software Development in  Pathology using Open Source  Software Peter Gershkovich, John Sinard Department of Pathology, Yale Medical School, Yale University School of Medicine,  New Haven, CT .",Non-OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
"S45 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgDepartment of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit,  MI.",Non-OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
S46 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgdata was primarily due to theft (52.18%) or accidental  disclosure (18.39%).,Non-OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
S47 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgsignificant customizations to be effective.,Non-OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
TECHNOLOGY The portal (https://kingmed.upmc.com) is a web-based  interface coded in ColdFusion which enables telepathology  by incorporating clinical workflow with a whole slide  image (WSI) viewer.,OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
S48 J Pathol Inform 2012 - Abstracts  http://www.jpathinformatics.orgtest probability had a value <1% [(0.99 + 5/439-1)/(0.99  + 0.95-1)].,OADS,/arxiv_data1/oa_pdf/88/83/JPI-3-37i.PMC3526830.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society Biochemical Journal    www.biochemj.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"An SeMet (selenomethionine) derivative of EssB-N was obtained using the protocol described above with full incorpor- ation achieved by metabolic inhibition [14] and conﬁrmed by c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Model geometry and the ﬁt to electron-density maps were monitored with MOLPROBITY [24] and the validation c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
Figures were prepared using PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"aureus coding sequences for EsxA, EsxB, EsaB and EssB-N [codon optimized for expression in E. coli K12 (Genscript)] were cloned into the XhoI/HindIII or BamHI/KpnI sites of a modiﬁed pT18 or pT25 plasmid [34] respectively (for primers see Supplementary Table S1 at http://www.biochemj.org/bj/449/bj4490469add.htm).",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"EsaB, EsxA and BAP-tagged EssB-N were cloned, expressed and puriﬁed essentially as described for EssB-N (for theprimers see Supplementary Table S2 at http://www.biochemj.",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
Binding of EsxA and EsaB was measured at 25 ◦Ca n d4◦Ci nt h e reported concentrations (Supplementary Figure S1 at http://www.biochemj.org/bj/449/bj4490469add.htm).,Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"This stretch is highly divergent, indeed absent in some EssB orthologues, as evidenced by a multiple sequence alignment (Supplementary Fig-ure S2 at http://www.biochemj.org/bj/449/bj4490469add.htm).",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
The dimeric state of EssB was furthermore corroborated by BN-PAGE (Blue native PAGE) analysis (Supplementary Figure S4 at http://www.biochemj.org/bj/449/bj4490469add.htm).,OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
Although EssB-N eluted at an apparent mass of 54 kDa in analytical gel ﬁltration the observed retention volume forEssB-C was lower than expected for a protein of mass 44 kDa (Supplementary Figure S5 at http://www.biochemj.org/bj/449/ bj4490469add.htm).,Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Rectangular plate crystals of EssB-C, measuring up to 80 μm after optimization, appeared after 3 weeks, but only diffracted to about 7 Å (Supplementary Figure S6 at http://www.biochemj.org/ bj/449/bj4490469add.htm) and were not studied further.",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Structure of EssB-N The crystal structure of S. aureus EssB-N was solved by SAD methods exploiting a SeMet derivative and produced an c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"ATP (shown as black lines) and two c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"ESI–Q–TOF-MS analysis of the EssB-N sample prior to crystallization revealed a mass difference of 1038 Da (Supplementary Figure S7 at http://www.biochemj.org/bj/449/bj4490469add.htm), which would correspond to nine missing C- terminal residues from Tyr 218onwards (YVRKVGHTV).",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"An intact N-terminal fragment was identiﬁed and the last C-terminal tryptic fragment covered the sequence from Lys 207to Ala217 (KQEQDYSQNY A) (Supplementary Table S3 at http://www.biochemj.org/bj/449/bj4490469add.htm), which is proximal to the peptide identiﬁed as missing by the ESI–Q–TOF-MS data.",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"The EssB-N structure is cylindrical with a length of approxim- ately 53 Å and diameter of 33 Å, and consists of two domains (Figure 2 and Supplementary Figure S8 at http://www.biochemj.org/bj/449/bj4490469add.htm).",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"A number of conserved residues (Thr113,P r o118,G l u120,A r g134and Gly134)c l u s t e r around the C-terminal side of the cleft (Supplementary FigureS9 at http://www.biochemj.org/bj/449/bj4490469add.htm).",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"EssB-N was fused to the T18 fragment, and T25 fusions of EsxA, EsxB, EsaB and EsaC were co-expressed(Supplementary Figure S10 at http://www.biochemj.org/bj/449/ bj4490469add.htm).",OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"27, 704–714 Received 30 July 2012/1 October 2012; accepted 25 October 2012 Published as BJ Immediate Publication 25 October 2012, doi:10.1042/BJ20121209 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"M. Zoltner and others Figure S2 Multiple sequence alignment of EssB-N orthologues c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Construct Primers (forward/reverse) pT18EssB-N 5/prime-GCGC CTCGAG GAAAAACCATAACCCGAAAAACGAAATG-3/prime 5/prime-GCGC AAGCTT GCCACGGTATGGCCCACTTTGCGCAC-3/prime pT25EsxA 5/prime-GCGC GGATCC CGCGATGATTAAAATGAGCCCGGAAG-3/prime 5/prime-GCGC GGTACC TTACTGCAGGCCAAAGTTGTTGCTCAGC-3/prime pT25EsxB 5/prime-GCGC GGATCC CGGCGGCTATAAAGGCATTAAAGC-3/prime 5/prime-GCGC GGTACC TTACGGGTTCACGCGATCCAGGCCCTG-3/prime pT25EsaB 5/prime-GCGC GGATCC CAATCAGCACGTAAAAGTAAC-3/prime 5/prime-GCGC GGTACC TTACAGCAGTTTCAGAATATCGCCATC-3/prime pT25EsaC 5/prime-GCGC GGATCC CAACTTTAACGATATTGAAACGATG-3/prime 5/prime-GCGC GGTACC TTAGTTCATCGCTTTGTTAAAATATTCGCTCG-3/prime c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Miss Score Expect Rank Peptide c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
"Miss Score Expect Rank Peptide 762 1043.061279 2084.108006 2083.094971 486 0 (24) 0.0036 1 R.GLQNVVDPLPVSEAEFLTR.Y 801 1141.108002 2280.201452 2280.188904 5.50 0 127 1.8e −13 1 K.VIEAATLDLLTAFLDEQYQK.Q 802 1141.108002 2280.201452 2280.188904 5.50 0 (104) 3.9e −11 1 K.VIEAATLDLLTAFLDEQYQK.Q 803 1141.108002 2280.201452 2280.188904 5.50 0 (105) 2.9e −11 1 K.VIEAATLDLLTAFLDEQYQK.Q 804 1141.108002 2280.201452 2280.188904 5.50 0 (85) 3.4e −09 1 K.VIEAATLDLLTAFLDEQYQK.Q 805 761.075882 2280.205818 2280.188904 7.42 0 (88) 1.6e −09 1 K.VIEAATLDLLTAFLDEQYQK.Q 806 761.075882 2280.205818 2280.188904 7.42 0 (89) 1.2e −09 1 K.VIEAATLDLLTAFLDEQYQK.Q 807 761.075882 2280.205818 2280.188904 7.42 0 (76) 2.5e −08 1 K.VIEAATLDLLTAFLDEQYQK.Q 808 761.075882 2280.205818 2280.188904 7.42 0 (77) 1.8e −08 1 K.VIEAATLDLLTAFLDEQYQK.Q 558 761.411194 2281.211754 2280.188904 449 0 (49) 1.2e −05 1 K.VIEAATLDLLTAFLDEQYQK.Q 559 761.411194 2281.211754 2280.188904 449 0 (42) 6.6e −05 1 K.VIEAATLDLLTAFLDEQYQK.Q 828 805.104858 2412.292746 2412.272934 8.21 1 23 0.0047 1 R.YTFVLAPDELFFTRDGLPIAK.T 829 805.104858 2412.292746 2412.272934 8.21 1 (23) 0.005 1 R.YTFVLAPDELFFTRDGLPIAK.T 830 609.037720 2432.121776 2432.103302 7.60 0 (14) 0.043 1 R.DSFQIHYDINDNHTPFDNIK.S831 811.714905 2432.122887 2432.103302 8.05 0 37 0.0002 1 R.DSFQIHYDINDNHTPFDNIK.S 832 1217.069397 2432.124242 2432.103302 8.61 0 (9) 0.13 1 R.DSFQIHYDINDNHTPFDNIK.S 906 911.717468 3642.840768 3642.818039 6.24 0 32 0.0006 1 K.SSIKPEHFHLMYLLEQHSPYFIDAELTELR.D907 729.577667 3642.851955 3642.818039 9.31 0 (15) 0.033 1 K.SSIKPEHFHLMYLLEQHSPYFIDAELTELR.D908 729.577667 3642.851955 3642.818039 9.31 0 (15) 0.031 1 K.SSIKPEHFHLMYLLEQHSPYFIDAELTELR.D 910 738.368835 3686.807795 3684.828598 537 0 (2) 0.7 1 K.SSIKPEHFHLMYLLEQHSPYFIDAELTELR.D acetyl Received 30 July 2012/1 October 2012; accepted 25 October 2012 Published as BJ Immediate Publication 25 October 2012, doi:10.1042/BJ20121209 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/00/bj4490469.PMC3526858.pdf
Photographs were analyzed using ImageJ64 (http://imagej.nih.gov/ij) to determine landmark coordinates of adductor muscle insertions and origins and lower jaw dimensions.,OADS,/arxiv_data1/oa_pdf/e5/2e/srep01009.PMC3526859.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/2e/srep01009.PMC3526859.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Grubich, J.R., Huskey, S., Crofts, S., Orti, G. & Porto, J. Mega-Bites: Extreme jaw forces of living and extinct piranhas (Serrasalmidae).",Non-OADS,/arxiv_data1/oa_pdf/e5/2e/srep01009.PMC3526859.pdf
Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Therapeutic Advances in Neurological Disorders Review http://tan.sagepub.com 3 Introduction Multiple sclerosis (MS) is the most common inflammatory demyelinating disorder of the cen-tral nervous system.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
"Therapeutic Advances in Neurological Disorders 6 (1) 4 http://tan.sagepub.com postmortem studies [Barnett and Prineas, 2004],  which provide invaluable insights, though each rep- resenting only a limited aspect of the disease.",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
" PI Creeke and RA Farrell http://tan.sagepub.com 5 2000], whereas for intramuscular IFN β-1a  treated patients, less than 10% were BAb posi - tive at this time point.",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
"Therapeutic Advances in Neurological Disorders 6 (1) 6 http://tan.sagepub.com leads to activation of the associated janus kinases  (JAKs), which go on to phosphorylate the signal transducers and activators of transcription (STATs); this is known as the JAK-STAT signal-ling pathway [Platanias, 2005].",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
" PI Creeke and RA Farrell http://tan.sagepub.com 7 annualized relapse rates from month 13 to month  36 than those who remained NAb negative (1.08 versus 0.56, p = 0.067).",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Therapeutic Advances in Neurological Disorders 6 (1) 8 http://tan.sagepub.com lesions was 0.3 in those who were NAb negative  and 1.4 in the NAb-positive group.,OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
 PI Creeke and RA Farrell http://tan.sagepub.com 9 parameters with regards to NAb status.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Therapeutic Advances in Neurological Disorders 6 (1) 10 http://tan.sagepub.com BAb sample and sample values related to this to  generate a titre.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
 PI Creeke and RA Farrell http://tan.sagepub.com 11 and is maximal at about 12 h post injection [Ber- tolotto et al.,OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Therapeutic Advances in Neurological Disorders 6 (1) 12 http://tan.sagepub.com included aspects of these recommendations in the  algorithm detailed in Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
"Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk (ABIRISK, http://www.abirisk.eu) is an Innovative Medicines Initiative funded project set up to investigate the diverse factors that appear to be involved in the immunogenicity of biopharma-ceuticals.",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
 PI Creeke and RA Farrell http://tan.sagepub.com 13 significant reduction in biological activity of the  drug.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
"Therapeutic Advances in Neurological Disorders 6 (1) 14 http://tan.sagepub.com Compston, A. and Coles, A.",Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
 PI Creeke and RA Farrell http://tan.sagepub.com 15 II.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Therapeutic Advances in Neurological Disorders 6 (1) 16 http://tan.sagepub.com bioactivity: monitoring in MS patients and the effect of  anti-IFNbeta antibodies.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
 PI Creeke and RA Farrell http://tan.sagepub.com 17 TNF-related apoptosis inducing ligand (TRAIL) as a  potential response marker for interferon-beta treatment in multiple sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Visit SAGE journals online  http://tan.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/0a/26/10.1177_1756285612469264.PMC3526949.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/be/srep01001.PMC3526957.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, P., Hunter, T., Bayen, A.M., Schechtner, K. & Gonza ´lez, M.C.",Non-OADS,/arxiv_data1/oa_pdf/c4/be/srep01001.PMC3526957.pdf
"R package version 0.8 –14.http://CRAN.R-project.org/ package=maptools ) Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E. and Getz, W. M. (2005).",Non-OADS,/arxiv_data1/oa_pdf/12/87/S003118201200090Xa.PMC3526958.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/12/87/S003118201200090Xa.PMC3526958.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/gfs544.PMC3526982.pdf
of Citations Citation per paper H-index  1975 372 2587 6.95 26  1976 460 3618 7.87 28  1977 583 3286 5.64 27  1978 670 4309 6.43 28  1979 499 3902 7.82 28 1980 343 2683 7.82 24 1981 266 1986 7.47 22 1982 163 1211 7.43 20 1983 151 1053 6.97 16 1984 142 918 6.46 16 1985 138 867 6.28 16 1986 184 1114 6.05 16  1987 165 1074 6.51 18  1988 165 1030 6.24 17 1989 154 1491 9.68 21 1990 190 1305 6.87 18 1991 235 2325 9.89 26 1992 260 2426 9.33 26 1993 416 3996 9.61 29 1994 488 3878 7.95 29  1995 603 5333 8.84 33  1996 718 6214 8.65 34 1997 980 8350 8.52 40 1998 1231 11086 9.01 47 1999 1310 15436 11.78 52 2000 1749 16088 9.20 47 2001 2088 19276 9.23 50  2002 2845 23960 8.42 52  2003 3922 32965 8.41 59 2004 5142 35978 7.00 54 2005 6868 42550 6.20 59 2006 9221 50389 5.46 61 2007 13377 * * * 2008 17256 * * * 2009 19823 * * * 2010 20610 * * *  Data were obtained from http://apps.webofscience.com accessed 25 September 2011.,Non-OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
Top 15 Iranian Universities based on scientific productivity according to the Institute for Scientific Information (ISI)   Grade University Number of Publication 1 University of Tehran 12462  2 Sharif University of Technology 8047  3 Islamic Azad University 7448  4 Tehran University of Medical Sciences 7074  5 Shiraz University 5239  6 Tarbiat Modarres University 4613  7 Iran University of Science and Technology 4229  8 Amirkabir University of Technology 4220  9 Isfahan University of Technology 3514  10 Shiraz University of Medical Sciences 2666  11 Ferdowsi University Mashhad 2451  12 Tabriz University 2054 13 Khajeh Nasir Toosi University of Technology 1843  14 Shahid Beheshti University  1614  15 Shahid Beheshti University of Medical Sciences 1579  Data were obtained from http://apps.webofknowledge.com accessed 03 August 2011.,Non-OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
Journals where most Iranian papers were published according to the Institute for Scientific Information (ISI)   Grade Journal's title Number of published  articles  1 Asian Journal of Chemistry 850  2 Applied Mathematics and Computation 653  3 Phosphorus Sulfur and Silicon and the Related Elements 623  4 Acta Crystallographica Section E-Structure Reports Online 613  5 Synthetic Communications 562  6 Lecture Notes in Computer Science 547  7 Iranian Polymer Journal  542  8 Journal of Applied Polymer Science 521  9 International Journal of Psychology 447  10 Iranian Journal of Science and Technology 422  11 Iranian Journal of Chemistry and Chemical Engineering-International English Edition 416  12 Acta Horticulturae  408  13 Transplantation Proceedings 400  14 Archives of Iranian Medicine 394  15 Journal of Chemical Research-S 392  Data were obtained from http://apps.webofknowledge.com accessed 03 August 2011.,Non-OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
Data were obtained from http://www.scimagojr.com accessed 03 August 2011.,OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
"Ranking of different subject categories in Iran based on Essential Science Indic ators (ESI) Field Papers Citations Citations per publication Chemistry  16982 103384 6.09  Engineering  12145 40236 3.31  Clinical Medicine  9740 35345 3.63  Physics  5385 23953 4.45 Materials Science  4828 16244 3.36  Plant & Animal Science  4354 9482 2.18  Mathematics  2628 5387 2.05  Agricultural Sciences  2378 7128 3.00  Biology & Biochemistry  2268 10616 4.68  Computer Science  1802 3624 2.01  Pharmacology & Toxicology  1778 9616 5.41  Geosciences  1414 5528 3.91  Environment/Ecology  1362 4849 3.56  Social Sciences, General  1267 2336 1.84  Neuroscience & Behavior  868 4947 5.70  Microbiology  755 2161 2.86  Molecular Biology & Genetics  691 4083 5.91  Immunology  414 2549 6.16  Space Science  362 1071 2.96  Psychiatry/Psychology  325 1817 5.59  Multidisciplinary  277 106 0.38  Economics & Business  156 273 1.75  Data were obtained from http://esi.webofknowledge.com/home.cgi accessed 31 July 2011.",OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
[cited 2011 Aug 3];  Available from: URL: http://apps.isiknowledge.com.,OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
[cited 2011  Aug 3]; Available from: URL: http://www.scimagojr.com.,OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
[cited 31 Jul 2011]; Available from: UrL: http://esi.webofknowledge.com/home.cgi.,Non-OADS,/arxiv_data1/oa_pdf/c9/d0/JRMS-17-275.PMC3527047.pdf
"Cell Cycle 11:7, 1296-1300; April 1, 2012; © 2012 Landes Bioscience extr A view 1296 Cell Cycle volume 11 issue 7Key words:  polycomb, chromatin,   histone marks, epigenetic inheritance,  DNA replication, bivalent domain, S phase, PRE  Submitted: 01/23/12Accepted: 02/14/12http://dx.doi.org/10.4161/cc.19710 *Correspondence to: Chiara Lanzuolo and Valerio  Orlando; Email: chiara.lanzuolo@inmm.cnr.it and vorlando@dti.telethon.itPolycomb group of proteins (PcG), by  controlling gene silencing transcrip - tional programs through cell cycle, lock cell identity and memory.",Non-OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Nature  2004; 431:873-8; PMID:15386022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Nat Genet  2006; 38:700-5; PMID:16732288; http://dx.doi.org/10.1038/ng1817.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell 2009; 138:885-97; PMID:19737517;  http://dx.doi.org/10.1016/j.cell.2009.08.020.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell  2010; 140:99-110; PMID:20085705; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Genes Dev 2003; 17:2406-20; PMID:14522946; http://dx.doi.org/10.1101/gad.269503.References 1.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell 2011; 144:214-26;  PMID:21241892; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Science 2002; 298:1039-43; PMID:12351676; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell 2002; 111:185-96; PMID:12408863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell  2002; 111:197-208; PMID:12408864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Genome Res 2011; 21:216-26; PMID:21177970;  http://dx.doi.org/10.1101/gr.114348.110.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
EMBO J 1998; 17:5141- 50; PMID:9724650; http://dx.doi.org/10.1093/ emboj /17.17.5141.,Non-OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Genes Dev 2006; 20:2041- 54; PMID:16882982; http://dx.doi.org/10.1101/ gad.388706.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell  2009; 137:110-22; PMID:19303136; http://dx.doi.org/10.1016/j.cell.2009.02.017.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Mech Dev 1993; 40:37-46;  PMID:8095152; http://dx.doi.org/10.1016/0925- 4773(93)90086-D.18.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
PLoS Genet 2011; 7:1002370; PMID:22072989;  http://dx.doi.org/10.1371/journal.pgen.1002370.,Non-OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
FEBS Lett  2011; 585:2067-77; PMID:21575638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Cell 2006; 125:315-26; PMID:16630819;  http://dx.doi.org/10.1016/j.cell.2006.02.041.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Nat Cell Biol 2006; 8:532-8; PMID:16570078; http://dx.doi.org/10.1038/ ncb1403.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
PLoS Genet 2008; 4:1000242;  PMID:18974828; http://dx.doi.org/10.1371/journal.pgen.1000242.,Non-OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
EMBO Rep  2004; 5:976-82; PMID:15448640; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Nat Genet 2006; 38:931-5; PMID:16823379; http://dx.doi.org/10.1038/ng1833.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Dev Cell 2006; 11:117-24;  PMID:16824958; http://dx.doi.org/10.1016/j.dev - cel.2006.05.009.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Nat Cell Biol 2007; 9:1167- 74; PMID:17828248; http://dx.doi.org/10.1038/ncb1637.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
Science 2010; 328:1161-4; PMID:20508129; http://dx.doi.org/10.1126/sci - ence.1186777.,OADS,/arxiv_data1/oa_pdf/6b/89/cc-11-1296.PMC3527071.pdf
"However, low transcription  *Correspondence to: Karissa Y. Sanbonmatsu; Email: kys@lanl.gov Submitted: 09/29/12; Revised: 10/18/12; Accepted: 10/18/12http://dx.doi.org/10.4161/bioarch.22592Long noncoding RNAs (lncRNAs) play a key role in many  important areas of epigenetics, stem cell biology, cancer, signaling and brain function.",Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nat Rev Genet 2011; 12:136- 49; PMID:21245830; http://dx.doi.org/10.1038/nrg2904 2.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cold Spring Harb Perspect Biol 2011; 3:a003756; PMID:20573714; http://dx.doi.org/10.1101/cshperspect.a003756 3.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2010; 464:1071-6; PMID:20393566; http://dx.doi.org/10.1038/nature08975 4.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell 2010; 142:358-60; PMID:20691894; http://dx.doi.org/10.1016/j.cell.2010.07.029 5.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
J Biol 2010; 9:5; PMID:20156321; http://dx.doi.org/10.1186/jbiol197 6.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell 2009; 136:629-41; PMID:19239885; http://dx.doi.org/10.1016/j.cell.2009.02.006 7.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2011; 470:284-8; PMID:21307942; http://dx.doi.org/10.1038/nature09701 8.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
T rends Genet 2012; 28:445-53; PMID:22785023; http://dx.doi.org/10.1016/j.tig.2012.06.002 9.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2009; 462:799-802; PMID:20010688; http://dx.doi.org/10.1038/nature08618 10.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Cell 2009; 33:784-90; PMID:19285444; http://dx.doi.org/10.1016/j.molcel.2009.02.019 11.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nat Protoc 2008; 3:288-302; PMID:18274531; http://dx.doi.org/10.1038/nprot.2007.533 13.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2009; 458:223-7; PMID:19182780; http://dx.doi.org/10.1038/nature07672 14.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell Stem Cell 2010; 7:288-98; PMID:20804966; http://dx.doi.org/10.1016/j.stem.2010.08.004 15.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nucleic Acids Res 2002; 30:3497-531; PMID:12177293; http://dx.doi.org/10.1093/nar/gkf481 16.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2012; 489:101-8; PMID:22955620; http://dx.doi.org/10.1038/nature11233 17.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Physiol Rev 2007; 87:799-823; PMID:17615389; http://dx.doi.org/10.1152/physrev.00036.2006 18.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2007; 316:1484-8; PMID:17510325; http://dx.doi.org/10.1126/science.1138341 19.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2012; 22:885-98; PMID:22406755; http://dx.doi.org/10.1101/gr.131037.111 20.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2008; 322:918-23; PMID:18988847; http://dx.doi.org/10.1126/science.1160489 21.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
EMBO Rep 2011; 12:1280-5; PMID:22015688; http://dx.doi.org/10.1038/embor.2011.196 22.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2012; 22:1646-57; PMID:22955977; http://dx.doi.org/10.1101/gr.134767.11123.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Epigenetics Chromatin 2011; 4:21; PMID:22085535; http://dx.doi.org/10.1186/1756-8935-4-21 24.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2002; 415:810-3; PMID:11845212; http://dx.doi.org/10.1038/415810a 25.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Cell 2008; 32:232-46; PMID:18951091; http://dx.doi.org/10.1016/j.molcel.2008.08.022 26.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2012; 22:1775-89; PMID:22955988; http://dx.doi.org/10.1101/gr.132159.111 27.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nucleic Acids Res 2012; PMID:22923516; http://dx.doi.org/10.1093/nar/gks776 30.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Neurobiol Dis 2012; 48:1-8; PMID:22709987; http://dx.doi.org/10.1016/j.nbd.2012.06.004 31.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2008; 18:1433-45; PMID:18562676; http://dx.doi.org/10.1101/gr.078378.108 32.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
J Cell Sci 2007; 120:2498-506; PMID:17623775; http://dx.doi.org/10.1242/jcs.009357 33.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2010; 468:784-9; PMID:21076397; http://dx.doi.org/10.1038/nature09516 66.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2009; 326:694-9; PMID:19833919; http://dx.doi.org/10.1126/sci-ence.1179709 67.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Biol Cell 2005; 16:5304-15; PMID:16148043; http://dx.doi.org/10.1091/mbc.E05-06-0587 69.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Exp Cell Res 2001; 263:131-44; PMID:11161712; http://dx.doi.org/10.1006/excr.2000.5097 70.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Biol Cell 2010; 21:4020-7; PMID:20881053; http://dx.doi.org/10.1091/mbc.E10-08-0690 71.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
RNA 2002; 8:1334-47; PMID:12403470; http://dx.doi.org/10.1017/S1355838202022070 72.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2012; 489:57-74; PMID:22955616; http://dx.doi.org/10.1038/nature11247 73.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2002; 296:1265-9; PMID:12016303; http://dx.doi.org/10.1126/science.1072457 74.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genes Dev 2003; 17:49-63; PMID:12514099; http://dx.doi.org/10.1101/gad.1048103 75.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2008;  319:1795-7; PMID:18369140; http://dx.doi.org/10.1126/science.1152621 76.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2002; 419:952-6; PMID:12410317; http://dx.doi.org/10.1038/nature01145 77.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nucleic Acids Res 2011; 39:2416-31; PMID:21097777; http://dx.doi.org/10.1093/nar/gkq1096 78.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Structure 2010; 18:787-97; PMID:20637415; http://dx.doi.org/10.1016/j.str.2010.04.006 79.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Biophys J 2009; 96:L7-9; PMID:19167285; http://dx.doi.org/10.1016/j.bpj.2008.10.033 80.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
J Am Chem Soc 2012; 134:12043-53; PMID:22612276; http://dx.doi.org/10.1021/ja301454u49.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Cell 2010; 40:939-53; PMID:21172659; http://dx.doi.org/10.1016/j.molcel.2010.12.011 50.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2008; 322:750-6; PMID:18974356; http://dx.doi.org/10.1126/sci-ence.1163045 51.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nat Genet 2002; 30:167-74; PMID:11780141; http://dx.doi.org/10.1038/ng820 52.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
PLoS Biol 2010; 8:e1000276; PMID:20052282; http://dx.doi.org/10.1371/journal.pbio.1000276 53.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
RNA 2010; 16:259-66; PMID:20007330; http://dx.doi.org/10.1261/rna.1907510 54.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2009; 19:347-59; PMID:19106332; http://dx.doi.org/10.1101/gr.087775.108 55.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
RNA 2008; 14:1270-5; PMID:18511501; http://dx.doi.org/10.1261/rna.1054608 56.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2006; 443:167-72; PMID:16915236; http://dx.doi.org/10.1038/nature05113 57.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
PLoS Genet 2006; 2:e168; PMID:17040131; http://dx.doi.org/10.1371/journal.pgen.0020168 58.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nucleic Acids Res 2012; 40:5034-51; PMID:22362738; http://dx.doi.org/10.1093/nar/gks071 59.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genes Dev 2010; 24:2543-55; PMID:20966046; http://dx.doi.org/10.1101/gad.1967810 60.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Curr Opin Struct Biol 2005; 15:302-8; PMID:15963891; http://dx.doi.org/10.1016/j.sbi.2005.04.005 61.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
T rends Biochem Sci 2007; 32:138-45; PMID:17289393; http://dx.doi.org/10.1016/j.tibs.2007.01.005 62.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nat Struct Mol Biol 2012; 19:555-7; PMID:22484319; http://dx.doi.org/10.1038/nsmb.2270 63.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nat Struct Mol Biol 2010; 17:513-8; PMID:20357774; http://dx.doi.org/10.1038/nsmb.1777 64.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
EMBO J 2010; 29:3082-93; PMID:20729808; http://dx.doi.org/10.1038/emboj.2010.199 35.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell 2008; 135:919-32; PMID:19041754; http://dx.doi.org/10.1016/j.cell.2008.10.012 36.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Cell 2009; 33:717-26; PMID:19217333; http://dx.doi.org/10.1016/j.molcel.2009.01.026 37.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell 2012; 149:819-31; PMID:22541069; http://dx.doi.org/10.1016/j.cell.2012.03.035 38.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cancer Res 2011; 71:3-7; PMID:21199792; http://dx.doi.org/10.1158/0008-5472.CAN-10-2483 39.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Annu Rev Biochem 2012; 81:145-66; PMID:22663078; http://dx.doi.org/10.1146/annurev-biochem-051410-092902 40.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Methods Enzymol 1998; 295:379-402; PMID:9750229; http://dx.doi.org/10.1016/S0076-6879(98)95050-9 41.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Science 2005; 310:827-34; PMID:16272117; http://dx.doi.org/10.1126/science.1117230 43.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Mol Cell 2011; 43:1040-6; PMID:21925392; http://dx.doi.org/10.1016/j.mol-cel.2011.08.019 44.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Cell 2011; 147:358-69; PMID:22000014; http://dx.doi.org/10.1016/j.cell.2011.09.028 45.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genes Dev 2008; 22:756-69; PMID:18347095; http://dx.doi.org/10.1101/gad.455708 46.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2007; 445:666-70; PMID:17237763; http://dx.doi.org/10.1038/nature05519 47.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Nature 2011; 477:295-300; PMID:21874018; http://dx.doi.org/10.1038/nature10398 48.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Genome Res 2009; 19:381-94; PMID:19116412; http://dx.doi.org/10.1101/gr.082503.108,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
EMBO J 2010; 29:770-81; PMID:20033061; http://dx.doi.org/10.1038/emboj.2009.384 86.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Curr Opin Struct Biol 2012; 22:168-74; PMID:22336622; http://dx.doi.org/10.1016/j.sbi.2012.01.008 87.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
J Am Chem Soc 2010; 132:13170-1; PMID:20806913; http://dx.doi.org/10.1021/ja106139981.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
J Mol Biol 2009; 386:648-61; PMID:19146858; http://dx.doi.org/10.1016/j.jmb.2008.12.035 83.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Biochimie 2006; 88:1053-9; PMID:16905237; http://dx.doi.org/10.1016/j.bio-chi.2006.06.012 84.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Biopolymers 2008; 89:565-77; PMID:18286627; http://dx.doi.org/10.1002/bip.2096188.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Annu Rev Biochem 2001; 70:415-35; PMID:11395413; http://dx.doi.org/10.1146/annurev.biochem.70.1.415 89.,Non-OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
T rends Biochem Sci 2001; 26:124-30; PMID:11166571; http://dx.doi.org/10.1016/S0968-0004(00)01737-0 90.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
Curr Opin Struct Biol 2009; 19:103-9; PMID:19223173; http://dx.doi.org/10.1016/j.sbi.2009.01.002.,OADS,/arxiv_data1/oa_pdf/48/97/bioa-2-189.PMC3527312.pdf
2 Combination of these techniques  Correspondence to: Peter Gunning; Email: p.gunning@unsw.edu.au Submitted: 10/30/12; Accepted: 10/30/12http://dx.doi.org/10.4161/bioa.22726BioArchitecture is a term used to describe the organization and  regulation of biological space.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:32- 8; PMID:21866260; http://dx.doi.org/10.4161/bioa.1.1.14799 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:271-6; PMID:22545179; http://dx.doi.org/10.4161/bioa.1.6.19338 3.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:240-4; PMID:22754616; http://dx.doi.org/10.4161/bioa.18471 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:225-9; PMID:22754613; http://dx.doi.org/10.4161/bioa.18405 5.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:66-8; PMID:21866265; http://dx.doi.org/10.4161/bioa.1.2.15467 6.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:165-8; PMID:22069508; http://dx.doi.org/10.4161/bioa.1.4.17314 7.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:205-8; PMID:22754609; http://dx.doi.org/10.4161/bioa.181158.,OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:127-33; PMID:21922043; http://dx.doi.org/10.4161/bioa.1.3.16714 9.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:192-5; PMID:22069513; http://dx.doi.org/10.4161/bioa.1.4.17643 10.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:135-64; PMID:22069507; http://dx.doi.org/10.4161/bioa.1.4.17897 11.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:284-9; PMID:22545181; http://dx.doi.org/10.4161/bioa.1.6.19336 12.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:29-31; PMID:21866259; http://dx.doi.org/10.4161/bioa.1.1.14665 13.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:49-59; PMID:21866263; http://dx.doi.org/10.4161/bioa.1.1.15172 14.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:257-60; PMID:22545176; http://dx.doi.org/10.4161/bioa.1.6.1919715.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:245-9; PMID:22754617; http://dx.doi.org/10.4161/bioa.18246 16.,OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:277-83; PMID:22545180; http://dx.doi.org/10.4161/bioa.1.6.19341 17.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:250-5; PMID:22754618; http://dx.doi.org/10.4161/bioa.18117 18.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:96-102; PMID:21866271; http://dx.doi.org/10.4161/bioa.1.2.16251 19.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:122-6; PMID:21922042; http://dx.doi.org/10.4161/bioa.1.3.17313 20.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:186-91; PMID:22069512; http://dx.doi.org/10.4161/bioa.1.4.17642,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:45-8; PMID:21866262; http://dx.doi.org/10.4161/bioa.1.1.15173 42.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:21-3; PMID:21866257; http://dx.doi.org/10.4161/bioa.1.1.14631 43.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:91-5; PMID:21866270; http://dx.doi.org/10.4161/bioa.1.2.16269 44.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:24-8; PMID:21866258; http://dx.doi.org/10.4161/bioa.1.1.14664 45.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:61-5; PMID:21866264; http://dx.doi.org/10.4161/bioa.1.2.15329 46.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:9-13; PMID:21866255; http://dx.doi.org/10.4161/bioa.1.1.14629 47.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:69-73; PMID:21866266; http://dx.doi.org/10.4161/bioa.1.2.15469 48.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:2-4; PMID:21866253; http://dx.doi.org/10.4161/bioa.1.1.14429 49.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:5-8; PMID:21866254; http://dx.doi.org/10.4161/bioa.1.1.1462832.,OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:80-7; PMID:21866268; http://dx.doi.org/10.4161/bioa.1.2.15807 33.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:180-5; PMID:22069511; http://dx.doi.org/10.4161/bioa.1.4.17594 34.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:196-9; PMID:22069514; http://dx.doi.org/10.4161/bioa.1.4.17697 35.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:74-9; PMID:21866267; http://dx.doi.org/10.4161/bioa.1.2.15549 36.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:221-4; PMID:22754612; http://dx.doi.org/10.4161/bioa.18403 37.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:261-6; PMID:22545177; http://dx.doi.org/10.4161/bioa.1.6.19199 38.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:267-70; PMID:22545178; http://dx.doi.org/10.4161/bioa.1.6.19198 39.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:14-20; PMID:21866256; http://dx.doi.org/10.4161/bioa.1.1.14630 40.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:39-44; PMID:21866261; http://dx.doi.org/10.4161/bioa.1.1.1481521.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:169-74; PMID:22069509; http://dx.doi.org/10.4161/bioa.1.4.17532 22.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:114-21; PMID:21922041; http://dx.doi.org/10.4161/bioa.1.3.17091 23.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:175-9; PMID:22069510; http://dx.doi.org/10.4161/bioa.1.4.17533 24.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:230-5; PMID:22754614; http://dx.doi.org/10.4161/bioa.18406 25.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:200-4; PMID:22069515; http://dx.doi.org/10.4161/bioa.1.4.17774 26.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:110-3; PMID:21922040; http://dx.doi.org/10.4161/bioa.1.3.16985 27.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:216-20; PMID:22754611; http://dx.doi.org/10.4161/bioa.18116 28.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:88-90; PMID:21866269; http://dx.doi.org/10.4161/bioa.1.2.16240 29.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:105-9; PMID:21922039; http://dx.doi.org/10.4161/bioa.1.3.16518 30.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:209-15; PMID:22754610; http://dx.doi.org/10.4161/bioa.18103 31.,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
Bioarchitecture 2011; 1:236-9; PMID:22754615; http://dx.doi.org/10.4161/bioa.18427,Non-OADS,/arxiv_data1/oa_pdf/bc/44/bioa-2-200.PMC3527313.pdf
"J Cell Sci 2012; 125:3977–88; PMID:22623727; http://dx.doi.org/10.1242/jcs.097667Keywords:  cytoskeleton, cofilin, profilin,  actin, cofilin rods, nuclear transport sig - nals, Huntington disease Submitted: 10/08/12Accepted: 10/14/12http://dx.doi.org/10.4161/bioa.22549 *Correspondence to: Ray Truant;   Email: truant@mcmaster.caThe cofilin-actin rod stress response  is an actin cytoskeletal dynamic  arrest that occurs in cells under a vari - ety of stress conditions.",Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Lancet Oncol 2012; 13:642-8; PMID:22503213; http://dx.doi.org/10.1016/S1470-2045(12)70132-8 30.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Prog Neurobiol 2007; 83:228-48; PMID:17467140; http://dx.doi.org/10.1016/j.pneu - robio.2007.03.004 33.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Hum Mol Genet 2003; 12:497-508; PMID:12588797; http://dx.doi.org/10.1093/hmg/ddg046 34.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Brain Pathol 1999; 9:147-63; PMID:9989457; http://dx.doi.org/10.1111/j.1750-3639.1999.tb00216.x 35.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Free Radic Biol Med 2008; 45:667-78; PMID:18588971; http://dx.doi.org/10.1016/j.fre - eradbiomed.2008.05.014 36.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Hum Mol Genet 2007; 16:2600-15; PMID:17704510; http://dx.doi.org/10.1093/hmg/ddm217 37.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Trends Biochem Sci 2002; 27:534-9; PMID:12368090; http://dx.doi.org/10.1016/S0968-0004(02)02182-5 38.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Cell Metab 2011; 14:724-38; PMID:22152301; http://dx.doi.org/10.1016/j.cmet.2011.08.016 39.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cell Biol 2010; 189:619-29; PMID:20457765; http://dx.doi.org/10.1083/jcb.201003008 40.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
EMBO J 2010; 29:1889-902; PMID:20407421; http://dx.doi.org/10.1038/emboj.2010.72 42.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Mol Biol Cell 2005; 16:649-64; PMID:15548599; http://dx.doi.org/10.1091/mbc.E04-07-0555 43.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Hum Mol Genet 2011; 20:1937-51; PMID:21355047; http://dx.doi.org/10.1093/hmg/ddr075 15.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nat Cell Biol 2004; 6:1094-101; PMID:15502823; http://dx.doi.org/10.1038/ncb1182 17.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Genes Dev 2004; 18:3010-5; PMID:15574586; http://dx.doi.org/10.1101/gad.1250804 18.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Mol Cell Biol 2008; 28:6342-57; PMID:18710935; http://dx.doi.org/10.1128/MCB.00766-08 19.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nucleus 2011; 2:72-9; PMID:21647301; http://dx.doi.org/10.4161/nucl.2.1.14508 20.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cell Biol 2007; 179:1095-103; PMID:18070915; http://dx.doi.org/10.1083/jcb.200710058 21.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cell Sci 2011; 124:123-32; PMID:21172822; http://dx.doi.org/10.1242/jcs.073197 22.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
"Mol Biol Cell 2010; 21:811-20; PMID:20053683; http://dx.doi.org/10.1091/mbc.E09-06-0534 23.  d e Lanerolle P, Serebryannyy L. Nuclear actin  and myosins: life without filaments.",OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nat Cell Biol 2011; 13:1282-8; PMID:22048410; http://dx.doi.org/10.1038/ncb2364 24.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Hum Mol Genet 2010; 19:573-83; PMID:19933700; http://dx.doi.org/10.1093/hmg/ddp524 25.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Hum Mol Genet 2000; 9:2799-809; PMID:11092756; http://dx.doi.org/10.1093/hmg/9.19.2799 26.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Mol Neurobiol 2003; 28:259-76; PMID:14709789; http://dx.doi.org/10.1385/MN:28:3:259 27.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nat Genet 1996; 13:442-9; PMID:8696339; http://dx.doi.org/10.1038/ng0896-442References 1.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Exp Cell Res 1980; 127:421-9; PMID:6892900; http://dx.doi.org/10.1016/0014-4827(80)90446-2 4.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nat Cell Biol 2000; 2:628-36; PMID:10980704; http://dx.doi.org/10.1038/35023579 5.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Biol Chem 2012; 287:3919-29; PMID:22184127; http://dx.doi.org/10.1074/jbc.M111.301911 6.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Exp Cell Res 2007; 313:2858-74; PMID:17512523; http://dx.doi.org/10.1016/j.yexcr.2007.04.016 7.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Nature 2012; 488:499-503; PMID:22801503; http://dx.doi.org/10.1038/nature11280 8.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cell Sci 2012; PMID:22623727; http://dx.doi.org/10.1242/jcs.097667 9.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Am J Physiol Cell Physiol 2006; 291:C828-39; PMID:16738008; http://dx.doi.org/10.1152/ajpcell.00066.2006 10.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Curr Mol Med 2008; 8:157-72; PMID:18473817; http://dx.doi.org/10.2174/156652408784221324 11.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cell Biol 2011; 195:721-7; PMID:22123860; http://dx.doi.org/10.1083/jcb.201102039 12.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Curr Alzheimer Res 2010; 7:241-50; PMID:20088812; http://dx.doi.org/10.2174/156720510791050902 13.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Mol Cell Biol 2008; 28:5196-208; PMID:18573880; http://dx.doi.org/10.1128/MCB.00079-0845.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
Neurobiol Dis 2008; 30:365-74; PMID:18417352; http://dx.doi.org/10.1016/j.nbd.2008.02.00744.,OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
J Cereb Blood Flow Metab 2001; 21:1133-45; PMID:11598490; http://dx.doi.org/10.1097/00004647-200110000-00001,Non-OADS,/arxiv_data1/oa_pdf/57/c9/bioa-2-204.PMC3527314.pdf
"PLoS Genet 2012; 8:e1002547; PMID:22396663; http://dx.doi.org/10.1371/journal.pgen.1002547Keywords:  Akirin, Twist, SWI/SNF,  chromatin, transcription, muscle,  Drosophila Submitted: 11/5/2012Accepted: 11/14/2012http://dx.doi.org/10.4161/bioa.22907 *Correspondence to: Mary K. Baylies;  Email: m-baylies@ski.mskcc.orgEmbryonic patterning relies upon an  exquisitely timed program of gene  regulation.",Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
BMC Evol  Biol 2009; 9:34; PMID:19200367; http://dx.doi.org/10.1186/1471-2148-9-34 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
PLoS Genet 2012; 8:e1002547; PMID:22396663; http://dx.doi.org/10.1371/jour - nal.pgen.1002547 3.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Nat Immunol 2008; 9:97-104; PMID:18066067; http://dx.doi.org/10.1038/ni1543 4.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Exp Cell Res 2009; 315:2012-21; PMID:19406121; http://dx.doi.org/10.1016/j.yexcr.2009.04.014 5.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Exp Cell Res 2008; 314:1013-29; PMID:18255059; http://dx.doi.org/10.1016/j.yexcr.2008.01.004 6.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
J Biol Chem 2000; 275:40235-43; PMID:10976104; http://dx.doi.org/10.1074/jbc.M004356200 9.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Nat Genet 2012; 44:148-56; PMID:22231485; http://dx.doi.org/10.1038/ng.1064 10.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Science 1996; 272:1481-4; PMID:8633240; http://dx.doi.org/10.1126/sci - ence.272.5267.1481 11.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Science 2003; 302:1727-36; PMID:14605208; http://dx.doi.org/10.1126/sci - ence.1090289 12.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Development 2005; 132:1211-22; PMID:15703278; http://dx.doi.org/10.1242/dev.01691 13.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
EMBO J 2012; 31:301-16; PMID:22068056; http://dx.doi.org/10.1038/emboj.2011.391 26.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Mol Cell 2003; 11:377-89; PMID:12620226; http://dx.doi.org/10.1016/S1097-2765(03)00034-0 27.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Exp Cell Res 2010; 316:3073-80; PMID:20553711; http://dx.doi.org/10.1016/j.yexcr.2010.05.023 28.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Cancer Res 2009; 69:8223-30; PMID:19843852; http://dx.doi.org/10.1158/0008-5472.CAN-09-2166 29.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Cell 2004; 117:927-39; PMID:15210113; http://dx.doi.org/10.1016/j.cell.2004.06.00620.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Nature 2004; 432:107-12; PMID:15525990; http://dx.doi.org/10.1038/nature03071 21.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Genes Dev 2003; 17:591-6; PMID:12629041; http://dx.doi.org/10.1101/gad.255703 23.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Biochem Biophys Res Commun 2006; 346:794-801; PMID:16782067; http://dx.doi.org/10.1016/j.bbrc.2006.05.211 24.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Genes Dev 2004; 18:3106-16; PMID:15601824; http://dx.doi.org/10.1101/gad.123810414.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Nat Genet 2004; 36:1019-23; PMID:15286786; http://dx.doi.org/10.1038/ng1404 16.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Oncogene 2009; 28:1653-68; PMID:19234488; http://dx.doi.org/10.1038/onc.2009.4 17.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Annu Rev Biochem 2009; 78:273-304; PMID:19355820; http://dx.doi.org/10.1146/annurev.biochem.77.062706.153223 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Curr Opin Genet Dev 2008; 18:397-403; PMID:18678250; http://dx.doi.org/10.1016/j.gde.2008.07.007 19.,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
Neuron 2007; 56:94-108; PMID:17920018; http://dx.doi.org/10.1016/j.neuron.2007.08.021,OADS,/arxiv_data1/oa_pdf/9f/d8/bioa-2-209.PMC3527315.pdf
"Do not distribute.BioArchitecture 2:6, 214–219; November/December 2012; © 2012 Landes Bioscience Short Commu NiCAtio N 214 BioA rchitecture  V olume 2 i ssue 6*Correspondence to: Katherine B. Szarama and Richard S. Chadwick; szaramak@nidcd.nih.gov and chadwick@helix.nih.gov Submitted: 09/04/12; Revised: 09/20/12; Accepted: 09/21/12http://dx.doi.org/10.4161/bioa.22332Introduction Modulation of cytoskeletal dynamics through growth factor sig - naling pathways is one of the main effectors of tissue morphogen - esis during organ development.",Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Cell Biol 2005; 168:141-53; PMID:15631994; http://dx.doi.org/10.1083/jcb.200405094 28.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Biol Chem 2012; 287:17050-64; PMID:22467876; http://dx.doi.org/10.1074/jbc.M111.316661 29.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Science 1990; 248:1537-9; PMID:1694307; http://dx.doi.org/10.1126/science.1694307 30.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Cell Signal 1996; 8:335-40; PMID:8911681; http://dx.doi.org/10.1016/0898-6568(96)00067-8 31.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Biol Chem 1998; 273:17186-91; PMID:9642287; http://dx.doi.org/10.1074/jbc.273.27.17186 32.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Nat Cell Biol 2008; 10:415-21; PMID:18364701; http://dx.doi.org/10.1038/ncb1703 33.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Neurosci 2008; 28:13008-13; PMID:19036994; http://dx.doi.org/10.1523/JNEUROSCI.2363-08.2008 34.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Mol Cell Biol 2010; 30:2206-19; PMID:20194617; http://dx.doi.org/10.1128/MCB.01181-09 35.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Neuron 2003; 38:887-98; PMID:12818175; http://dx.doi.org/10.1016/S0896-6273(03)00354-4 37.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Nat Cell Biol 2010; 12:330-40; PMID:20228810; http://dx.doi.org/10.1038/ncb203414.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Nat Genet 1996; 12:390-7; PMID:8630492; http://dx.doi.org/10.1038/ng0496-390 15.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Nature 2002; 419:300-4; PMID:12239568; http://dx.doi.org/10.1038/nature01059 16.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Neuroscience 2009; 164:1312-9; PMID:19712724; http://dx.doi.org/10.1016/j.neuro-science.2009.08.043 19.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Development 2007; 134:3021-9; PMID:17634195; http://dx.doi.org/10.1242/dev.02874 20.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Genes Cells 2004; 9:749-61; PMID:15298682; http://dx.doi.org/10.1111/j.1356-9597.2004.00761.x 21.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Science 1997; 276:955-60; PMID:9139660; http://dx.doi.org/10.1126/science.276.5314.955 22.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Hear Res 2000; 148:161-72; PMID:10978833; http://dx.doi.org/10.1016/S0378-5955(00)00149-0 23.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Neurocytol 2003; 32:185-97; PMID:14707552; http://dx.doi.org/10.1023/B:NEUR.0000005602.18713.02 24.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Neurosci 2005; 25:9658-68; PMID:16237170; http://dx.doi.org/10.1523/JNEUROSCI.1773-05.2005 25.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Genes Cells 2005; 10:127-37; PMID:15676024; http://dx.doi.org/10.1111/j.1365-2443.2005.00824.x 26.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Cell 2001; 104:923-35; PMID:11290329; http://dx.doi.org/10.1016/S0092-8674(01)00288-4References 1.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Comp Neurol 1997; 386:635-51; PMID:9378857; http://dx.doi.org/10.1002/(SICI)1096-9861(19971006)386:4<635::AID-CNE9>3.0.CO;2-3 3.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
J Assoc Res Otolaryngol 2012; 13:185-97; PMID:22302113; http://dx.doi.org/10.1007/s10162-011-0308-x 5.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Laryngoscope 2004; 114:1609-18; PMID:15475791; http://dx.doi.org/10.1097/00005537-200409000-00020 6.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Hear Res 1984; 13:203-14; PMID:6376454; http://dx.doi.org/10.1016/0378-5955(84)90074-1 7.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Dev Dyn 2007; 236:1905-17; PMID:17557302; http://dx.doi.org/10.1002/dvdy.21192 8.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Neuroscience 2008; 156:1039-47; PMID:18793701; http://dx.doi.org/10.1016/j.neuro-science.2008.08.027 9.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Neuron 2002; 35:671-80; PMID:12194867; http://dx.doi.org/10.1016/S0896-6273(02)00824-3 10.,OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Development 2012; 139:2187-97; PMID:22573615; http://dx.doi.org/10.1242/dev.073734 12.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Am J Med Genet A 2007; 143A:3204-15; PMID:18000976; http://dx.doi.org/10.1002/ajmg.a.32078 13.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
Hum Mol Genet 2009; 18:43-50; PMID:18818193; http://dx.doi.org/10.1093/hmg/ddn311,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/bioa-2-214.PMC3527316.pdf
"Do not distribute.BioArchitecture 2:6, 220–227; November/December 2012; © 2012 Landes Bioscience Short Commu NiCAtio N 220 BioA rchitecture  V olume 2 i ssue 6*Correspondence to: Torsten Wittmann; Email: torsten.wittmann@ucsf.edu Submitted: 09/04/12; Revised: 09/21/12; Accepted: 09/21/12http://dx.doi.org/10.4161/bioa.22190Introduction The basic mechanism of adherent cell migration in a two-dimen - sional (2D) environment has been studied extensively, and is  thought to predominantly rely on a coordinated cycle of actin polymerization-mediated protrusion, integrin-mediated adhesion and cell body translocation resulting from actomyosin contractil - ity.",Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J  Cell Sci 2009; 122:199-206; PMID:19118212; http://dx.doi.org/10.1242/jcs.018564 2.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Nat Rev Mol Cell Biol 2008; 9:309-22; PMID:18322465; http://dx.doi.org/10.1038/nrm2369 4.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Biol 2009; 184:895-908; PMID:19289791; http://dx.doi.org/10.1083/jcb.200901042 5.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Cell 2008; 135:137-48; PMID:18854161; http://dx.doi.org/10.1016/j.cell.2008.07.045 6.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Nat Cell Biol 2003; 5:599-609; PMID:12833063; http://dx.doi.org/10.1038/ncb0703-5997.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Biol 2012; 198:481-9; PMID:22908306; http://dx.doi.org/10.1083/jcb.201206050 8.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Nat Cell Biol 1999; 1:45-50; PMID:10559863; http://dx.doi.org/10.1038/9018 10.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
T rends Cell Biol 2008; 18:210-9; PMID:18394899; http://dx.doi.org/10.1016/j.tcb.2008.02.006 11.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Curr Opin Cell Biol 2004; 16:14-23; PMID:15037300; http://dx.doi.org/10.1016/j.ceb.2003.11.001 12.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Mol Biol Cell 2002; 13:4470-83; PMID:12475966; http://dx.doi.org/10.1091/mbc.E02-04-0241 13.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Semin Cancer Biol 2005; 15:378-86; PMID:15975825; http://dx.doi.org/10.1016/j.semcancer.2005.05.004 15.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Muscle Res Cell Motil 2004; 25:337-41; PMID:15548862; http://dx.doi.org/10.1007/s10974-004-6060-7 17.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Curr Biol 2009; 19:260-5; PMID:19185493; http://dx.doi.org/10.1016/j.cub.2008.12.045 18.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
T rends Cell Biol 2012; 22:418-28; PMID:22748381; http://dx.doi.org/10.1016/j.tcb.2012.05.005 19.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Mol Cancer Ther 2008; 7:2080-9; PMID:18645018; http://dx.doi.org/10.1158/1535-7163.MCT-08-0156,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Dev Cell 2007; 12:917-30; PMID:17543864; http://dx.doi.org/10.1016/j.dev-cel.2007.04.002 31.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Biol 2006; 173:733-41; PMID:16754957; http://dx.doi.org/10.1083/jcb.200601060 32.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Sci 2003; 116:1157-73; PMID:12615960; http://dx.doi.org/10.1242/jcs.00359 33.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Front Biosci 2009; 14:3159-67; PMID:19273264; http://dx.doi.org/10.2741/3442 34.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Methods Cell Biol 2010; 97:15-33; PMID:20719263; http://dx.doi.org/10.1016/S0091-679X(10)97002-726.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
PLoS ONE 2010; 5:e10124; PMID:20405031; http://dx.doi.org/10.1371/journal.pone.0010124 27.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Cell 2001; 104:923-35; PMID:11290329; http://dx.doi.org/10.1016/S0092-8674(01)00288-4 28.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Biol 2005; 168:141-53; PMID:15631994; http://dx.doi.org/10.1083/jcb.200405094 29.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Cell Biol 2005; 169:929-39; PMID:15955847; http://dx.doi.org/10.1083/jcb.20041211420.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Curr Biol 1996; 6:1279-89; PMID:8939572; http://dx.doi.org/10.1016/S0960-9822(02)70714-8 21.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Cancer Res 2005; 65:2433-40; PMID:15781659; http://dx.doi.org/10.1158/0008-5472.CAN-04-2624 22.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Cancer Res 2006; 66:3256-63; PMID:16540678; http://dx.doi.org/10.1158/0008-5472.CAN-05-3885 23.,Non-OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
J Biomech 2010; 43:23-30; PMID:19815217; http://dx.doi.org/10.1016/j.jbiomech.2009.09.005 24.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Nat Methods 2010; 7:761-8; PMID:20729842; http://dx.doi.org/10.1038/nmeth.1493 25.,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
Curr Biol 2012; 22:753-62; PMID:22483942; http://dx.doi.org/10.1016/j.cub.2012.02.069,OADS,/arxiv_data1/oa_pdf/44/89/bioa-2-220.PMC3527317.pdf
"CD133+progenitor cells are present as a minor population within the renal tubules of the nephron and were previously isolated by immunomagnetic sorting.6,11As in tissue undergoing vacuum and cooling the percentage of viable cells was very low *Correspondence to: Benedetta Bussolati; Email: benedetta.bussolati@unito.it Submitted: 06/18/12; Revised: 07/26/12; Accepted: 08/11/12 http://dx.doi.org/10.4161/org.21816RESEARCH PAPER Organogenesis 8:3, 71 –75; July/August/September 2012; G2012 Landes Bioscience www.landesbioscience.com Organogenesis 71",Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Sci Total Environ 2010; 408:3092-5; PMID:204 44497; http://dx.doi.org/10.1016/j.scitotenv.2010.04.022 3.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Virchows Arch 2008; 452: 229-31; PMID:18097686; http://dx.doi.org/10.1007/ s00428-007-0529-x 4.,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Nat Rev Mol Cell Biol 2008; 9:285-96; PMID:18285802; http://dx.doi.org/10.1038/nrm2354 6.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Am J Pathol 2005; 166:545-55; PMID:15681837; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Methods Mol Biol 2009; 482:215-32; PMID:1908 9359; http://dx.doi.org/10.1007/978-1-59745-060-7_148.,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
J Exp Med 1996; 183:1797-806; PMID:8666936; http://dx.doi.org/10.1084/jem.183.4.1797 9.,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Am J Physiol Renal Physiol 2012; 302:F116-28; PMID:21900452; http://dx.doi.org/10.1152/ajprenal.00184.2011 12.,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Development 2009; 136: 3863-74; PMID:19906853; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
Development 2009; 136: 2311-22; PMID:19542351; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
J Histochem Cytochem 1996; 44:445-61; PMID: 8627002; http://dx.doi.org/10.1177/44.5.8627002 17.,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
PLoS One 2010; 5:e11803; PMID:20668554; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e5/0a/org-8-71.PMC3527318.pdf
"The outcome of these studies supported the notion Application of amniotic fluid stem cells   in basic science and tissue regeneration Petra Klemmt institute for c ell Biology and n euroscience; Goethe University; Frankfurt, Germany Correspondence to: Petra Klemmt; Email: bernardi@bio.uni-frankfurt.de Submitted: 11/21/12; Accepted: 11/21/12http://dx.doi.org/10.4161/org.23023that AFS are indeed a suitable cellular source for tissue repair pro - cesses by improving the endogenous tissue repair through secre - tion of soluble factors or by providing progeny capable to actively  participate in tissue repair.",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/org-8-76.PMC3527319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/ff/hcs210.PMC3527745.pdf
"Tolstoy L. Anna Karenina, Part 7, p. 1095. http://www.planet pdf.com/ebookarticle.asp?ContentID=anna%5Fkarenina%5F&gid=6130 (August 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/41/ff/hcs210.PMC3527745.pdf
Image is adapted from QGRS mapper (http://bioinformatics.ramapo.edu/QGRS/ index.php).,OADS,/arxiv_data1/oa_pdf/ae/e3/srep01016.PMC3527825.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ae/e3/srep01016.PMC3527825.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fratta, P. et al.C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes.Sci.",Non-OADS,/arxiv_data1/oa_pdf/ae/e3/srep01016.PMC3527825.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/cd/srep01018.PMC3527826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kong, Q. et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/cd/srep01018.PMC3527826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Araujo, P.T.",Non-OADS,/arxiv_data1/oa_pdf/4b/34/srep01017.PMC3527827.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/ac/srep01013.PMC3527828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ang, Y.S., Ma, Z.",Non-OADS,/arxiv_data1/oa_pdf/39/ac/srep01013.PMC3527828.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/66/srep01015.PMC3527829.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Siems, U. et al.",Non-OADS,/arxiv_data1/oa_pdf/00/66/srep01015.PMC3527829.pdf
"Google Workshop  on Quantum Biology , Oktober 22, 2010.; http://sitescontent.google.",Non-OADS,/arxiv_data1/oa_pdf/32/4c/TOBIOCJ-6-139.PMC3527877.pdf
"com/google-workshop-on-quantum-biology; http://youtube.be/V  QngptkPYE 8   [95]  Heimburg, T.; Jackson, A.D.  On soliton propagation in biomem- branes and nerves.",Non-OADS,/arxiv_data1/oa_pdf/32/4c/TOBIOCJ-6-139.PMC3527877.pdf
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.,Non-OADS,/arxiv_data1/oa_pdf/32/4c/TOBIOCJ-6-139.PMC3527877.pdf
"[33] McNeil-NSAID Washington, D.C.: Food and Drug Adminstration;  2002 [cited 2012 September 9]; Available from: http://www.fda.gov/  ohrms/dockets/ac/02/briefing/3882B2_02_McNeil-NSAID.htm [34] Antman E, Bennett J, Daugherty A, Furberg C, Roberts H, Taubert  K. Use of nonsteroidal antiinflammatory drugs: an update for  clinicians: a scientific statement from the American Heart  Association.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Surrey, England: Electronic  medicines compendium; 2005 [updated December 2008; cited 2012  September 9]; Available from: http://www.medicines.org.uk/emc  /medicine/22653#INCOMPAT IBILITIES  [46] Anadin ibuprofen 200mg tablets.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Surrey, England: Electronic  Medicines Compendium; 2011 [updated March 31, 2011; cited 2012  September 9]; Available from: http://www.medicines.org.uk/EMC/  medicine/15681/SPC/Anadin+Ibuprofen+200mg+Tablets/  [47] Naproxen 250mg tablets.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Surrey, England: Electronic Medicines  Compendium; 2011 [updated April 18, 2012; cited 2012 September  9]; Available from: http://www.medicines.org.uk/emc/medicine  /23037/SPC#INCOMPATIBILITIES  [48] Celebrex 100mg & 200mg capsules.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Surrey, England: Electronic  Medicines Compendium; 2011 [updated May 3, 2011; cited 2012  September 9]; Available from: http://www.medicines.org.uk/emc/  medicine/14534#INCOMPATIBILITIES  [49] NICE.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
London: NICE; 2009 [cited 2010 December 18]; Available  from: http://www.nice.org.uk/nicemedia/live/12131/43327/43327.pdf   [50] NICE.,Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"London: National Institute for Health and Clinical Excellence;  2008; Available from: http://www.nice.org.uk/ nicemedia/pdf/CG59  NICEguideline.pdf [cited 2011 May 13]  [51] Hochberg M, Dougados M. Pharmacological therapy of  osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Geneva, Switzerland: World Health  Organization; 1986 [updated 2011; cited 2012 June 15]; Available  from: http://www.who.int/cancer/palliative/painladder/en/.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Surrey, England: Datapharm  Communications Ltd; 2011 [updated 2 February 2011; cited 2011  December 15]; Available from: http://www.medicines.org.uk/emc/  medicine/24186/SPC/tramadol%20hydrochloride%2050mg%20caps ules/.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Available  from: http://www.nhs.uk/Conditions/Corticosteroid-%28drugs%29/P  ages/Sideeffects.aspx [Cited 2012 September 12];  [96] Haynes S, Gemmell H. Topical treatments for osteoarthritis of the  knee.",Non-OADS,/arxiv_data1/oa_pdf/35/53/TORJ-6-320.PMC3527878.pdf
"Available at http://www.aidsinfo.nih.gov/contentfiles/  lvguidelines/adultandadolescentgl.pdf  [11] Hirsch MS, Günthard HF, Schapiro JM, et al .",Non-OADS,/arxiv_data1/oa_pdf/d5/99/TOVJ-6-135.PMC3527893.pdf
"Avaiable  from: http://www.uptodate.com/  [22] Li JZ, Paredes R, Ribaudo HJ, et al .",Non-OADS,/arxiv_data1/oa_pdf/d5/99/TOVJ-6-135.PMC3527893.pdf
The atomic coordinates and structure factors (code 4bbk ) have been deposited in the Protein Data Bank ( http://wwpdb.org/ ).,OADS,/arxiv_data1/oa_pdf/21/de/zbc43246.PMC3527912.pdf
The atomic coordinates and structure factors (code 3VYW ) have been deposited in the Protein Data Bank ( http://wwpdb.org/ ).,OADS,/arxiv_data1/oa_pdf/84/a8/zbc43950.PMC3527978.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.© 2012 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/db/4a/ers236.PMC3528024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/4a/ers236.PMC3528024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Transport properties of members of the ZIP family in plants  and their role in Zn and Mn homeostasis Matthew J. Milner1,2, Jesse Seamon1, Eric Craft1 and Leon V. Kochian1,* 1 Robert W. Holley Center for Agriculture and Health, USDA-ARS, Cornell University, Ithaca, NY 14853, USA 2 Boyce Thompson Institute, Cornell University, Tower Road, Ithaca, NY 14853, USA * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/a6/df/ers315.PMC3528025.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/a6/df/ers315.PMC3528025.pdf
"Protein predictions The translated AtZIP proteins were analysed using the online site,  WoLF pSORT (http://psort.ims.u-tokyo.ac.jp ), to estimate their pre- dicted membrane localization.",OADS,/arxiv_data1/oa_pdf/a6/df/ers315.PMC3528025.pdf
"To esti-mate the secondary protein structure, including the number of predicted transmembrane domains, the translated proteins were analysed using the Mobyle, a bioinformatics analysis tool (von Heijne, 1992) (http://mobyle.pasteur.fr/cgi-bin/portal.py?form=toppred ).",OADS,/arxiv_data1/oa_pdf/a6/df/ers315.PMC3528025.pdf
"The data are publically available at http://jsp.weigelworld.org/.Yeast studies Four different yeast mutant strains were used in these studies: the Zn  uptake-defective mutant zrt1/zrt2Δ ( MATα ade6 can1 his3 leu2 trp1  ura3 zrt1::LEU2 zrt2::HIS3), the Fe uptake-defective mutant fet3/ fet4Δ ( MATa can1 his3 leu2 trp1 ura3 fet3::HIS3 fet4::LEU2), the Mn  uptake-defective mutant smf1Δ (SLY8; MATa ura3 lys2 ade2 trp1 his3 leu2 smf1::HIS3), and the Cu uptake-defective mutant ctr1/ctr3Δ ( MATa  ctr1::ura3::Kanr ctr3::TRP1 his3 lys2-802 CUP1r).",Non-OADS,/arxiv_data1/oa_pdf/a6/df/ers315.PMC3528025.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Developmental and growth controls of tillering and   water-soluble carbohydrate accumulation in contrasting  wheat (Triticum aestivum L.) genotypes: can we  dissect them?",Non-OADS,/arxiv_data1/oa_pdf/95/6f/ers317.PMC3528026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/6f/ers317.PMC3528026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR A novel family of γ-gliadin genes are highly regulated by  nitrogen supply in developing wheat grain Yongfang Wan, Peter R. Shewry* and Malcolm J. Hawkesford Department of Plant Biology and Crop Science, Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/44/40/ers318.PMC3528027.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/44/40/ers318.PMC3528027.pdf
Genome sequence blasting in URGI (http://urgi.versailles.inra.fr)  confirmed that CS-1 and He-1 are located on chromosome 1DS and also showed that CS-2 and He-2 are located on 1BS.,OADS,/arxiv_data1/oa_pdf/44/40/ers318.PMC3528027.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Identification of quantitative trait loci controlling fibre length  and lignin content in Arabidopsis thaliana stems Arnaud Capron1, Xue Feng Chang2, Hardy Hall3, Brian Ellis3, Rodger P. Beatson2 and Thomas Berleth1,* 1 University of Toronto-CSB, 25 Willcocks Street, Toronto, ON, Canada, M5S 3B2 2 British Columbia Institute of Technology, 3700 Willingdon Avenue, Burnaby, BC, Canada, V5G 3H2 3 University of British Columbia – Michael Smith Laboratories, #301–2185 East Mall, Vancouver, BC, V6T 1Z4, Canada * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/4b/0d/ers319.PMC3528028.pdf
"Cellulosic biomass, for example from woody species, has become increasingly important as a source of bioenergy  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© 2012 The Authors.Abbreviations: BAC, bacterial artificial chromosome; BLUP , best linear unbiased predictor; CIM, composite interval mapping; FQA, fibre quality analyser; QTL,   quantitative trait locus; RIL, recombinant inbred line; SFP , single-feature polymorphisms.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/4b/0d/ers319.PMC3528028.pdf
Candidate gene selection The list of all protein-encoding genes included in the intervals delimited  by FQ2 and FQ5 (see Results) was screened for genes with enriched  expression in the second-internode data set of the Bio-Array Resources  for Plant Biology’s expression browser (http://bar.utoronto.ca/welcome.htm).,OADS,/arxiv_data1/oa_pdf/4b/0d/ers319.PMC3528028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Floret development and grain setting differences between  modern durum wheats under contrasting nitrogen availability Ariel Ferrante1,*, Roxana Savin1 and Gustavo A. Slafer1,2 1 Department of Crop and Forest Sciences and AGROTECNIO (Centre for Research in Agrotechnology), University of Lleida, Av.",Non-OADS,/arxiv_data1/oa_pdf/69/2f/ers320.PMC3528029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/2f/ers320.PMC3528029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Phenological response of grassland species to manipulative  snowmelt and drought along an altitudinal gradient Christine Cornelius1,*, Annette Leingärtner2, Bernhard Hoiss2, Jochen Krauss2, Ingolf Steffan-Dewenter2 and  Annette Menzel1 1 Chair of Ecoclimatology, Technische Universität München, Hans-Carl-von-Carlowitz-Platz 2, 85354 Freising, Germany 2 Department of Animal Ecology and Tropical Biology, University of Würzburg, Am Hubland, 97074 Würzburg, Germany * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/98/1f/ers321.PMC3528030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/98/1f/ers321.PMC3528030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Role of brassinosteroids in alleviation of phenanthrene– cadmium co-contamination-induced photosynthetic  inhibition and oxidative stress in tomato Golam Jalal Ahammed1,*, Sikander Pal Choudhary1, Shuangchen Chen1, Xiaojian Xia1, Kai Shi1, Yanhong Zhou1  and Jingquan Yu1,2,* 1 Department of Horticulture, Zijingang Campus, Zhejiang University, Yuhangtang Road 866, Hangzhou 310058, People’s Republic of  China 2 Key Laboratory of Horticultural Plants Growth, Development and Quality Improvement, Ministry of Agriculture, Yuhangtang Road 866,  Hangzhou 310058, People’s Republic of China * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/38/33/ers323.PMC3528031.pdf
"Such plants grown in these polluted  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© 2012 The Author(s).This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/38/33/ers323.PMC3528031.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Developmental onset of reproductive barriers and associated  proteome changes in stigma/styles of Solanum pennellii Subbaiah C. Chalivendra1,4,*, Gloria Lopez-Casado2,6,*, Aruna Kumar3,5, Alina R. Kassenbrock1, Suzanne Royer1,  Alejandro Tovar-Mèndez3, Paul A. Covey1, Laura A. Dempsey1, April M. Randle1, Stephen M. Stack1, Jocelyn  K.C.",Non-OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
"Consequently,  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abbreviations: ABF, Aniline Blue fluorochrome; ANOVA, analysis of variance; CI, confidence index; CRP , cysteine-rich protein; iTRAQ, isobaric tag for relative and absolute quantitation; LTP , lipid-transfer protein; PVDF, polyvinylidene diflouride; QTL, quantitative trait locus; SC, self-compatible/self-compatibility; SDS/PAGE, sodium dodecyl sulphate/polyacrylamide-gel electrophoresis; SI, self-incompatible/self-incompatibility; SP , signal peptide; UI, unilateral incongruity/incompatibility.",Non-OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
All style and pollen-tube lengths were measured using the programme MicroMeasure ver - sion 3.3 (http://rydberg.biology.colostate.edu/MicroMeasure).,OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
"The resulting mass spectra data from the iTRAQ  runs, corresponding to the different peptides, were analysed using  Mascot 2.2 (www.matrixscience.com/) with a protein database built using transcriptomic data derived from 454-based cDNA sequencing (RNA-Seq) from several tomato tissues (stigma/styles, pollen, leaves and fruit; http://ted.bti.cornell.edu/cgi-bin/TFGD/digital/experi- ment.cgi?ID=D002) together with a customized in-house database",OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
"Protein identity was determined using both GenBank (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the tomato genome sequence (The Tomato Genome Consortium, 2012).",OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
Classification  is according to the AmiGO gene ontology database (http://amigo.geneontology.org).,OADS,/arxiv_data1/oa_pdf/4d/7a/ers324.PMC3528032.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Exine dehiscing induces rape microspore polarity, which  results in different daughter cell fate and fixes the apical– basal axis of the embryo Xingchun Tang1,2,*, Yuan Liu1,*, Yuqing He1, Ligang Ma1 and Meng-xiang Sun1,† 1 Department of Cell and Developmental Biology, College of Life Science and State Key Laboratory of Hybrid Rice, Wuhan University,  Wuhan 430072, China 2 College of Life and Science, Hubei University, Wuhan 430062, China † To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/d2/d0/ers327.PMC3528033.pdf
"Cell polarity can usually be recognized by the differential  distributions of cellular components, mRNA, and proteins, vesicle trafficking, and directional relocation of organelles, or different characters of cell morphology and distinct This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© 2012 The Author(s).Abbreviations:AGP , arabinogalactan protein; CW, Calcofluor White; DAPI, 4’,6-diamidino-2-phenylidole; EDM, exine-dehisced microspore; ex-axis, exine-dehisced microspores expanded long axis; ru-plane, the spatial plane indicated by the end of the broken exine between the exine-covered part and exine-detached part in exine-dehisced microspores.",Non-OADS,/arxiv_data1/oa_pdf/d2/d0/ers327.PMC3528033.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Physiological and genetic analysis of Arabidopsis thaliana  anthocyanin biosynthesis mutants under chronic adverse  environmental conditions Maksym Misyura, Joseph Colasanti and Steven J. Rothstein* Department of Molecular and Cellular Biology, University of Guelph, 50 Stone rd.",Non-OADS,/arxiv_data1/oa_pdf/6b/6c/ers328.PMC3528034.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/6b/6c/ers328.PMC3528034.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR New insights into the early steps of oil body mobilization  during pollen germination Agnieszka Zienkiewicz1,3, Krzysztof Zienkiewicz1,2, Juan David Rejón1, María Isabel Rodríguez-García1 and  Antonio Jesús Castro1,* 1  Department of Biochemistry, Cell and Molecular Biology of Plants, Estación Experimental del Zaidín, Consejo Superior de  Investigaciones Científicas (CSIC), 18008 Granada, Spain 2  Department of Physiology and Molecular Biology of Plants, Nicolaus Copernicus University, 87–100 Toruń, Poland 3  Department of Cell Biology, Nicolaus Copernicus University, 87–100 Toruń, Poland *  To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/26/5f/ers332.PMC3528035.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/26/5f/ers332.PMC3528035.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. © 2012 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/77/ff/ers334.PMC3528036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abbreviations: ANA, apparent nitrogenase activity; C, control; D, drought; DAHPS, 3-deoxy- d-arabino-heptulosonate-7-phosphate synthase; ET, evapotranspira- tion; FW, fresh weight; FITC, fluorescein isothiocyanate; (N)DW, (nodule) dry weight; NF, nitrogen fixation; PD, partial drought; SRS, split-root system; δ13C, carbon  isotopic composition; Ψ leaf, leaf water potential;Ψ nodule, nodule water potential.ReseaRch papeR Is N-feedback involved in the inhibition of nitrogen fixation in  drought-stressed Medicago truncatula?",Non-OADS,/arxiv_data1/oa_pdf/77/ff/ers334.PMC3528036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Enhanced seed production under prolonged heat stress  conditions in Arabidopsis thaliana plants deficient in  cytosolic ascorbate peroxidase 2 Nobuhiro Suzuki1, Gad Miller2, Hiroe Sejima3, Jeffery Harper3 and Ron Mittler1,* 1 Department of Biological Sciences, College of Arts and Sciences, University of North Texas, 1155 Union Circle #305220, Denton, TX  76203-5017, USA 2 The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 52900, Israel 3 Department of Biochemistry and Molecular Biology, University of Nevada, Mail Stop 330, Reno NV 89557, USA * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/93/ed/ers335.PMC3528037.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/93/ed/ers335.PMC3528037.pdf
"Knockout plants deficient in cytosolic APX1  (SALK_000249; apx1) or APX2 (SALK_091880; apx2) were obtained  through the SIGnAL project (http://signal.salk.edu/tabout.html ), back- crossed, and screened in homozygous form as described in Rizhsky  et al.",Non-OADS,/arxiv_data1/oa_pdf/93/ed/ers335.PMC3528037.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Natural diversity in the model legume Medicago truncatula  allows identifying distinct genetic mechanisms conferring  partial resistance to Verticillium wilt Cécile Ben1,2, Maoulida Toueni1,2, Sara Montanari1, Marie-Claire Tardin3, Magalie Fervel4, Azam Negahi1,2,  Laure Saint-Pierre3, Guillaume Mathieu1, Marie-Christine Gras3, Dominique Noël4, Jean-Marie Prospéri5,  Marie-Laure Pilet-Nayel6, Alain Baranger6, Thierry Huguet1,2, Bernadette Julier7, Martina Rickauer1,2 and  Laurent Gentzbittel1,2,* 1 Université de Toulouse; INP , UPS; Laboratoire d’Écologie Fonctionnelle et Environnement (EcoLab); ENSAT, 18 chemin de Borderouge,  31326 Castanet Tolosan, France 2 CNRS; EcoLab; 31326 Castanet Tolosan, France 3 R2n – Centre de Recherche Le Bourg, 12510 Druelle, France 4 Barenbrug Tourneur Recherches, Negadis, 82600 Mas Grenier, France 5 INRA, UMR AGAP 1334, Montpellier, F34130 Mauguio, France 6 INRA, Agrocampus Ouest, Université de Rennes1, UMR118, Amélioration des Plantes et Biotechnologies Végétales, 35653 Le Rheu  Cedex, Rennes, France 7 INRA, UR 4, Unité de Recherche Pluridisciplinaire Prairies et Plantes Fourragères, Le Chêne, RD 150, BP 80006, 86600, Lusignan, France * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
"The lines, except Jemalong-A17, and mutants are derived  from natural populations of different geographical origins (http://www1.montpellier.inra.fr/BRC-MTR/mauguio/mauguio.php ).",Non-OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
"Symptoms  were rated on a scale from 0 to 4, similar to that described for alfalfa  (http://www.naaic.org/stdtests/verticil.htm , Fig.",Non-OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
"Genetic maps Previously described low-density genetic maps of A17 × DZA315.16  (LR4; Julier et al., 2007) and A17 × F83005.5 (LR5; Arraouadi et al.,  2012) recombinant inbred line (RIL) populations were improved by adding simple sequence repeat markers based on the M. truncatula  genome sequence assembly (Young et al., 2011, http://www.medicago - hapmap.org/?genome ) and unigene set of the Medicago  Gene Index at  DFCI (http://compbio.dfci.harvard.edu/).",OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
Eight homologous sequences were detected which were further analysed by mul-tiple alignment and establishment of a phylogenetic tree using  clustal  w version 2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/)  (Supplementary Fig.,OADS,/arxiv_data1/oa_pdf/6a/a7/ers337.PMC3528038.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. ReseaRch papeR Optical detection of downy mildew in grapevine leaves: daily  kinetics of autofluorescence upon infection Sébastien Bellow1, Gwendal Latouche1, Spencer C. Brown2, Anne Poutaraud3,4 and Zoran G. Cerovic1,* 1 Université Paris-Sud, Laboratoire Écologie Systématique et Évolution, UMR 8079, Bât.",Non-OADS,/arxiv_data1/oa_pdf/06/99/ers338.PMC3528039.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details)",Non-OADS,/arxiv_data1/oa_pdf/06/99/ers338.PMC3528039.pdf
"Image analysis, including composition, was performed using the software ImageJ (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/06/99/ers338.PMC3528039.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. © 2012 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/23/b9/ers339.PMC3528040.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ReseaRch papeR Excess manganese differentially inhibits photosystem  I versus II in Arabidopsis thaliana R. Millaleo1, M. Reyes-Díaz2,3, M. Alberdi2,3,*, A. G. Ivanov4, M. Krol4 and N. P. A. Hüner4 1 Programa de Doctorado en Ciencias de Recursos Naturales, Universidad de La Frontera, Temuco, Chile 2 Departamento de Ciencias Químicas y Recursos Naturales; Facultad de Ingeniería, Ciencias y Administración, Universidad de La  Frontera, Temuco, Chile 3 Center of Plant, Soil Interaction and Natural Resources Biotechnology, Scientific and Technological Bioresource Nucleus (BIOREN- UFRO), Universidad de La Frontera, Temuco, Chile 4 Department of Biology and The Biotron Centre for Experimental Climate Change Research, Western University, London, Ontario, N6A  5B7, Canada * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/23/b9/ers339.PMC3528040.pdf
"Densitometric scanning and analysis of X-ray films from each replicate immunoblot was performed with a Hewlett Packard ScanJet 4200C desktop scan-ner and ImageJ 1.41o densitometry software (Wayne Rosband, National Institute of Health, USA, http://rsbweb.nih.gov/ij ).",OADS,/arxiv_data1/oa_pdf/23/b9/ers339.PMC3528040.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d. © 2012 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/84/5f/ers341.PMC3528041.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abbreviations: APase, acid phosphatase; cPTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; DAF-FM DA, diaminofluorescein-FM diacetate; N, nitrogen; NO, nitric oxide; NOS, nitric oxide synthase; NR, nitrate reductase; P , phosphorus; SNP , sodium nitroprusside; AtPHR1, PHOSPHATE STARVATION RESPONSE 1; AtPHT1, PHOSPHATE TRANSPORTER 1; AtPHO1, PHOSPHATE 1; AtPHO2, PHOSPHATE 2.",Non-OADS,/arxiv_data1/oa_pdf/84/5f/ers341.PMC3528041.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiation Protection Dosimetry (2013), Vol.",Non-OADS,/arxiv_data1/oa_pdf/44/2f/ncs099.PMC3528098.pdf
":A Survey on Ectoparasite ... 70 Available at: http://ijad.tums.ac.irOriginal Article A Survey on Ectoparasite Infestations in Companion Dogsof AhvazDistrict,South-west of Iran B Mosallanejad1,*ARAlborzi2, N Katvandi2 1Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ah vaz, Ahvaz, Iran 2Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran (Received 4 Nov 2011 ; accepted 7 Dec 2011 ) Abstract Background :The objective was to determine the prevalence of ectoparasite infestations in referred companion dogs toveterinary hospital of Shahid Chamran University of Ahvaz, from 2009 to 2010 .",Non-OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
:A Survey on Ectoparasite ... 71 Available at: http://ijad.tums.ac.irfrom Bosnia and Greece (Fournier et al.,OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
":A Survey on Ectoparasite ... 72 Available at: http://ijad.tums.ac.irskin,clinical trials, skin scraping, acetate tape preparation, otic swabs, andcombing of the whole body with a stainless steel fine - toothed comb (Zakson et al.",Non-OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
":A Survey on Ectoparasite ... 73 Available at: http://ijad.tums.ac.ir(Table2)and in the season of winter (30.95%,13 out of 42) (Table3), but the dif - ference was not significant relative to host gender, age , breedand season (P>0.05).",OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
:A Survey on Ectoparasite ... 74 Available at: http://ijad.tums.ac.ir Fig.,OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
:A Survey on Ectoparasite ... 75 Available at: http://ijad.tums.ac.irDiscussion The present study is the first reachonthe prevalence of infestation s in companion dogs in Ahvaz District.,Non-OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
":A Survey on Ectoparasite ... 76 Available at: http://ijad.tums.ac.ir344 dogs belonging to peo ple in North West Province, South Africa, were examined for ectoparasites, accordinglythe dogs harbored 14,724 ixodid ticks bel onging to 6 species, 1,028 fleas belonging to 2 species, and 26 lice.",Non-OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
":A Survey on Ectoparasite ... 77 Available at: http://ijad.tums.ac.irAraujo FR, Silva MP, Lopes AA, Ribeiro OC, Pires PP, Carvalho CM, Balbuena CB, Villas AA, Ramos JK (1998)Se- vere cat flea infestati on of dairy calves in Brazil.",OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
:A Survey on Ectoparasite ... 78 Available at: http://ijad.tums.ac.irOn kenneled dogs in Pretoria north .,Non-OADS,/arxiv_data1/oa_pdf/43/59/ijad-6-70.PMC3528164.pdf
":Analysis of Immunogenic Relevant ... 35 Available at: http://ijad.tums.ac.irOriginal Article Analysis of Immunogenic RelevantProteins in Rhipicephalus (Boophilus )annulatus Tick *ANikpay1,SNabian2,MTaheri2 1Department of Pathobiology , Faculty of Veterinary Medicine, University of Mazandaran ,Amol, Iran 2Department of Pa rasitology, Faculty of Veterinary Medicine, University of Tehran , Tehran, Iran (Received 19 May 2010 ; accepted 6 Nov 2011 ) Abstract Background :Considering the importance of tick sas amain group transmitting pathogen organisms , this study de - signed to recognize immunogenic proteins indifferent tissues ofRhipicephalus (Boophilus )annulatus tickand to find out if there are common proteins in these tissues.",Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
":Analysis of Immunogenic Relevant ... 2 Available at: http://ijad.tums.ac.irof cattle that present in West Africa, Central Africa, Asia, certain parts of South ern Sudan and Europe .",Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
:Analysis of Immunogenic Relevant ... 3 Available at: http://ijad.tums.ac.irthe separation gel.,OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
:Analysis of Immunogenic Relevant ... 4 Available at: http://ijad.tums.ac.irpromise as an alternative method for tick control (Wickel et al.,Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
:Analysis of Immunogenic Relevant ... 2 Available at: http://ijad.tums.ac.ir Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
:Analysis of Immunogenic Relevant ... 3 Available at: http://ijad.tums.ac.ir Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
":Analysis of Immunogenic Relevant ... 2 Available at: http://ijad.tums.ac.ir2002,Cruzet al.2008,Nikpay et al .2008, Perez 2010 ).",OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
:Analysis of Immunogenic Relevant ... 3 Available at: http://ijad.tums.ac.irBrown SJ (1988) Western blot analysis of Amblyomma americanum -derived stage - specific and shared antigens us ing se- rum from guinea pigs expressing resis- tance.Vet Parasitol.,Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
":Analysis of Immunogenic Relevant ... 4 Available at: http://ijad.tums.ac.irTurni C, Lee RP, Jackson LA (2004) A com - parison of the immunosuppressive ef - fects of salivary gland extracts from two laboratory strains of Boophilus mi - croplus.Int J Parasitol.",Non-OADS,/arxiv_data1/oa_pdf/c2/91/ijad-6-36.PMC3528165.pdf
":Comparative Study on the … 18 Available at: http://ijad.tums.ac.irOriginal Article Comparative Study on the EffectivenessofCoumavec® and ZincPhosphide inControllingZoonotic Cutaneous Leishmaniasis in a Hyperendemic Focus in Central Iran A Veysi1, H Vatandoost1, MR Yaghoobi -Ershadi1, MH Arandian2,R Jafari2, M Hosseini3,H abdoli2, Y Rassi1, K  Heidari4, A Sadjadi4, R Fadaei4, J Ramazanpour4, K Aminian4, MR Shirzadi5,*AA Akhavan1,6 1Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Teh ran, Iran 2Esfahan Training and Health Research Center, National Institute of Health Research, Tehran University of Medical Sciences, Esfahan, Iran 3Department of Epidemiology and biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 4Esfahan Health Center, Esfahan University of Medical Sciences, Esfahan, Iran 5Department of Zoonosis, CDC, Ministry of Health and Medical Education, Tehran, Iran 6Institute for Environmental Research (IER), Tehran Uni versity of Medical Sc iences, Tehran, Iran (Received 30Dec2011; accepted 3Jan2012) Abstract Background: Zoonotic  cutaneous leishmaniasis (ZCL) is an increasing health pro blems in many rural areas of Iran .",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 19 Available at: http://ijad.tums.ac.irErshadiandJavadian.,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 20 Available at: http://ijad.tums.ac.irThe aim of the current study was to intro - duce anew alternative rodenticide for con- trolling ZCL in Iran .,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 21 Available at: http://ijad.tums.ac.irlectedinthe following morning.,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 22 Available at: http://ijad.tums.ac.ircreasingtrendcomparedto the intervention areas.,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
":Comparative Study on the … 23 Available at: http://ijad.tums.ac.ir Table2.Comparison of the incidence (per thousand) of zoonotic cutaneous leishmaniosis in the intervention and control villages, Esfahan County, Esfahan, Iran, 2011 –2012 2011 2012 Name of the villageNo.",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
":Comparative Study on the … 24 Available at: http://ijad.tums.ac.irof the disease and vector control ( Shirzadi 2010,Saidi et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 25 Available at: http://ijad.tums.ac.irIt is concluded that both rodenticides were effective forcontrolling ZCL and ro- dent population as well.,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
:Comparative Study on the … 26 Available at: http://ijad.tums.ac.irJavadianE(2008)Epidemiology ofcuta- neous leishmaniasis in Iran .,Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
":Comparative Study on the … 27 Available at: http://ijad.tums.ac.irYaghoobi -Ershadi MR, Akhavan AA, Mohe - bali M (2001) Monthly variation of Leishmania major MON -26 infection rates inPhlebotomus papatasi (Diptera: Psychodidae ) from rodent burrows in Badrood area of Iran.",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/ijad-6-18.PMC3528166.pdf
":Pediculosis capitis among … 79 Available at: http://ijad.tums.ac.irOriginal Article Pediculosis capitis among Primary School Children andRelated Risk Factors in Urmia,theMain City of WestAzarbaijan , Iran KHazrati Tappeh1,*AR Chavshin2, H Mohammadzadeh Hajipirloo1, S Khashaveh1, H Hanifian1, A Bozorgo mid1, M Mohammadi2, D Jabbari Gharabag1, H Azizi1 1Department of Medical Parasitology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran 2Department of Medical Entomology and Vector control, School of Public Health, Urmia University of Medical Sciences , Urmia, Iran (Received 26Apr2011; accepted 1 8Sep2011) Abstract Background: Pediculosis capitis is cosmopolitan health problem.",Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
:Pediculosis capitis among … 80 Available at: http://ijad.tums.ac.irseen inchronicinfestation (Fernandez et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
:Pediculosis capitis among … 81 Available at: http://ijad.tums.ac.irResults Observation on 2040 pupils by experts showed that the total prevalence of head louse infesta tion among them is 4%.,Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
:Pediculosis capitis among … 82 Available at: http://ijad.tums.ac.irLength of hairGirlsshaved completely 0 0 P<0.05less than 1 cm 30 1 Until ear 68 4 less than sho ulder 385 23 until shoulder and more 689 31 Boysshaved completely 25 1 P<0.05less than 1 cm 261 9 Until ear 420 3 less than shoulder 159 4 until shoulder and more 1 0 Gas plumbingYes 1734 64P>0.05No 305 17 Having water b oiler at homeYes 1982 73P<0.05No 57 8 Weekly bath Numberonce per week 900 29 P>0.05 twice per week 824 39 three and more 315 13 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
:Pediculosis capitis among … 83 Available at: http://ijad.tums.ac.irDiscussion This study showed that 4% of examined pupilsof primary schools were infested with head louse.,Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
:Pediculosis capitis among … 84 Available at: http://ijad.tums.ac.irnoticeable pediatric problem.,Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
":Pediculosis capitis among … 85 Available at: http://ijad.tums.ac.irMalcolm CE ,Bergman JN(2006) Trying to keep ahead of lice: a therapeutic chal - lenge.",Non-OADS,/arxiv_data1/oa_pdf/1a/19/ijad-6-79.PMC3528167.pdf
":Evaluation of Melaleuca cajuputi … 28 Available at: http://ijad.tums.ac.irOriginal Article Evaluation of Melaleuca cajuputi (Family: Myrtaceae) Essen tial Oil in Aerosol SprayCansagainstDengue Vectors in Low Cost Housing Flats *A Abu Bakar1, S Sulaiman1, B Omar1, R Mat Ali2 1Department of Biomedical Science, Faculty of Allied Health Sciences, Universit yKebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur ,Malaysia 2Forest Research Institute Malaysia (FRIM), Kepong, 52100 Selangor, Malaysia (Received 1 May 2010 ; accepted 16 Nov 2011 ) Abstract Backgroun d:Melaleuca cajuputi essential oil in aerosol spray was evaluated against the dengue vectors Aedes ae- gyptiandAe.",Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
":Evaluation of Melaleuca cajuputi … 29 Available at: http://ijad.tums.ac.irmendous efforts are being made to isolate, screen and to develop phytochemicals pos - sessing pesticidal activity (Mulla and Su 1999).",Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
:Evaluation of Melaleuca cajuputi … 30 Available at: http://ijad.tums.ac.ircontain 0.07% prallethrin and 0.05% d -phe- nothrin+40% kerosene+60% LPG.,Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
:Evaluation of Melaleuca cajuputi … 31 Available at: http://ijad.tums.ac.irknockdown values and regression slope us - ing a probit analysis .Knockdown Time (KT50and KT 95)is the value of time taken for aerosols to give knockdown effects of the 50% and 95% sample populations.,OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
:Evaluation of Melaleuca cajuputi … 32 Available at: http://ijad.tums.ac.irTable 1.,Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
":Evaluation of Melaleuca cajuputi … 33 Available at: http://ijad.tums.ac.irDiscussion In context of pollution environment such as residue problem, health risks of the con - sumer and the development of insect resis - tance to synthetic insecticides, recent interest among researchers has developed to investi - gateand explor e potential of plants extract that are environmentally safe and target spe cific butstill effective to control vector popula tions.",Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
:Evaluation of Melaleuca cajuputi … 34 Available at: http://ijad.tums.ac.irthis study could provide a useful information in future research.,Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
Availableat:http://www.cdc.g ov/travel.,Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
":Evaluation of Melaleuca cajuputi … 35 Available at: http://ijad.tums.ac.irMulla MS, Su T (1999) Activity and bio - logicaleffects of neem products against arthropods of medical and vet erinary importance .",Non-OADS,/arxiv_data1/oa_pdf/12/09/ijad-6-28.PMC3528168.pdf
":WoundMyiasisdue to … Available at: http://ijad.tums.ac.irCase Report WoundMyiasisdue toMusca domestica (Diptera: Muscidae) in Persian Horned Viper, Pseudocerastes persicus (Squamata: Viperidae) RDehghani1,*MMSedaghat2, MSabahi Bi dgoli1 1Deptof Environment Health, Kashan University of Medical Science s, Iran 2Dept of Medical Entomology, School of Public Health, Teheran University of Medical Sciences, Iran (Received 5Feb2011; accepted 12Oct2012) Abstract A case of myiasis due to Musca domestica describes in Pseudocerastes persicus forthefirst time.",Non-OADS,/arxiv_data1/oa_pdf/da/5b/ijad-6-86.PMC3528169.pdf
:WoundMyiasisdue to … Available at: http://ijad.tums.ac.ir Dermal myiasis has been reported in sheep caused by M. domestica in the Middle East (Amin et al.,Non-OADS,/arxiv_data1/oa_pdf/da/5b/ijad-6-86.PMC3528169.pdf
:WoundMyiasisdue to … Available at: http://ijad.tums.ac.irDiscussion Snake myiasis has been reported rarely.,Non-OADS,/arxiv_data1/oa_pdf/da/5b/ijad-6-86.PMC3528169.pdf
:WoundMyiasisdue to … Available at: http://ijad.tums.ac.irCarriers of Pathogenic Bacteria.,Non-OADS,/arxiv_data1/oa_pdf/da/5b/ijad-6-86.PMC3528169.pdf
"62 Available at: http://ijad.tums.ac.irOriginal Article AnEpidemiological andClinicalStudyonScorpionism in Hospitalized ChildreninKhuzestan , Iran *B Vazirianzadeh1, F Farhadpour2, M Hosseinzadeh3, M Zarean4, SA Moravvej5 1Department of Medical Entomology and Infectious and Tropica l Diseases Research Centre, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran 2Department of Medical Entomology, Shiraz University of Medical Sciences, Shiraz, Iran 3Department of Pediatrics, College of Medicine, Ahvaz Jundi Shapour Universi ty of Medical Sciences, Ahvaz, Iran 4Department of Parasitology and Mycology, Ahvaz Jundi Shapour University of Medical Sciences, Ahvaz, Iran 5Department of Medical Entomology,Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran (Received 15 Mar2011; accepted 7 Dec 2011 ) Abstract Background :Scorpion sting is a public health problem in Khuzestan, South-WestIran.The aims of the current study were to monitor the hospitalized children, due to scorpion sting, and releasing more clinical and epi demiologic data related to scorpionism in this Province.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
63 Available at: http://ijad.tums.ac.irIn a retrospective study which conducted by Mir Dehghan et al.,OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
"64 Available at: http://ijad.tums.ac.irhaemoglobinuria among the child patients following stung with 53.84% and 80% of data, respectively.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
"65 Available at: http://ijad.tums.ac.irTable3.Sting sites in hospitalized children in the Abuzar Children's Hospital, Ahvaz Jondishapour University of Medical Sciences 2006 Part of body Frequency (%) head,neck,trunk 45.61 upper limp s(hands) 19.29 lower limp (legs) 35.08 total 100 Table4.Frequencies of signs /symptoms following stung by scorpions ,Abuzar Children's Hospital, Ahvaz Jondishapour University of Medical Sciences ,Spring 2006 Clinical signs/ symptomsStung by scorpions A. crassicauda H. lepturus Unknown specie s Total Number %Number %Number %Number % Local : pain 3 23.07 1 20 10 25.64 1424.56 swelling 2 15.38 - - 8 20.51 1017.54 edema - - - - 5 12.82 58.77 erythema , rash and itching- - 3 60 14 35.89 1729.82 cellolite - - - - 2 5.12 23.50 Respiratory: Respiratory distress 2 15.38 1 20 4 10.25 712.28 Gastroentritis: abdominal pain and diarrhea1 7.69 - - 2 5.12 35.26 vomiting 6 46.15 1 20 7 17.94 1424.56 Sialorrehoea - - - - 1 2.56 11.75 Neurologic: convulsion - - - - 2 5.12 23.50 headache - - 1 20 - - 11.75 unconscious - - - - 1 2.56 11.75 vertigo - - 1 20 2 5.12 35.26 Others: fever 2 15.38 - - 11 28.20 1322.80 death - - - - 1 2.56 11.75 Table5.Medications that were used as treatments among the stung children among hospitalized children in Abuzar Children's Hospital, Ahvaz Jondishapour University of Medical Sciences ,Spring 2006 TreatmentsStung by scorpions A. crassicauda H. lepturus Unknown species Total Number %Number %Number % Number % Antivenin 1292.30 3 60 27 69.23 42 73.68 Alkaline diuresis 10 76.92 5 100 17 43.58 30 55.10 Calcium gluconate 1 7.69 - - - - 1 1.75 Diazepam 1 7.69 - - 1 2..56 2 3.50 Phenobarbital 1 7.69 - - 2 5.12 3 5.26 Antibiotic penicillin - - - - 2 5.12 2 3.50 Antibiotic Kefline - - - - 4 10.25 4 7.01 Dexamethazone - - - - 1 2..56 1 1.75 Atropine - - - - 2 5.12 2 3.50",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
66 Available at: http://ijad.tums.ac.irDiscussion Scorpionism is a widespread phenomenon in the tropical and sub -tropical regions.,Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
67 Available at: http://ijad.tums.ac.irwithH.,Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
"68 Available at: http://ijad.tums.ac.irHida M (2009) Epidemiological and clinical characteristics of scorpion stings in children in fez, Morocco.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
"69 Available at: http://ijad.tums.ac.irVaziriznzadeh B, Samie M, Montazeri M (2006)Epidemiolog ical study of scor - pionism in the Kh uzestan.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/ijad-6-62.PMC3528170.pdf
": Using Ultraviolet Irradiation … 1 Available at: http://ijad.tums.ac.irOriginal Article Using Ultraviolet Irradiation for Removalof Malathion Pesticide inWater M Shayeghi1,*MHDehghani2,M Alimohammadi2,KGoodini3 1Department of Medical Entomology and Vector Control, School of Public Health, Tehran University o f Medical Sciences, Tehran, Iran 2Department of Environmental Health Engineering, School of Public Health, Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran 3Department of Environmental Health, Ilam University of Med ical Sciences, Ilam, Iran (Received 14 Sep 2010; accepted 16 Nov 2011) Abstract Background :Organophosphorus pesticides are one of the most consumable poisons.",Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 2 Available at: http://ijad.tums.ac.irattention disorder ( Videria et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 3 Available at: http://ijad.tums.ac.irMaterials and Methods This research is theexperimental -appli- cablestudy that performed in chemical la - boratories of environment health engineering andEntomology oftheTehranUniversity Medical Sciences in2009 –2010.Malathion poison was prepared in the different con- centrations andanalyzed.,OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 4 Available at: http://ijad.tums.ac.irThe specifications of ultraviolet reactor The used reactor in this studycontains one closed bottom cyl inder with 3 liters size and kind of the rustproof steel made in Teh - ranSteelof IranCompany.,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 5 Available at: http://ijad.tums.ac.iry = 4x + 58 R2 = 1 5860626466687072 6 7 9 pHDegradation percentage Fig.1.Degradation percentage vs. pH for 0.5 mg/l y = 4x + 52.667 R2 = 0.9796 5254565860626466 6 7 9 pHDegradation percentage Fig.2.Degradation percentage vs. pH for 1mg/l y = 4.5x + 50 R2 = 1 505254565860626466 6 7 9 pHDegradation percentage Fig.3.Degradation percen tage vs. pH for 2 mg/l 49,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 6 Available at: http://ijad.tums.ac.iry = 8.3857x + 45.733 R2 = 0.9692 020406080100120 10 20 30 40 50 60 Time(min)Degradation percentage Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
": Using Ultraviolet Irradiation … 7 Available at: http://ijad.tums.ac.irDiscussion This study showed that the effecti veness of malathion degradation from water by ul - traviolet ir radiation depend son three param - eters; the initial concentration, the irradiation time and the pH .This study showed that ini - tialconcentration decreaseswith irradiation time.These researche s results conform to Khodadadi (2008), Walid et al.",OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
: Using Ultraviolet Irradiation … 8 Available at: http://ijad.tums.ac.irbased case control stu dy.,Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
": Using Ultraviolet Irradiation … 9 Available at: http://ijad.tums.ac.irVideria RA, Antunes -Madiera  MC, Lopes VI,Madeira Vı́tor MC (2001) Change induced by malathion, methylparation andparathion on membrane lipid phys - iochemical properties cor relate with their toxicity.",Non-OADS,/arxiv_data1/oa_pdf/c0/d0/ijad-6-45.PMC3528171.pdf
":Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irOriginal Article Mosquito ( Diptera: Culicidae) Fauna of Qom Province , Iran A Saghafipo ur1,*MR Abai2, B Farzinnia3, R Nafar1, H Ladonni2,*S Azari-Hamidian4 1QomProvincial Health Center, Qom University of Medical Sciences, Qom, Iran 2Department ofMedical Entomology and Vector Control, School of Public Health, Tehran Un iversity of Medical Sciences, Tehran, Iran 3School of PublicHealth, Qom University of Medical Sciences, Qom, Iran 4School of Health, Guilan University of Medical Sciences, Rasht, Ir an (Received 18 Sep 2010 ; accepted 8 Jun 2011 ) Abstract Background: There is very little information about the mosquito fauna of Qom Province , central Iran .",Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
:Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irin this species and it is not con sidered a vector in the country.,Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
":Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irProvince during 2008 –2009and morpho- logically identified including 14 species rep- resentingfour genera: An.claviger,An.",Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
:Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irTable 2.,Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
:Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irCx.,Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
":Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irand southern Iran (Institute of Malari ology and Parasitology 1953 ,Gaffary 1954 ,Saebi 1987).Culex arbieeni wasrecorded in 9 provinces before:former Khorasan, L oristan, Chaharmahal andBakhtiari, Yazd, Kerman, SistanandBaluchistan, Hormozgan, F ars, and Bushehr (Zaim 1987).",Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
:Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.ir15(60):102–113[Persian with English abstract].,Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
":Mosquito (Diptera: Culicidae) … Available at: http://ijad.tums.ac.irOshaghi MA, Yaghobi -Ershadi MR, Shemshad Kh, Pedram M ,Amani H (2008) The Anopheles superpictus complex: int ro- duction of a new malaria vector complex in Iran.",Non-OADS,/arxiv_data1/oa_pdf/fc/ec/ijad-6-54.PMC3528172.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 1 Available at: http://ijad.tums.ac.irReview Article Phlebotomine SandFlies (Diptera: Psychodidae) in Iran and their RoleonLeishmania Transmission MR Yaghoobi -Ershadi Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehr an, Iran (Received 20May2012; accepted 11June2012) Abstract Sand fly research has a long history in Iran beginning with the work of Adler, Theodor and Lourie in 1930 and followed by Mesghali ’s foundational taxonomic work on sand flies in 1943.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 2 Available at: http://ijad.tums.ac.irprovinces and still is a great health problem in Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 3 Available at: http://ijad.tums.ac.irgenera occurring in the country was much more than reported by earlier workers .",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 4 Available at: http://ijad.tums.ac.irPh.sergenti similis reportedinTable 1arenot counted,being considered subs pecies.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 5 Available at: http://ijad.tums.ac.irflyseason,being greatest in September, co- incidentwith second activity peak ofPh.",OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 1 Available at: http://ijad.tums.ac.irGenus Sub-genus Species PhlebotomusAdleriusNitzulescu, 19311.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 2 Available at: http://ijad.tums.ac.irTable  2.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 3 Available at: http://ijad.tums.ac.irPh.ansarii L.major Esfahan (Nadimet al.1968c), (Yaghoobi -Ershadi and Javadian, 1996) L.near gerbilli Esfahan (Parvizi and Ready, 2008) Ph.salehi L.major Sistan and Baluchestan(Kasiri and Javadian ,2001) Ph.alexandri L.infantum Fars (Azizi et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 1 Available at: http://ijad.tums.ac.irPhlebotomus alexandri This species is usually found in moun - tainous areas and has been reported all over the country.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 2 Available at: http://ijad.tums.ac.irTable 2 show sthe list of proven or sus - pected vec tor species pre sent inIran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 3 Available at: http://ijad.tums.ac.iropmentin the sand fly of typed in fections throughitscomplete extrinsic life cycle, and experimental transmission by bite (Killick - Kendrick and Ward 1981 ).It should be me n- tioned that members of WHO have stated in 2010 that existing knowledge and molec ular tools for the identifi cation and characteriz ation ofLeishmania parasites and sand flies should be improved and har monized(WHO2010).",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 4 Available at: http://ijad.tums.ac.irMR, Mohebali M (2006) Phlebotomus (Paraphlebotomus )alexandri: a prob- able vector of Leishmania infantum in Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 5 Available at: http://ijad.tums.ac.irmaniaand leishmaniasis.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 6 Available at: http://ijad.tums.ac.irin Iran: B. Khorassan, Part VI: Cuta neous leishmaniasis in Neishabur, Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 7 Available at: http://ijad.tums.ac.irVectors and res ervoirs of cu taneous leishmaniasis in Marvdasht district, southern Islamic Republic of Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 8 Available at: http://ijad.tums.ac.ir(Paraphlebotomus )caucasicusin Es- fahan Province, Is lamic Republic of Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"J Arthropod -Borne Dis, 2012, 6(1): 1–17 MR Yaghoobi -Ershadi:Phlebotomine SandFlies … 9 Available at: http://ijad.tums.ac.irYaghoobi-Ershadi MR, Hakimiparizi M, Zahraei-Ramazani AR, Abdoli H, Aghasi M, Arandian MH, Ranjbar AA (2010) Sand fly surveillance within an emerging epidemic focus of cutaneous leish - maniasis in southeastern Iran.",Non-OADS,/arxiv_data1/oa_pdf/2e/90/ijad-6-1.PMC3528173.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/7c/95/mtna201253a.PMC3528299.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3b/c6/mtna201252a.PMC3528300.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/1.",Non-OADS,/arxiv_data1/oa_pdf/ab/9e/mtna201245a.PMC3528301.pdf
"The acquired images were analyzed using ImageJ (http://rsb.info.nih.gov/ij/) and  Imaris software (Bitplane AG, Zurich, Switzerland).",OADS,/arxiv_data1/oa_pdf/47/75/mtna201250a.PMC3528302.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/47/75/mtna201250a.PMC3528302.pdf
The academic sup-port of the MDEX Consortium (http://www.mdex.org.uk/) and the EU TREAT -NMD Network of Excellence (LSHM-CT -2006-036825) are also acknowledged.,Non-OADS,/arxiv_data1/oa_pdf/b0/28/mtna201254a.PMC3528303.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/b0/28/mtna201254a.PMC3528303.pdf
"As such, heading date ha s been comprehensively stud- ied, and hundreds of quantitative trait loci (QTLs) have beenreported (http://www.gramene .org/qtl).",OADS,/arxiv_data1/oa_pdf/3e/4a/62_310.PMC3528327.pdf
"To further analyze linkage, additional insertion/deletion (InDel) markers were developed by designing primers basedon DNA sequence diversity between the indica  cultivar ‘93- 11’ (http://rise.genomics.org.cn) and the japonica  cultivar Nipponbare (http://rgp.dna.affrc .go.jp/).",Non-OADS,/arxiv_data1/oa_pdf/3e/4a/62_310.PMC3528327.pdf
"T wo additional Indel markers, Indel7-1 and Indel7-2, were de signed based on the publicly available rice genome sequence and the likelihood of detect-ing diversity between Bo B and Baoxuan 2 was predicted bycomparing sequences from Nipponbare (http://rgp.dna.affrc.go.jp/) and the indica  cultivar ‘93-11’ (h ttp://rise.genomics.",Non-OADS,/arxiv_data1/oa_pdf/3e/4a/62_310.PMC3528327.pdf
"Based on the available sequence annotation database (http://www.tigr.org), there Fig.",OADS,/arxiv_data1/oa_pdf/3e/4a/62_310.PMC3528327.pdf
D. The BAC AP003755 was annotated by TIGR (http://rice.plantbiology.,OADS,/arxiv_data1/oa_pdf/3e/4a/62_310.PMC3528327.pdf
"OGTR (Office of the gene technol ogy regulator) (2 011) The Biology of Brassica napus  L. (canola), Version 2.1. , http://www.ogtr.gov.au/ internet/ogtr/publishing.nsf/cont ent/canola-3/$FILE/BiologyCanola 2011.pdf#search=‘OGTR 201 1 Brassica napus biology’Piquemal,  J., E.  Cinquin, F.  Couton, C.  Rondeau, E.  Seignoret, I.  Doucet, D.  Perret, M.J.  Villeger, P.  Vincourt and P.  Blanchard (2005) Con- struction of an oilseed rape ( Brassica napus  L.) genetic map with SSR markers.",OADS,/arxiv_data1/oa_pdf/0b/75/62_328.PMC3528329.pdf
Primer se- quences of “RM” markers were obtained from Gramene(http://www.gramene.org/) and primers of the other markerswere designed using the ge nome sequence of Nipponbare (http://rgp.dna.affrc.go.jp/IRGSP/).,OADS,/arxiv_data1/oa_pdf/bf/2c/62_334.PMC3528330.pdf
948 kb in ‘Nipponbare’ (http://rgp.dna.affrc.go.jp/IRGSP/).,OADS,/arxiv_data1/oa_pdf/bf/2c/62_334.PMC3528330.pdf
"1998, http://ineweb.narcc.",Non-OADS,/arxiv_data1/oa_pdf/bf/2c/62_334.PMC3528330.pdf
"In the present study, a region containing Pias(t) was delimited to a ‘Nipponbare’ genome sequence of ca.162 kb by fine mapping using gene-derived DNA markers.Since several genes related to disease resistance are annotat- ed in this region by RAP-DB  (http://rapdb.dna.affrc.go.jp), Pias(t) is expected to be identif ied at the molecular level by analysis of these genes.",OADS,/arxiv_data1/oa_pdf/bf/2c/62_334.PMC3528330.pdf
Japan Pasta Association (2012) http://www.pasta.or.jp/association/ report/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/5f/62_340.PMC3528331.pdf
"In2010, pineapple production in  Okinawa was about 10,000 t (Ministry of Agriculture, Fore stry and Fisheries Statistical Yearbook; http://www.maff.go.j p/j/tokei), 60% for fresh fruit consumption and the remainder for processing.",OADS,/arxiv_data1/oa_pdf/32/a1/62_352.PMC3528333.pdf
"DNA profiling of pineapple cultivars 353 In the plant variety protection (PVP) system in Japan, two main points were added by “Amendment of the Act in 2005”(http://www.hinsyu.maff.go.",Non-OADS,/arxiv_data1/oa_pdf/32/a1/62_352.PMC3528333.pdf
"Primer pairswere designed with the Prim er3 Web interface (Rozen and Skaletsky 2000, http://frodo.wi.mit.edu/primer3/input.htm).The general primer-picking conditions included a primer size of 20–25 bp (optimum 23 bp), a primer T m of 57–67 °C (optimum 63 °C), a maximum Tm difference of 1 °C, a primer GC content of 50%–60% (opt imum 55%) and a product size range of 100–300 bp.",Non-OADS,/arxiv_data1/oa_pdf/32/a1/62_352.PMC3528333.pdf
"), strawberry ( Fragaria ×ananassa  Duchesne), sweet cherry (Prunus avium  L.) and Japanese pear ( Pyrus pyrifolia Nakai), have been released on the Plant Variety Protectionhome page (http://www.hins yu.maff.go.jp/en/en_top.html).",Non-OADS,/arxiv_data1/oa_pdf/32/a1/62_352.PMC3528333.pdf
Gene expres- sion data are publicly available at the GEO repository(http://www.ncbi.nlm.nih.gov/projects/geo/ ) with the GSE31040 ID .,OADS,/arxiv_data1/oa_pdf/c5/44/11357_2011_Article_9307.PMC3528377.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 11/27/12; Accepted: 11/27/12http://dx.doi.org/10.4161/epi.23025in methylation levels cannot be detected  confidently.,Non-OADS,/arxiv_data1/oa_pdf/af/d1/epi-7-1339.PMC3528688.pdf
"These allelic “imprints” are acquired in either the sperm or the oocyte and, rather exceptionally, are resistant to the global waves of DNA demethylation and de novo methylation that occur during  *Correspondence to: Michael Giradot and Robert Feil;   Email: michael.girardot@igmm.cnrs.fr and robert.feil@igmm.cnrs.frSubmitted: 10/11/12; Accepted: 11/13/12http://dx.doi.org/10.4161/epi.22884More than a hundred protein-coding genes are controlled  by genomic imprinting in humans.",Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Annu Rev Genet 2011; 45:379-403; PMID:21942369; http://dx.doi.org/10.1146/ annurev-genet-110410-132459.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Bioessays  2011; 33:565-73; PMID:21618561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Cell Sci 2004; 117:5949-51; PMID:15564372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002.6.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
"MRC  Harwell, Oxfordshire 2012; http://www.har.mrc.ac.uk/ research/genomic_imprinting/.",Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
T rends Genet 2008; 24:306-16;  PMID:18471925; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 2003; 35:97-102; PMID:12937418; http://dx.doi.org/10.1038/ng1233.10.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 2003; 34:261-2;  PMID:12796779; http://dx.doi.org/10.1038/ng1171.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 2008; 40:243- 8; PMID:18176565; http://dx.doi.org/10.1038/ ng.2007.51.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Proc Natl Acad Sci U S A 2011; 108:11650- 5; PMID:21697510; http://dx.doi.org/10.1073/ pnas.1017576108.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Cell Sci 2012; 125:2709- 20; PMID:22393237; http://dx.doi.org/10.1242/ jcs.100354.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Reprod Immunol  2011; 89:185-91; PMID:21513988; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Placenta 2010; 31:951-7; PMID:20869770; http://dx.doi.org/10.1016/j.placenta.2010.08.008.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Mol Cancer 2011; 10:52; PMID:21575166; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Breast Cancer Res 2010; 12:201; PMID:20346098; http://dx.doi.org/10.1186/ bcr2484.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cancer Cell 2009; 16:533- 46; PMID:19962671; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
PLoS One 2010; 5:e9485;  PMID:20209130; http://dx.doi.org/10.1371/journal.pone.0009485.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Epigenomics 2009; 1:347-69; PMID:22122706; http://dx.doi.org/10.2217/epi.09.24.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet  2008; 40:971-6; PMID:18587395; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Cell Biol 2012; 14:659-65; PMID:22684254;  http://dx.doi.org/10.1038/ncb2521.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Biol Chem 2010; 285:24381-7; PMID:20529846;  http://dx.doi.org/10.1074/jbc.M110.111328.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Carcinogenesis  2010; 31:350-8; PMID:19926638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Hum Mol Genet 2002; 11:1527- 38; PMID:12045206; http://dx.doi.org/10.1093/ hmg/11.13.1527.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Leukemia  2012; 26:2052-60; PMID:22522792; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Epigenomics 2010; 2:743-63; PMID:22122080;  http://dx.doi.org/10.2217/epi.10.61.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 2008; 40:719-21; PMID:18500341; http://dx.doi.org/10.1038/ng.158.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Eur J Hum Genet 2010; 18:1196- 201; PMID:20588305; http://dx.doi.org/10.1038/ ejhg.2010.102.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Hum Mol Genet 2009; 18:3257-65; PMID:19498035;  http://dx.doi.org/10.1093/hmg/ddp263.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Cell Biol 2005; 169:745- 53; PMID:15939761; http://dx.doi.org/10.1083/ jcb.200411129.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet  2005; 37:766-70; PMID:15965474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Hum Mol Genet 2010; 19:3566-82;  PMID:20610438; http://dx.doi.org/10.1093/hmg/ddq272.14.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Neurochem Int 2011; 59:551- 8; PMID:21723895; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nature  2008; 455:1124-8; PMID:18806776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Med 2010; 16:1134-40; PMID:20871609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nature 2010; 465:175- 81; PMID:20418860; http://dx.doi.org/10.1038/ nature09017.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J  Biol Chem 2010; 285:19483-90; PMID:20382743;  http://dx.doi.org/10.1074/jbc.M110.131995.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cell Stem Cell 2011; 8:633-8; PMID:21620789;  http://dx.doi.org/10.1016/j.stem.2011.05.001.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Clin  Invest 2010; 120:1298-309; PMID:20237410; http://dx.doi.org/10.1172/JCI39566.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Proc Natl Acad Sci U S A  2012; 109:11264-9; PMID:22733778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
PLoS One 2008; 3:e2141;  PMID:18478077; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Genome  Res 2004; 14:1741-8; PMID:15310658; http://dx.doi.org/10.1101/gr.2743304.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Genomics 2006; 87:225- 35; PMID:16309881; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nature 2008; 453:539- 43; PMID:18404146; http://dx.doi.org/10.1038/ nature06908.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Genomics  2007; 89:687-96; PMID:17418524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cell Stem Cell 2011; 9:272-81; PMID:21885022; http://dx.doi.org/10.1016/j.stem.2011.07.007.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Dev Cell 2006; 11:711-22;  PMID:17084362; http://dx.doi.org/10.1016/j.dev- cel.2006.09.003.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
BMC Genomics 2011; 12:204;  PMID:21510876; http://dx.doi.org/10.1186/1471- 2164-12-204.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Brief Funct Genomics 2010; 9:340-6;  PMID:20591835; http://dx.doi.org/10.1093/bfgp/ elq015.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 2006; 38:101-6;  PMID:16341224; http://dx.doi.org/10.1038/ng1699.66.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Am J Med Genet C Semin Med Genet  2010; 154C:377-86; PMID:20803660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cell  2007; 129:1401-14; PMID:17604727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
RNA 2012; 18:135-44; PMID:22114321;  http://dx.doi.org/10.1261/rna.029561.111.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nucleic  Acids Res 2011; 39:8078-91; PMID:21724611; http://dx.doi.org/10.1093/nar/gkr492.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cancer Cell 2008; 14:382-93; PMID:18977327;  http://dx.doi.org/10.1016/j.ccr.2008.10.005.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
J Biol Chem 2009; 284:1971- 81; PMID:18986979; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Science  2011; 332:848-52; PMID:21566194; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Genes Dev 2008; 22:908-17; PMID:18381894; http://dx.doi.org/10.1101/gad.1640708.58.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cancer  2011; 117:1630-9; PMID:21472710; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Cancer Res 2010; 70:3140-9;  PMID:20388800; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4456.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 1995; 11:52-9;  PMID:7550314; http://dx.doi.org/10.1038/ng0995- 52.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nat Genet 1998; 20:163-9; PMID:9771709; http://dx.doi.org/10.1038/2464.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Clin Genet  2012; 81:298-300; PMID:22211632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Nature  2008; 451:147-52; PMID:18185580; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Genes Dev  2011; 25:226-31; PMID:21289068; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
Int J Cancer 2011; 129:2797- 806; PMID:21618216; http://dx.doi.org/10.1002/ijc.25962.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/epi-7-1341.PMC3528689.pdf
"www.landesbioscience.com Epigenetics 1349Epigenetics 7:12, 1349–1354; December 2012; © 2012 Landes Bioscience BriEf rEport BriEf rEport *Correspondence to: Jose Ramon Bilbao; Email: joseramon.bilbao@ehu.es Submitted: 09/08/12; Revised: 11/05/12; Accepted: 11/10/12http://dx.doi.org/10.4161/epi.22846Introduction DNA methylation plays a crucial role in normal development and  has relevant effects on gene regulation, X chromosome inactiva - tion and genomic stabilization through transcriptional silencing of repetitive elements.",Non-OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Methods 2010; 52:242- 7; PMID:20362673; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Nucleic Acids Res 2011;  39:e77; PMID:21486748; http://dx.doi.org/10.1093/ nar/gkr213.,Non-OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Lab Invest 2005; 85:464-73; PMID:15711568; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Nat Rev Genet 2011; 12:529-41;  PMID:21747404; http://dx.doi.org/10.1038/nrg3000.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
PLoS  One 2012; 7:e29686; PMID:22235325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Nat Rev Drug Discov 2006;  5:37-50; PMID:16485345; http://dx.doi.org/10.1038/ nrd1930.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Nucleic Acids Res 2004; 32:e38;  PMID:14973332; http://dx.doi.org/10.1093/nar/ gnh032.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
PLoS One 2012; 7:e37928; PMID:22701537; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Hum Mol Genet 2000; 9:2395-402; PMID:11005794;  http://dx.doi.org/10.1093/hmg/9.16.2395.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Clin Cancer Res 2009; 15:3927-37;  PMID:19509173; http://dx.doi.org/10.1158/1078- 0432.CCR-08-2784.,Non-OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Brief Funct Genomics 2010; 9:477-85;  PMID:21062751; http://dx.doi.org/10.1093/bfgp/ elq026.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Am J Hum Genet 2008; 82:696-711;  PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
Genome  Res 2010; 20:170-9; PMID:20028698; http://dx.doi.org/10.1101/gr.100289.109.,OADS,/arxiv_data1/oa_pdf/27/fb/epi-7-1349.PMC3528690.pdf
"Patients and methods Study design and patients This study is a part of a multicenter, prospective, not com- parative study of adjuvant hormonal therapy with letrozole after 4, 5 years to 6 years of tamoxifen (GIM5—GruppoItaliano Mammella GIM-5 trial—EudraCT n. 2005-001213- 18; EU clinical trial register; https://www.clinicaltrial sregister.eu/ctr-search/trial/2005-001213-18/IT )i np o s t m e n - opausal early BC patients, which aims at evaluating thecorrelation between SNPs of CYP19A1 and Disease-Free Survival (DFS).",Non-OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
An aliquot of 100 lL was used to evaluate estrone sulfate con- centration using a commercially available estrone-sulfateradioimmunoassay kit (DSL-5400 Diagnostic Systems Table 1 Primers and conditions for the tetra-primer ARMS-PCR: SNPs rs749292 and rs727479 MutationsaName Primer sequence Primer concentrations(lmol/L)Amplicon size Annealing conditions b rs749292 c.1-23624 C[T292-F 50TTTGCCTCCAGCTTTCTCACACGGT 300.4 292F–292R =476 bp Ta=63/C176C 35 cycles for 3000292-R 50GGCACTTGCATCTCCACGGACA 300.4 292Fi( C)–292R =308 bp 292-Fi( C)50CTGATAGAAATTGTGCAGGAATC GTC301.0 292F–292Ri( T)=219 bp 292-Ri( T)50CAGTCCTTCTTCAAACCTCGGAG CCA300.6 rs727479 c.145 ?418 T[G479-F 50TAGATAAACCCTTCCACTCTGTGCTGT 300.4 479F–479R =572 bp Ta=62/C176C 35 cycles for 3000479-R 50CACTGAAACCTAAAGAAGCAGTCTGAA 300.5 479Fi( G)–479R =385 bp 479-Fi( G)50TCTTCTCCCTTTCACTTTGTTT GCG301.25 479F–479Ri( T)=236 bp 479-Ri( T)50ATACAAGACAAAGAGGGGGCAT AGA300.5 aThe SNP nomenclature is according to NCBI at http://www.ncbi.nlm.nih.gov/SNP/index.html .,Non-OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
Deviation from Hardy–Weinberg equilibrium (HWE) was analyzed by Pearson X 2test by means of the Finetti program ( http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/ hwa2.pl [14]).,OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
Haplotypes and the deviation between observed and expected frequencies were evaluated by V2of 3 93 table (http://www.oege.org/software/cubex/ [15]).,OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
BMC Cancer 10:36.http://www.biomedcentral.com/1471-2407/10/36 .,Non-OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
BMCBioinformatics 8:428. http://www.biomedcentral.com/1471- 2105/8/428 .,Non-OADS,/arxiv_data1/oa_pdf/49/cd/10549_2012_Article_2306.PMC3528956.pdf
"February 7, 2012. http://www.gene.com/gene/news/ press-releases/display.do?method=detail&id=13847 .",OADS,/arxiv_data1/oa_pdf/6e/7a/10549_2012_Article_2328.PMC3528960.pdf
"To date, over 40 mutations have been identifi  ed in  TARDBP  , 7 of which  were found in FTLD or FTLD-ALS patients ( http://www.molgen.vib-ua.be/FTDMutations ).",Non-OADS,/arxiv_data1/oa_pdf/27/c8/ANN-44-817.PMC3529157.pdf
Over 40  FUS  mutations have now been reported in ALS and 3  mutations in FTLD-ALS or FTLD ( http://www.molgen.vib-ua.be/FTDMutations ).,Non-OADS,/arxiv_data1/oa_pdf/27/c8/ANN-44-817.PMC3529157.pdf
Available at:  http://www.eatlas.idf.org/webdata/docs/back- ground_opening_pc.pdf [accessed 2 September 2011].,Non-OADS,/arxiv_data1/oa_pdf/61/25/ANN-44-836.PMC3529158.pdf
Avail- able at:  http://www.cdc.gov/diabetes/statistics/prev/national/ tnumage.htm [accessed 15 September 2011].,Non-OADS,/arxiv_data1/oa_pdf/61/25/ANN-44-836.PMC3529158.pdf
Available at:  http://www.idf.org/webdata/ docs/IDF%20GGT2D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/25/ANN-44-836.PMC3529158.pdf
Available at:  http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/61/25/ANN-44-836.PMC3529158.pdf
"1 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org Comorbid diseases are a common problem in older popula - tions because aging is associated with the development of sev - eral chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/aair-5-1.PMC3529223.pdf
"2013 January;5(1):1-2. http://dx.doi.org/10.4168/aair.2013.5.1.1 pISSN 2092-7355 • eISSN 2092-7363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/aair-5-1.PMC3529223.pdf
"2013 January;5(1):1-2.  http://dx.doi.org/10.4168/aair.2013.5.1.1Volume 5, Number 1, January 2013 2 http://e-aair.orgneutrophilic airway inflammation.8 This suggests that comor - bidities may differ according to the phenotype of asthma.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/aair-5-1.PMC3529223.pdf
"16 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Asthma is a common condition in many countries, with a prev - alence of 6 to 10% in high-income countries.1 Moreover, the  prevalence of asthma in adults increases with age, suggesting  that greater attention should be paid to middle-aged and elder - ly subjects, who are more likely to have concomitant diseases.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
2013 January;5(1):16-25. http://dx.doi.org/10.4168/aair.2013.5.1.16 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   Asthma  is prevalent  in many  countries.,Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"Key Words:   Asthma;  arthritis;  rhinitis;  depression;  obesityThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16AAIR  17 http://e-aair.orgMATERIALS AND METHODS Fourth Korean National Health and Nutrition Examination  Survey We retrospectively analyzed the fourth Korean National Health  and Nutrition Survey database (4th KNHANES), which was  performed in 2008 and consisted of a nationwide stratified ran - dom sampling based on the census of the Korean Statistical Of - fice.6 In this survey, trained interviewers administered ques - tionnaires on chronic diseases, including arthritis, hyperten - sion, gastrointestinal (GI) ulcers, dyslipidemia, DM, rhinitis, de - pression, stroke, obesity, and asthma.",OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16Volume 5, Number 1, January 2013 18 http://e-aair.orgTable 1.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16AAIR  19 http://e-aair.orgnitis (OR: 1.60, 95% CI: 1.16-2.19, P=0.004), depression (OR:  1.94, 95% CI: 1.51-2.48, P<0.001), and obesity (OR: 1.56, 95%  CI: 1.17-2.09, P=0.002) were independently associated with  wheezing, after adjustment for gender, age, income, cigarette  smoking, and other chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16Volume 5, Number 1, January 2013 20 http://e-aair.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16AAIR  21 http://e-aair.org(28.9% vs. 16.6%, P<0.001), and obesity (16.1% vs. 11.0% P= 0.03) were significantly more common among wheezers than  non-wheezers.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16Volume 5, Number 1, January 2013 22 http://e-aair.orgCI: 1.05-3.30, P=0.035), depression (OR: 2.08, 95% CI: 1.44-2.98,  P<0.001), and obesity (OR: 1.67, 95% CI: 1.07-2.60, P=0.024)  were significantly associated with wheezing in elderly subjects.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16AAIR  23 http://e-aair.orgparticular attention to elderly asthma patients with depression.,Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16Volume 5, Number 1, January 2013 24 http://e-aair.orgLancet 2010;376:803-13.",Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
2013 January;5(1):16-25.  http://dx.doi.org/10.4168/aair.2013.5.1.16AAIR  25 http://e-aair.org32.,Non-OADS,/arxiv_data1/oa_pdf/a4/60/aair-5-16.PMC3529224.pdf
"26 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Exercise-induced bronchoconstriction (EIB) is associated with  vigorous physical exertion in 45%-85% of children with asthma.1  EIB is a highly prevalent but discrete clinical phenotype that  shares common features with other measures of indirect bron - chial hyperresponsiveness (BHR).2 The presence of EIB as a dis - tinct pathophysiology in children may precede the develop - ment of other features of asthma, representing an early stage of  the disease.3 Exercise causes asthma attacks due to the loss of water from  the surface of the airways by evaporation when inspired air is  exposed to conditions inside the body.4 This loss of water in - creases airway osmolarity, which initiates the activation of epi - thelial and mast cells and releases inflammatory mediators into  the airways, leading to bronchoconstriction.5-8 The pathogene -Ratio of Leukotriene E 4 to Exhaled Nitric Oxide and the  Therapeutic Response in Children With Exercise-Induced  Bronchoconstriction Hey-Sung Baek,1 Juhwan Cho,2 Joo-Hwa Kim,3 Jae-Won Oh,3 Ha-Baik Lee3* 1Department of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University School of Medicine, Seoul, Korea 2Department of Biochemistry and Molecular Biology, Hanyang University School of Medicine, Seoul, Korea 3Department of Pediatrics, Hanyang University School of Medicine, Seoul, Korea sis of EIB involves the release of cysteinyl leukotrienes (CysLTs),  demonstrated by the release of CysLTs into the airways,9,10 an  increase in leukotriene E 4 (LTE 4; a marker of CysLTs production  and elimination) in the urine,11 and the inhibition of EIB phar - macologically by drugs that antagonize CysLTs.12 Clinicians currently have two main options for the initiation  of pharmacotherapy in children with mild-to-moderate persis - tent asthma.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
2013 January;5(1):26-33. http://dx.doi.org/10.4168/aair.2013.5.1.26 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   This  study  assessed  the association  between  the ratio of leukotriene  E4 (LTE 4) to fractional  exhaled  nitric  oxide  (FE NO) in the response  of  children  with exercise-induced  bronchoconstriction  (EIB) enrolled  in a therapeutic  trial with montelukast  or inhaled  corticosteroid  (fluticasone  propio - nate [FP]).,Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"Key Words:   Exercise-induced  bronchoconstriction;  fractional  exhaled  nitric  oxide;  inhaled  corticosteroid;  leukotriene  E4; montelukastThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26AAIR  27 http://e-aair.orgtreatments with ICSs and leukotriene modifiers alleviate EIB.13-15  Clinical trials have shown that ICSs improve asthma control  more effectively in both children and adults than leukotriene  modifiers.16 However, there is a subset of patients who appear  to respond better to leukotriene modifiers with greater improve - ment in lung function and asthma control.17-19 Two recent stud - ies suggested that high LTE 4 levels relative to fractional exhaled  nitric oxide (FE NO) were associated with a better response to  montelukast compared to ICS therapy in the attenuation of alb - uterol usage20 and a greater forced expiratory volume in one  second (FEV1).19 FENO and urinary LTE 4 have been used as noninvasive mark - ers of airway inflammation in children with asthma.21-23 The in - volvement of CysLT and eosinophilic inflammation can be mea - sured by urinary LTE 4 and FE NO, respectively.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26Volume 5, Number 1, January 2013 28 http://e-aair.orgThe inspired air temperature and humidity were measured.",OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26AAIR  29 http://e-aair.orgdifferences were observed in the baseline values of postexercise  maximum decrease in FEV1 and PC20 (Table 1).,OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26Volume 5, Number 1, January 2013 30 http://e-aair.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26AAIR  31 http://e-aair.org(baseline, 347.1 ±323.4 pg/mL vs. 253.2 ±199.4 pg/mL, P=0.021;  postexercise, 1,109.5 ±841.0 pg/mL vs. 554.5 ±281.9 pg/mL;  P=0.018) and the FP group (baseline, 452.6 ±281.9 pg/mL vs.  203.1±213.7 pg/mL, P=0.038; postexercise, 1,447.5 ±921.1 pg/ mL vs. 778.6 ±689.7 pg/mL, P=0.017), but there were no fur - ther significant differences in the Δbaseline sputum LTE 4 or the  Δpostexercise sputum LTE 4 between the groups.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26Volume 5, Number 1, January 2013 32 http://e-aair.orgmechanisms that trigger EIB seem to involve neutrophilic or  mixed-type airway inflammation.41-45 This inflammation is not  consistently associated with BHR and does not respond to in - haled steroids as is characteristic of asthma.47,48 The results of  the present study are similar to those of earlier studies that re - ported an association between LTE 4/FE NO ratios and greater  FEV1, and that montelukast led to a better asthma control re - sponse than ICS therapy.19 Our results are also similar to anoth - er recent study on children with moderate-to-severe asthma  who predominantly received ICS therapy, which suggested that  increased albuterol usage among schoolchildren was associat - ed with high LTE 4 levels, relative to FE NO, and was attenuated af - ter randomization for treatment with montelukast.20 Due to the small sample size, the results of the present study  have several limitations that must be considered when inter - preting the data.",Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
2013 January;5(1):26-33.  http://dx.doi.org/10.4168/aair.2013.5.1.26AAIR  33 http://e-aair.organd Blood Institute.,Non-OADS,/arxiv_data1/oa_pdf/8e/8c/aair-5-26.PMC3529225.pdf
"3 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Food allergy, which results from an exaggerated and inappro - priate immune response to certain foods, has become a major  public health problem in westernized countries, and also a ma - jor source of anxiety and stress for both affected children and  their parents.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15. http://dx.doi.org/10.4168/aair.2013.5.1.3 pISSN 2092-7355 • eISSN 2092-7363 Food allergy has increased dramatically in prevalence over the past decade in westernized countries, and is now a major public health problem.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"Key Words:  Oral immunotherapy; omalizumab; anti-IgE; xolair; food allergy; desensitizationThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 4 http://e-aair.orgOral allergy syndrome is manifested mainly by oral symptoms  (lips, mouth, and throat) that occur after ingestion of certain  fresh foods of plant origin in patients with allergic rhinitis/pol - len allergy.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  5 http://e-aair.orgbe administered sublingually is limited, which may limit the  maximum dose of food that can be ultimately tolerated.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 6 http://e-aair.orgTable.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  7 http://e-aair.orgupdosing visits.,Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 8 http://e-aair.orgthen given daily at home, for a period of 24 months.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  9 http://e-aair.orgLong term efficacy and tolerance Although previous studies have demonstrated short-term ef - ficacy with induced desensitization, data on the long-term effi - cacy of immunotherapy is limited.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 10 http://e-aair.orgPOSSIBLE IMPROVED APPROACHES WITH OIT As discussed above, because current protocols for OIT are  lengthy and associated with significant side effects, with some  patients not responding, additional protocols are being exam - ined to address the problems of safety and unresponsiveness to  desensitization.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  1 1 http://e-aair.orgplacebo-controlled, parallel-group trial using omalizumab was  initiated to replicate the findings with TNX-901 in peanut aller - gy.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 12 http://e-aair.orgdose of 1,000 mg (cumulative dose 1,992 mg).",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  13 http://e-aair.orgsolute and full patient cooperation.,Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3Volume 5, Number 1, January 2013 14 http://e-aair.org122:977-83.e1.",Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
2013 January;5(1):3-15.  http://dx.doi.org/10.4168/aair.2013.5.1.3AAIR  15 http://e-aair.orgplus specific immunotherapy in polysensitized children and ado - lescents with seasonal allergic rhinitis.,Non-OADS,/arxiv_data1/oa_pdf/0c/f5/aair-5-3.PMC3529226.pdf
"34 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Asthma is a common disease worldwide that affects a large  number of people, with approximately 300 million patients all  over the world.1 Some of the symptoms of the disease include  lung inflammation and difficulty of breathing when the patient  is under the influence of various asthma-inducing factors.",Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
2013 January;5(1):34-41. http://dx.doi.org/10.4168/aair.2013.5.1.34 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   Aspirin  exacerbated  respiratory  disease  (AERD)  results  in a severe  asthma  attack  after  aspirin  ingestion  in asthmatics.,Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"Key Words:  Filamin A interacting protein 1 ; single  nucleotide  polymorphism;  haplotype;  asthma;  aspirin  exacerbated  respiratory  diseaseThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34AAIR  35 http://e-aair.orgis essential for cell shape modification, spreading and cell mi - gration (OMIM).7 Along with filamin A, FILIP1 has also been  associated with cell migration and motility on various ac - counts;8-10 many researchers have shown that these two pro - teins interact together in most cases.",OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34Volume 5, Number 1, January 2013 36 http://e-aair.orgfrom an Asian (Chinese and Japanese) population database of  the International HapMap Project (http://hapmap.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"To correct for the multiple testing error, we cal - culated the correction number of 27.21 using SNPSpD software  (http://gump.qimr.edu.au/general/daleN/SNPSpD/).",OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34AAIR  37 http://e-aair.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34Volume 5, Number 1, January 2013 38 http://e-aair.orgLogistic analysis of FILIP1  SNPs Logistic analyses on each SNP and haplotype showed that 5  SNPs ( rs93690910, rs2808182, rs2998394, rs2951932 , and  rs2951929 ) in the haplotype block 1 were nominally associated  with AERD ( P=0.006-0.01, Table 2).",OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34AAIR  39 http://e-aair.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
†Correction  for multiple  testing  is calculated  by  SNPSpD  program  (http://gump.qimr.edu.au/general/daleN/SNPSpD/).,Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34Volume 5, Number 1, January 2013 40 http://e-aair.orgThis study conducted an association analysis of the genetic  variants of FILIP1  with aspirin hypersensitivity (case-control  study) and the fall rate of FEV1 (phenotypic regression analysis)  in asthmatics.",Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"As a re - sult, EMBL-EBI splice site prediction (http://www.ebi.ac.uk/asd- srv/wb.cgi?method =2) found that the TTT AT sequence con - taining ‘ A’ variant of rs2951929G >A could act as a potential  branch point (BP) site for an alternative splicing, with BP score = 3.09 (Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
2013 January;5(1):34-41.  http://dx.doi.org/10.4168/aair.2013.5.1.34AAIR  41 http://e-aair.org10.,Non-OADS,/arxiv_data1/oa_pdf/13/29/aair-5-34.PMC3529227.pdf
"42 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Hen egg is the most frequent cause of food allergy,1,2 affecting  approximately 1.6% of children.3,4 Egg has been shown to be the  most common food allergy in children with atopic dermatitis,  and approximately two-thirds of children with atopic dermati - tis are reactive to egg white (EW).5-7 It has been reported that a  majority of children develop tolerance within the first five years  of life.2,8 However, recent study has shown that tolerance to egg  does not take place as early as was previously thought, and that  the majority of children with egg allergy only developed egg tol - erance by late childhood.9 Heat treatment has been recognized as a simple way of reduc - ing allergenicity.10 When a protein is denatured and undergoes  random-coiled aggregation by heat, it becomes insoluble and  most of the original tertiary structure is lost, causing a decrease  in allergenicity.11 Many studies have demonstrated that the al -The Influence of the Presence of Wheat Flour on the Antigenic  Activities of Egg White Proteins Meeyong Shin,1 Jeongok Lee,2 Kangmo Ahn,3 Sang Il Lee,3 Youngshin Han2* 1Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea 2 Environmental Health Center for Atopic Dermatitis, 3Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  Korea lergenicity of EW proteins can be reduced by heating.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"2013 January;5(1):42-47. http://dx.doi.org/10.4168/aair.2013.5.1.42 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   It is known  that ovomucoid,  an egg allergen,  is heat resistant  and remains  soluble  after  heating.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"Key Words:   Egg  white;  wheat  flour;  hot temperature;  ovomucoidThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"2013 January;5(1):42-47.  http://dx.doi.org/10.4168/aair.2013.5.1.42AAIR  43 http://e-aair.orglable, and therefore remains soluble after heating.14-17 However,  several recent studies have shown that the antigenic activity of  ovomucoid can be reduced by heating when EW is mixed with  wheat flour.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"2013 January;5(1):42-47.  http://dx.doi.org/10.4168/aair.2013.5.1.42Volume 5, Number 1, January 2013 44 http://e-aair.orgμg/mL) in coating buffer (0.05 M carbonate-bicarbonate buffer,  pH 9.6) was incubated in a 96-well microtiter plate overnight at  4°C to coat the wells.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"2013 January;5(1):42-47.  http://dx.doi.org/10.4168/aair.2013.5.1.42AAIR  45 http://e-aair.orgInhibition ELISA The heating of EW with wheat flour induced a small decrease  in IgE reactivity to ovomucoid even when heated for 10 min - utes, and a significant decrease in the antigenicity of ovomucoid  was observed when heated for 30 minutes.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"2013 January;5(1):42-47.  http://dx.doi.org/10.4168/aair.2013.5.1.42Volume 5, Number 1, January 2013 46 http://e-aair.org(baked at 176°C for 30 minutes) and waffles (baked at 260°C for  30 minutes), but only 23 tolerated regular egg (in a form of  scrambled egg or French toast).",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
2013 January;5(1):42-47.  http://dx.doi.org/10.4168/aair.2013.5.1.42AAIR  47 http://e-aair.orgdigestion of chicken egg white ovomucoid and allergenic potential  of pepsin fragments.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/aair-5-42.PMC3529228.pdf
"48 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Food allergy is an abnormal response triggered by the immune  system.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
2013 January;5(1):48-54. http://dx.doi.org/10.4168/aair.2013.5.1.48 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   Specific  oral immunotherapy  (SOIT)  using  interferon-γ (IFN-γ) has been  successful  as a food allergy  treatment.,Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"Key Words:   Atopic  dermatitis;  IFN-γ; IL-10-producing  regulatory  B cell; non-IgE-mediated  milk allergy;  oral immunotherapy;  toleranceThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48AAIR  49 http://e-aair.orgImmune tolerance comprises complex immunological mech - anisms involving both cellular and humoral immune compo - nents, including cytokines.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48Volume 5, Number 1, January 2013 50 http://e-aair.orgity of atopic eczema.24 Diagnosis of milk allergy was made if the  clinical severity score increased by more than 20% in subjects  demonstrating a basal score greater than 50 points, or if the  score increased by over 10 points in those with a basal score  less than or equal to 50 points.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48AAIR  51 http://e-aair.orgP=0.002) after casein stimulation and recovered to 22.6 ±8.5%  when casein stimulation occurred in the presence of IFN- γ  (IFN+Casein) (None vs. IFN+Casein, P=0.208; Casein vs.  IFN+Casein, P=0.006).",OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48Volume 5, Number 1, January 2013 52 http://e-aair.orgfood allergens that cause late eczematous reactions.15,17 A simi - lar effect is seen by the induction of IL-10-producing CD4(+) CD25(+) T cells during grass pollen immunotherapy.27 These  results support the hypothesis that IL-10-producing CD19(+) CD5(+) regulatory B cells (Br1s), in addition to IL-10-producing  CD4(+)CD25(+) regulatory T cells (Tr1s), play an important  role in food allergen tolerance.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48AAIR  53 http://e-aair.orgallergen-specific Br1 responses in milk allergy patients.,Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"2013 January;5(1):48-54.  http://dx.doi.org/10.4168/aair.2013.5.1.48Volume 5, Number 1, January 2013 54 http://e-aair.org2006;176:705-10.",Non-OADS,/arxiv_data1/oa_pdf/36/16/aair-5-48.PMC3529229.pdf
"55 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Non-steroidal anti-inflammatory drugs (NSAIDs) are a com - mon cause of hypersensitivity, which may manifest more broad - ly as a cross-intolerance to multiple NSAIDs, or a more specific  intolerance to a single drug or group of derivatives, such as the  pyrazolone derivatives, including antipyrine (phenazone),  4-aminopyrine (aminophenazone), metamizol (also known as  sulpyrine or dipyrone), or 4-isopropylpyrine (isopropylantipy - rine or propyphenazone).1,2 Mechanistically, the former is  thought to be related to cyclooxygenase-1 (COX-1) inhibition,  whereas the latter seems to depend on an allergic, IgE-mediat - ed mechanism involving specific antibodies to the given drug  or group of derivatives.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
"2013 January;5(1):55-58. http://dx.doi.org/10.4168/aair.2013.5.1.55 pISSN 2092-7355 • eISSN 2092-7363 Hypersensitivities induced by isopropylantipyrine (IPA), a pyrazolone derivative within the wider family of non-steroidal anti-inflammatory drugs  (NSAIDs), are rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
"Key Words:  Drug hypersensitivity; immediate hypersensitivity; isopropylantipyrine; pyrazoloneThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
"2013 January;5(1):55-58.  http://dx.doi.org/10.4168/aair.2013.5.1.55Volume 5, Number 1, January 2013 56 http://e-aair.orghypersensitivity reactions to IPA, and this sensitivity was con - firmed through an IPA oral challenge test.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
2013 January;5(1):55-58.  http://dx.doi.org/10.4168/aair.2013.5.1.55AAIR  57 http://e-aair.orggroup II was positive in the IPA intradermal test.,Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
"2013 January;5(1):55-58.  http://dx.doi.org/10.4168/aair.2013.5.1.55Volume 5, Number 1, January 2013 58 http://e-aair.org4.",Non-OADS,/arxiv_data1/oa_pdf/e5/ea/aair-5-55.PMC3529230.pdf
"59 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Angioedema is a localized, transient, episodic edema of the  deeper layer of the skin or of the gastrointestinal tract mucosa.",Non-OADS,/arxiv_data1/oa_pdf/f0/08/aair-5-59.PMC3529231.pdf
2013 January;5(1):59-61. http://dx.doi.org/10.4168/aair.2013.5.1.59 pISSN 2092-7355 • eISSN 2092-7363 Hereditary angioedema (HAE) is a rare autosomal dominant disease that usually occurs in adolescence and early adulthood.,Non-OADS,/arxiv_data1/oa_pdf/f0/08/aair-5-59.PMC3529231.pdf
"Key Words:  Hereditary angioedema; angioedema; young children; KoreaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/08/aair-5-59.PMC3529231.pdf
"2013 January;5(1):59-61.  http://dx.doi.org/10.4168/aair.2013.5.1.59Volume 5, Number 1, January 2013 60 http://e-aair.organd 139 mg/dL (normal range 77-195 mg/dL), respectively.",Non-OADS,/arxiv_data1/oa_pdf/f0/08/aair-5-59.PMC3529231.pdf
2013 January;5(1):59-61.  http://dx.doi.org/10.4168/aair.2013.5.1.59AAIR  61 http://e-aair.orgon the basis of these typical symptoms plus abnormal laborato - ry findings.,Non-OADS,/arxiv_data1/oa_pdf/f0/08/aair-5-59.PMC3529231.pdf
"62 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Eosinophilic cellulitis (EC) is a rare idiopathic disorder, first  described by Wells in 1971 as a “recurrent granulomatous der - matitis with eosinophilia” and it is also reported as Wells syn - drome.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/aair-5-62.PMC3529232.pdf
"2013 January;5(1):62-64. http://dx.doi.org/10.4168/aair.2013.5.1.62 pISSN 2092-7355 • eISSN 2092-7363 Eosinophilic cellulitis (EC) is a rare idiopathic disorder, first described as a “recurrent granulomatous dermatitis with eosinophilia”, that mimics cellu - litis of infectious origin.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/aair-5-62.PMC3529232.pdf
"Key Words:  Eosinophilic cellulitis; cyclosporine; prednisoloneThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/aair-5-62.PMC3529232.pdf
"2013 January;5(1):62-64.  http://dx.doi.org/10.4168/aair.2013.5.1.62AAIR  63 http://e-aair.orgnegative for parasites, and her antinuclear antibody, ANCA  (anti-neutrophil cytoplasmic antibody) and anti-double- stranded DNA antibody were all within normal limits.",OADS,/arxiv_data1/oa_pdf/8b/5b/aair-5-62.PMC3529232.pdf
"2013 January;5(1):62-64.  http://dx.doi.org/10.4168/aair.2013.5.1.62Volume 5, Number 1, January 2013 64 http://e-aair.orgtokine production.11 In addition, cyclosporine has effects on eo - sinophils and basophils in cutaneous inflammation and sup - presses blood eosinophil counts and the production of IL-5.12  Cyclosporine treatment of our patient led to complete remis - sion.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/aair-5-62.PMC3529232.pdf
"REVIEW Korean J Intern Med 2012;27:369-377 http://dx.doi.org/10.3904/kjim.2012.27.4.369pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Treatment of Diffuse Large B Cell Lymphoma Jae-Yong Kwak Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in all countries and  all age groups.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"Department of Internal Medicine, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea Tel: 82-63-250-1791, Fax: 82-63-254-1609, E-mail: jykwak@jbnu.ac.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.organd extranodal site involvement), is the most commonly  used means of risk stratification in DLBCL and has been  further validated in the rituximab era [4].",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"Kwak JY, Treatment of DLBCL    371 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.orgage with good prognosis and demonstrated prolonged  EFS and OS in the rituximab-treated group [14].",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.orgexpected, the OS of both GCB and ABC DLBCL was bet - ter than in the pre-rituximab era.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"Kwak JY, Treatment of DLBCL    373 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.orgdifference between patients with GCB and ABC DL - BCL, suggesting that bortezomib overcame the adverse  prognostic effect of the ABC DLBCL subtype.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.orgyears [69].",OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"Kwak JY, Treatment of DLBCL    375 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.orga randomised controlled trial (RICOVER-60).",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.org2011;378:1858-1867.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"Kwak JY, Treatment of DLBCL    377 http://dx.doi.org/10.3904/kjim.2012.27.4.369 http://www.kjim.org(DLBCL) with nongerminal center B-cell phenotype to le - nalidomide (L) alone or in combination with rituximab (R)  [abstract].",Non-OADS,/arxiv_data1/oa_pdf/90/0e/kjim-27-369.PMC3529233.pdf
"REVIEW Korean J Intern Med 2012;27:378-387 http://dx.doi.org/10.3904/kjim.2012.27.4.378pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE Recent Paradigm Shifts in the Diagnosis and Treatment of  Rheumatoid Arthritis Young Ok Jung and Hyun Ah Kim Department of Internal Medicine, Hallym University College of Medicine, Anyang, Korea Rheumatoid arthritis (RA) is a progressive inflammatory disease with severe symptoms of pain and stiffness.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 22 Gwanpyeong-ro 170 beon-gil,  Dongan-gu, Anyang 431-796, Korea Tel: 82-31-380-1826, Fax: 82-31-381-8812, E-mail: kimha@hallym.ac.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Jung YO and Kim HA, Diagnosis and treatment of RA    379 http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgwith the ultimate goal of reaching remission.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"4, December 2012    http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgtiation and bone resorption [22].",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Jung YO and Kim HA, Diagnosis and treatment of RA    381 http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgAgents targeting Janus kinase (JAK) and spleen tyro - sine kinase (Syk) showed good data in clinical trials.",OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"4, December 2012    http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgTable 3.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Jung YO and Kim HA, Diagnosis and treatment of RA    383 http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgclinical trials of promising new agents, and reflect hope  that in the future, RA will no longer be characterised by  erosive joint disease and persistence of symptoms [2].",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"4, December 2012    http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.org< 2.6 had foot metatarsophalangeal (MTP) and ankle  involvement with some patients even showing isolated  foot or MTP joint involvement without evidence of  disease activity in other joints [38].",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Jung YO and Kim HA, Diagnosis and treatment of RA    385 http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgabatacept or tocilizumab may be recommended.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"4, December 2012    http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.orgREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"Jung YO and Kim HA, Diagnosis and treatment of RA    387 http://dx.doi.org/10.3904/kjim.2012.27.4.378 http://www.kjim.org28.",OADS,/arxiv_data1/oa_pdf/ce/08/kjim-27-378.PMC3529234.pdf
"EDITORIAL Korean J Intern Med 2012;27:388-390 http://dx.doi.org/10.3904/kjim.2012.27.4.388pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE The Optimal Revascularization Therapy for Coronary  Artery Disease Patients with Chronic Kidney Disease Chul Soo Park Division of Cardiology, Department of Internal Medicine, Yeouido St. Mary’s Hospital, The Catholic University of  Korea College of Medicine, Seoul, Korea  Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/30/kjim-27-388.PMC3529235.pdf
http://dx.doi.org/10.3904/kjim.2012.27.4.388 http://www.kjim.orgPark C S. Revascularization in CKD    389 BMS OR DES Several studies have shown that patients with CKD who un - dergo revascularization with PCI and stenting consistently have  worse short- and long-term outcomes relative to patients without  CKD [8].,Non-OADS,/arxiv_data1/oa_pdf/52/30/kjim-27-388.PMC3529235.pdf
"4, December 2012    http://dx.doi.org/10.3904/kjim.2012.27.4.388 http://www.kjim.organd impact of diabetes.",Non-OADS,/arxiv_data1/oa_pdf/52/30/kjim-27-388.PMC3529235.pdf
"EDITORIAL Korean J Intern Med 2012;27:391-393 http://dx.doi.org/10.3904/kjim.2012.27.4.391pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Epigenetic Regulation of RUNX3  in Thyroid Carcinoma Kyong Hye Joung and Minho Shong Research Center for Endocrine and Metabolic Diseases, Department of Internal Medicine, Chungnam National  University School of Medicine, Daejeon, Korea Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/c0/kjim-27-391.PMC3529236.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.391 http://www.kjim.orgparticularly hypermethylation of tumor suppressor genes,  occur concurrently in PTC [4].",Non-OADS,/arxiv_data1/oa_pdf/fd/c0/kjim-27-391.PMC3529236.pdf
http://dx.doi.org/10.3904/kjim.2012.27.4.391 http://www.kjim.orgJoung KH and Shong M. RUNX in thyroid carcinoma    393 3.,Non-OADS,/arxiv_data1/oa_pdf/fd/c0/kjim-27-391.PMC3529236.pdf
"EDITORIAL Korean J Intern Med 2012;27:394-396 http://dx.doi.org/10.3904/kjim.2012.27.4.394pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE Treatment of Hepatitis B Virus-Associated Membranous  Nephropathy: Lamivudine Era versus Post-Lamivudine Era Ju-Young Moon and Sang Ho Lee Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul,  Korea Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/9a/kjim-27-394.PMC3529237.pdf
http://dx.doi.org/10.3904/kjim.2012.27.4.394 http://www.kjim.orgMoon  JY and Lee SH.,OADS,/arxiv_data1/oa_pdf/d1/9a/kjim-27-394.PMC3529237.pdf
"4, December 2012          http://dx.doi.org/10.3904/kjim.2012.27.4.394 http://www.kjim.orgof immunosuppressive agents should be reevaluated in  terms of intractable cases in the coming post-lamivudine  era.",Non-OADS,/arxiv_data1/oa_pdf/d1/9a/kjim-27-394.PMC3529237.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:397-406 http://dx.doi.org/10.3904/kjim.2012.27.4.397pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Comparison of Drug-Eluting Stents in Acute Myocardial   Infarction Patients with Chronic Kidney Disease Daisuke Hachinohe1,2, Myung Ho Jeong1, Shigeru Saito2, Min Chol Kim1, Kyung Hoon Cho1,    Khurshid Ahmed1, Seung Hwan Hwang1, Min Goo Lee1, Doo Sun Sim1, Keun-Ho Park1, Ju Han Kim1,  Young Joon Hong1, Youngkeun Ahn1, Jung Chaee Kang1, Jong Hyun Kim3, Shung Chull Chae4,   Young Jo Kim5, Seung Ho Hur6, In Whan Seong7, Taek Jong Hong8, Donghoon Choi9,    Myeong Chan Cho10, Chong Jin Kim11, Ki Bae Seung12, Wook Sung Chung12, Yang Soo Jang9,    Seung Woon Rha13, Jang Ho Bae14, Seung Jung Park15, and Korea Acute Myocardial Infarction Registry  Investigators Department of Internal Medicine, 1Chonnam National University Hospital, Gwangju, Korea; 2Sapporo Higashi  Tokushukai Hospital, Sapporo, Japan; 3Pusan Hanseo Hospital, Busan; 4Kyungpook National University Hospital,  Daegu; 5Yeungnam University Medical Center, Daegu; 6Keimyung University Dongsan Medical Center, Daegu;  7Chungnam National University Hospital, Daejeon; 8Pusan National University Hospital, Busan; 9Severance  Hospital, Yonsei University College of Medicine, Seoul; 10Chungbuk National University Hospital, Cheongju;  11Kyung Hee University Medical Center, Seoul; 12Seoul St. Mary’s Hospital, The Catholic University of Korea  College of Medicine, Seoul; 13Korea University Guro Hospital, Seoul; 14Konyang University Hospital, Daejeon;  15Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background/Aims: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI)  patients with chronic kidney disease (CKD).",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"Department of Internal Medicine, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: 82-62-220-6243, Fax: 82-62-227-3105, E-mail: myungho@chollian.net Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgINTRODUCTION Primary percutaneous coronary intervention (PCI)  with stent implantation is considered the standard  treatment strategy in patients with acute myocardial  infarction (MI) [1].",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"Comparison of DES in AMI with CKD    399 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgStatistical analysis All analyses were performed using SPSS version 17.0  (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"Comparison of DES in AMI with CKD    401 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgRESULTS Baseline clinical and procedural characteristics A comparison of the clinical characteristics among  the three DES groups suggested that age was greater  in the PES group, BMI was higher and usage rate of GP  IIb/IIIa inhibitor during the procedure lower in the  SES group, and usage rate of cilostazol was lower in the  ZES group (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgsults for all comparisons are shown in Fig.",OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
Comparison of DES in AMI with CKD    403 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgimplantation is considered to be the gold standard in  treatment for acute MI [1].,Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgcompared with first-generation DES [7].",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"Comparison of DES in AMI with CKD    405 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.org[24,25].",OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.397 http://www.kjim.orgphologic and clinical determinants of procedural outcome  with angioplasty for multivessel coronary disease: implica - tions for patient selection.",Non-OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
http://dx.doi.org/10.1016/j.ijcard.2011.10.012.,OADS,/arxiv_data1/oa_pdf/b0/db/kjim-27-397.PMC3529238.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:407-410 http://dx.doi.org/10.3904/kjim.2012.27.4.407pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org DNA Methylation of RUNX3  in Papillary Thyroid Cancer Hee Ja Ko, Bo Yeon Kim, Chan Hee Jung, Sung Wan Chun, Ji Oh Mok, Yeo Joo Kim, Hyeong Kyu Park,  Chul Hee Kim, Sang Jin Kim, Dong Won Byun, Kyo Il Suh, Myung Hi Yoo, and Sung Gu Kang Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea Background/Aims: The relationship between Runt-related transcription factor 3 ( RUNX3 ) gene inactivation and  various solid tumors has been reported; however, little information is available about  RUNX3 in thyroid cancers.",Non-OADS,/arxiv_data1/oa_pdf/28/30/kjim-27-407.PMC3529239.pdf
"Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, 31 Suncheonhyang  6-gil, Dongnam-gu, Cheonan 330-930, Korea  Tel: 82-41-570-2378, Fax: 82-41-574-5762, E-mail: ksj1113@schmc.ac.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/30/kjim-27-407.PMC3529239.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.407 http://www.kjim.orgMETHODS Tissues and cell lines Human thyroid tissues collected during surgery were  immediately frozen in liquid nitrogen.",Non-OADS,/arxiv_data1/oa_pdf/28/30/kjim-27-407.PMC3529239.pdf
RUNX3  methylation in thyroid cancer    409 http://dx.doi.org/10.3904/kjim.2012.27.4.407 http://www.kjim.orgwere treated with the demethylating agent DAC and  histone-deacetylating agent TSA in an attempt to reac - tivate RUNX3 .,Non-OADS,/arxiv_data1/oa_pdf/28/30/kjim-27-407.PMC3529239.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.407 http://www.kjim.orgWe evaluated RUNX3  only in papillary thyroid cancer  tissues, which showed a high methylation rate.",Non-OADS,/arxiv_data1/oa_pdf/28/30/kjim-27-407.PMC3529239.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:411-416 http://dx.doi.org/10.3904/kjim.2012.27.4.411pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Experience of Anti-Viral Therapy in Hepatitis B-Associated  Membranous Nephropathy, Including Lamivudine-    Resistant Strains In O Sun, Yu Ah Hong, Hoon Suk Park, Sun Ryoung Choi, Byung Ha Chung, Cheol Whee Park,   Chul Woo Yang, Yong Soo Kim, and Bum Soon Choi Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine,  Seoul, Korea  Background/Aims: Chronic hepatitis B infection is a common cause of secondary membranous nephropathy (MN) in  endemic areas.",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine,    222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: 82-2-2258-6040, Fax: 82-2-599-3589, E-mail: sooncb@catholic.ac.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.411 http://www.kjim.org(e.g., systemic lupus erythematosus), infectious disease  (e.g., hepatitis B virus [HBV] infection), tumors, and  drugs or toxins.",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"Treatment of membranous nephropathy    413 http://dx.doi.org/10.3904/kjim.2012.27.4.411 http://www.kjim.orgone female, with a mean age of 37 years (range, 19 to  64).",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.411 http://www.kjim.orgDISCUSSION In this study, we report our experience treating HBV- MN, including lamivudine-resistant strains, with sev - eral antiviral drugs.",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
Treatment of membranous nephropathy    415 http://dx.doi.org/10.3904/kjim.2012.27.4.411 http://www.kjim.orgwas lost to follow-up at 8 months.,Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.411 http://www.kjim.org16.",Non-OADS,/arxiv_data1/oa_pdf/7e/70/kjim-27-411.PMC3529240.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:417-425 http://dx.doi.org/10.3904/kjim.2012.27.4.417pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Intensive Exercise Reduces the Fear of Additional Falls in   Elderly People: Findings from the Korea Falls Prevention  Study Dong Hyun Oh1, Ji Eun Park1, Eon Sook Lee2, Sang Woo Oh3, Sung Il Cho4, Soong Nang Jang5,   and Hyun Wook Baik1 1Department of Internal Medicine, Bundang Jesaeng General Hospital, Seongnam; 2Department of Family  Medicine, Inje University Ilsan Paik Hospital, Goyang; 3Department of Family Medicine, Dongguk University Ilsan  Hospital, Goyang; 4Seoul National University School of Public Health, Seoul; 5Department of Nursing, Chung-Ang  University Red Cross College of Nursing, Seoul, Korea Background/Aims:  Falls among older people are a major public health problem and may result in fracture, medical  complications that require hospitalization, and fear of additional falls.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"Division of Gastroenterology & Clinical Nutrition, Department of Internal Medicine, Bundang Jesaeng General  Hospital, 20  Seohyeon-ro,  180beon-gil,  Bundang-gu, Seongnam 463-774, Korea  Tel: 82-31-779-0210, Fax: 82-31-779-0897 , E-mail: hbaik@dmc.or.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgprevent falls in elderly people because falls can be fatal  to frail seniors.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
Exercise for fall prevention    419 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.org11.1% in the EG and 20.7% in the CG.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgincluded 10 minutes of a warm-up exercise, such as  walking or stretching, 20 minutes of floor exercise for  abdominal strength, 20 minutes of strength exercises  for both legs, 20 minutes of balance exercise, and 10  minutes of cool-down activities.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"Exercise for fall prevention    421 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgtus, there were no significant differences between the  two groups in terms of demographic variables, initial  fitness, fear of falling, or functional state ( p = 0.019).",OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgFew studies have addressed whether the fear of falling  is significantly associated with overall functional per - formance, which is related to quality of life, especially  in the elderly [29].",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
Exercise for fall prevention    423 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgquency of going outdoors would be expected for subjects  with improved ABC-K scores.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgto perform another study with a longer research period  in the near future to address this issue.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
Exercise for fall prevention    425 http://dx.doi.org/10.3904/kjim.2012.27.4.417 http://www.kjim.orgof Instrument of Function and QOL for the Disabled: Service  Report of National Rehabilitation Center and Local Com - munity Health Research Center.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/kjim-27-417.PMC3529241.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:426-435 http://dx.doi.org/10.3904/kjim.2012.27.4.426pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE Patient’s Perception of Symptoms Related to Morning   Activity in Chronic Obstructive Pulmonary Disease:    The SYMBOL Study Yeon Jae Kim1, Byung Ki Lee1, Chi Young Jung2, Young June Jeon2, Dae Sung Hyun3,    Kyung Chan Kim3, Sung Ken Yu4, Hye Sook Choi5, Won Hyuk Shin6, and Kwan Ho Lee4 1Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital, Daegu; 2Department of Internal  Medicine, Keimyung University School of Medicine, Daegu; 3Department of Internal Medicine, Catholic University  of Daegu School of Medicine, Daegu; 4Department of Internal Medicine, Yeungnam University College of  Medicine, Daegu; 5Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju;  6Department of Internal Medicine, Sunlin Hospital, Handong Global University, Pohang, Korea Background/Aims:  Patients with chronic obstructive pulmonary disease (COPD) experience more problematic  respiratory symptoms and have more trouble performing daily activities in the morning.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
"Department of Internal Medicine, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea Tel: 82-53-620-3838, Fax: 82-53-654-8386, E-mail: ghlee@med.yu.ac.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
"Patient’s perception of morning symptoms    427 http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.orgINTRODUCTION Chronic obstructive pulmonary disease (COPD) is a  complex condition associated with long-term exposure  to environmental toxic gases and particles, most often  cigarette smoke, on a susceptible genetic background  and is a major cause of chronic morbidity and mortality  globally [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.org428    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
Patient’s perception of morning symptoms    429 http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.orgNovember 2009.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.org430    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
Patient’s perception of morning symptoms    431 http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.orgtime of day for experiencing COPD symptoms with the  exception of except sleep disturbance (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.org432    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
Patient’s perception of morning symptoms    433 http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.orgwith morning symptoms than in those without morn - ing symptoms.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.org434    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
Available from: http://www.gold - copd.org/uploads/users/files/GOLD_Report_2011_Feb21.,OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
Patient’s perception of morning symptoms    435 http://dx.doi.org/10.3904/kjim.2012.27.4.426 http://www.kjim.orgerability of budesonide/formoterol added to tiotropium in  patients with chronic obstructive pulmonary disease.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/kjim-27-426.PMC3529242.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:436-442 http://dx.doi.org/10.3904/kjim.2012.27.4.436pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE The Progression of Bone Mineral Density Loss in     Dialysis Patients Compared with the General Population Petar Avramovski1 and Aleksandar Sikole2 1Department of Internal Medicine and Hemodialysis, Clinical Hospital, Bitola; 2Department of Nephrology, Ss.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
"Department of Internal Medicine and Hemodialysis, Clinical Hospital, Ivan Milutinovik 37/4-26, Bitola 7000, Republic of Macedonia Tel: 389-70-207-187, Fax: 389-47-253-435, E-mail: avramovski@gmail.com Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
The progression of bone mineral density    437 http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.orgbone mass loss in chronic hemodialysis patients (CHPs)  with that of general population patients (GPPs) over an  18-month period.,Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.org438    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
"The progression of bone mineral density    439 http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.orgThe average femur neck bone mass loss in the GPP  group was 0.056 g/cm2 during the investigated period of  18 months, or 3.11 mg/cm2 per month.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.org440    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
The progression of bone mineral density    441 http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.orgneck region tha n the lumbar region ( p = 0.0002).,Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
                   http://dx.doi.org/10.3904/kjim.2012.27.4.436 http://www.kjim.org442    The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/87/8d/kjim-27-436.PMC3529243.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2012;27:443-450 http://dx.doi.org/10.3904/kjim.2012.27.4.443pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org A Comparison of Active Surveillance Programs Including a  Spontaneous Reporting Model for Phamacovigilance of   Adverse Drug Events in a Hospital Il Seon Yun1,2, Myung Jin Koo1, Eun Hye Park1, Sung-Eun Kim1, Jae-Hyun Lee1,2, Jung-Won Park1,2,   and Chein-Soo Hong1,2 1Severance Hospital Regional Pharmacovigilance Center, 2Division of Allergy and Immunology, Department of  Internal Medicine, Yonsei University College of Medicine, Seoul, Korea Background/Aims: Spontaneous reporting systems have several weak points, such as low reporting rates and  insufficient clinical information.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120- 749, Korea Tel: 82-2-2228-1940, Fax: 82-2-2227-7932, E-mail: parkjw@yuhs.ac Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed und er the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.orgbe due to systemic problems that could be corrected by  an adequate information system [9,10].",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
Surveillance programs of adverse drug events    445 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.orgmanifestations.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.org(10.4%) (Fig.",OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
Surveillance programs of adverse drug events    447 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.org(Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.orgDISCUSSION Spontaneous reporting facilitates identification of  possible ADEs and drug associations but has a number  of limitations.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"Surveillance programs of adverse drug events    449 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.orgous reporting system, including cost-effectiveness [15]  and is less dependent on the education and motivation  of health professionals.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.443 http://www.kjim.orgadverse drug events: ADE Prevention Study Group.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/kjim-27-443.PMC3529244.pdf
"CASE REPORT Korean J Intern Med 2012;27:451-454 http://dx.doi.org/10.3904/kjim.2012.27.4.451pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Successful Treatment of Eosinophilic Gastroenteritis with  Clarithromycin Masashi Ohe1 and Satoshi Hashino2 1Department of General Medicine, Hokkaido Social Insurance Hospital; 2Department of Gastroenterology and Hematology,  Hokkaido University Graduate School of Medicine, Sapporo, Japan Eosinophilic gastroenteritis (EGE) is an uncommon disease characterized by eosinophilic infiltration of the  gastrointestinal tract, which is usually associated with abdominal pain, diarrhea, ascites, and peripheral eosinophilia.",Non-OADS,/arxiv_data1/oa_pdf/44/cd/kjim-27-451.PMC3529245.pdf
"Department of General Medicine, Hokkaido Social Insurance Hospital , 1-8-3-18 Nakanoshima, Toyohira-ku, Sapporo 062-8618,  Japan Tel: 81-11-831-5151 , Fax: 81-11-821-3851 , E-mail: masshi@isis.ocn.ne.jp Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/cd/kjim-27-451.PMC3529245.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.451 http://www.kjim.orgserum immunoglobulin E level was 2,400 U/mL (nor - mal, 6 to 90) and a radioallergosorbent test was positive  for numerous allergens, including common foods.",Non-OADS,/arxiv_data1/oa_pdf/44/cd/kjim-27-451.PMC3529245.pdf
"Ohe M and Hashino S. Successful CAM treatment of eosinophilia   453 http://dx.doi.org/10.3904/kjim.2012.27.4.451 http://www.kjim.orgeral eosinophil counts (9,772/mm3; first relapse).",Non-OADS,/arxiv_data1/oa_pdf/44/cd/kjim-27-451.PMC3529245.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.451 http://www.kjim.orgtenance dose of PSL.",Non-OADS,/arxiv_data1/oa_pdf/44/cd/kjim-27-451.PMC3529245.pdf
"CASE REPORT Korean J Intern Med 2012;27:455-458 http://dx.doi.org/10.3904/kjim.2012.27.4.455pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Subaortic Membrane Late after Surgical Correction of    Tetralogy of Fallot Kyung-Hee Kim1, Hyung-Kwan Kim1, Sung-A Chang1, Seil Oh1, Kyung-Hwan Kim2, and Dae-Won Sohn1 1Department of Internal Medicine and Cardiovascular Center, 2Department of Thoracic and Cardiovascular  Surgery, Seoul National University Hospital, Seoul, Korea We herein report a rare case of subaortic stenosis in association with a previous tetralogy of Fallot (TOF) surgical  repair, which was not taken into account as a differential diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/60/aa/kjim-27-455.PMC3529246.pdf
"Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: 82-2-2072-0243, Fax: 82-2-2072-2577, E-mail: cardiman@medimail.co.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/aa/kjim-27-455.PMC3529246.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.455 http://www.kjim.orgclinical follow-up had been performed after the opera - tion.",Non-OADS,/arxiv_data1/oa_pdf/60/aa/kjim-27-455.PMC3529246.pdf
Subaortic membrane in collected TOF   457 http://dx.doi.org/10.3904/kjim.2012.27.4.455 http://www.kjim.orgremains uncertain.,Non-OADS,/arxiv_data1/oa_pdf/60/aa/kjim-27-455.PMC3529246.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.455 http://www.kjim.orgfollow-up.",Non-OADS,/arxiv_data1/oa_pdf/60/aa/kjim-27-455.PMC3529246.pdf
"CASE REPORT Korean J Intern Med 2012;27:459-462 http://dx.doi.org/10.3904/kjim.2012.27.4.459pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Langerhans Cell Histiocytosis Followed by Hodgkin’s    Lymphoma IK Soo Park1, In Keun Park1, Eun Kyoung Kim1, Shin Kim1, Sang Ryong Jeon2, Joo Ryung Huh3,   and Cheol Won Suh1 Departments of 1Internal Medicine, 2Neurosurgery, and 3Pathology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea A 22-year-old man was referred to our institution due to lower back pain and was diagnosed with Langerhans  cell histiocytosis of the thoracic and lumbar spine.",Non-OADS,/arxiv_data1/oa_pdf/6a/04/kjim-27-459.PMC3529247.pdf
"Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: 82-2-3010-3209, Fax: 82-2-3010-6961, E-mail: csuh@amc.seoul.kr Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/04/kjim-27-459.PMC3529247.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.459 http://www.kjim.orgosteoblasts and osteoclasts.",Non-OADS,/arxiv_data1/oa_pdf/6a/04/kjim-27-459.PMC3529247.pdf
Langerhans cell histiocytosis followed by Hodgkin’s lymphoma   461 http://dx.doi.org/10.3904/kjim.2012.27.4.459 http://www.kjim.orgaround the nodules.,Non-OADS,/arxiv_data1/oa_pdf/6a/04/kjim-27-459.PMC3529247.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.459 http://www.kjim.orgor modulation of the monocyte-histiocyte system.",OADS,/arxiv_data1/oa_pdf/6a/04/kjim-27-459.PMC3529247.pdf
"CASE REPORT Korean J Intern Med 2012;27:463-466 http://dx.doi.org/10.3904/kjim.2012.27.4.463pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Sudden Atelectasis and Respiratory Failure in a Neutropenic  Patient: Atypical Presentation of Pseudomembranous    Necrotizing Bronchial Aspergillosis Ji Yun Noh1, Seok Jin Kim2, Eun Hae Kang1, Bo Kyoung Seo3, Kyoung Ho Rho4, Yang-Seok Chae5,    and Byung Soo Kim1 1Department of Internal Medicine, Korea University Medical Center; 2Department of Internal Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine; Departments of 3Radiology, 4Laboratory Medicine,  and 5Pathology, Korea University Medical Center, Seoul, Korea Pseudomembranous necrotizing bronchial aspergillosis (PNBA) is a rare form of invasive aspergillosis with a very  poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/df/4d/kjim-27-463.PMC3529248.pdf
"Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710,  Korea Tel: 82-2-3410-1766, Fax: 82-2-3410-1754, E-mail: kstwoh@skku.edu Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/4d/kjim-27-463.PMC3529248.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.463 http://www.kjim.orgwith induction chemotherapy including idarubicin (12  mg/m2 for 3 days) and cytarabin (100 mg/m2 for 7 days).",Non-OADS,/arxiv_data1/oa_pdf/df/4d/kjim-27-463.PMC3529248.pdf
Pseudomembranous necrotizing bronchial aspergillosis   465 http://dx.doi.org/10.3904/kjim.2012.27.4.463 http://www.kjim.orgCulture of the bronchial washing yielded Aspergillus  nidulans .,Non-OADS,/arxiv_data1/oa_pdf/df/4d/kjim-27-463.PMC3529248.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.463 http://www.kjim.orgpatients with bronchial aspergillosis [9].",Non-OADS,/arxiv_data1/oa_pdf/df/4d/kjim-27-463.PMC3529248.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2012;27:467-469 http://dx.doi.org/10.3904/kjim.2012.27.4.467pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Pelvic Bone Fractures  Mimicking Bone Metastases  in a Patient with Hepatitis  B Virus-Associated Liver  Cirrhosis and Hepatocellular  Carcinoma   To the Editor, Metabolic bone disease has been reported in patients  with chronic liver disease, especially those with cho - lestatic type and those awaiting liver transplantation.",Non-OADS,/arxiv_data1/oa_pdf/dd/10/kjim-27-467.PMC3529249.pdf
"The  patient underwent several treatments of immobilization  Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/10/kjim-27-467.PMC3529249.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.467 http://www.kjim.orgwith pain control for these minor pelvic fractures after  consultation with an orthopedic surgeon.",Non-OADS,/arxiv_data1/oa_pdf/dd/10/kjim-27-467.PMC3529249.pdf
Pelvic fractures induced by hepatic osteodystrophy    469 http://dx.doi.org/10.3904/kjim.2012.27.4.467 http://www.kjim.orgfractures [5].,Non-OADS,/arxiv_data1/oa_pdf/dd/10/kjim-27-467.PMC3529249.pdf
"LETTER TO THE EDITOR  Korean J Intern Med 2012;27:470-473 http://dx.doi.org/10.3904/kjim.2012.27.4.470 pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Cytomegalovirus Induced  Interstitial Nephritis and  Ureteral Stenosis in Renal  Transplant Recipient To the Editor, Cytomegalovirus (CMV) infections occur in up to  60% of kidney transplant recipients, with most cases  developing between the second and 6 months after  transplantation [1].",Non-OADS,/arxiv_data1/oa_pdf/e6/af/kjim-27-470.PMC3529250.pdf
"Glomerular capillary intracytoplasmic CMV inclusions  Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/af/kjim-27-470.PMC3529250.pdf
CMV induced interstitial nephritis     471 http://dx.doi.org/10.3904/kjim.2012.27.4.470 http://www.kjim.orgwere seen on IHC stain (Figs.,Non-OADS,/arxiv_data1/oa_pdf/e6/af/kjim-27-470.PMC3529250.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.470 http://www.kjim.orgreview by Ulrich et al.",OADS,/arxiv_data1/oa_pdf/e6/af/kjim-27-470.PMC3529250.pdf
"CMV induced interstitial nephritis     473 http://dx.doi.org/10.3904/kjim.2012.27.4.470 http://www.kjim.orglar epithelium, thereby making it a better target for cell- mediated immune injury, and that T cells sensitized  to CMV antigens within the kidney or at extrarenal  sites can release interferon- γ or tumor necrosis factor,  thereby leading to parenchymal injury mimicking acute  rejection.",Non-OADS,/arxiv_data1/oa_pdf/e6/af/kjim-27-470.PMC3529250.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2012;27:474-477 http://dx.doi.org/10.3904/kjim.2012.27.4.474pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org An Adult Case of Severe  Chronic Active Epstein- Barr Virus Infection with  T-Cell Lymphoproliferative  Disorder To the Editor, The Epstein-Barr virus (EBV) is an ubiquitous human  herpesvirus that mainly infects B-cells.",Non-OADS,/arxiv_data1/oa_pdf/df/66/kjim-27-474.PMC3529251.pdf
"Imaging studies revealed the presence of multi - Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/66/kjim-27-474.PMC3529251.pdf
"Severe chronic EBV infection in an adult    475 http://dx.doi.org/10.3904/kjim.2012.27.4.474 http://www.kjim.orgple small, nodular ground-glass opacities (GGOs) in the  upper lobes of both lungs and hepatosplenomegaly (Fig.",Non-OADS,/arxiv_data1/oa_pdf/df/66/kjim-27-474.PMC3529251.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.474 http://www.kjim.orgthe lymphocytic infiltrates of the lung tissue and in a  few lymphocytes in the sinusoids of the liver biopsy tis - sue.",Non-OADS,/arxiv_data1/oa_pdf/df/66/kjim-27-474.PMC3529251.pdf
Severe chronic EBV infection in an adult    477 http://dx.doi.org/10.3904/kjim.2012.27.4.474 http://www.kjim.orginfection [2].,Non-OADS,/arxiv_data1/oa_pdf/df/66/kjim-27-474.PMC3529251.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2012;27:478-479 http://dx.doi.org/10.3904/kjim.2012.27.4.478pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org A Case of Combined  Cholinergic and Cold  Urticaria To the Editor, Cold urticaria is a disorder in which patients experi - ence pruritus and urticaria within a few minutes after  exposure to cold [1].",Non-OADS,/arxiv_data1/oa_pdf/57/c8/kjim-27-478.PMC3529252.pdf
"The mechanism underlying  cholinergic urticaria is generally believed to involve an  abnormal cutaneous response in the presence of cho - Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/c8/kjim-27-478.PMC3529252.pdf
Isolated bowed endometriosis    479 http://dx.doi.org/10.3904/kjim.2012.27.4.478 http://www.kjim.orglinergic agents.,Non-OADS,/arxiv_data1/oa_pdf/57/c8/kjim-27-478.PMC3529252.pdf
"IMAGE OF INTEREST Korean J Intern Med 2012;27:480 http://dx.doi.org/10.3904/kjim.2012.27.4.480pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org ORIGINAL ARTICLE A Large, Free-Floating Right Atrial Thrombus Evoking  Periodic Dizziness A 62-year-old man suffered from exertional dyspnea  and repetitive momentary dizziness that began occur - ring just after forceful chest beating to end an episode  of acute shortness of breath 3 days prior.",Non-OADS,/arxiv_data1/oa_pdf/0b/5c/kjim-27-480.PMC3529253.pdf
"Sun Hwa Lee, Kyoung-Suk Rhee, Won Ho Kim,  and Jae-Ki Ko Division of Cardiology, Department of Internal Medicine  and Research Institute of Clinical Medicine, Chonbuk  National University Medical School, Jeonju, Korea Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/5c/kjim-27-480.PMC3529253.pdf
IMAGE OF INTEREST Korean J Intern Med 2012;27:481-482 http://dx.doi.org/10.3904/kjim.2012.27.4.481pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org Asymptomatic Disseminated Cysticercosis in     an Immunocompetent Patient A 68-year-old previously healthy man presented with  chest discomfort.,Non-OADS,/arxiv_data1/oa_pdf/14/b5/kjim-27-481.PMC3529254.pdf
"Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/b5/kjim-27-481.PMC3529254.pdf
"4, December 2012 http://dx.doi.org/10.3904/kjim.2012.27.4.",Non-OADS,/arxiv_data1/oa_pdf/14/b5/kjim-27-481.PMC3529254.pdf
481 http://www.kjim.orgConflict of interest No potential conflict of interest relevant to this article  was reported.,Non-OADS,/arxiv_data1/oa_pdf/14/b5/kjim-27-481.PMC3529254.pdf
"Erratum Korean J Intern Med 2012;27:483 http://dx.doi.org/10.3904/kjim.2012.27.4.483 pISSN 1226-3303    eISSN 2005-6648 http://www.kjim.org A Case of Green Urine after Ingestion of Herbicides Yun-Suk Shim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Soo-Hyun Kim, and Sae-Yong Hong Korean J Intern Med 2008;23:42-44. http://dx.doi.org/10.3904/kjim.2008.23.1.42 In this article, Table 1’s data was given incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/83/82/kjim-27-483.PMC3529255.pdf
"Copyright © 2012 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/82/kjim-27-483.PMC3529255.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/17/TODENTJ-6-190.PMC3529391.pdf
"This is an open access  article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/ac/TODENTJ-6-197.PMC3529396.pdf
"These digital images were processed via Roman v1.7 software (Roman software  version V1.70; Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, UK; http://www.cookedbits.co.uk/roma n/).",Non-OADS,/arxiv_data1/oa_pdf/ca/c3/TOORTHJ-6-593.PMC3529402.pdf
http://www.dmac.adelaide.edu.au/aoanjirr/pub  lications.jsp?section=reports2011 (date last accessed 19 June  2012).,Non-OADS,/arxiv_data1/oa_pdf/ca/c3/TOORTHJ-6-593.PMC3529402.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3445 | Page 1 of 7Video Article MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease Jörg Hanrieder1,2, Anna Ljungdahl1, Malin Andersson1 1Department of Pharmaceutical Biosciences, Uppsala University 2Department of Chemical and Biological Engineering, Chalmers University of Technology Correspondence to: Malin Andersson at malin.andersson@farmbio.uu.se URL: http://www.jove.com/video/3445 DOI: doi:10.3791/3445 Keywords: Medicine, Issue 60, Parkinson's disease, L-DOPA induced dyskinesia, striatum, opioid peptides, MALDI Imaging MS Date Published: 2/14/2012 Citation: Hanrieder, J., Ljungdahl, A., Andersson, M. MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease.",Non-OADS,/arxiv_data1/oa_pdf/b0/7e/jove-60-3445.PMC3529518.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/3445/ Protocol The protocol is adjusted for the purpose of statistical analysis of MALDI IMS data from multiple rat brain sections, typically 20-30 sections, and consists of five different steps comprising tissue preparation, matrix application, MALDI-TOF MS analysis, data evaluation, and neuropeptide identification.",Non-OADS,/arxiv_data1/oa_pdf/b0/7e/jove-60-3445.PMC3529518.pdf
Available from http://www.vicc.org/biostatistics/software.php (2012).,OADS,/arxiv_data1/oa_pdf/b0/7e/jove-60-3445.PMC3529518.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1161/ATVBAHA.108.17425 0 Anastasiadis, P.Z., S.Y.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1038/3502358 8 Antonetti, D.A., A.J.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1074/jbc.274.33.2346 3 Braga, V.M., L.M.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1083/jcb.137.6.142 1 Carramusa, L., C. Ballestrem, Y. Zilberman, and A.D. Bershadsky.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1242/jcs.01436 5 Cattelino, A., S. Liebner, R. Gallini, A. Zanetti, G. Balconi, A. Corsi, P. Bianco,  H. Wolburg, R. Moore, B. Oreda, et al.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1083/jcb.20021215 7 Dejana, E., E. Tournier-Lasserve, and B.M.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1016/j.devcel.2009.01.00 4 De Toledo, M., V. Coulon, S. Schmidt, P. Fort, and A. Blangy.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1038/sj.onc.120492 1 Dong, Q.G., S. Bernasconi, S. Lostaglio, R.W.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1161/01.ATV   .17.8.159 9 Döppler, H., P. Storz, J. Li, M.J. Comb, and A. Toker.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10   .1074/jbc.C40057520 0 Dow, L.E., and P.O.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/S0074-7696(07)62006- 3 Eiseler, T., H. Döppler, I.K.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1038/ncb186 1 Ernkvist, M., N. Luna Persson, S. Audebert, P. Lecine, I. Sinha, M. Liu, M.  Schlueter, A. Horowitz, K. Aase, T. Weide, et al.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1182/blood-2008-04-15387 4 Esser, S., M.G.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1111/j.1471-4159   .2008.05472. x Feng, Y., M.H.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10   .1073/pnas.060962810 4 Fischer, U.M., C.S.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
http://dx.doi.org/10.1080/0894193050044443 8the carotid vein.,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201207009/DC1.,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"168:705– 711. http://dx.doi.org/10.1083/jcb.20040806 4 Soto, E., M. Yanagisawa, L.A. Marlow, J.A.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1083/jcb.20080511 3 Spindler, V., N. Schlegel, and J. Waschke.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1093/cvr/cvq08 6 Straight, S.W., J.N.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1074/jbc.M60705920 0 Suri, C., P.F.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81813- 9 Takaishi, K., T. Sasaki, H. Kotani, H. Nishioka, and Y. Takai.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1083/jcb.139.4.104 7 Taylor, C.J., K. Motamed, and B. Lilly.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1007/s10456-006-9028- y Tepass, U.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1006/dbio.1996.015 7 Terry, S.J., C. Zihni, A. Elbediwy, E. Vitiello, I.V.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1038/ncb215 6 Thurston, G., C. Suri, K. Smith, J. McClain, T.N.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"6:460– 463. http://dx.doi.org/10.1038/7472 5 Tiruppathi, C., A.B.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1074/jbc.M40193020 0 Watanabe, N., T. Kato, A. Fujita, T. Ishizaki, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1038/1105 6 Weis, S.M., and D.A.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1038/nature0398 7 Wojciak-Stothard, B., and A.J.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1016/S1537-1891(03)00008- 9 Wong, C., and Z.G.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"280:33262– 33269. http://dx.doi.org/10.1074/jbc.M50319820 0 Xiao, K., D.F.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10   .1083/jcb.20030600 1 Yamana, N., Y. Arakawa, T. Nishino, K. Kurokawa, M. Tanji, R.E.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1128/MCB.00283-0 6Fukata, M., M. Nakagawa, and K. Kaibuchi.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/S0955-0674(03)00097- 8 Garnaas, M.K., K.L.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.108.18138 8 Gavard, J., V. Patel, and J.S.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.01 9 Ha, C.H., and Z.G.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1007/s10059-009-0109- 9 Hall, A.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1042/BST2005089 1 Huang, H., A. Bhat, G. Woodnutt, and R. Lappe.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1038/3505059 8 Jho, D., D. Mehta, G. Ahmmed, X.P.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1161/01.RES.0000171894.03801.0 3 Kamberov, E., O. Makarova, M. Roh, A. Liu, D. Karnak, S. Straight, and B.  Margolis.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi   .org/10.1074/jbc.275.15.1142 5 Katz, A.M. 2006.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/S0960-9822(99)00277- 8 Lee, S.S., B. Glaunsinger, F. Mantovani, L. Banks, and R.T. Javier.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1128/JVI.74.20.9680-9693.200 0 Liu, M., and A. Horowitz.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1091/mbc.E06-01-000 2 Mackow, E.R., and I.N.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
http://dx.doi.org/10.1111/j.1471-4159.2004.02930.,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1038/nrm191 1 Parikh, S.M., T. Mammoto, A. Schultz, H.T.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1371/journal.pmed.003004 6 Pedram, A., M. Razandi, and E.R.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1074/jbc.M20239120 0 Popoff, M.R., and B. Geny.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/10.1016/j.bbamem.2009.01.01 1 Qin, Y., C. Capaldo, B.M.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
"http://dx.doi.org/   10.1083/jcb.20050609 4 Roh, M.H., O. Makarova, C.J.",OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
http://dx.doi.org/   10.1083/jcb.20010901 0,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB_201207009.PMC3529520.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201205149/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi   .org/10.1093/nar/gkp124 7 Bergink, S., W. Toussaint, M.S.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/   10.1083/jcb.20110705 0 Bradsher, J., J. Auriol, L. Proietti de Santis, S. Iben, J.L.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/S1097-2765(02)00678- 0Cadet, J., T. Douki, and J.L.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi   .org/10.1016/j.mrfmmm.2011.02.00 4 Charlet-Berguerand, N., S. Feuerhahn, S.E.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1038/sj.emboj.760140 3 Citterio, E., V. Van Den Boom, G. Schnitzler, R. Kanaar, E. Bonte, R.E.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1038/sj.emboj.760127 7 Dianov, G., C. Bischoff, M. Sunesen, and V.A.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1093/nar/27.5.136 5 Dinant, C., M. de Jager, J. Essers, W.A.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1242/jcs.00452 3 Gorski, S.A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.04.02 1 Grummt, I., and A.G. Ladurner.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.cell   .2008.04.02 6 Hanawalt, P.C., and G. Spivak.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1038/nrm254 9 Hegde, M.L., T.K.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
http://dx.doi.org/10.1038/cr.2008.,Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/S1097-   2765(02)00709- 8 Hoogstraten, D., S. Bergink, J.M.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"121:2850– 2859. http://dx.doi.org/10.1242/jcs.03170 8 Houtsmuller, A.B., and W. Vermeulen.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.bbrc.2007.06.00 5 Katsumi, S., N. Kobayashi, K. Imoto, A. Nakagawa, Y. Yamashina, T.  Muramatsu, T. Shirai, S. Miyagawa, S. Sugiura, F. Hanaoka, et al.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
http://dx.doi.org/10.1046/j.0022-202x.2001.01540.,Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.dnarep.2008.11.00 6 Kirkali, G., N.C. de Souza-Pinto, P. Jaruga, V .A.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.dnarep.2008.09.00 9 Kitsera, N., D. Stathis, B. Lühnsdorf, H. Müller, T. Carell, B. Epe, and A.  Khobta.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1093/nar/gkr16 3 Lagerwerf, S., M.G.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.dnarep.2011.04.02 4 Lan, L., S. Nakajima, Y. Oohata, M. Takao, S. Okano, M. Masutani, S.H.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1021/bi002440 9 Saxowsky, T.T., K.L.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi .org/10.1073/pnas.080646410 5 Sedelnikova, O.A., C.E.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/   j.mrrev.2009.12.00 5 Shibutani, S., M. Takeshita, and A.P.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1038/349431a 0 Singh, S.K., M.W.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1093/nar/gkr27 5 Spivak, G., and P.C.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.dnarep.2005.06.01 7 Stevnsner, T., M. Muftuoglu, M.D.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1016/S1568-7864(02)00116- 7 van den Boom, V., E. Citterio, D. Hoogstraten, A. Zotter, J.M.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1083/   jcb.20040105 6 Volker, M., M.J. Moné, P. Karmakar, A. van Hoffen, W. Schul, W. Vermeulen,  J.H.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00281- 7 Will, O., E. Gocke, I. Eckert, I. Schulz, M. Pflaum, H.C. Mahler, and B. Epe.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1016/S0921-8777(99)00039- 7 Yuan, X., W. Feng, A. Imhof, I. Grummt, and Y. Zhou.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi   .org/10.1016/j.molcel.2007.06.02 1 Zharkov, D.O., T.A.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/   10.1074/jbc.M00244120 0Lipscomb, L.A., M.E.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/   10.1093/carcin/bgn25 0 Melis, J.P., S.W.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"68:1347– 1353. http://dx.doi.org/10.1158/0008-5472.CAN-07-606 7 Melis, J.P., M. Luijten, L.H.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.mrrev.2011.07.00 1 Menoni, H., D. Gasparutto, A. Hamiche, J. Cadet, S. Dimitrov, P .",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1128/MCB.00376-0 7 Menoni, H., M.S.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"40:692– 700. http://dx.doi.org/10.1093/nar/gkr76 1 Mori, T., M. Nakane, T. Hattori, T. Matsunaga, M. Ihara, and O. Nikaido.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
http://dx.doi.org/10.1111/j.1751-1097.1991.tb02010.,Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"8:81. http://dx.doi.org/   10.1186/1471-2199-8-8 1 Naegeli, H., and K. Sugasawa.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.dnarep.2011.04.01 9 Ng, J.M., W. Vermeulen, G.T.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1101/gad.26000 3 Oda, Y., S. Uesugi, M. Ikehara, S. Nishimura, Y. Kawase, H. Ishikawa, H. Inoue,  and E. Ohtsuka.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10   .1093/nar/19.7.140 7 Osterod, M., E. Larsen, F. Le Page, J.G.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1038/sj.onc.120602 7 Perry, R.P., and D.E.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1002/jcp.104076020 2 Politi, A., M.J. Moné, A.B.",Non-OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1016/j.molcel.2005.06.03 6 Rademakers, S., M. Volker, D. Hoogstraten, A.L.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
"http://dx.doi.org/10.1128/   MCB.23.16.5755-5767.200 3 Radicella, J.P., C. Dherin, C. Desmaze, M.S.",OADS,/arxiv_data1/oa_pdf/6e/b8/JCB_201205149.PMC3529521.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/   10.1084/jem.2005115 0 Bekker, P.J., and C.V .",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/   10.1002/jbmr.565005060 6 Berger, C.E., H. Rathod, J.I.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1359/jbmr.2001.16.11.209 2 Bhargava, A., R.S.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1210/   me.16.7.162 9 Boyle, W.J., W.S.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1038/nature0165 8 Brini, M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/   10.1007/s00424-008-0505- 6 Buch, M.H., A. Pickard, A. Rodriguez, S. Gillies, A.H. Maass, M. Emerson,  E.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1074/jbc   .M50132620 0 Cartwright, E.J., D. Oceandy, and L. Neyses.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1007/   s00424-008-0455- z Chami, M., D. Ferrari, P. Nicotera, P. Paterlini-Bréchot, and R. Rizzuto.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1074/jbc.M30420220 0 Chang, E.J., J. Ha, H. Huang, H.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1242/jcs.02821 7 Chang, E.J., J. Ha, F. Oerlemans, Y.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1038/nm.186 0 Clapham, D.E.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.11.02 8Osteoblast differentiation Calvarial cells were isolated from 1-d-old mice as described previously (Lee  et al., 2009).",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1038/sj.cdd.440214 5 Ryu, J., H.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760143 0 Salo, J., P. Lehenkari, M. Mulari, K. Metsikkö, and H.K.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1126/science.276.5310.27 0 Schuh, K., S. Uldrijan, M. Telkamp, N. Rothlein, and L. Neyses.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1083/jcb.20010413 1 Schuh, K., T. Quaschning, S. Knauer, K. Hu, S. Kocak, N. Roethlein, and L.  Neyses.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1074/jbc.M31259920 0 Sharma, S.M., A. Bronisz, R. Hu, K. Patel, K.C.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"282:15921– 15929. http://dx.doi.org/10.1074/jbc.M60972320 0 Shinohara, M., T. Koga, K. Okamoto, S. Sakaguchi, K. Arai, H. Yasuda, T.  Takai, T. Kodama, T. Morio, R.S.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1016/j.cell.2007.12.03 7 Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura,  M. Isobe, T. Yokochi, J. Inoue, et al.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1016/S1534-5807(02)00369- 6 van der Eerden, B.C., J.G.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.24.021605.09064 6 Yang, S., and Y.P.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1101/gad.154410 7 Yang, Y.M., M.S.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1359/jbmr.09042 0 Yoon, S.H., Y. Lee, H.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1016/j.febslet.2009.03.00 5Di Leva, F., T. Domi, L. Fedrizzi, D. Lim, and E. Carafoli.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1016/   j.abb.2008.02.02 6 Gatto, C., and M.A.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1021/bi00003a03 1 Ha, H., H.B.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1016/j.yexcr.2004.07.03 5 Ha, J., H.S.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.4049/jimmunol.090244 4 Kaneda, T., T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H.  Mano, M. Kumegawa, and Y. Hakeda.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1124/mol.107.03417 3 Kim, K., J.H.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1074/ jbc.M50581520 0 Kuroda, Y., C. Hisatsune, T. Nakamura, K. Matsuo, and K. Mikoshiba.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1182/blood-2007-03-08294 1 Lee, Y., J. Ha, H.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1074/ jbc.M109.04223 4 Lee, Y., H.J.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi   .org/10.1002/jbmr.156 1 Li, J.P., H. Kajiya, F. Okamoto, A. Nakao, T. Iwamoto, and K. Okabe.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1210/en.2006-132 1 Lorget, F., S. Kamel, R. Mentaverri, A. Wattel, M. Naassila, M. Maamer, and M.  Brazier.",Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1006/bbrc.2000.222 9 Moonga, B.S., R. Davidson, L. Sun, O.A.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1016/j.niox.2009.04.00 2 Nowycky, M.C., and A.P.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
"http://dx.doi.org/10.1242/jcs.0007 8 Okunade, G.W., M.L.",OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
http://dx.doi.org/10.1074/jbc.M40462820 0,Non-OADS,/arxiv_data1/oa_pdf/e6/8f/JCB_201204067.PMC3529522.pdf
http://dx.doi.org/10   .1083/jcb.201207150) show that the kinase Tao promotes  the endocytosis of the cell adhesion molecule Fasciclin 2  from the lateral surface of the cell and is critical for the  cuboidal to squamous cell shape transition.,OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"Data provided by the authors suggest Cell height: Tao rising Liang Cai1 and Keith E. Mostov2,3,4 1State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, Shanghai 200433, China 2Department of Anatomy, 3Department of Biochemistry and Biophysics, and 4Cardiovascular Research Institute, University of California, San Francisco,   San Francisco, CA 94143 © 2012 Cai and Mostov  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1016/j.dev cel  .2011.08.02 8 Gassama-Diagne, A., W. Yu, M. ter Beest, F. Martin-Belmonte, A. Kierbel, J.  Engel, and K. Mostov.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1038/ncb146 1 Gomez, J.M., Y. Wang, and V. Riechmann.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1126/science.318751 9 Hutchison, M., K.S.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1074/   jbc.273.44.2862 5 Lipschutz, J.H., W. Guo, L.E.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/   10.1074/jbc.M21321020 0 Liu, T., J.L.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1242/jcs.06872 6 Poon, C.L., J.I.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1016/j.devcel.2011   .09.01 2 Snow, P.M., K. Zinn, A.L.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1073/   pnas.85.14.529 1 Szafranski, P., and S. Goode.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
"http://dx.doi.org/10.1242/dev.0109 7 Widmann, T.J., and C. Dahmann.",OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
http://dx.doi.org/10.1242/   jcs.04427 1that none of these previously known functions is involved in  Fasciclin 2 endocytosis.,Non-OADS,/arxiv_data1/oa_pdf/af/2a/JCB_201211015.PMC3529524.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201209050/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1016/j.neuron   .2006.04.02 7 Callahan, M.K., M.S.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1189/jlb.090243 3 Conradt, B.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1146/ annurev.genet.42.110807.09153 3 Conradt, B., and D. Xue.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1073/   pnas.110271410 8 Ettinger, A.W., M. Wilsch-Bräuninger, A.M. Marzesco, M. Bickle, A. Lohmann,  Z. Maliga, J. Karbanová, D. Corbeil, A.A. Hyman, and W.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"2:503. http://dx.doi   .org/10.1038/ncomms151 1 Galluzzi, L., O. Kepp, C. Trojel-Hansen, and G. Kroemer.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1038/embor.2012.1 9 Glotzer, M. 2009.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1038/   nrm260 9 Hoopfer, E.D., T. McLaughlin, R.J. Watts, O. Schuldiner, D.D.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"50:883– 895. http://dx.doi.org/10.1016/j.neuron.2006.05.01 3 Hyman, B.T., and J. Yuan.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1038/nrn322 8 Kaitna, S., M. Mendoza, V. Jantsch-Plunger, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00721- 1 Kinchen, J.M., and K.S.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi   .org/10.1038/nrm251 5 Kuo, T.C., C.T.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi   .org/10.1038/ncb233 2out that midbody degradation was known to be associated  with human lysosomal storage disorders or mammalian cell  fate determination (Pohl and Jentsch, 2009; Ettinger et al.,  2011; Kuo et al., 2011; Schink and Stenmark, 2011).",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1083/jcb.20111105 3 Liu, B., H. Du, R. Rutkowski, A. Gartner, and X. Wang.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1126/science.122028 1 Logan, M.A., R. Hackett, J. Doherty, A. Sheehan, S.D.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"15:722– 730. http://dx.doi.org/10.1038/nn.306 6 MacDonald, J.M., M.G.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi   .org/10.1016/j.cub.2012.05.05 2 Mercer, J., and A. Helenius.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi   .org/10.1126/science.115516 4 Mullins, J.M., and J.J. Biesele.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1083/jcb.73.3.67 2 Ou, G., and R.D.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1083/jcb   .20081207 7 Ou, G., N. Stuurman, M. D’Ambrosio, and R.D.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1126/science.119611 2 Pohl, C., and S. Jentsch.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi   .org/10.1038/ncb181 3 Raich, W.B., A.N.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.04.00 8 Schink, K.O., and H. Stenmark.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1016/   j.cub.2011.10.03 5 Steigemann, P., and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/   10.1016/j.tcb.2009.07.00 8 Sulston, J.E., and H.R.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
"http://dx.doi.org/10.1016/0012-1606(83)90201- 4 Yang, D., N. Rismanchi, B. Renvoisé, J. Lippincott-Schwartz, C. Blackstone,  and J.H.",OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
15:1278– 1286. http://dx.doi.org/10.1038/nsmb.151 2,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/JCB_201209050.PMC3529525.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1242/jcs.00523 1 Backer, C.B., J.H.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1091/mbc.E11-11-093 1 Baker, S.A., K. Freeman, K. Luby-Phelps, G.J.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1074/jbc.M30015620 0 Banting, G., and S. Ponnambalam.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/   S0167-4889(96)00146- 2 Baron Gaillard, C.L., E. Pallesi-Pocachard, D. Massey-Harroche, F. Richard,  J.P. Arsanto, J.P. Chauvin, P. Lecine, H. Krämer, J.P. Borg, and A.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1091/mbc   .E11-05-040 5 Boehlke, C., M. Bashkurov, A. Buescher, T. Krick, A.K.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"123:1460– 1467. http://dx.doi.org/10.1242/jcs.05888 3 Burkhardt, J.K., C.J.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.139.2.46 9 Casenghi, M., P. Meraldi, U. Weinhart, P.I.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1016/S1534-5807(03)00193- X Chaki, M., R. Airik, A.K.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/   j.cell.2012.06.02 8 Cheeseman, I.M., and A. Desai.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1126/stke.2662005pl 1 Chen, C.H., S.L.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1016/S0006-291X(03)01510- 9 D’Angelo, A., and B. Franco.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"2:3. http://dx.doi.org/10.1186/1755-8417-2- 3 Dammermann, A., and A. Merdes.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.20020402 3 Deretic, D., and D.S.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.113.6.128 1 Fabbro, M., B.B.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
http://dx.doi.org/10.1016/j.devcel   .2005.09.00 3Yeast two-hybrid screen The yeast two-hybrid screening was performed using the Matchmaker  two-hybrid system 3 and a human testis cDNA library (Takara Bio Inc.).,OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201202126/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/S0014-5793(01)03290- 2 Mazelova, J., N. Ransom, L. Astuto-Gribble, M.C.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1242/jcs.03998 2 Mikule, K., B. Delaval, P. Kaldis, A. Jurcyzk, P. Hergert, and S. Doxsey.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1038/ncb152 9 Mogensen, M.M., A. Malik, M. Piel, V. Bouckson-Castaing, and M. Bornens.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/   10.1242/jcs.05951 9 Moreno-Borchart, A.C., and M. Knop.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1078/0944-5013-0019 4 Nachury, M.V.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.03.05 3 Nakamura, N., C. Rabouille, R. Watson, T. Nilsson, N. Hui, P. Slusarewicz,  T.E.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/   jcb.131.6.171 5 Nigg, E.A., and J.W.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/j.cell.2009.10.03 6 Pedersen, L.B., and J.L.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"85:23– 61. http://dx.doi.org/10.1016/S0070-2153(08)00802- 8 Pedersen, L.B., I.R.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/   10.1002/dvdy.2152 1 Peränen, J., P. Auvinen, H. Virta, R. Wepf, and K. Simons.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1083/jcb.135.1.15 3 Pfeifer, A.C., D. Kaschek, J. Bachmann, U. Klingmüller, and J. Timmer.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"4:106. http://dx.doi.org/10.1186/1752-0509-4-10 6 Rogers, K.K., P.D.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94004- V Shimoda, C. 2004.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/   10.1242/jcs.0098 0 Sillibourne, J.E., C.G.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.12.02 2 Sivasubramaniam, S., X.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"22:587– 600. http://dx.doi.org/10.1101/gad.162770 8 Sorokin, S. 1962.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1083/jcb.15.2.36 3 Sorokin, S.P.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/   10.1016/j.cell.2007.06.02 7Fliegauf, M., J. Horvath, C. von Schnakenburg, H. Olbrich, D. Müller, J. Thumfart,  B. Schermer, G.J.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1681/ASN.200512135 1 Ganesh, K., S. Adam, B. Taylor, P. Simpson, C. Rada, and M. Neuberger.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1074/jbc.M110.20876 9 Ghossoub, R., A. Molla-Herman, P. Bastin, and A. Benmerah.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1042/BC2010012 8 Graser, S., Y.D.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1083/jcb.20070718 1 Gromley, A., C. Yeaman, J. Rosa, S. Redick, C.T.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10   .1016/j.cell.2005.07.02 7 Guarguaglini, G., P.I.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1091/mbc.E04-   10-093 9 Haller, K., and S. Fabry.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1006/bbrc.1997.801 5 Hattula, K., and J. Peränen.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1016/S0076-6879   (05)03024- 7 Hehnly, H., C.T.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1681/ASN.200805045 6 Huber, L.A., S. Pimplikar, R.G.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.123.1.3 5 Ishikawa, H., A. Kubo, S. Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1038/ncb125 1 Jin, H., S.R.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"141:1208– 1219. http://dx.doi.org/10.1016/j.cell.2010.05.01 5 Jurczyk, A., A. Gromley, S. Redick, J. San Agustin, G. Witman, G.J.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb   .20040502 3 Kim, J., S.R.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1093/hmg/ddn27 7 Knödler, A., S. Feng, J. Zhang, X. Zhang, A. Das, J. Peränen, and W. Guo.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.147.5.96 9 Li, Y., and J. Hu.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
http://dx.doi   .org/10.1074/jbc.273.6.342 2,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi   .org/10.1016/0092-8674(91)90390- K Stephens, R.E.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1002/jez.101 5 Tasouri, E., and K.L.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1007/   s00441-011-1192- 8 Vaughan, K.T., and R.B.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.131.6.150 7 Westlake, C.J., L.M.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1074/jbc.M109.07095 3 Winkelbauer, M.E., J.C. Schafer, C.J.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1242/jcs.0266 5 Wolff, A., B. de Néchaud, D. Chillet, H. Mazarguil, E. Desbruyères, S. Audebert,  B. Eddé, F. Gros, and P. Denoulet.",Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1083/jcb.20070304 7 Yoshino, A., B.M.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
"http://dx.doi.org/10.1242/   jcs.0074 6 Zou, C., J. Li, Y. Bai, W.T.",OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
http://dx.doi.org/   10.1083/jcb.20050618 5,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/JCB_201202126.PMC3529528.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10   .1126/science.117732 1 Baumann, P., F.E.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81394- X Berkovich, E., R.J. Monnat Jr., and M.B.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/ncb159 9 Brunton, H., A.A. Goodarzi, A.T.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1128/MCB.05289-1 1 Chai, B., J. Huang, B.R.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1101/gad.127310 5 Chailleux, C., S. Tyteca, C. Papin, F. Boudsocq, N. Puget, C. Courilleau, M.  Grigoriev, Y. Canitrot, and D. Trouche.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1042/BJ2009132 9 Chou, D.M., B. Adamson, N.E.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10   .1073/pnas.101294610 7 Clapier, C.R., and B.R.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1146/   annurev.biochem.77.062706.15322 3 Downs, J.A., S. Allard, O. Jobin-Robitaille, A. Javaheri, A. Auger, N. Bouchard,  S.J.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.molcel.2004.12.00 3 Dumay, A., C. Laulier, P. Bertrand, Y. Saintigny, F. Lebrun, J.L.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/sj   .onc.120934 4 Fuchs, M., J. Gerber, R. Drapkin, S. Sif, T. Ikura, V. Ogryzko, W.S.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1016/S0092-8674(01)00450- 0 Gévry, N., H.M. Chan, L. Laflamme, D.M.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1101/gad.154570 7 Golub, E.I., O.V.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1093/nar/25.20.410 6 Gospodinov, A., T. Vaissiere, D.B.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"31:4735– 4745. http://dx.doi.org/10.1128/MCB.06182-1 1 Gottschalk, A.J., G. Timinszky, S.E.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/3507723 2 Iacovoni, J.S., P. Caron, I. Lassadi, E. Nicolas, L. Massip, D. Trouche, and G.  Legube.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"29:1446– 1457. http://dx.doi.org/10.1038/emboj.2010.3 8 Ikura, T., V.V.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)00051- 9 Ikura, T., S. Tashiro, A. Kakino, H. Shima, N. Jacob, R. Amunugama, K. Yoder,  S. Izumi, I. Kuraoka, K. Tanaka, et al.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
http://dx.doi.org/10.1128/MCB.00579-0 7Comet Tail Moment was scored for 100 cells/slide by using the Komet 6.0  (Andor Technology) software.,OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
Online supplemental material is avail - able online at http://www.jcb.org/cgi/content/full/jcb.201205059/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1083/jcb.20101102 5 Ahel, D., Z. Horejsí, N. Wiechens, S.E.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1101/gad.144020 6 Park, J.H., X.J.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1128/MCB.00804-0 9 Puget, N., M. Knowlton, and R. Scully.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"4:149– 161. http://dx.doi.org/10.1016/j.dnarep.2004.08.01 0 Rodrigue, A., M. Lafrance, M.C.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"25:222– 231. http://dx.doi.org/10.1038/sj.emboj.760091 4 Rogakou, E.P., C. Boon, C. Redon, and W.M.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1083/jcb.146.5.90 5 Ruhf, M.L., A. Braun, O. Papoulas, J.W.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1074/jbc.M41456420 0 Smeenk, G., W.W. Wiegant, H. Vrolijk, A.P.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1073/pnas.050421110 2 Symington, L.S., and J. Gautier.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1146/annurev-genet-110410-13243 5 Tsukuda, T., A.B.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/nature0414 8 Tyteca, S., M. Vandromme, G. Legube, M. Chevillard-Briet, and D. Trouche.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/sj.emboj.760106 6 Ueda, T., R. Watanabe-Fukunaga, H. Ogawa, H. Fukuyama, Y. Higashi, S.  Nagata, and R. Fukunaga.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
http://dx.doi.org/10.1111/j.1365-2443.2007.01080.,Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.cell.2004.11.03 3 van Attikum, H., O. Fritsch, and S.M.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/sj.emboj   .760183 5 Xie, A., A. Kwok, and R. Scully.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1038/nsmb.164 0 Xu, Y., Y.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1083/jcb.20100116 0 Ziv, Y., D. Bielopolski, Y. Galanty, C. Lukas, Y. Taya, D.C. Schultz, J. Lukas,  S. Bekker-Jensen, J. Bartek, and Y. Shiloh.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1038/ncb144 6Kalocsay, M., N.J. Hiller, and S. Jentsch.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.01.01 6 Kruhlak, M.J., A. Celeste, G. Dellaire, O. Fernandez-Capetillo, W.G.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1083/jcb.20051001 5 Kusch, T., L. Florens, W.H.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1126/science.110345 5 Lan, L., A. Ui, S. Nakajima, K. Hatakeyama, M. Hoshi, R. Watanabe, S.M.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.12.00 3 Larsen, D.H., C. Poinsignon, T. Gudjonsson, C. Dinant, M.R.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1083/jcb.20091213 5 Lee, H.S., J.H.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1038/emboj.2010.2 7 Llères, D., M. Denegri, M. Biggiogera, P. Ajuh, and A.I.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1038/embor.2010.6 4 Luijsterburg, M.S., and H. van Attikum.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"24:439– 447. http://dx.doi.org/10.1016/j.ceb.2012.03.00 8 Mailand, N., S. Bekker-Jensen, H. Faustrup, F. Melander, J. Bartek, C. Lukas,  and J. Lukas.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.04 0 Mattera, L., F. Escaffit, M.J. Pillaire, J. Selves, S. Tyteca, J.S.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1371/ journal.pgen.100098 3 Meyn, M.S.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1126/science.849357 7 Mizuguchi, G., X. Shen, J. Landry, W.H.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi   .org/10.1126/science.109070 1 Morrison, A.J., J. Highland, N.J. Krogan, A. Arbel-Eden, J.F.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1016/j.cell.2004.11.03 7 Murr, R., J.I.",OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"8:91– 99. http://dx.doi.org/10.1038/ncb134 3 Neumaier, T., J. Swenson, C. Pham, A. Polyzos, A.T.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1073/   pnas.111784910 8 Nievergall, E., P.W.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
"http://dx.doi.org/10.1128/MCB.01269-1 0 Papamichos-Chronakis, M., J.E.",Non-OADS,/arxiv_data1/oa_pdf/9d/c7/JCB_201205059.PMC3529529.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature1052 5 Bellis, J., I. Duluc, B. Romagnolo, C. Perret, M.C.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1083/jcb.20120408 6 Belmont, L.D., and T.J. Mitchison.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81037- 5 Bettencourt-Dias, M., F. Hildebrandt, D. Pellman, G. Woods, and S.A. Godinho.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"27:307– 315. http://dx.doi.org/10.1016/j.tig.2011.05.00 4 Bilgüvar, K., A.K.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature0932 7 Bogoyevitch, M.A., Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1242/jcs.10732 6 Bond, J., E. Roberts, G.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng99 5 Bond, J., E. Roberts, K. Springell, S.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng153 9 Bornens, M. 2012.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"335:422– 426. http://dx.doi.org/10.1126/science.120903 7 Borrell-Pagès, M., D. Zala, S. Humbert, and F. Saudou.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1007/s00018-006-6242- 0 Brito, D.A., S.M.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.01.00 3 Caldwell, C.M., R.A. Green, and K.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1083/jcb.20070318 6 Capalbo, L., P.P.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1073/pnas.110372010 8 Castanon, I., and M. González-Gaitán.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1016/j.ceb.2011.09.00 9 Castellanos, E., P. Dominguez, and C. Gonzalez.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.cub.2008.07.02 9 Caussinus, E., and C. Gonzalez.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng163 2 Chansard, M., J.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.04 8 Cizmecioglu, O., M. Arnold, R. Bahtz, F. Settele, L. Ehret, U. Haselmann-Weiss,  C. Antony, and I. Hoffmann.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1083/jcb.20100710 7 Clayton, E., D.P.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature0557 4 Cockell, M.M., K. Baumer, and P. Gönczy.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
http://dx.doi.org/10.1242/jcs.0134 4brains.,Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/sj.onc.121006 3 Al-Dosari, M.S., R. Shaheen, D. Colak, and F.S.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1016/j.ajhg.2011.04.00 3 Aplan, P.D., D.P.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1007/978-1-4419-1145-2_ 6 Bakircioglu, M., O.P.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.ajhg.2011.03.01 9 Barr, A.R., J.V.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
http://dx.doi.org/10.1083/jcb.20091216 3,Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.biocel.2011.03.00 9 Godin, J.D., K. Colombo, M. Molina-Calavita, G. Keryer, D. Zala, B.C.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.neuron.2010.06.02 7 Gönczy, P., J.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1016/S1534-5807(01)00046- 6 Green, R.A., and K.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"163:949– 961. http://dx.doi.org/10.1083/jcb.20030707 0 Gruber, R., Z. Zhou, M. Sukchev, T. Joerss, P.O.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb234 2 Guernsey, D.L., H. Jiang, J. Hussin, M. Arnold, K. Bouyakdan, S. Perry, T.  Babineau-Sturk, J. Beis, N. Dumas, S.C. Evans, et al.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.ajhg.2010.06.00 3 Gunawardena, S., L.S.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"100:57– 70. http://dx.doi.org/10.1016/S0092-8674(00)81683- 9 Hansen, D.V., J.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature0884 5 Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1093/emboj/18.21.593 1 Haydar, T.F., E. Ang Jr., and P. Rakic.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1038/ncb89 9 Higgins, J., C. Midgley, A.M. Bergh, S.M.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"11:85. http://dx.doi.org/10.1186/1471-2121-11-8 5 Hollander, M.C., G.M.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nrc303 7 Hsu, T. 2012.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/onc.2011.44 2 Huang, J., A.J.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1016/ j.cell.2012.07.02 2 Huttner, W.B., and M. Brand.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1016/S0959-4388(97)80117- 1 Jackson, A.P., H. Eastwood, S.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10 .1086/   34128 3 Kaelin, W.G.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1038/nrc250 2 Kalay, E., G. Yigit, Y. Aslan, K.E.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1007/s00427010017 6 Delaval, B., A.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb220 2 des Portes, V., J.M.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80898- 3 Doherty, D., A.E.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.ajhg.2012.04.00 8 Driessens, G., B. Beck, A. Caauwe, B.D.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"488:527– 530. http://dx.doi.org/10.1038/nature1134 4 Du, Q., P.T.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb1201-106 9 Duchek, P., K. Somogyi, G. Jékely, S. Beccari, and P. Rørth.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00502- 5 Duchi, S., L. Fagnocchi, V. Cavaliere, A. Hsouna, G. Gargiulo, and T. Hsu.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1242/dev.04280 4 Faulkner, N.E., D.L.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/3504102 0 Feng, Y., and C.A.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.neuron.2004.09.02 3 Ferrara, N. 2002.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/S0093-7754(02)70064- X Fietz, S.A., I. Kelava, J. Vogt, M. Wilsch-Bräuninger, D. Stenzel, J.L.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1038/nn.255 3 Fischer, E., E. Legue, A. Doyen, F. Nato, J.F.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng170 1 Fish, J.L., Y. Kosodo, W. Enard, S. Pääbo, and W.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1073/pnas.060406610 3 Fleming, E.S., M. Zajac, D.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1369/jhc.7A7234.200 7 Fleming, E.S., M. Temchin, Q. Wu, L. Maggio-Price, and J.S.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1002/mc.2050 6 Fodde, R., and R. Smits.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/ S1471-   4914(01)02050- 0 Frew, I.J., and W. Krek.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.ceb.2007.10.00 1 Frew, I.J., C.R.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/emboj.2008.9 6 Fridolfsson, H.N., N. Ly, M. Meyerzon, and D.A.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.ydbio.2009.12.00 4 Gleeson, J.G., K.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
http://dx.doi.org/10.1016/S0092-8674(00)80899- 5,OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1038/3507012 3 Kataoka, N., M.D.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"20:6424– 6433. http://dx.doi.org/10.1093/emboj/20.22.642 4 Kitagawa, D., G. Kohlmaier, D. Keller, P. Strnad, F.R.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1242/jcs.08988 8 Kolano, A., S. Brunet, A.D.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb167 3 Kosodo, Y., K. Röper, W. Haubensak, A.M. Marzesco, D. Corbeil, and W.B.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/sj.emboj.760022 3 Kosodo, Y., K. Toida, V. Dubreuil, P. Alexandre, J. Schenk, E. Kiyokage, A.  Attardo, F. Mora-Bermúdez, T. Arii, J.D.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/   emboj.2008.22 7 Kouprina, N., A. Pavlicek, N.K.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1093/hmg/ddi22 0 Kumar, A., S.C. Girimaji, M.R.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1016/j.ajhg.2009.01.01 7 Le Hir, H., and G.R.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1016/j.sbi.2007.11.00 2 Lechler, T., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1016/j.devcel.2005.08.00 4 Lesage, B., I. Gutierrez, E. Martí, and C. Gonzalez.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.gde.2010.04.01 3 Li, W., R. Boswell, and W.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1006/dbio.1999.959 3 Lin, S.Y., H.W.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-07-526 2 Lizarraga, S.B., S.P.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1242/dev.04041 0 Lo Nigro, C., C.S.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1093/hmg/6.2.15 7 Lobo, N.A., Y. Shimono, D. Qian, and M.F.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1146/annurev.cellbio.22.010305.10415 4 Löffler, H., A. Fechter, M. Matuszewska, R. Saffrich, M. Mistrik, J. Marhold,  C. Hornung, F. Westermann, J. Bartek, and A. Krämer.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-268 4 Lorson, M.A., H.R.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1083/jcb.148.1.7 3Magee, J.A., E. Piskounova, and S.J.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1016/j.ccr.2012.03.00 3 McAllister, S.S., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1200/   JCO.2010.28.425 7 McCartney, B.M., and I.S.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.ceb.2008.02.00 1 McCartney, B.M., D.G.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1038/ncb1001-93 3 McKenney, R.J., M. Vershinin, A. Kunwar, R.B.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.03 5 Megraw, T.L., J.T.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"21:470– 480. http://dx.doi.org/10.1016/j.tcb.2011.04.00 7 Minde, D.P., Z. Anvarian, S.G. Rüdiger, and M.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"10:101. http://dx.doi.org/10.1186/   1476-4598-10-10 1 Mizumoto, K., and H. Sawa.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.tcb.2007.08.00 4 Morin, X., and Y. Bellaïche.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"21:102– 119. http://dx.doi.org/10.1016/j.devcel.2011.06.01 2 Morrison, S.J., and J. Kimble.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1038/nature0495 6 Näthke, I.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1038/nrc201 0 Nicholas, A.K., M. Khurshid, J. Désir, O.P.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng.68 2 Noctor, S.C., V. Martínez-Cerdeño, and A.R.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1002/cne.2166 9 Ogg, S., and G. Ruvkun.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"2:887– 893. http://dx.doi.org/10.1016/S1097-2765(00)80303- 2 Palacios, I.M.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   S0960-9822(01)00671- 6 Pease, J.C., and J.S.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi   .org/10.1242/jcs.08140 6 Peyre, E., and X. Morin.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.neuron   .2011.09.02 2 Pramparo, T., Y.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4851-09.201 0 Pulvers, J.N., J. Bryk, J.L.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.stem.2009.12.00 7 Radulescu, A.E., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.tcb   .2010.01.00 3 Reiner, O., R. Carrozzo, Y. Shen, M. Wehnert, F. Faustinella, W.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/364717a 0 Reya, T., and H. Clevers.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature0331 9 Rusan, N.M., K. Akong, and M. Peifer.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1083/jcb.20080707 9 Sanada, K., and L.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.00 9 Saunders, R.D., M.C.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1083/jcb.137.4.88 1 Schubart, U.K., J. Yu, J.A.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"271:14062– 14066. http://dx.doi.org/10.1074/jbc.271.24.1406 2 Shitamukai, A., and F. Matsuzaki.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2005.08.03 8 Siller, K.H., and C.Q.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1016/j.ydbio.2008.03.01 8 Siller, K.H., and C.Q.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb0409-36 5 Silver, D.L., D.E.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"13:551– 558. http://dx.doi.org/10.1038/nn.252 7 Sir, J.H., A.R.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng.97 1 Sitohy, B., J.A.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-11-340 6 Smith, D.S., M. Niethammer, R. Ayala, Y. Zhou, M.J. Gambello, A. Wynshaw- Boris, and L.H.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"2:767– 775. http://dx.doi.org/10.1038/3504100 0 Smith, E., D. Dejsuphong, A. Balestrini, M. Hampel, C. Lenz, S. Takeda, A.  Vindigni, and V. Costanzo.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb183 5 Snippert, H.J., L.G.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2010.09.01 6 Srinivasan, D.G., R.M.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1101/gad.108120 3 Stocker, H., and E. Hafen.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/S0959-437X(00)00123- 4 Su, L.K., M. Burrell, D.E.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.ccr.2011.08.01 1 Swan, A., T. Nguyen, and B. Suter.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/1568 0 Tarsitano, M., S. De Falco, V. Colonna, J.D.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
http://dx.doi.org/10.1096/fj.05-4147co m The Huntington’s Disease Collaborative Research Group.,Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   0092-8674(93)90585- E Thoma, C.R., I.J.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1038/ncb157 9 Thoma, C.R., A. Toso, K.L.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/   j.tig.2009.09.01 1 Tighe, A., V.L.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1242/jcs.0155 6 Toyoshima, F., S. Matsumura, H. Morimoto, M. Mitsushima, and E. Nishida.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.01 4 van der Voet, M., C.W.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ncb183 4 Varmark, H. 2004.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1002/   jcb.2001 3 von Stein, W., A. Ramrath, A. Grimm, M. Müller-Borg, and A. Wodarz.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1242/dev.0172 0 Wainman, A., J. Creque, B. Williams, E.V.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1242/jcs.04179 8 Walsh, T., H. Shahin, T. Elkan-Miller, M.K.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1016/j.ajhg.2010.05.01 0 Wang, C., S. Li, J. Januschke, F. Rossi, Y. Izumi, G. Garcia-Alvarez, S.S. Gwee,  S.B.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"21:520– 533. http://dx.doi.org/10.1016/j.devcel.2011.08.00 2 Weaver, B.A., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10   .1083/jcb.20090509 8 Wells, R.A., C. Catzavelos, and S. Kamel-Reid.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng0997-10 9 Williams, S.E., S. Beronja, H.A.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/nature0979 3 Wynshaw-Boris, A., T. Pramparo, Y.H.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/   10.1016/j.semcdb.2010.07.00 8 Yamashita, Y.M., D.L.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1126/science.108779 5 Yingling, J., Y.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1016/j.cell.2008.01.02 6 Yu, T.W., G.H.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
"http://dx.doi.org/10.1038/ng.68 3 Zheng, Z., H. Zhu, Q. Wan, J. Liu, Z. Xiao, D.P.",OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
http://dx.doi.org/10.1083/jcb   .20091002 1,Non-OADS,/arxiv_data1/oa_pdf/58/aa/JCB_201209015.PMC3529530.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1083/jcb.20100914 1 Boggiano, J.C., P.J.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j   .devcel.2011.08.02 8 Clark, I.E., L.Y.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/   j.ydbio.2009.11.02 7 Georgiou, M., E. Marinari, J.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10   .1016/j.cub.2008.09.02 9 Grammont, M. 2007.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/0092-   8674(91)90571- F Gupta, T., and T. Schüpbach.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1242/dev.0081 7 Harris, T.J. 2012.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/   B978-0-12-394304-0.00007- 5 Harris, T.J., and U. Tepass.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10   .1038/nrm292 7 Horne-Badovinac, S., and D. Bilder.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi   .org/10.1002/dvdy.2028 6 Hutchison, M., K.S.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1074/   jbc.273.44.2862 5 King, I., L.T.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1083/jcb.20070515 4 Kolahi, K.S., P.F.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10   .1016/j.ydbio.2009.04.02 8 Laprise, P., and U. Tepass.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
http://dx.doi.org/10   .1016/j.tcb.2011.03.00 5was calculated between each Taoeta + RNAi and RNAi only counterpart.,OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201207150/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1038/   3501710 1 Wang, Y., and V. Riechmann.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j.cub.2007.06.06 7 Xu, T., and G.M.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.08.02 0 Zarnescu, D.C., and G.H.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1083/jcb.146.5.107 5Leibfried, A., R. Fricke, M.J. Morgan, S. Bogdan, and Y. Bellaiche.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j.cub.2008.09.06 3 Levayer, R., and T. Lecuit.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi   .org/10.1016/j.tcb.2011.10.00 1 Liu, T., J.L.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1242/jcs.06872 6 López-Schier, H., and D. St Johnston.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi   .org/10.1101/gad.20090 1 Lu, H., and D. Bilder.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/   10.1038/ncb132 4 Meignin, C., I. Alvarez-Garcia, I. Davis, and I.M.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi   .org/10.1016/j.cub.2007.09.06 2 Müller, H.A.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1002/(SICI)1097- 0177(200005)218:1<52::AID-DVDY5>3.0.CO;2- L Olivieri, D., M.M.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1038/emboj.2010.21 2 Parks, A.L., K.R.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10   .1038/ng131 2 Polesello, C., and N. Tapon.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j.cub.2007.09.04 9 Poon, C.L., J.I.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j   .devcel.2011.09.01 2 Pope, K.L., and T.J. Harris.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1242/dev.01980 2 Raman, M., S. Earnest, K. Zhang, Y. Zhao, and M.H.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1038/sj.emboj.760166 8 Riechmann, V., and A. Ephrussi.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1242/dev.0151 5 Sato, K., Y. Hayashi, Y. Ninomiya, S. Shigenobu, K. Arita, M. Mukai, and S.  Kobayashi.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1038/nn.265 6 St Johnston, D., and B. Sanson.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"http://dx.doi.org/10.1016/j.ceb   .2011.07.00 5 Suzanne, M., K. Irie, B. Glise, F. Agnès, E. Mori, K. Matsumoto, and S. Noselli.",OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
"131:2023– 2036. http://dx.doi.org/10.1242/dev.0109 7 Tanentzapf, G., C. Smith, J. McGlade, and U. Tepass.",Non-OADS,/arxiv_data1/oa_pdf/a2/fb/JCB_201207150.PMC3529531.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1083/jcb.20070316 6 Cooper, A.A., and T.H.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1091/mbc.E11-09-082 6 Dancourt, J., and C. Barlowe.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10   .1146/annurev-biochem-061608-09131 9 Feng, M., D.M.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1016/j.cell.2010.08.04 0 Honoré, B.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/   10.1016/S0014-5793(99)01780- 9 Jin, L., K.B.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1038/nature1082 2 Kamiya, Y., D. Kamiya, K. Yamamoto, B. Nyfeler, H.-P. Hauri, and K. Kato.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1146/annurev.cb.05.110189.00241 1 Lam, P.P.L., K. Hyvärinen, M. Kauppi, L. Cosen-Binker, S. Laitinen, S. Keränen,  H.Y .",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1091/ mbc.E06-10-095 0 Le Borgne, R., and B. Hoflack.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1083/jcb.137.2.33 5 Lissandron, V., P. Podini, P. Pizzo, and T. Pozzan.",Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1083/jcb.20020807 4 Mellman, I., and W.J.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1016/0092-   8674(87)90086- 9 Nichols, W.C., U. Seligsohn, A. Zivelin, V .H.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81146- 0 Nyfeler, B., B. Zhang, D. Ginsburg, R.J. Kaufman, and H.-P. Hauri.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
http://dx.doi.org/10.1111/j.1600-0854.2006.00483.,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1038/ncb119 5 Pfeffer, S.R.",Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1101/cshperspect.a00527 2 Reitman, M.L., and S. Kornfeld.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.12.02 5applying a 3,000-D molecular mass cut-off spin column (EMD Millipore).",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201207180/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1038/nature0437 7 Belden, W.J., and C. Barlowe.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
http://dx.doi.org/10.1126/science.106522 4,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1083/   jcb.133.2.25 7 Sepúlveda, M.R., J. Vanoevelen, L. Raeymaekers, A.M. Mata, and F. Wuytack.",Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2014-09   .2009 Sorin, A., G. Rosas, and R. Rao.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi   .org/10.1074/jbc.272.15.989 5 Townsley, F.M., D.W. Wilson, and H.R.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1083/jcb.20090804 0 von Blume, J., A.M. Alleaume, G. Cantero-Recasens, A. Curwin, A. Carreras- Sureda, T. Zimmermann, J. van Galen, Y. Wakana, M.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi   .org/10.1016/j.devcel.2011.03.01 4 Whyte, J.R., and S. Munro.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)   00273- 1 Wilson, D.G., K. Phamluong, L. Li, M. Sun, T.C.",OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
http://dx.doi.org/10.1083/jcb.20100716 2,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/JCB_201207180.PMC3529532.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201208080/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1097/01   .mpa.0000240608.56806.0 a Alessi, D.R., K. Sakamoto, and J.R. Bayascas.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1146/ annurev.biochem.75.103004.14270 2 Amin, N., A. Khan, D. St Johnston, I. Tomlinson, S. Martin, J. Brenman, and  H. McNeill.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00114- X Bardeesy, N., M. Sinha, A.F.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10   .1038/nature0104 5 Barnes, A.P., B.N.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1016/j.cell.2007.03.02 5 Bishop, A.C., J.A.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/3503014 8 Cardoso, W.V., A. Itoh, H. Nogawa, I. Mason, and J.S.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2- X Cheng, H., P. Liu, Z.C.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1126/scisignal.200036 9 Contreras, C.M., S. Gurumurthy, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
http://dx.doi.org/10.1158/0008- 5472.CAN-07-501 4Live imaging Explants cultured on the transwell filters could be directly imaged using  conventional phase and fluorescence microscopy.,OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nature0582 8 Leung, C.T., and J.S.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nature1082 6 Lizcano, J.M., O. Göransson, R. Toth, M. Deak, N.A.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760011 0 Löhr, M., G. Klöppel, P. Maisonneuve, A.B.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1593/neo.0444 5 Martin, S.G., and D. St Johnston.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nature0129 6 McCarthy, A., C.J.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1002/path.259 9 Mehenni, H., N. Resta, J.G.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"55:984– 990. http://dx.doi.org/10.1136/gut.2005.08299 0 Metzger, R.J., O.D.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1083/jcb.20070205 3 Miyoshi, H., M. Nakau, T.O.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1053/j.gastro.2010.04.05 5 Muthuswamy, S.K., and B. Xue.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1146/annurev-cellbio-092910-15424 4 Nogawa, H., and T. Ito.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-11-041 2 Partanen, J.I., T.A.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-516 9 Puri, S., and M. Hebrok.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/   10.1016/j.ydbio.2007.03.00 3 Rossi, D.J., A. Ylikorkala, N. Korsisaari, R. Salovaara, K. Luukko, V. Launonen,  M. Henkemeyer, A. Ristimaki, L.A. Aaltonen, and T.P.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1073/pnas.19230139 9 Saadat, I., H. Higashi, C. Obuse, M. Umeda, N. Murata-Kamiya, Y. Saito, H. Lu,  N. Ohnishi, T. Azuma, A. Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nature0576 5 Sahin, F., A. Maitra, P. Argani, N. Sato, N. Maehara, E. Montgomery, M.  Goggins, R.H. Hruban, and G.H.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1097/01.MP.0000075645.97329.8 6 Sanchez-Cespedes, M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10   .1038/sj.onc.121059 4Francis, S.S., J. Sfakianos, B.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/   10.1083/jcb.20100900 1 Fu, D., Y. Wakabayashi, J. Lippincott-Schwartz, and I.M.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1074/jbc   .M70653620 0 Hawley, S.A., J. Boudeau, J.L.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"2:28. http://dx.doi   .org/10.1186/1475-4924-2-2 8 Hearle, N., V. Schumacher, F.H.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"391:184– 187. http://dx.doi.org/10.1038/3443 2 Hezel, A.F., S. Gurumurthy, Z. Granot, A. Swisa, G.C.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"28:2414– 2425. http://dx.doi.org/10.1128/MCB.01621-0 7 Hingorani, S.R., E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10   .1016/S1535-6108(03)00309- X Holland, A.M., S.J.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1002/dvg.2021 4 Hruban, R.H., N.V. Adsay, J. Albores-Saavedra, C. Compton, E.S.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"25:579– 586. http://dx.doi.org/10.1097/00000478-200105000-0000 3 Hruban, R.H., N.V. Adsay, J. Albores-Saavedra, M.R.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-216 8 Huang, X., S. Wullschleger, N. Shpiro, V.A.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1042/BJ2008055 7 Jeghers, H., V.A.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1056/NEJM19491229241260 1 Jenne, D.E., H. Reimann, J. Nezu, W. Friedel, S. Loff, R. Jeschke, O. Müller,  W. Back, and M. Zimmer.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nature0603 0 Jishage, K., J. Nezu, Y. Kawase, T. Iwata, M. Watanabe, A. Miyoshi, A. Ose, K.  Habu, T. Kake, N. Kamada, et al.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/ng.9 8 Kemphues, K.J., J.R. Priess, D.G.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1016/S0092-8674(88)80024- 2 Kure, S., Y. Matsuda, M. Hagio, J. Ueda, Z. Naito, and T. Ishiwata.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1074/jbc   .M70654320 0 Shaw, R.J., M. Kosmatka, N. Bardeesy, R.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/   10.1073/pnas.030806110 0 Shorning, B.Y., J. Zabkiewicz, A. McCarthy, H.B.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1371/journal.pone.000426 4 ten Klooster, J.P., M. Jansen, J. Yuan, V. Oorschot, H. Begthel, V. Di Giacomo,  F. Colland, J. de Koning, M.M.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.01.01 6 van der Velden, Y.U., L. Wang, J. Zevenhoven, E. van Rooijen, M. van  Lohuizen, R.H. Giles, H. Clevers, and A.P.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1073/pnas.101021010 8 Villasenor, A., D.C. Chong, M. Henkemeyer, and O. Cleaver.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1242/dev.05299 3 Warming, S., N. Costantino, D.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1093/nar/gni03 5 Watts, J.L., D.G.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1042/BJ2010172 1 Ylikorkala, A., D.J.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi   .org/10.1126/science.106207 4 Zagórska, A., M. Deak, D.G.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1126/scisignal.200061 6 Zeng, P.Y., and S.L.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"66:10701– 10708. http://dx.doi.org/10.1158/0008-5472.CAN-06-099 9 Zhang, C., D.M.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
"http://dx.doi.org/10.1038/nmeth76 4 Zhang, L., J. Li, L.H.",OADS,/arxiv_data1/oa_pdf/ef/e9/JCB_201208080.PMC3529533.pdf
http://dx.doi.org/10.1371/journal.pone .0030030 .,Non-OADS,/arxiv_data1/oa_pdf/66/8f/mBio.00220-12.PMC3529541.pdf
7:311. http://dx.doi.org/10.1186 /1743-422X-7-311 .,Non-OADS,/arxiv_data1/oa_pdf/66/8f/mBio.00220-12.PMC3529541.pdf
http://dx.doi.org/10.1371/journal.pone.0024429 .,Non-OADS,/arxiv_data1/oa_pdf/66/8f/mBio.00220-12.PMC3529541.pdf
http://dx.doi.org/10 .1371/journal.pone.0031240 .,Non-OADS,/arxiv_data1/oa_pdf/66/8f/mBio.00220-12.PMC3529541.pdf
(http://speciateIT.sourceforge.net ).,OADS,/arxiv_data1/oa_pdf/52/58/mBio.00370-12.PMC3529542.pdf
"We recently discovered ﬁve new bactobolins (D toH) and a cluster of genes involved in bactobolin biosynthesis (thegenes are BTH_II1222 to BTH_II1242 from genomic coordinates1445675 to 1482269; see http://www.burkholderia.com ), which is reasonably well conserved in the related species Burkholderia pseu- domallei (2, 3, 6).",Non-OADS,/arxiv_data1/oa_pdf/eb/12/mBio.00499-12.PMC3529544.pdf
Amino acid sequences of selected L2 pro- teins were obtained from the Integrated Microbial Genome Database(http://img.jgi.doe.gov/cgi-bin/w/main.cgi ) and aligned using the soft- ware tool Clustal Omega ( http://www.ebi.ac.uk/Tools/msa/clustalo/ ) with default settings.,OADS,/arxiv_data1/oa_pdf/eb/12/mBio.00499-12.PMC3529544.pdf
http://dx.doi.org/10.1371/journal .pone.0036507 .,Non-OADS,/arxiv_data1/oa_pdf/eb/12/mBio.00499-12.PMC3529544.pdf
"http://www.ninds.nih.gov/disorders/gbs/detail_gbs.htm?css =print (accessed April 22, 2012 ).",OADS,/arxiv_data1/oa_pdf/64/04/crn-0004-0137.PMC3529579.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ www.jidonline.org 459F Oliveira et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/df/jid2012315a.PMC3529997.pdf
"Jamison, D. et al (eds) (2012) Disease control priorities in developing countries – NCBI bookshelf, http://www.ncbi.nlm.nih.gov/books/NBK11728/, accessed 15 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"(2012) Emergency medical services – Disease control priorities in develop- ing countries – NCBI bookshelf, http://www.ncbi.nlm.nih.gov/books/NBK11744/, accessed 15 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"Geneva, Switzerland: World Health Organization, http://www.who .int/gb/ebwha/pdf_files/WHA60/A60_R22-en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"WHO , http://www.who.int/heli/risks/urban/transpdirectory/en/ index6.html, accessed 15 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"(2011) Tanzania Demographic and Health Survey 2010 , Dar es Salaam, Tanzania, 2010, http://www.measuredhs.com/publica- tions/publication-fr243-dhs-final-reports.cfm, accessed 2 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"(2012) UNICEF – Tanzania, United Republic of – statistics, http://www.unicef.org/infobycountry/tanzania_statistics.html, accessed 2 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
"General Health Statistical Profile , http://www.who.int/healthinfo/ global_burden_disease/estimates_country/en/index.html, accessed 18 October 2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/86/jphp201241a.PMC3530028.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/35/b1/NMJ-53-1.PMC3530236.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/35/b1/NMJ-53-1.PMC3530236.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/60/2c/NMJ-53-21.PMC3530239.pdf
Available from: http://www.faqs.org/periodicals/201003/1973238791.html.,Non-OADS,/arxiv_data1/oa_pdf/a1/c3/NMJ-53-31.PMC3530241.pdf
Available from: http://www.worldbank.org.,Non-OADS,/arxiv_data1/oa_pdf/36/0f/NMJ-53-47.PMC3530244.pdf
Available from: http://www.isn.org.,Non-OADS,/arxiv_data1/oa_pdf/36/0f/NMJ-53-47.PMC3530244.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/36/0f/NMJ-53-47.PMC3530244.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/4c/0e/NMJ-53-51.PMC3530245.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/52/59/NMJ-53-9.PMC3530246.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c6/35/NMJ-53-105.PMC3530248.pdf
Available from: http://www.cdc.gov/ncidod/ dhqp/pdf/Scott_CostPaper.pdf.,OADS,/arxiv_data1/oa_pdf/e0/2e/NMJ-53-59.PMC3530249.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d9/d4/NMJ-53-80.PMC3530253.pdf
"(Reproduced with permission  from Dr. A. K. Vats, http://dizziness.webs.com/bppv.htm.)",Non-OADS,/arxiv_data1/oa_pdf/cb/dd/NMJ-53-94.PMC3530256.pdf
Available from:  http://www.who.int/hiv/data/global_data/en/index.html .,OADS,/arxiv_data1/oa_pdf/37/6d/IJPVM-3-824.PMC3530299.pdf
Available from: http://www.emro.who.int/asd/ hivsituation_countryprofiles.htm.,Non-OADS,/arxiv_data1/oa_pdf/37/6d/IJPVM-3-824.PMC3530299.pdf
Available  from: http://www.siteresources.worldbank.org/ INTSAREGTOPHIV AIDS/Resources/HIV-AIDS-brief- August06-PKA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/6d/IJPVM-3-824.PMC3530299.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/37/6d/IJPVM-3-824.PMC3530299.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/37/6d/IJPVM-3-824.PMC3530299.pdf
Available from: http://www.roche.com/pages/facets/3/ diabetes_2.jpg.,Non-OADS,/arxiv_data1/oa_pdf/9f/6b/IJPVM-3-827.PMC3530300.pdf
Available from: http://apps.who.int/ medicinedocs/pdf/s2218e/s2218e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/b3/IJPVM-3-839.PMC3530301.pdf
2009 Available  from: http://www.amar.org.ir/esfahan/default-3188.,Non-OADS,/arxiv_data1/oa_pdf/ea/32/IJPVM-3-867.PMC3530305.pdf
Available from: http://www.who.int/whosis/whostat/ EN_WHS09_Full.pdf [Last accessed on 2010 Jun 15].,OADS,/arxiv_data1/oa_pdf/d4/97/IJPVM-3-875.PMC3530306.pdf
Available from: http://www.unicef.org/ sowc07/docs/sowc07_execsummary.pdf [Last accessed  on 2012 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/d4/97/IJPVM-3-875.PMC3530306.pdf
Available from: http://www.who.int/whosis/whostat/ EN_WHS10_Full.pdf [Last accessed on 2010 Aug 10].,OADS,/arxiv_data1/oa_pdf/d4/97/IJPVM-3-875.PMC3530306.pdf
Available from: http://www.who.int/whosis/whostat/ EN_WHS09_Full.pdf [Last accessed on 2010 Jun 20].,OADS,/arxiv_data1/oa_pdf/d4/97/IJPVM-3-875.PMC3530306.pdf
Available from: http://www.who.int/whosis/whostat/ EN_WHS09_Full.pdf [Last accessed on 2010 Jun 15].,OADS,/arxiv_data1/oa_pdf/d4/97/IJPVM-3-875.PMC3530306.pdf
Available from: http://www.nidm.gov.in/PDF/policies/ndm_policy2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/58/IJPVM-3-902.PMC3530312.pdf
Available from:  http://www.adpc.net/audmp/rllw/themes/gen-in.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/58/IJPVM-3-902.PMC3530312.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/NAJMS-4-619.PMC3530316.pdf
Available from: http://www.sajpc.org/ vol9/vol9_2/highprevalenceofcoronaryheartdisease.htm.,Non-OADS,/arxiv_data1/oa_pdf/c3/d8/NAJMS-4-630.PMC3530318.pdf
Available  from: http://news.bbc.co.uk/2/hi/south_asia/8557215.stm.,Non-OADS,/arxiv_data1/oa_pdf/c3/d8/NAJMS-4-630.PMC3530318.pdf
http://www.cadiresearch.org/?page_ id=398.,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/NAJMS-4-636.PMC3530319.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/3a/83/NAJMS-4-638.PMC3530320.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/3a/83/NAJMS-4-638.PMC3530320.pdf
Access this article online Quick Response Code: Website:    www.najms.org DOI:    10.4103/1947-2714.104316 Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/26/d5/NAJMS-4-641.PMC3530321.pdf
"Design the oligonucleotide primers  according the published coding sequence (CDs) of the gene on NCBI (http://www.ncbi.nlm.nih.gov/ pubmed/), and add the indicated restriction enzyme  sites in the primers.",Non-OADS,/arxiv_data1/oa_pdf/c1/6f/NAJMS-4-651.PMC3530323.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/c1/6f/NAJMS-4-651.PMC3530323.pdf
Available from: http://www.ekantipur.com/2007   /10/28/top‑story/ diarrhoea‑claims‑3‑more‑lives‑leaves‑   dozens‑affected /126654.,Non-OADS,/arxiv_data1/oa_pdf/2f/be/NAJMS-4-657.PMC3530325.pdf
Available from: http://www.cdc.gov/cholera/pdf/ laboratory‑methods‑for‑the‑diagnosis‑of‑vibrio‑cholerae‑  chapter‑6.pdf).,Non-OADS,/arxiv_data1/oa_pdf/2f/be/NAJMS-4-657.PMC3530325.pdf
Available from: http://www.cdc.gov/cholera/pdf/ laboratory‑methods‑for‑the‑diagnosis‑of‑vibrio‑cholerae‑  chapter‑5.pdf).,Non-OADS,/arxiv_data1/oa_pdf/2f/be/NAJMS-4-657.PMC3530325.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/lds031.PMC3530408.pdf
Annu rev genet  2007; 41:1-11; pmiD:17474874; http://dx.doi.org/10.1146/annurev.genet.41.110306.130240.3.,Non-OADS,/arxiv_data1/oa_pdf/fc/ad/bact-2-137.PMC3530522.pdf
Annu r ev m icrobiol  1994; 48:193-222; pmiD:7826005; http://dx.doi.org/10.1146/annurev.mi.48.100194.001205.5.,OADS,/arxiv_data1/oa_pdf/fc/ad/bact-2-137.PMC3530522.pdf
m icrobiol m ol Biol r ev 2011; 75:610- 35; pmiD:22126996; http://dx.doi.org/10.1128/mmBr.00011-11.6.,Non-OADS,/arxiv_data1/oa_pdf/fc/ad/bact-2-137.PMC3530522.pdf
cold Spring harb Symp Quant Biol 1981; 45:439- 45; pmiD:6271488; http://dx.doi.org/10.1101/SQB.1981.045.01.058.7.,OADS,/arxiv_data1/oa_pdf/fc/ad/bact-2-137.PMC3530522.pdf
nat r ev g enet 2003; 4:471-7; pmiD:12776216;  http://dx.doi.org/10.1038/nrg1089.8.,OADS,/arxiv_data1/oa_pdf/fc/ad/bact-2-137.PMC3530522.pdf
Mol Biol Cell 2008; 19:95-104;  PMID:17959827; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Bacteriol  2007; 189:7223-33; PMID:17693515; http://dx.doi.org/10.1128/JB.00824-07.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Lancet 1983; 2:573; PMID:6136724; http://dx.doi.org/10.1016/S0140- 6736(83)90601-3.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Infect Immun  2002; 70:1896-908; PMID:11895953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Infect Immun 2000; 68:4856-64; PMID:10948097; http://dx.doi.org/10.1128/ IAI.68.9.4856-4864.2000.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Appl Environ Microbiol 2010; 76:2360-5; PMID:20139312; http://dx.doi.org/10.1128/ AEM.02923-09.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Bacteriol  2003; 185:3596-605; PMID:12775697; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Nature  2001; 409:529-33; PMID:11206551; http://dx.doi.org/10.1038/35054089.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
T rends Microbiol 2001; 9:481-5; PMID:11597449; http://dx.doi.org/10.1016/S0966- 842X(01)02173-4.13.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Cell 1983; 35:253-63;  PMID:6627396; http://dx.doi.org/10.1016/0092- 8674(83)90228-3.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Exp Med 1988; 168:1487- 92; PMID:2902187; http://dx.doi.org/10.1084/ jem.168.4.1487.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Science 2000; 288:333-5;  PMID:10764646; http://dx.doi.org/10.1126/sci-ence.288.5464.333.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Nature 1981;  292:413-7; PMID:7019725; http://dx.doi.org/10.1038/292413a0.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Cell Biol 1998; 143:601- 12; PMID:9813083; http://dx.doi.org/10.1083/ jcb.143.3.601.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Microb  Pathog 1989; 6:381-90; PMID:2671581; http://dx.doi.org/10.1016/0882-4010(89)90080-6.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Science  1984; 226:694-6; PMID:6387911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Curr Opin Microbiol  2005; 8:459-65; PMID:15979389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Infect Immun 2002; 70:3985- 93; PMID:12117903; http://dx.doi.org/10.1128/ IAI.70.8.3985-3993.2002.References 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
T rends Microbiol  2002; 10:521-9; PMID:12419617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Adv Virus Res 2012; 82:91-118;  PMID:22420852; http://dx.doi.org/10.1016/B978-0- 12-394621-8.00014-5.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Proc Natl Acad Sci U S A 1990; 87:5968-72; PMID:2116013; http://dx.doi.org/10.1073/ pnas.87.15.5968.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Nature 1959;  183:1533-4; PMID:13666809; http://dx.doi.org/10.1038/1831533a0.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Science  1996; 272:1910-4; PMID:8658163; http://dx.doi.org/10.1126/science.272.5270.1910.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Bacteriol 2000; 182:5530- 8; PMID:10986258; http://dx.doi.org/10.1128/ JB.182.19.5530-5538.2000.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Mol Cell 2005; 19:559-66;  PMID:16109379; http://dx.doi.org/10.1016/j.mol- cel.2005.07.002.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
"Proc Natl Acad Sci U S A 2010; 107:4377-82; PMID:20133778; http://dx.doi.org/10.1073/ pnas.0910212107.Acknowledgments We thank members of our group for their enthusiasm and hard  work: Laura Powell, Sai S. Kalburge, Luke Raber, Brandy Haines Menges, Jean Bernard Lubin, Serge Ongagna-Yhombi and W. Brian Whitaker.",Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
J Bacteriol  2004; 186:5883-98; PMID:15317794; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Proc Natl Acad Sci U S A  2002; 99:8956-61; PMID:12072558; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Infect Genet Evol 2009; 9:996-1005; PMID:19393770; http://dx.doi.org/10.1016/j.meegid.2009.04.011.,OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Mol Microbiol  1995; 15:749-59; PMID:7783645; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
Science  1995; 269:400-3; PMID:7618105; http://dx.doi.org/10.1126/science.7618105.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
EMBO J 1997; 16:5376- 85; PMID:9311997; http://dx.doi.org/10.1093/emboj/16.17.5376.,Non-OADS,/arxiv_data1/oa_pdf/6d/ec/bact-2-139.PMC3530523.pdf
